Cover
Cover - shares | 3 Months Ended | |
Dec. 31, 2023 | Jan. 30, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2023 | |
Document Transition Report | false | |
Securities Act File Number | 1-33901 | |
Entity Registrant Name | Oaktree Specialty Lending Corporation | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 26-1219283 | |
Entity Address, Address Line One | 333 South Grand Avenue | |
Entity Address, Address Line Two | 28th Floor | |
Entity Address, City or Town | Los Angeles | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 90071 | |
City Area Code | 213 | |
Local Phone Number | 830-6300 | |
Title of 12(b) Security | Common Stock, par value $0.01 per share | |
Trading Symbol | OCSL | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 78,965,350 | |
Entity Central Index Key | 0001414932 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --09-30 |
Consolidated Statements of Asse
Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 | ||
ASSETS | ||||
Investments at fair value | $ 3,018,552 | $ 2,892,420 | ||
Cash and cash equivalents | 112,369 | 136,450 | ||
Restricted cash | 19,328 | 9,089 | ||
Interest, dividends and fees receivable | 43,038 | 44,570 | ||
Due from portfolio companies | 7,912 | 6,317 | ||
Receivables from unsettled transactions | 23,931 | 55,441 | ||
Due from broker | 26,520 | 54,260 | ||
Deferred financing costs | 11,827 | 12,541 | ||
Deferred offering costs | 131 | 160 | ||
Derivative assets at fair value | 0 | 4,910 | ||
Other assets | 2,587 | 1,681 | ||
Total assets | 3,266,195 | 3,217,839 | ||
Liabilities: | ||||
Accounts payable, accrued expenses and other liabilities | 3,273 | 2,950 | ||
Base management fee and incentive fee payable | 19,004 | 19,547 | ||
Due to affiliate | 3,815 | 4,310 | ||
Interest payable | 18,980 | 16,007 | ||
Director fees payable | 160 | 0 | ||
Payables from unsettled transactions | 57,279 | 11,006 | ||
Derivative liability at fair value | 29,316 | 47,519 | ||
Deferred tax liability | 0 | 5 | ||
Credit facilities payable | 710,000 | 710,000 | ||
Unsecured notes payable (net of $6,534 and $7,076 of unamortized financing costs as of December 31, 2023 and September 30, 2023, respectively) | 912,717 | 890,731 | ||
Total liabilities | 1,754,544 | 1,702,075 | ||
Commitments and contingencies (Note 13) | ||||
Net assets: | ||||
Common stock, $0.01 par value per share, 250,000 shares authorized; 78,965 and 77,225 shares issued and outstanding as of December 31, 2023 and September 30, 2023, respectively | 790 | 772 | ||
Additional paid-in-capital | 2,200,561 | 2,166,330 | ||
Accumulated overdistributed earnings | (689,700) | (651,338) | ||
Total net assets (equivalent to $19.14 and $19.63 per common share as of December 31, 2023 and September 30, 2023, respectively) (Note 11) | 1,511,651 | 1,515,764 | ||
Total liabilities and net assets | 3,266,195 | 3,217,839 | ||
Control investments | ||||
ASSETS | ||||
Investments at fair value | 316,309 | [1],[2] | 297,091 | [3],[4] |
Affiliate investments | ||||
ASSETS | ||||
Investments at fair value | 24,442 | 23,349 | ||
Non-control/Non-affiliate investments | ||||
ASSETS | ||||
Investments at fair value | $ 2,677,801 | [5] | $ 2,571,980 | [4] |
[1] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. |
Consolidated Statements of As_2
Consolidated Statements of Assets and Liabilities (Parenthetical) shares in Thousands, $ in Thousands | 3 Months Ended | |||
Dec. 31, 2023 USD ($) $ / shares shares | Sep. 30, 2023 USD ($) $ / shares shares | |||
Investment, cost | $ 3,187,750 | $ 3,044,119 | ||
Unamortized financing costs | $ 6,534 | $ 7,076 | ||
Common stock, par value, (in dollars per share) | $ / shares | $ 0.01 | $ 0.01 | ||
Common stock, shares authorized (in shares) | shares | 250,000 | 250,000 | ||
Common stock, shares issued (in shares) | shares | 78,965 | 77,225 | ||
Common stock, shares outstanding (in shares) | shares | 78,965 | [1] | 77,225 | |
Net asset value per common share (in dollars per share) | $ / shares | $ 19.14 | [1] | $ 19.63 | |
Stock split, conversion ratio | 0.3333 | |||
Control investments | ||||
Investment, cost | $ 363,124 | [2],[3] | $ 345,245 | [4],[5] |
Affiliate investments | ||||
Investment, cost | 26,916 | 24,898 | ||
Non-control/Non-affiliate investments | ||||
Investment, cost | $ 2,797,710 | [6] | $ 2,673,976 | [5] |
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.[2] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. |
Consolidated Statements of Oper
Consolidated Statements of Operations shares in Thousands, $ in Thousands | 3 Months Ended | ||
Dec. 31, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | ||
Interest income: | |||
Interest on cash and cash equivalents | $ 2,364 | $ 472 | |
Total interest income | 91,414 | 69,978 | |
Interest income, PIK | 3,849 | 6,130 | |
Fee income | 1,307 | 2,021 | |
Dividend income | 1,415 | 1,050 | |
Total investment income | 97,985 | 79,179 | |
Expenses: | |||
Base management fee | 11,477 | 9,917 | |
Part I incentive fee | 9,028 | 7,703 | |
Professional fees | 1,504 | 1,500 | |
Directors fees | 160 | 160 | |
Interest expense | 32,170 | 20,719 | |
Administrator expense | 366 | 298 | |
General and administrative expenses | 591 | 746 | |
Total expenses | 55,296 | 41,043 | |
Fees waived | (1,500) | (750) | |
Net expenses | 53,796 | 40,293 | |
Net investment income before taxes | 44,189 | 38,886 | |
Excise tax | 0 | (78) | |
Net investment income | 44,189 | 38,808 | |
Unrealized appreciation (depreciation): | |||
Foreign currency forward contracts | (7,824) | (11,001) | |
Net unrealized appreciation (depreciation) | (25,025) | (22,982) | |
Realized gains (losses): | |||
Foreign currency forward contracts | 4,101 | 4,448 | |
Net realized gains (losses) | (8,453) | (3,203) | |
(Provision) benefit for taxes on realized and unrealized gains (losses) | (176) | 549 | |
Net realized and unrealized gains (losses), net of taxes | (33,654) | (25,636) | |
Net increase (decrease) in net assets resulting from operations | $ 10,535 | $ 13,172 | |
Net investment income per common share - basic and diluted (in dollars per share) | $ / shares | [1] | $ 0.57 | $ 0.63 |
Earnings (loss) per common share - basic (dollars per share) | $ / shares | [1] | 0.14 | 0.22 |
Earnings (loss) per common share - diluted (dollars per share) | $ / shares | [1] | $ 0.14 | $ 0.22 |
Weighted average common shares outstanding - basic (shares) | shares | [1] | 77,840 | 61,142 |
Weighted average common shares outstanding - diluted (shares) | shares | [1] | 77,840 | 61,142 |
Stock split, conversion ratio | 0.3333 | ||
Control investments | |||
Interest income: | |||
Interest income | $ 6,005 | $ 4,567 | |
Interest income, PIK | 544 | 0 | |
Fee income | 13 | 13 | |
Dividend income | 1,400 | 1,050 | |
Unrealized appreciation (depreciation): | |||
Net unrealized appreciation (depreciation) | 1,339 | (3,309) | |
Realized gains (losses): | |||
Realized gain (loss) | 786 | 0 | |
Affiliate investments | |||
Interest income: | |||
Interest income | 324 | 641 | |
Fee income | 5 | 5 | |
Unrealized appreciation (depreciation): | |||
Net unrealized appreciation (depreciation) | (925) | 3 | |
Non-control/Non-affiliate investments | |||
Interest income: | |||
Interest income | 82,721 | 64,298 | |
Interest income, PIK | 3,305 | 6,130 | |
Fee income | 1,289 | 2,003 | |
Dividend income | 15 | 0 | |
Unrealized appreciation (depreciation): | |||
Net unrealized appreciation (depreciation) | (17,615) | (8,675) | |
Realized gains (losses): | |||
Realized gain (loss) | $ (13,340) | $ (7,651) | |
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Consolidated Statements of Chan
Consolidated Statements of Changes in Net Assets shares in Thousands, $ in Thousands | 3 Months Ended | ||
Dec. 31, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | ||
Operations: | |||
Net investment income | $ 44,189 | $ 38,808 | |
Net unrealized appreciation (depreciation) | (25,025) | (22,982) | |
Net realized gains (losses) | (8,453) | (3,203) | |
(Provision) benefit for taxes on realized and unrealized gains (losses) | (176) | 549 | |
Net increase (decrease) in net assets resulting from operations | 10,535 | 13,172 | |
Stockholder transactions: | |||
Net increase (decrease) in net assets from stockholder transactions | (48,897) | (58,679) | |
Capital share transactions: | |||
Issuance of common stock under dividend reinvestment plan | 1,936 | 1,933 | |
Issuance of common stock in connection with the "at the market" offering | 32,313 | 0 | |
Net increase (decrease) in net assets from capital share transactions | 34,249 | 1,933 | |
Total increase (decrease) in net assets | (4,113) | (43,574) | |
Net assets | $ 1,511,651 | $ 1,201,989 | |
Net asset value per common share (in dollars per share) | $ / shares | [1] | $ 19.14 | $ 19.63 |
Common shares outstanding at end of period (in shares) | shares | [1] | 78,965 | 61,220 |
Stock split, conversion ratio | 0.3333 | ||
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating activities: | ||
Net increase (decrease) in net assets resulting from operations | $ 10,535 | $ 13,172 |
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | ||
Net unrealized (appreciation) depreciation | 25,025 | 22,982 |
Net realized (gains) losses | 8,453 | 3,203 |
PIK interest income | (3,849) | (6,130) |
Accretion of original issue discount on investments | (5,342) | (5,127) |
Accretion of original issue discount on unsecured notes payable | 326 | 170 |
Amortization of deferred financing costs | 1,248 | 828 |
Deferred taxes | (5) | (35) |
Purchases of investments | (359,866) | (261,404) |
Proceeds from the sales and repayments of investments | 217,624 | 108,831 |
Changes in operating assets and liabilities: | ||
(Increase) decrease in interest, dividends and fees receivable | 1,533 | (1,842) |
(Increase) decrease in due from portfolio companies | (1,595) | 16,314 |
(Increase) decrease in receivables from unsettled transactions | 31,510 | (3,966) |
(Increase) decrease in due from broker | 27,740 | 5,770 |
(Increase) decrease in other assets | (905) | (2,546) |
Increase (decrease) in accounts payable, accrued expenses and other liabilities | 323 | (554) |
Increase (decrease) in base management fee and incentive fee payable | (542) | 931 |
Increase (decrease) in due to affiliate | (494) | 80 |
Increase (decrease) in interest payable | 2,973 | 5,432 |
Increase (decrease) in payables from unsettled transactions | 46,273 | (6,007) |
Increase (decrease) in director fees payable | 160 | 0 |
Net cash provided by (used in) operating activities | 1,125 | (109,898) |
Financing activities: | ||
Distributions paid in cash | (46,961) | (56,746) |
Borrowings under credit facilities | 20,000 | 202,000 |
Repayments of borrowings under credit facilities | (20,000) | (42,000) |
Shares issued under the "at the market" offering | 32,398 | 0 |
Deferred offering costs paid | (85) | 0 |
Net cash provided by (used in) financing activities | (14,648) | 103,254 |
Effect of exchange rate changes on foreign currency | (319) | (475) |
Net increase (decrease) in cash and cash equivalents and restricted cash | (13,842) | (7,119) |
Cash and cash equivalents and restricted cash, beginning of period | 145,539 | |
Cash and cash equivalents and restricted cash, end of period | 131,697 | 19,245 |
Supplemental information: | ||
Cash paid for interest | 27,623 | 14,289 |
Non-cash financing activities: | ||
Issuance of shares of common stock under dividend reinvestment plan | 1,936 | $ 1,933 |
Reconciliation to the Consolidated Statements of Assets and Liabilities | ||
Cash and cash equivalents | 112,369 | |
Restricted cash | 19,328 | |
Total cash and cash equivalents and restricted cash | $ 131,697 |
Consolidated Schedule of Invest
Consolidated Schedule of Investments € in Thousands, £ in Thousands, $ in Thousands | Dec. 31, 2023 USD ($) shares | Dec. 31, 2023 EUR (€) shares | Dec. 31, 2023 GBP (£) shares | Sep. 30, 2023 USD ($) shares | Sep. 30, 2023 EUR (€) shares | Sep. 30, 2023 GBP (£) shares | Dec. 31, 2022 USD ($) shares | Sep. 30, 2022 USD ($) | |||||||
Investment, cost | $ 3,187,750 | $ 3,044,119 | |||||||||||||
Investments at fair value | $ 3,018,552 | $ 2,892,420 | |||||||||||||
Investment owned, percent of net assets | 199.69% | 199.69% | 199.69% | 190.82% | 190.82% | 190.82% | |||||||||
Money market funds, at carrying value | $ 131,697 | $ 145,539 | |||||||||||||
Money market funds, percent of net assets | 8.70% | 8.70% | 8.70% | 9.60% | 9.60% | 9.60% | |||||||||
Investment owned and money market funds, percent of net assets | 208.40% | 208.40% | 208.40% | ||||||||||||
Total investment owned, at cost and money market funds, at carrying value | $ 3,319,447 | [1],[2],[3],[4] | $ 3,189,658 | [5],[6],[7],[8] | |||||||||||
Total investment owned, at fair value and money market funds, at carrying value | 3,150,249 | [1],[2],[3],[4] | 3,037,959 | [5],[6],[7],[8] | |||||||||||
Control investments | |||||||||||||||
Investment, principal | 211,365 | $ 186,002 | |||||||||||||
Investment, cost | 363,124 | [9],[10] | 345,245 | [11],[12] | |||||||||||
Investments at fair value | $ 316,309 | [9],[10] | $ 297,091 | [11],[12] | $ 232,462 | $ 214,165 | |||||||||
Investment owned, percent of net assets | 20.90% | 20.90% | 20.90% | 20.90% | [9],[10] | 20.90% | [9],[10] | 20.90% | [9],[10] | 19.30% | |||||
Affiliate Investments | |||||||||||||||
Investment, principal | $ 25,936 | $ 21,464 | |||||||||||||
Investment, cost | 26,916 | [13] | $ 24,898 | [14] | |||||||||||
Investments at fair value | $ 24,442 | [13] | $ 23,349 | [14] | $ 23,173 | 26,196 | |||||||||
Investment owned, percent of net assets | 1.60% | 1.60% | 1.60% | 1.60% | [13] | 1.60% | [13] | 1.60% | [13] | 1.90% | |||||
Non-control/Non-affiliate investments | |||||||||||||||
Investment, cost | $ 2,797,710 | [15] | $ 2,673,976 | [12] | |||||||||||
Investments at fair value | $ 2,677,801 | [15] | $ 2,571,980 | [12] | |||||||||||
Investment owned, percent of net assets | [15] | 177.10% | 177.10% | 177.10% | |||||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 12.50% | [16],[17],[18],[19],[20] | 12.50% | [16],[17],[18],[19],[20] | 12.50% | [16],[17],[18],[19],[20] | 12.50% | [21],[22],[23],[24],[25] | 12.50% | [21],[22],[23],[24],[25] | 12.50% | [21],[22],[23],[24],[25] | |||
Investment, principal | $ 1,269 | [16],[17],[18],[26] | $ 1,269 | [21],[22],[24],[27] | |||||||||||
Investment, cost | 1,251 | [16],[17],[18] | 1,240 | [21],[22],[24] | |||||||||||
Investments at fair value | $ 1,228 | [16],[17],[18] | $ 1,214 | [21],[22],[24] | |||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | |||||||||||||||
Investment, interest rate | 11% | [16],[17],[19],[20] | 11% | [16],[17],[19],[20] | 11% | [16],[17],[19],[20] | 11% | [21],[23],[24],[25] | 11% | [21],[23],[24],[25] | 11% | [21],[23],[24],[25] | |||
Investment, principal | $ 18,869 | [16],[17],[26] | $ 18,869 | [21],[24],[27] | |||||||||||
Investment, cost | 18,691 | [16],[17] | 18,687 | [21],[24] | |||||||||||
Investments at fair value | $ 18,443 | [16],[17] | $ 18,443 | [21],[24] | |||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 12% | [16],[17],[18],[19],[20] | 12% | [16],[17],[18],[19],[20] | 12% | [16],[17],[18],[19],[20] | 12% | [21],[22],[23],[24],[25] | 12% | [21],[22],[23],[24],[25] | 12% | [21],[22],[23],[24],[25] | |||
Investment, principal | $ 4,274 | [16],[17],[18],[26] | $ 4,070 | [21],[22],[24],[27] | |||||||||||
Investment, cost | 4,256 | [16],[17],[18] | 4,038 | [21],[22],[24] | |||||||||||
Investments at fair value | $ 4,210 | [16],[17],[18] | $ 4,022 | [21],[22],[24] | |||||||||||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 14.25% | [16],[19],[20],[28],[29] | 14.25% | [16],[19],[20],[28],[29] | 14.25% | [16],[19],[20],[28],[29] | 14.25% | [23],[24],[25],[30],[31] | 14.25% | [23],[24],[25],[30],[31] | 14.25% | [23],[24],[25],[30],[31] | |||
Investment, principal | $ 21,434 | [16],[26],[28],[29] | $ 21,434 | [24],[27],[30],[31] | |||||||||||
Investment, cost | 21,604 | [16],[28],[29] | 21,612 | [24],[30],[31] | |||||||||||
Investments at fair value | $ 21,273 | [16],[28],[29] | $ 21,220 | [24],[30],[31] | |||||||||||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | |||||||||||||||
Investment, interest rate, paid in kind | 22.50% | [16],[28] | 22.50% | [16],[28] | 22.50% | [16],[28] | 20% | [24],[30] | 20% | [24],[30] | 20% | [24],[30] | |||
Investment, principal | $ 6,329 | [16],[26],[28] | $ 6,021 | [24],[27],[30] | |||||||||||
Investment, cost | 6,295 | [16],[28] | 6,013 | [24],[30] | |||||||||||
Investments at fair value | $ 6,219 | [16],[28] | $ 5,900 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 12.11% | [16],[19],[20] | 12.11% | [16],[19],[20] | 12.11% | [16],[19],[20] | 11.90% | [23],[24],[25] | 11.90% | [23],[24],[25] | 11.90% | [23],[24],[25] | |||
Investment, principal | $ 3,373 | [16],[20],[26] | $ 3,446 | [23],[24],[27] | |||||||||||
Investment, cost | 3,343 | [16],[20] | 3,411 | [23],[24] | |||||||||||
Investments at fair value | $ 3,295 | [16],[20] | $ 3,383 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 12.14% | [16],[19],[20] | 12.14% | [16],[19],[20] | 12.14% | [16],[19],[20] | 12.15% | [23],[24],[25] | 12.15% | [23],[24],[25] | 12.15% | [23],[24],[25] | |||
Investment, principal | $ 944 | [16],[20],[26] | $ 17,901 | [23],[24],[27] | |||||||||||
Investment, cost | 931 | [16],[20] | 17,743 | [23],[24] | |||||||||||
Investments at fair value | $ 922 | [16],[20] | $ 17,575 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 12.11% | [16],[19],[20] | 12.11% | [16],[19],[20] | 12.11% | [16],[19],[20] | 12.13% | [23],[24],[25] | 12.13% | [23],[24],[25] | 12.13% | [23],[24],[25] | |||
Investment, principal | $ 17,532 | [16],[20],[26] | $ 963 | [23],[24],[27] | |||||||||||
Investment, cost | 17,394 | [16],[20] | 948 | [23],[24] | |||||||||||
Investments at fair value | $ 17,130 | [16],[20] | $ 945 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[20],[28] | 7.50% | [16],[20],[28] | 7.50% | [16],[20],[28] | 7.50% | [23],[24],[30] | 7.50% | [23],[24],[30] | 7.50% | [23],[24],[30] | |||
Investment, interest rate | [23],[24],[25],[30] | 13.04% | 13.04% | 13.04% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26],[28] | $ 6,589 | [23],[24],[27],[30] | |||||||||||
Investment, cost | (38) | [16],[17],[20],[28] | 6,305 | [23],[24],[30] | |||||||||||
Investments at fair value | $ (38) | [16],[17],[20],[28] | $ 6,276 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[20],[28] | 7.50% | [16],[20],[28] | 7.50% | [16],[20],[28] | 7.50% | [21],[23],[24],[30] | 7.50% | [21],[23],[24],[30] | 7.50% | [21],[23],[24],[30] | |||
Investment, interest rate | [19],[20] | 13% | 13% | 13% | |||||||||||
Investment, principal | $ 6,589 | [16],[20],[26],[28] | $ 0 | [21],[23],[24],[27],[30] | |||||||||||
Investment, cost | 6,317 | [16],[20],[28] | (38) | [21],[23],[24],[30] | |||||||||||
Investments at fair value | $ 6,276 | [16],[20],[28] | $ (38) | [21],[23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 28,948 | [16],[28] | 28,948 | [16],[28] | 28,948 | [16],[28] | 28,948 | [24],[30] | 28,948 | [24],[30] | 28,948 | [24],[30] | |||
Investment, cost | $ 174 | [16],[28] | $ 174 | [24],[30] | |||||||||||
Investments at fair value | $ 13 | [16],[28] | $ 6 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[30] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [23],[25],[30] | 8.86% | 8.86% | 8.86% | |||||||||||
Investment, principal | € | [23],[27],[30] | € 5,500 | |||||||||||||
Investment, cost | [23],[30] | $ 6,024 | |||||||||||||
Investments at fair value | [23],[30] | $ 5,825 | |||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 17,870 | [16] | 17,870 | [16] | 17,870 | [16] | 17,870 | [24] | 17,870 | [24] | 17,870 | [24] | |||
Investment, cost | $ 1,733 | [16] | $ 1,733 | [24] | |||||||||||
Investments at fair value | $ 2,494 | [16] | $ 2,826 | [24] | |||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [16],[20] | 7.75% | [16],[20] | 7.75% | [16],[20] | 7.75% | [23],[24] | 7.75% | [23],[24] | 7.75% | [23],[24] | |||
Investment, interest rate | 13.21% | [16],[19],[20] | 13.21% | [16],[19],[20] | 13.21% | [16],[19],[20] | 13.17% | [23],[24],[25] | 13.17% | [23],[24],[25] | 13.17% | [23],[24],[25] | |||
Investment, principal | $ 16,032 | [16],[20],[26] | $ 17,873 | [23],[24],[27] | |||||||||||
Investment, cost | 15,844 | [16],[20] | 17,655 | [23],[24] | |||||||||||
Investments at fair value | $ 15,743 | [16],[20] | $ 17,687 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20],[28] | 6% | [16],[17],[20],[28] | 6% | [16],[17],[20],[28] | 6% | [21],[23],[24],[30] | 6% | [21],[23],[24],[30] | 6% | [21],[23],[24],[30] | |||
Investment, principal | $ 0 | [16],[17],[20],[26],[28] | $ 0 | [21],[23],[24],[27],[30] | |||||||||||
Investment, cost | (12) | [16],[17],[20],[28] | (13) | [21],[23],[24],[30] | |||||||||||
Investments at fair value | $ (24) | [16],[17],[20],[28] | $ (23) | [21],[23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20],[28] | 6% | [16],[20],[28] | 6% | [16],[20],[28] | 6% | [23],[24],[30] | 6% | [23],[24],[30] | 6% | [23],[24],[30] | |||
Investment, interest rate | 11.64% | [19],[20] | 11.64% | [19],[20] | 11.64% | [19],[20] | 11.63% | [23],[24],[25],[30] | 11.63% | [23],[24],[25],[30] | 11.63% | [23],[24],[25],[30] | |||
Investment, principal | $ 3,268 | [16],[20],[26],[28] | $ 3,276 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 3,259 | [16],[20],[28] | 3,267 | [23],[24],[30] | |||||||||||
Investments at fair value | 3,072 | [16],[20],[28] | 3,084 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment, principal | 12,583 | [16],[26],[28],[29] | 12,222 | [24],[27],[30],[31] | |||||||||||
Investment, cost | 12,618 | [16],[28],[29] | 12,260 | [24],[30],[31] | |||||||||||
Investments at fair value | $ 12,268 | [16],[28],[29] | $ 11,795 | [24],[30],[31] | |||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | |||
Investment, interest rate | 11.52% | [16],[17],[19],[20] | 11.52% | [16],[17],[19],[20] | 11.52% | [16],[17],[19],[20] | 11.55% | [21],[23],[24],[25] | 11.55% | [21],[23],[24],[25] | 11.55% | [21],[23],[24],[25] | |||
Investment, principal | $ 2,033 | [16],[17],[20],[26] | $ 2,033 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 2,015 | [16],[17],[20] | 2,013 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 2,027 | [16],[17],[20] | $ 2,027 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | [23],[24],[25] | 11.55% | 11.55% | 11.55% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 20,234 | [23],[24],[27] | |||||||||||
Investment, cost | (2) | [16],[17],[20] | 20,150 | [23],[24] | |||||||||||
Investments at fair value | $ (8) | [16],[17],[20] | $ 20,194 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | |||
Investment, interest rate | 11.52% | [16],[19],[20] | 11.52% | [16],[19],[20] | 11.52% | [16],[19],[20] | [21],[23],[24],[25] | [21],[23],[24],[25] | [21],[23],[24],[25] | ||||||
Investment, principal | $ 20,182 | [16],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 20,107 | [16],[20] | (2) | [21],[23],[24] | |||||||||||
Investments at fair value | $ 20,141 | [16],[20] | $ (8) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | |||
Investment, interest rate | 12.72% | [16],[17],[19],[20] | 12.72% | [16],[17],[19],[20] | 12.72% | [16],[17],[19],[20] | 12.72% | [21],[23],[24],[25] | 12.72% | [21],[23],[24],[25] | 12.72% | [21],[23],[24],[25] | |||
Investment, principal | $ 1,333 | [16],[17],[20],[26] | $ 1,333 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 1,324 | [16],[17],[20] | 1,322 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 1,333 | [16],[17],[20] | $ 1,324 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate | 12.74% | [16],[19],[20] | 12.74% | [16],[19],[20] | 12.74% | [16],[19],[20] | 12.34% | [23],[24],[25] | 12.34% | [23],[24],[25] | 12.34% | [23],[24],[25] | |||
Investment, principal | $ 6,400 | [16],[20],[26] | $ 6,400 | [23],[24],[27] | |||||||||||
Investment, cost | 6,343 | [16],[20] | 6,335 | [23],[24] | |||||||||||
Investments at fair value | $ 6,406 | [16],[20] | $ 6,380 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate | 12.74% | [16],[17],[19],[20] | 12.74% | [16],[17],[19],[20] | 12.74% | [16],[17],[19],[20] | 12.34% | [23],[24],[25] | 12.34% | [23],[24],[25] | 12.34% | [23],[24],[25] | |||
Investment, principal | $ 25,332 | [16],[17],[20],[26] | $ 25,332 | [23],[24],[27] | |||||||||||
Investment, cost | 25,293 | [16],[17],[20] | 25,288 | [23],[24] | |||||||||||
Investments at fair value | $ 25,357 | [16],[17],[20] | $ 25,253 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 5,715 | [16] | 5,715 | [16] | 5,715 | [16] | 5,715 | [24] | 5,715 | [24] | 5,715 | [24] | |||
Investment, cost | $ 90 | [16] | $ 90 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [16],[20],[32] | 8.50% | [16],[20],[32] | 8.50% | [16],[20],[32] | 8.50% | [23],[24],[33] | 8.50% | [23],[24],[33] | 8.50% | [23],[24],[33] | |||
Investment, principal | $ 23,562 | [16],[20],[26],[32] | $ 23,562 | [23],[24],[27],[33] | |||||||||||
Investment, cost | 22,795 | [16],[20],[32] | 22,795 | [23],[24],[33] | |||||||||||
Investments at fair value | $ 9,797 | [16],[20],[32] | $ 9,797 | [23],[24],[33] | |||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 5.50% | [19],[20],[28] | 5.50% | [19],[20],[28] | 5.50% | [19],[20],[28] | 5.50% | [23],[25],[30] | 5.50% | [23],[25],[30] | 5.50% | [23],[25],[30] | |||
Investment, principal | $ 4,050 | [26],[28] | $ 4,050 | [27],[30] | |||||||||||
Investment, cost | 3,592 | [28] | 3,577 | [30] | |||||||||||
Investments at fair value | $ 3,181 | [28] | $ 2,918 | [30] | |||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 11.50% | [16],[20] | 11.50% | [16],[20] | 11.50% | [16],[20] | 11.50% | [23],[24] | 11.50% | [23],[24] | 11.50% | [23],[24] | |||
Investment, interest rate | 5% | [16],[19],[20] | 5% | [16],[19],[20] | 5% | [16],[19],[20] | 5% | [23],[24],[25] | 5% | [23],[24],[25] | 5% | [23],[24],[25] | |||
Investment, interest rate, paid in kind | 11.95% | [16],[20] | 11.95% | [16],[20] | 11.95% | [16],[20] | 11.99% | [23],[24] | 11.99% | [23],[24] | 11.99% | [23],[24] | |||
Investment, principal | $ 9,331 | [16],[20],[26] | $ 9,057 | [23],[24],[27] | |||||||||||
Investment, cost | 8,748 | [16],[20] | 8,434 | [23],[24] | |||||||||||
Investments at fair value | $ 8,585 | [16],[20] | $ 8,332 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 598,283 | 598,283 | 598,283 | 598,283 | [24] | 598,283 | [24] | 598,283 | [24] | ||||||
Investment, cost | $ 642 | [16],[20] | $ 642 | [24] | |||||||||||
Investments at fair value | $ 1,562 | [16],[20] | $ 1,915 | [24] | |||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [23],[24] | 7.50% | [23],[24] | 7.50% | [23],[24] | |||
Investment, interest rate | 13% | [16],[19],[20] | 13% | [16],[19],[20] | 13% | [16],[19],[20] | 13.04% | [23],[24],[25] | 13.04% | [23],[24],[25] | 13.04% | [23],[24],[25] | |||
Investment, principal | $ 16,825 | [16],[20],[26] | $ 17,053 | [23],[24],[27] | |||||||||||
Investment, cost | 16,766 | [16],[20] | 16,982 | [23],[24] | |||||||||||
Investments at fair value | $ 15,732 | [16],[20] | $ 15,929 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 382,275 | [28] | 382,275 | [28] | 382,275 | [28] | 471,253 | [30] | 471,253 | [30] | 471,253 | [30] | |||
Investment, cost | $ 689 | [28] | $ 849 | [30] | |||||||||||
Investments at fair value | $ 4,389 | [28] | $ 4,298 | [30] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 141,640 | [16],[28],[34] | 141,640 | [16],[28],[34] | 141,640 | [16],[28],[34] | 141,640 | [24],[30],[35] | 141,640 | [24],[30],[35] | 141,640 | [24],[30],[35] | |||
Investment, cost | $ 566 | [16],[28],[34] | $ 566 | [24],[30],[35] | |||||||||||
Investments at fair value | $ 446 | [16],[28],[34] | $ 368 | [24],[30],[35] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [24],[30] | 3.50% | [24],[30] | 3.50% | [24],[30] | |||
Investment, principal | $ 28,964 | [16],[26],[28] | $ 28,464 | [24],[27],[30] | |||||||||||
Investment, cost | 28,838 | [16],[28] | 28,329 | [24],[30] | |||||||||||
Investments at fair value | $ 28,167 | [16],[28] | $ 27,687 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [24],[30] | 3.50% | [24],[30] | 3.50% | [24],[30] | |||
Investment, principal | $ 28,178 | [16],[26],[28] | $ 2,121 | [24],[27],[30] | |||||||||||
Investment, cost | 28,076 | [16],[28] | 1,945 | [24],[30] | |||||||||||
Investments at fair value | $ 27,403 | [16],[28] | $ 2,063 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3 | |||||||||||||||
Investment, interest rate | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [24],[30] | 3.50% | [24],[30] | 3.50% | [24],[30] | |||
Investment, principal | $ 2,159 | [16],[26],[28] | $ 27,692 | [24],[27],[30] | |||||||||||
Investment, cost | 1,982 | [16],[28] | 27,582 | [24],[30] | |||||||||||
Investments at fair value | $ 2,099 | [16],[28] | $ 26,936 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4 | |||||||||||||||
Investment, interest rate | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [16],[19],[20],[28] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | 8.50% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [16],[28] | 3.50% | [24],[30] | 3.50% | [24],[30] | 3.50% | [24],[30] | |||
Investment, principal | $ 2,100 | [16],[26],[28] | $ 2,064 | [24],[27],[30] | |||||||||||
Investment, cost | 1,927 | [16],[28] | 1,891 | [24],[30] | |||||||||||
Investments at fair value | $ 2,042 | [16],[28] | $ 2,007 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [23],[24],[25] | 14.14% | 14.14% | 14.14% | |||||||||||
Investment, principal | [23],[24],[27] | $ 17,048 | |||||||||||||
Investment, cost | [23],[24] | 16,440 | |||||||||||||
Investments at fair value | [23],[24] | $ 15,087 | |||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [16],[19],[20] | 14.25% | 14.25% | 14.25% | |||||||||||
Investment, principal | [16],[20],[26] | $ 17,048 | |||||||||||||
Investment, cost | [16],[20] | 16,469 | |||||||||||||
Investments at fair value | [16],[20] | $ 15,940 | |||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [20] | 6.25% | [20] | 6.25% | [20] | 6.25% | [23] | 6.25% | [23] | 6.25% | [23] | |||
Investment, interest rate | 11.91% | [19],[20] | 11.91% | [19],[20] | 11.91% | [19],[20] | 11.81% | [23],[25] | 11.81% | [23],[25] | 11.81% | [23],[25] | |||
Investment, principal | $ 14,907 | [20],[26] | $ 19,115 | [23],[27] | |||||||||||
Investment, cost | 14,189 | [20] | 18,278 | [23] | |||||||||||
Investments at fair value | $ 12,548 | [20] | $ 16,798 | [23] | |||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[30] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [23],[25],[30] | 13.54% | 13.54% | 13.54% | |||||||||||
Investment, principal | [23],[27],[30] | $ 12,500 | |||||||||||||
Investment, cost | [23],[30] | 12,188 | |||||||||||||
Investments at fair value | [23],[30] | $ 11,865 | |||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (112) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (113) | |||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [16],[19],[20] | 11.10% | 11.10% | 11.10% | |||||||||||
Investment, principal | [16],[20],[26] | $ 33,558 | |||||||||||||
Investment, cost | [16],[20] | 32,728 | |||||||||||||
Investments at fair value | [16],[20] | $ 32,719 | |||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (60) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (60) | |||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | [20] | 3.75% | [20] | 3.75% | [20] | 3.75% | [23] | 3.75% | [23] | 3.75% | [23] | |||
Investment, interest rate | 9.36% | [19],[20] | 9.36% | [19],[20] | 9.36% | [19],[20] | 9.40% | [23],[25] | 9.40% | [23],[25] | 9.40% | [23],[25] | |||
Investment, principal | $ 3,691 | [20],[26] | $ 3,700 | [23],[27] | |||||||||||
Investment, cost | 3,059 | [20] | 3,067 | [23] | |||||||||||
Investments at fair value | $ 2,257 | [20] | $ 2,669 | [23] | |||||||||||
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [16],[19],[20] | 10.86% | 10.86% | 10.86% | |||||||||||
Investment, principal | [16],[20],[26] | $ 47,810 | |||||||||||||
Investment, cost | [16],[20] | 47,095 | |||||||||||||
Investments at fair value | [16],[20] | $ 47,093 | |||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 7% | [23],[24],[30] | 7% | [23],[24],[30] | 7% | [23],[24],[30] | |||
Investment, interest rate | 12.71% | [16],[19],[20],[28] | 12.71% | [16],[19],[20],[28] | 12.71% | [16],[19],[20],[28] | 10.95% | [23],[24],[25],[30] | 10.95% | [23],[24],[25],[30] | 10.95% | [23],[24],[25],[30] | |||
Investment, principal | € | € 4,949 | [16],[20],[26],[28] | € 3,017 | [23],[24],[27],[30] | |||||||||||
Investment, cost | $ 6,253 | [16],[20],[28] | $ 3,331 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 6,372 | [16],[20],[28] | $ 3,226 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20],[28] | 6% | [16],[20],[28] | 6% | [16],[20],[28] | 5.75% | [23],[24],[30] | 5.75% | [23],[24],[30] | 5.75% | [23],[24],[30] | |||
Investment, interest rate | 11.82% | [16],[19],[20],[28] | 11.82% | [16],[19],[20],[28] | 11.82% | [16],[19],[20],[28] | 11.57% | [23],[24],[25],[30] | 11.57% | [23],[24],[25],[30] | 11.57% | [23],[24],[25],[30] | |||
Investment, principal | $ 10,519 | [16],[20],[26],[28] | $ 10,519 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 10,411 | [16],[20],[28] | 10,400 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 10,624 | [16],[20],[28] | $ 10,624 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20],[28] | 6% | [16],[20],[28] | 6% | [16],[20],[28] | 7% | [23],[24],[30] | 7% | [23],[24],[30] | 7% | [23],[24],[30] | |||
Investment, interest rate | 9.95% | [16],[19],[20],[28] | 9.95% | [16],[19],[20],[28] | 9.95% | [16],[19],[20],[28] | 12.46% | [23],[24],[25],[30] | 12.46% | [23],[24],[25],[30] | 12.46% | [23],[24],[25],[30] | |||
Investment, principal | £ | £ 3,649 | [16],[20],[26],[28] | £ 4,949 | [23],[24],[27],[30] | |||||||||||
Investment, cost | $ 4,094 | [16],[20],[28] | $ 6,318 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 4,083 | [16],[20],[28] | $ 6,101 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 7% | [23],[24],[30] | 7% | [23],[24],[30] | 7% | [23],[24],[30] | |||
Investment, interest rate | 11.20% | [16],[19],[20],[28] | 11.20% | [16],[19],[20],[28] | 11.20% | [16],[19],[20],[28] | 12.46% | [23],[24],[25],[30] | 12.46% | [23],[24],[25],[30] | 12.46% | [23],[24],[25],[30] | |||
Investment, principal | £ | £ 3,017 | [16],[20],[26],[28] | £ 23,675 | [23],[24],[27],[30] | |||||||||||
Investment, cost | $ 3,319 | [16],[20],[28] | $ 28,713 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 3,366 | [16],[20],[28] | $ 29,185 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 5.75% | [23],[24],[30] | 5.75% | [23],[24],[30] | 5.75% | [23],[24],[30] | |||
Investment, interest rate | 12.71% | [16],[19],[20],[28] | 12.71% | [16],[19],[20],[28] | 12.71% | [16],[19],[20],[28] | 9.70% | [23],[24],[25],[30] | 9.70% | [23],[24],[25],[30] | 9.70% | [23],[24],[25],[30] | |||
Investment, principal | £ | £ 23,675 | [16],[20],[26],[28] | £ 3,649 | [23],[24],[27],[30] | |||||||||||
Investment, cost | $ 28,395 | [16],[20],[28] | $ 4,094 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 30,482 | [16],[20],[28] | $ 3,914 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 12,463,242 | [16] | 12,463,242 | [16] | 12,463,242 | [16] | 1,783,332 | [24] | 1,783,332 | [24] | 1,783,332 | [24] | 1,609,201 | ||
Investment, cost | $ 1,963 | [16] | $ 804 | [24] | |||||||||||
Investments at fair value | $ 997 | [16] | $ 89 | [24] | $ 354 | 370 | |||||||||
Investment owned, percent of net assets | 0.10% | 0.10% | 0.10% | 0% | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [21],[23],[24] | 6.75% | [21],[23],[24] | 6.75% | [21],[23],[24] | 6.75% | ||||||||
Investment, interest rate | 12.14% | [21],[23],[24],[25] | 12.14% | [21],[23],[24],[25] | 12.14% | [21],[23],[24],[25] | 11.48% | ||||||||
Investment, principal | $ 21,852 | [21],[23],[24],[27] | $ 21,464 | ||||||||||||
Investment, cost | [21],[23],[24] | 21,855 | |||||||||||||
Investments at fair value | $ 0 | $ 21,823 | [21],[23],[24] | $ 21,252 | 24,225 | ||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 1.80% | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | [24] | 1,129,453 | [24] | 1,129,453 | [24] | 1,019,169 | ||||||||
Investment, cost | [24] | $ 1,159 | |||||||||||||
Investments at fair value | $ 0 | $ 1,005 | [24] | $ 1,243 | 1,223 | ||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0.10% | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | [16] | 78,045 | [16] | 78,045 | [16] | 78,045 | [24] | 78,045 | [24] | 78,045 | [24] | 70,425 | ||
Investment, cost | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | $ 0 | 0 | |||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [20] | 5.25% | [20] | 5.25% | [20] | 5.25% | [23] | 5.25% | [23] | 5.25% | [23] | |||
Investment, interest rate | 10.86% | [19],[20] | 10.86% | [19],[20] | 10.86% | [19],[20] | 10.90% | [23],[25] | 10.90% | [23],[25] | 10.90% | [23],[25] | |||
Investment, principal | $ 15,688 | [20],[26] | $ 8,490 | [23],[27] | |||||||||||
Investment, cost | 13,112 | [20] | 8,168 | [23] | |||||||||||
Investments at fair value | $ 10,230 | [20] | $ 6,414 | [23] | |||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20],[28] | 7% | [16],[20],[28] | 7% | [16],[20],[28] | 6% | [23],[24],[30] | 6% | [23],[24],[30] | 6% | [23],[24],[30] | |||
Investment, interest rate | 8.45% | [16],[19],[20],[28] | 8.45% | [16],[19],[20],[28] | 8.45% | [16],[19],[20],[28] | 11.49% | [23],[24],[25],[30] | 11.49% | [23],[24],[25],[30] | 11.49% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 4% | 4% | 4% | ||||||||||||
Investment, principal | $ 29,801 | [16],[20],[26],[28] | $ 29,509 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 29,483 | [16],[20],[28] | 29,164 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 28,311 | [16],[20],[28] | $ 28,284 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[17],[20] | 7.25% | [16],[17],[20] | 7.25% | [16],[17],[20] | 7.25% | [21],[23],[24] | 7.25% | [21],[23],[24] | 7.25% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (102) | [16],[17],[20] | (108) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (63) | [16],[17],[20] | $ (78) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [23],[24] | 7.25% | [23],[24] | 7.25% | [23],[24] | |||
Investment, interest rate | 12.60% | [19],[20] | 12.60% | [19],[20] | 12.60% | [19],[20] | 12.64% | [23],[24],[25] | 12.64% | [23],[24],[25] | 12.64% | [23],[24],[25] | |||
Investment, principal | $ 50,470 | [16],[20],[26] | $ 50,470 | [23],[24],[27] | |||||||||||
Investment, cost | 49,718 | [16],[20] | 49,679 | [23],[24] | |||||||||||
Investments at fair value | $ 49,839 | [16],[20] | $ 49,688 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[20] | 5% | [16],[20] | 5% | [16],[20] | 5% | [23],[24] | 5% | [23],[24] | 5% | [23],[24] | |||
Investment, interest rate | 10.61% | [16],[19],[20] | 10.61% | [16],[19],[20] | 10.61% | [16],[19],[20] | 10.65% | [23],[24],[25] | 10.65% | [23],[24],[25] | 10.65% | [23],[24],[25] | |||
Investment, principal | $ 3,239 | [16],[20],[26] | $ 3,247 | [23],[24],[27] | |||||||||||
Investment, cost | 3,208 | [16],[20] | 3,216 | [23],[24] | |||||||||||
Investments at fair value | $ 3,119 | [16],[20] | $ 3,169 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[20] | 5% | [16],[20] | 5% | [16],[20] | 5% | [23],[24] | 5% | [23],[24] | 5% | [23],[24] | |||
Investment, interest rate | 10.61% | [16],[19],[20] | 10.61% | [16],[19],[20] | 10.61% | [16],[19],[20] | 10.65% | [23],[24],[25] | 10.65% | [23],[24],[25] | 10.65% | [23],[24],[25] | |||
Investment, principal | $ 1,258 | [16],[20],[26] | $ 1,261 | [23],[24],[27] | |||||||||||
Investment, cost | 1,265 | [16],[20] | 1,269 | [23],[24] | |||||||||||
Investments at fair value | $ 1,211 | [16],[20] | $ 1,231 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [23],[24] | 8.50% | [23],[24] | 8.50% | [23],[24] | |||
Investment, interest rate | 14.15% | [16],[19],[20] | 14.15% | [16],[19],[20] | 14.15% | [16],[19],[20] | 14.15% | [23],[24],[25] | 14.15% | [23],[24],[25] | 14.15% | [23],[24],[25] | |||
Investment, principal | $ 2,091 | [16],[20],[26] | $ 8,920 | [23],[24],[27] | |||||||||||
Investment, cost | 2,070 | [16],[20] | 8,819 | [23],[24] | |||||||||||
Investments at fair value | $ 1,842 | [16],[20] | $ 8,492 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [23],[24] | 8.50% | [23],[24] | 8.50% | [23],[24] | |||
Investment, interest rate | 14.11% | [16],[19],[20] | 14.11% | [16],[19],[20] | 14.11% | [16],[19],[20] | 14.15% | [23],[24],[25] | 14.15% | [23],[24],[25] | 14.15% | [23],[24],[25] | |||
Investment, principal | $ 4,361 | [16],[20],[26] | $ 2,091 | [23],[24],[27] | |||||||||||
Investment, cost | 4,298 | [16],[20] | 2,068 | [23],[24] | |||||||||||
Investments at fair value | $ 3,842 | [16],[20] | $ 1,991 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [23],[24] | 8.50% | [23],[24] | 8.50% | [23],[24] | |||
Investment, interest rate | 14.11% | [16],[19],[20] | 14.11% | [16],[19],[20] | 14.11% | [16],[19],[20] | 14.15% | [23],[24],[25] | 14.15% | [23],[24],[25] | 14.15% | [23],[24],[25] | |||
Investment, principal | $ 8,920 | [16],[20],[26] | $ 4,361 | [23],[24],[27] | |||||||||||
Investment, cost | 8,818 | [16],[20] | 4,297 | [23],[24] | |||||||||||
Investments at fair value | $ 7,859 | [16],[20] | $ 4,152 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [16],[17],[20] | 4.50% | [16],[17],[20] | 4.50% | [16],[17],[20] | 4.50% | [21],[23],[24] | 4.50% | [21],[23],[24] | 4.50% | [21],[23],[24] | |||
Investment, interest rate | 13% | [16],[17],[19],[20] | 13% | [16],[17],[19],[20] | 13% | [16],[17],[19],[20] | 13% | [21],[23],[24],[25] | 13% | [21],[23],[24],[25] | 13% | [21],[23],[24],[25] | |||
Investment, principal | $ 1,836 | [16],[17],[20],[26] | $ 2,221 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 1,806 | [16],[17],[20] | 2,188 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 1,798 | [16],[17],[20] | $ 2,178 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [16],[20] | 5.50% | [16],[20] | 5.50% | [16],[20] | 5.50% | [23],[24] | 5.50% | [23],[24] | 5.50% | [23],[24] | |||
Investment, interest rate | 11.03% | [16],[19],[20] | 11.03% | [16],[19],[20] | 11.03% | [16],[19],[20] | 11.02% | [23],[24],[25] | 11.02% | [23],[24],[25] | 11.02% | [23],[24],[25] | |||
Investment, principal | $ 40,557 | [16],[20],[26] | $ 40,660 | [23],[24],[27] | |||||||||||
Investment, cost | 40,352 | [16],[20] | 40,440 | [23],[24] | |||||||||||
Investments at fair value | $ 40,070 | [16],[20] | $ 40,213 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20],[28] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [23],[24],[25],[30] | 8% | 8% | 8% | |||||||||||
Investment, interest rate, paid in kind | [24],[30] | 2.25% | 2.25% | 2.25% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26],[28] | $ 6,757 | [24],[27],[30] | |||||||||||
Investment, cost | 0 | [16],[17],[20],[28] | 6,560 | [24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[20],[28] | 6,225 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [16],[20],[28] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [16],[19],[20],[28] | 12.89% | 12.89% | 12.89% | |||||||||||
Investment, principal | $ 2,815 | [16],[20],[26],[28] | 3,316 | [21],[24],[27],[30],[31] | |||||||||||
Investment, cost | 2,815 | [16],[20],[28] | 3,335 | [21],[24],[30],[31] | |||||||||||
Investments at fair value | $ 2,625 | [16],[20],[28] | $ 3,169 | [21],[24],[30],[31] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | 8% | [16],[17],[19],[20],[28] | 8% | [16],[17],[19],[20],[28] | 8% | [16],[17],[19],[20],[28] | 8% | [21],[23],[24],[25],[30] | 8% | [21],[23],[24],[25],[30] | 8% | [21],[23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 2.25% | [16],[28] | 2.25% | [16],[28] | 2.25% | [16],[28] | 2.25% | [21],[24],[30] | 2.25% | [21],[24],[30] | 2.25% | [21],[24],[30] | |||
Investment, principal | $ 0 | [16],[17],[26],[28] | $ 0 | [21],[24],[27],[30] | |||||||||||
Investment, cost | 0 | [16],[17],[28] | 0 | [21],[24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[28] | $ 0 | [21],[24],[30] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | |||||||||||||||
Investment, interest rate | 8% | [16],[17],[19],[20],[28] | 8% | [16],[17],[19],[20],[28] | 8% | [16],[17],[19],[20],[28] | 8% | [21],[23],[24],[25],[30] | 8% | [21],[23],[24],[25],[30] | 8% | [21],[23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 2.25% | [16],[17],[28] | 2.25% | [16],[17],[28] | 2.25% | [16],[17],[28] | 2.25% | [21],[24],[30] | 2.25% | [21],[24],[30] | 2.25% | [21],[24],[30] | |||
Investment, principal | $ 0 | [16],[17],[26],[28] | $ 0 | [21],[24],[27],[30] | |||||||||||
Investment, cost | 0 | [16],[17],[28] | 0 | [21],[24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[28] | 0 | [21],[24],[30] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | |||||||||||||||
Investment, interest rate | [16],[19],[20],[28] | 8% | 8% | 8% | |||||||||||
Investment, interest rate, paid in kind | [16],[28] | 2.25% | 2.25% | 2.25% | |||||||||||
Investment, principal | $ 6,785 | [16],[26],[28] | 0 | [21],[24],[27],[30],[31] | |||||||||||
Investment, cost | 6,602 | [16],[28] | 0 | [21],[24],[30],[31] | |||||||||||
Investments at fair value | $ 6,327 | [16],[28] | 0 | [21],[24],[30],[31] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | |||||||||||||||
Investment, principal | [21],[24],[27],[30],[31] | 0 | |||||||||||||
Investment, cost | [21],[24],[30],[31] | 0 | |||||||||||||
Investments at fair value | [21],[24],[30],[31] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 32,664 | [16],[28] | 32,664 | [16],[28] | 32,664 | [16],[28] | 26,131 | [24],[30] | 26,131 | [24],[30] | 26,131 | [24],[30] | |||
Investment, cost | $ 225 | [16],[28] | $ 225 | [24],[30] | |||||||||||
Investments at fair value | $ 46 | [16],[28] | $ 3 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [20] | 7% | [20] | 7% | [20] | 7% | [23] | 7% | [23] | 7% | [23] | |||
Investment, interest rate | 12.46% | [19],[20] | 12.46% | [19],[20] | 12.46% | [19],[20] | 12.43% | [23],[25] | 12.43% | [23],[25] | 12.43% | [23],[25] | |||
Investment, principal | $ 30,625 | [20],[26] | $ 30,625 | [23],[27] | |||||||||||
Investment, cost | 30,394 | [20] | 30,370 | [23] | |||||||||||
Investments at fair value | $ 30,319 | [20] | $ 29,989 | [23] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [16] | 394,297 | [16] | 394,297 | [16] | 394,297 | [24] | 394,297 | [24] | 394,297 | [24] | |||
Investment, cost | $ 424 | [16] | $ 424 | [24] | |||||||||||
Investments at fair value | $ 95 | [16] | $ 158 | [24] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 9% | [16],[19],[20] | 9% | [16],[19],[20] | 9% | [16],[19],[20] | 9% | [23],[24],[25] | 9% | [23],[24],[25] | 9% | [23],[24],[25] | |||
Investment, principal | $ 5,257 | [16],[26] | $ 5,257 | [24],[27] | |||||||||||
Investment, cost | 5,263 | [16] | 5,258 | [24] | |||||||||||
Investments at fair value | $ 5,205 | [16] | $ 5,251 | [24] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,708,618 | [16] | 1,708,618 | [16] | 1,708,618 | [16] | 1,708,618 | [24] | 1,708,618 | [24] | 1,708,618 | [24] | |||
Investment, cost | $ 1,711 | [16] | $ 1,711 | [24] | |||||||||||
Investments at fair value | $ 1,982 | [16] | $ 1,999 | [24] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [16] | 394,297 | [16] | 394,297 | [16] | 394,297 | [24] | 394,297 | [24] | 394,297 | [24] | |||
Investment, cost | $ 395 | [16] | $ 395 | [24] | |||||||||||
Investments at fair value | $ 434 | [16] | $ 442 | [24] | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 829 | [16] | 829 | [16] | 829 | [16] | 829 | [24] | 829 | [24] | 829 | [24] | 829 | ||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | $ 0 | 0 | |||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | [16] | 34,984,460 | [16] | 34,984,460 | [16] | 34,984,460 | [24] | 34,984,460 | [24] | 34,984,460 | [24] | 34,984,460 | ||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | $ 34,984 | [16] | $ 34,984 | [24] | |||||||||||
Investments at fair value | $ 27,638 | [16] | $ 27,638 | [24] | $ 27,638 | 27,638 | |||||||||
Investment owned, percent of net assets | 1.80% | 1.80% | 1.80% | 2.30% | |||||||||||
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [20],[28] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [19],[20],[28] | 11.29% | 11.29% | 11.29% | |||||||||||
Investment, principal | [20],[26],[28] | $ 16,185 | |||||||||||||
Investment, cost | [20],[28] | 20,053 | |||||||||||||
Investments at fair value | [20],[28] | $ 20,281 | |||||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [16],[20],[32] | 7.75% | [16],[20],[32] | 7.75% | [16],[20],[32] | 7.75% | [23],[24],[33] | 7.75% | [23],[24],[33] | 7.75% | [23],[24],[33] | |||
Investment, principal | $ 727 | [16],[20],[26],[32] | $ 727 | [23],[24],[27],[33] | |||||||||||
Investment, cost | 413 | [16],[20],[32] | 462 | [23],[24],[33] | |||||||||||
Investments at fair value | $ 365 | [16],[20],[32] | $ 396 | [23],[24],[33] | |||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [23],[24],[27] | $ 37 | |||||||||||||
Investment, cost | [23],[24] | 37 | |||||||||||||
Investments at fair value | [23],[24] | $ 37 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [23],[24],[27] | $ 3,031 | |||||||||||||
Investment, cost | [23],[24] | 2,899 | |||||||||||||
Investments at fair value | [23],[24] | $ 3,031 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [23],[24],[27] | $ 1,557 | |||||||||||||
Investment, cost | [23],[24] | 1,489 | |||||||||||||
Investments at fair value | [23],[24] | $ 1,557 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [23],[24],[27] | $ 1,024 | |||||||||||||
Investment, cost | [23],[24] | 994 | |||||||||||||
Investments at fair value | [23],[24] | $ 1,024 | |||||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,398 | [16] | 1,080,398 | [16] | 1,080,398 | [16] | 1,080,399 | [24] | 1,080,399 | [24] | 1,080,399 | [24] | 1,080,399 | ||
Investment, cost | $ 1,079 | [16] | $ 1,080 | [24] | |||||||||||
Investments at fair value | $ 432 | [16] | $ 432 | [24] | $ 324 | 378 | |||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | 7.50% | [19],[20],[28] | 7.50% | [19],[20],[28] | 7.50% | [19],[20],[28] | 7.50% | [23],[25],[30] | 7.50% | [23],[25],[30] | 7.50% | [23],[25],[30] | |||
Investment, principal | $ 2,632 | [26],[28] | $ 2,632 | [27],[30] | |||||||||||
Investment, cost | 2,632 | [28] | 2,632 | [30] | |||||||||||
Investments at fair value | $ 2,191 | [28] | $ 2,017 | [30] | |||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | 7.75% | [19],[20],[28] | 7.75% | [19],[20],[28] | 7.75% | [19],[20],[28] | 7.75% | [23],[25],[30] | 7.75% | [23],[25],[30] | 7.75% | [23],[25],[30] | |||
Investment, principal | $ 176 | [26],[28] | $ 176 | [27],[30] | |||||||||||
Investment, cost | 170 | [28] | 170 | [30] | |||||||||||
Investments at fair value | $ 152 | [28] | $ 141 | [30] | |||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 7.38% | [19],[20] | 7.38% | [19],[20] | 7.38% | [19],[20] | 7.38% | [23],[25] | 7.38% | [23],[25] | 7.38% | [23],[25] | |||
Investment, principal | $ 10,720 | [26] | $ 8,420 | [27] | |||||||||||
Investment, cost | 10,282 | 8,261 | |||||||||||||
Investments at fair value | $ 9,804 | 7,059 | |||||||||||||
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20],[28] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, principal | [26],[28] | $ 1,670 | |||||||||||||
Investment, cost | [28] | 1,625 | |||||||||||||
Investments at fair value | [28] | $ 1,661 | |||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | [16] | 22,267,661 | 22,267,661 | 22,267,661 | |||||||||||
Investment, cost | [16] | $ 16,172 | |||||||||||||
Investments at fair value | $ 16,173 | [16] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 1.10% | 1.10% | 1.10% | ||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24],[33] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [23],[24],[27],[33] | $ 22,084 | |||||||||||||
Investment, cost | [23],[24],[33] | 21,336 | |||||||||||||
Investments at fair value | [23],[24],[33] | 16,040 | |||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants | |||||||||||||||
Investment, cost | [24] | 706 | |||||||||||||
Investments at fair value | [24] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,851 | [16] | 417,851 | [16] | 417,851 | [16] | 417,851 | [24] | 417,851 | [24] | 417,851 | [24] | |||
Investment, cost | $ 605 | [16] | $ 605 | [24] | |||||||||||
Investments at fair value | $ 894 | [16] | $ 894 | [24] | |||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (19) | [16],[17],[20] | (20) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (19) | [16],[17],[20] | $ (20) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [23],[24] | 7.50% | [23],[24] | 7.50% | [23],[24] | |||
Investment, interest rate | [23],[24],[25] | 12.82% | 12.82% | 12.82% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 13,157 | [23],[24],[27] | |||||||||||
Investment, cost | (15) | [16],[17],[20] | 12,855 | [23],[24] | |||||||||||
Investments at fair value | $ (11) | [16],[17],[20] | $ 12,858 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | |||
Investment, interest rate | [16],[19],[20] | 12.86% | 12.86% | 12.86% | |||||||||||
Investment, principal | $ 13,157 | [16],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 12,867 | [16],[20] | (15) | [21],[23],[24] | |||||||||||
Investments at fair value | $ 12,883 | [16],[20] | $ (13) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [20] | 5% | [20] | 5% | [20] | 5% | [23] | 5% | [23] | 5% | [23] | |||
Investment, interest rate | 10.35% | [19],[20] | 10.35% | [19],[20] | 10.35% | [19],[20] | 10.39% | [23],[25] | 10.39% | [23],[25] | 10.39% | [23],[25] | |||
Investment, principal | $ 14,713 | [20],[26] | $ 14,750 | [23],[27] | |||||||||||
Investment, cost | 14,160 | [20] | 14,173 | [23] | |||||||||||
Investments at fair value | $ 14,724 | [20] | $ 14,616 | [23] | |||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | |||
Investment, interest rate | [21],[23],[24],[25] | 11.47% | 11.47% | 11.47% | |||||||||||
Investment, principal | $ 0 | [16],[20],[26] | $ 933 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (13) | [16],[20] | 920 | [21],[23],[24] | |||||||||||
Investments at fair value | $ (15) | [16],[20] | $ 918 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.53% | [19],[20] | 11.53% | [19],[20] | 11.53% | [19],[20] | 11.52% | [23],[24],[25] | 11.52% | [23],[24],[25] | 11.52% | [23],[24],[25] | |||
Investment, principal | $ 17,967 | [16],[20],[26] | $ 18,013 | [23],[24],[27] | |||||||||||
Investment, cost | 17,666 | [16],[20] | 17,690 | [23],[24] | |||||||||||
Investments at fair value | $ 17,765 | [16],[20] | $ 17,812 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, principal | [16],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[20] | (53) | |||||||||||||
Investments at fair value | [16],[20] | $ (52) | |||||||||||||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [16] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, interest rate | [19],[20] | 12.10% | 12.10% | 12.10% | |||||||||||
Investment, principal | [16],[26] | $ 20,924 | |||||||||||||
Investment, cost | [16] | 20,412 | |||||||||||||
Investments at fair value | [16] | $ 20,422 | |||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | [20] | 4.75% | [20] | 4.75% | [20] | 4.75% | [23] | 4.75% | [23] | 4.75% | [23] | |||
Investment, interest rate | 10.13% | [19],[20] | 10.13% | [19],[20] | 10.13% | [19],[20] | 10.12% | [23],[25] | 10.12% | [23],[25] | 10.12% | [23],[25] | |||
Investment, principal | $ 4,938 | [20],[26] | $ 4,950 | [23],[27] | |||||||||||
Investment, cost | 4,862 | [20] | 4,871 | [23] | |||||||||||
Investments at fair value | $ 4,893 | [20] | $ 4,831 | [23] | |||||||||||
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 8% | 8% | 8% | |||||||||||
Investment, principal | [26] | $ 440 | |||||||||||||
Investment, cost | 423 | ||||||||||||||
Investments at fair value | $ 436 | ||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 2 | [16],[28] | 2 | [16],[28] | 2 | [16],[28] | 2 | [24],[30] | 2 | [24],[30] | 2 | [24],[30] | |||
Investment, cost | $ 2 | [16],[28] | $ 2 | [24],[30] | |||||||||||
Investments at fair value | $ 2 | [16],[28] | $ 2 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 419 | [16],[28] | 419 | [16],[28] | 419 | [16],[28] | 419 | [24],[30] | 419 | [24],[30] | 419 | [24],[30] | |||
Investment, cost | $ 419 | [16],[28] | $ 419 | [24],[30] | |||||||||||
Investments at fair value | $ 419 | [16],[28] | $ 419 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | |||||||||||||||
Investment, interest rate | 3% | [16],[19],[20],[28] | 3% | [16],[19],[20],[28] | 3% | [16],[19],[20],[28] | 3% | [21],[23],[24],[25],[30] | 3% | [21],[23],[24],[25],[30] | 3% | [21],[23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 7% | [16],[28] | 7% | [16],[28] | 7% | [16],[28] | 7% | [21],[24],[30] | 7% | [21],[24],[30] | 7% | [21],[24],[30] | |||
Investment, principal | $ 32,104 | [16],[26],[28] | $ 17,465 | [21],[24],[27],[30] | |||||||||||
Investment, cost | 32,104 | [16],[28] | 17,465 | [21],[24],[30] | |||||||||||
Investments at fair value | $ 32,104 | [16],[28] | $ 17,465 | [21],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 31 | [16],[28] | 31 | [16],[28] | 31 | [16],[28] | 31 | [24],[30] | 31 | [24],[30] | 31 | [24],[30] | |||
Investment, cost | $ 0 | [16],[28] | $ 0 | [24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[28] | $ 0 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 9% | [16],[20] | 9% | [16],[20] | 9% | [16],[20] | 9% | [23],[24] | 9% | [23],[24] | 9% | [23],[24] | |||
Investment, interest rate | 14.50% | [16],[19],[20] | 14.50% | [16],[19],[20] | 14.50% | [16],[19],[20] | 14.54% | [23],[24],[25] | 14.54% | [23],[24],[25] | 14.54% | [23],[24],[25] | |||
Investment, principal | $ 20,757 | [16],[20],[26] | $ 20,757 | [23],[24],[27] | |||||||||||
Investment, cost | 20,201 | [16],[20] | 20,146 | [23],[24] | |||||||||||
Investments at fair value | $ 20,639 | [16],[20] | $ 20,653 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | |||||||||||||||
Investment, interest rate, paid in kind | 8% | [16] | 8% | [16] | 8% | [16] | 8% | [24] | 8% | [24] | 8% | [24] | |||
Investment, principal | $ 667 | [16],[26] | $ 654 | [24],[27] | |||||||||||
Investment, cost | 666 | [16] | 653 | [24] | |||||||||||
Investments at fair value | $ 643 | [16] | $ 631 | [24] | |||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 6,397,254 | [16] | 6,397,254 | [16] | 6,397,254 | [16] | 6,397,254 | [24] | 6,397,254 | [24] | 6,397,254 | [24] | |||
Investment, cost | $ 1,642 | [16] | $ 1,642 | [24] | |||||||||||
Investments at fair value | $ 128 | [16] | $ 1,152 | [24] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | |||
Investment, interest rate | 12.45% | [16],[17],[19],[20] | 12.45% | [16],[17],[19],[20] | 12.45% | [16],[17],[19],[20] | 12.49% | [21],[23],[24],[25] | 12.49% | [21],[23],[24],[25] | 12.49% | [21],[23],[24],[25] | |||
Investment, principal | $ 578 | [16],[17],[20],[26] | $ 284 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 561 | [16],[17],[20] | 265 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 550 | [16],[17],[20] | $ 252 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate | 12.45% | [16],[19],[20] | 12.45% | [16],[19],[20] | 12.45% | [16],[19],[20] | 12.49% | [23],[24],[25] | 12.49% | [23],[24],[25] | 12.49% | [23],[24],[25] | |||
Investment, principal | $ 12,355 | [16],[20],[26] | $ 12,386 | [23],[24],[27] | |||||||||||
Investment, cost | 12,191 | [16],[20] | 12,208 | [23],[24] | |||||||||||
Investments at fair value | $ 12,083 | [16],[20] | $ 12,101 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | [23] | 5% | [23] | 5% | [23] | ||||||
Investment, interest rate | 10.65% | [19],[20] | 10.65% | [19],[20] | 10.65% | [19],[20] | 10.43% | [23],[25] | 10.43% | [23],[25] | 10.43% | [23],[25] | |||
Investment, principal | $ 4,514 | [20],[26] | $ 4,641 | [23],[27] | |||||||||||
Investment, cost | 4,491 | [20] | 4,619 | [23] | |||||||||||
Investments at fair value | $ 4,522 | [20] | $ 4,546 | [23] | |||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 5.88% | 5.88% | 5.88% | |||||||||||
Investment, principal | [26] | $ 5,090 | |||||||||||||
Investment, cost | 4,455 | ||||||||||||||
Investments at fair value | $ 4,787 | ||||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | [16] | 30,031 | [16] | 30,031 | [16] | 30,031 | [24] | 30,031 | [24] | 30,031 | [24] | 30,031 | ||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | $ 15,222 | [16] | $ 15,222 | [24] | |||||||||||
Investments at fair value | $ 2,711 | [16] | $ 2,711 | [24] | $ 4,227 | 4,946 | |||||||||
Investment owned, percent of net assets | 0.20% | 0.20% | 0.20% | 0.40% | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[20] | 5% | [16],[20] | 5% | [16],[20] | 5% | [23],[24] | 5% | [23],[24] | 5% | [23],[24] | 5% | ||
Investment, interest rate | 10.50% | [16],[19],[20] | 10.50% | [16],[19],[20] | 10.50% | [16],[19],[20] | 10.54% | [23],[24],[25] | 10.54% | [23],[24],[25] | 10.54% | [23],[24],[25] | |||
Investment, principal | $ 5,574 | [16],[20],[26] | $ 5,574 | [23],[24],[27] | $ 0 | ||||||||||
Investment, cost | 5,574 | [16],[20] | 5,574 | [23],[24] | |||||||||||
Investments at fair value | $ 5,574 | [16],[20] | $ 5,574 | [23],[24] | $ 0 | 0 | |||||||||
Investment owned, percent of net assets | 0.40% | 0.40% | 0.40% | 0% | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | ||||||||||||||
Investment, interest rate | 9.73% | ||||||||||||||
Investment, principal | $ 14,297 | ||||||||||||||
Investments at fair value | $ 14,297 | 14,333 | |||||||||||||
Investment owned, percent of net assets | 1.20% | ||||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[20] | 5% | [16],[20] | 5% | [16],[20] | 5% | [23],[24] | 5% | [23],[24] | 5% | [23],[24] | |||
Investment, interest rate | 10.50% | [16],[19],[20] | 10.50% | [16],[19],[20] | 10.50% | [16],[19],[20] | 10.54% | [23],[24],[25] | 10.54% | [23],[24],[25] | 10.54% | [23],[24],[25] | |||
Investment, principal | $ 14,033 | [16],[20],[26] | $ 14,068 | [23],[24],[27] | |||||||||||
Investment, cost | 14,032 | [16],[20] | 14,068 | [23],[24] | |||||||||||
Investments at fair value | $ 14,033 | [16],[20] | $ 14,068 | [23],[24] | |||||||||||
Investment owned, percent of net assets | 0.90% | 0.90% | 0.90% | ||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[17],[20] | 5% | [16],[17],[20] | 5% | [16],[17],[20] | 5% | [21],[23],[24] | 5% | [21],[23],[24] | 5% | [21],[23],[24] | |||
Investment, interest rate | 10.46% | [16],[17],[19],[20] | 10.46% | [16],[17],[19],[20] | 10.46% | [16],[17],[19],[20] | 10.42% | [21],[23],[24],[25] | 10.42% | [21],[23],[24],[25] | 10.42% | [21],[23],[24],[25] | |||
Investment, principal | $ 1,393 | [16],[17],[20],[26] | $ 2,090 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 1,393 | [16],[17],[20] | 2,090 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 1,394 | [16],[17],[20] | $ 2,090 | [21],[23],[24] | |||||||||||
Investment owned, percent of net assets | 0.10% | 0.10% | 0.10% | ||||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 12,500 | [16] | 12,500 | [16] | 12,500 | [16] | 12,500 | [24] | 12,500 | [24] | 12,500 | [24] | |||
Investment, cost | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 488 | [16] | 488 | [16] | 488 | [16] | 488 | [24] | 488 | [24] | 488 | [24] | |||
Investment, cost | $ 488 | [16] | $ 488 | [24] | |||||||||||
Investments at fair value | $ 1,345 | [16] | $ 1,345 | [24] | |||||||||||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [23],[24] | 7.50% | [23],[24] | 7.50% | [23],[24] | |||
Investment, interest rate | 13% | [16],[19],[20] | 13% | [16],[19],[20] | 13% | [16],[19],[20] | 13.04% | [23],[24],[25] | 13.04% | [23],[24],[25] | 13.04% | [23],[24],[25] | |||
Investment, principal | $ 8,974 | [16],[20],[26] | $ 8,974 | [23],[24],[27] | |||||||||||
Investment, cost | 8,884 | [16],[20] | 8,884 | [23],[24] | |||||||||||
Investments at fair value | $ 8,032 | [16],[20] | $ 7,987 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (28) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (28) | |||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [16],[19],[20] | 10.84% | 10.84% | 10.84% | |||||||||||
Investment, principal | [16],[20],[26] | $ 24,865 | |||||||||||||
Investment, cost | [16],[20] | 24,492 | |||||||||||||
Investments at fair value | [16],[20] | $ 24,492 | |||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (19) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (19) | |||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 3% | [16],[19],[20],[28] | 3% | [16],[19],[20],[28] | 3% | [16],[19],[20],[28] | 3% | [23],[24],[25],[30] | 3% | [23],[24],[25],[30] | 3% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 6% | [16],[28] | 6% | [16],[28] | 6% | [16],[28] | 6% | [24],[30] | 6% | [24],[30] | 6% | [24],[30] | |||
Investment, principal | $ 1,799 | [16],[26],[28] | $ 11,065 | [24],[27],[30] | |||||||||||
Investment, cost | 1,777 | [16],[28] | 10,953 | [24],[30] | |||||||||||
Investments at fair value | $ 1,718 | [16],[28] | $ 10,677 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | 3% | [16],[17],[19],[20],[28] | 3% | [16],[17],[19],[20],[28] | 3% | [16],[17],[19],[20],[28] | 3% | [23],[24],[25],[30] | 3% | [23],[24],[25],[30] | 3% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 6% | [16],[17],[28] | 6% | [16],[17],[28] | 6% | [16],[17],[28] | 6% | [24],[30] | 6% | [24],[30] | 6% | [24],[30] | |||
Investment, principal | $ 0 | [16],[17],[26],[28] | $ 1,772 | [24],[27],[30] | |||||||||||
Investment, cost | 1 | [16],[17],[28] | 1,748 | [24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[28] | $ 1,710 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | 3% | [16],[17],[19],[20],[28] | 3% | [16],[17],[19],[20],[28] | 3% | [16],[17],[19],[20],[28] | 3% | [21],[23],[24],[25],[30] | 3% | [21],[23],[24],[25],[30] | 3% | [21],[23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 6% | [16],[17],[28] | 6% | [16],[17],[28] | 6% | [16],[17],[28] | 6% | [21],[24],[30] | 6% | [21],[24],[30] | 6% | [21],[24],[30] | |||
Investment, principal | $ 0 | [16],[17],[26],[28] | $ 0 | [21],[24],[27],[30] | |||||||||||
Investment, cost | 1 | [16],[17],[28] | 1 | [21],[24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[28] | $ 0 | [21],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | |||||||||||||||
Investment, interest rate | 3% | [16],[19],[20],[28] | 3% | [16],[19],[20],[28] | 3% | [16],[19],[20],[28] | 3% | [21],[23],[24],[25],[30] | 3% | [21],[23],[24],[25],[30] | 3% | [21],[23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 6% | [16],[28] | 6% | [16],[28] | 6% | [16],[28] | 6% | [21],[24],[30] | 6% | [21],[24],[30] | 6% | [21],[24],[30] | |||
Investment, principal | $ 11,232 | [16],[26],[28] | $ 0 | [21],[24],[27],[30] | |||||||||||
Investment, cost | 11,129 | [16],[28] | 1 | [21],[24],[30] | |||||||||||
Investments at fair value | $ 10,727 | [16],[28] | $ 0 | [21],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (39) | [16],[17],[20] | (41) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (37) | [16],[17],[20] | $ (41) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.35% | [19],[20] | 11.35% | [19],[20] | 11.35% | [19],[20] | 11.32% | [23],[24],[25] | 11.32% | [23],[24],[25] | 11.32% | [23],[24],[25] | |||
Investment, principal | $ 14,736 | [16],[17],[20],[26] | $ 14,736 | [23],[24],[27] | |||||||||||
Investment, cost | 14,381 | [16],[17],[20] | 14,368 | [23],[24] | |||||||||||
Investments at fair value | $ 14,394 | [16],[17],[20] | $ 14,368 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [20] | 4% | 4% | 4% | |||||||||||
Investment, interest rate | [19],[20] | 9.47% | 9.47% | 9.47% | |||||||||||
Investment, principal | [20],[26] | $ 4,324 | |||||||||||||
Investment, cost | [20] | 3,497 | |||||||||||||
Investments at fair value | [20] | $ 3,457 | |||||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [20] | 6.75% | [20] | 6.75% | [20] | 6.75% | [23],[30] | 6.75% | [23],[30] | 6.75% | [23],[30] | |||
Investment, interest rate | 12.22% | [19],[20] | 12.22% | [19],[20] | 12.22% | [19],[20] | 12.18% | [23],[25],[30] | 12.18% | [23],[25],[30] | 12.18% | [23],[25],[30] | |||
Investment, principal | $ 31,074 | [20],[26] | $ 31,074 | [23],[27],[30] | |||||||||||
Investment, cost | 29,191 | [20] | 29,127 | [23],[30] | |||||||||||
Investments at fair value | $ 18,745 | [20] | $ 19,917 | [23],[30] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 9% | [16],[17],[19],[20] | 9% | [16],[17],[19],[20] | 9% | [16],[17],[19],[20] | 9% | [21],[23],[24],[25] | 9% | [21],[23],[24],[25] | 9% | [21],[23],[24],[25] | |||
Investment, principal | $ 61,500 | [16],[17],[26] | $ 59,950 | [21],[24],[27] | |||||||||||
Investment, cost | 61,500 | [16],[17] | 59,950 | [21],[24] | |||||||||||
Investments at fair value | $ 61,500 | [16],[17] | $ 59,950 | [21],[24] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 3,750 | [16],[28],[36] | 3,750 | [16],[28],[36] | 3,750 | [16],[28],[36] | 3,750 | [24],[30] | 3,750 | [24],[30] | 3,750 | [24],[30] | |||
Investment, cost | $ 0 | [16],[28],[36] | $ 0 | [24],[30] | |||||||||||
Investments at fair value | $ 4 | [16],[28],[36] | $ 3 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[17],[20],[28] | 7.25% | [16],[17],[20],[28] | 7.25% | [16],[17],[20],[28] | 7.25% | [21],[23],[24],[30] | 7.25% | [21],[23],[24],[30] | 7.25% | [21],[23],[24],[30] | |||
Investment, interest rate | 12.61% | [16],[17],[19],[20],[28] | 12.61% | [16],[17],[19],[20],[28] | 12.61% | [16],[17],[19],[20],[28] | 12.55% | [21],[23],[24],[25],[30] | 12.55% | [21],[23],[24],[25],[30] | 12.55% | [21],[23],[24],[25],[30] | |||
Investment, principal | $ 322 | [16],[17],[20],[26],[28] | $ 258 | [21],[23],[24],[27],[30] | |||||||||||
Investment, cost | 299 | [16],[17],[20],[28] | 234 | [21],[23],[24],[30] | |||||||||||
Investments at fair value | $ 301 | [16],[17],[20],[28] | $ 234 | [21],[23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 7.25% | [16],[20],[28] | 7.25% | [23],[24],[30] | 7.25% | [23],[24],[30] | 7.25% | [23],[24],[30] | |||
Investment, interest rate | 12.71% | [16],[19],[20],[28] | 12.71% | [16],[19],[20],[28] | 12.71% | [16],[19],[20],[28] | 12.55% | [23],[24],[25],[30] | 12.55% | [23],[24],[25],[30] | 12.55% | [23],[24],[25],[30] | |||
Investment, principal | $ 11,742 | [16],[20],[26],[28] | $ 11,742 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 11,519 | [16],[20],[28] | 11,509 | [23],[24],[30] | |||||||||||
Investments at fair value | 11,538 | [16],[20],[28] | 11,511 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest | |||||||||||||||
Investments at fair value | $ 0 | $ 0 | |||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | ||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 11% | [16],[19],[20],[28] | 11% | [16],[19],[20],[28] | 11% | [16],[19],[20],[28] | 11% | [23],[24],[25],[30] | 11% | [23],[24],[25],[30] | 11% | [23],[24],[25],[30] | |||
Investment, principal | $ 11,918 | [16],[26],[28] | $ 11,918 | [24],[27],[30] | |||||||||||
Investment, cost | 11,653 | [16],[28] | 11,612 | [24],[30] | |||||||||||
Investments at fair value | $ 11,173 | [16],[28] | $ 11,144 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,011 | [16],[28] | 417,011 | [16],[28] | 417,011 | [16],[28] | 417,011 | [24],[30] | 417,011 | [24],[30] | 417,011 | [24],[30] | |||
Investment, cost | $ 427 | [16],[28] | $ 427 | [24],[30] | |||||||||||
Investments at fair value | $ 354 | [16],[28] | $ 42 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 6% | [19],[20],[28] | 6% | [19],[20],[28] | 6% | [19],[20],[28] | 6% | [23],[25],[30] | 6% | [23],[25],[30] | 6% | [23],[25],[30] | |||
Investment, principal | $ 4,881 | [26],[28] | $ 4,881 | [27],[30] | |||||||||||
Investment, cost | 4,482 | [28] | 4,469 | [30] | |||||||||||
Investments at fair value | $ 4,170 | [28] | $ 3,577 | [30] | |||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[17],[20] | 7.25% | [16],[17],[20] | 7.25% | [16],[17],[20] | 7.25% | [21],[23],[24] | 7.25% | [21],[23],[24] | 7.25% | [21],[23],[24] | |||
Investment, interest rate | 12.60% | [16],[17],[19],[20] | 12.60% | [16],[17],[19],[20] | 12.60% | [16],[17],[19],[20] | 12.64% | [21],[23],[24],[25] | 12.64% | [21],[23],[24],[25] | 12.64% | [21],[23],[24],[25] | |||
Investment, principal | $ 1,215 | [16],[17],[20],[26] | $ 1,638 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 1,117 | [16],[17],[20] | 1,535 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 1,152 | [16],[17],[20] | $ 1,535 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [23],[24] | 7.25% | [23],[24] | 7.25% | [23],[24] | |||
Investment, interest rate | 12.60% | [16],[19],[20] | 12.60% | [16],[19],[20] | 12.60% | [16],[19],[20] | 12.64% | [23],[24],[25] | 12.64% | [23],[24],[25] | 12.64% | [23],[24],[25] | |||
Investment, principal | $ 23,714 | [16],[20],[26] | $ 23,774 | [23],[24],[27] | |||||||||||
Investment, cost | 23,082 | [16],[20] | 23,110 | [23],[24] | |||||||||||
Investments at fair value | $ 23,306 | [16],[20] | $ 23,110 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[20] | 5% | [16],[20] | 5% | [16],[20] | 5% | [23] | 5% | [23] | 5% | [23] | |||
Investment, interest rate | 10.66% | [16],[19],[20] | 10.66% | [16],[19],[20] | 10.66% | [16],[19],[20] | 10.57% | [23],[25] | 10.57% | [23],[25] | 10.57% | [23],[25] | |||
Investment, principal | $ 2,450 | [16],[20],[26] | $ 2,456 | [23],[27] | |||||||||||
Investment, cost | 2,070 | [16],[20] | 2,055 | [23] | |||||||||||
Investments at fair value | $ 2,197 | [16],[20] | $ 2,063 | [23] | |||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment, basis spread, variable rate | 2.85% | [20],[28] | 2.85% | [20],[28] | 2.85% | [20],[28] | 2.85% | [23],[30] | 2.85% | [23],[30] | 2.85% | [23],[30] | |||
Investment, interest rate | 6.84% | [19],[20],[28] | 6.84% | [19],[20],[28] | 6.84% | [19],[20],[28] | 6.56% | [23],[25],[30] | 6.56% | [23],[25],[30] | 6.56% | [23],[25],[30] | |||
Investment, principal | € | € 1,000 | [20],[26],[28] | € 1,000 | [23],[27],[30] | |||||||||||
Investment, cost | $ 880 | [20],[28] | $ 876 | [23],[30] | |||||||||||
Investments at fair value | $ 1,033 | [20],[28] | $ 963 | [23],[30] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[17],[20] | 8% | [16],[17],[20] | 8% | [16],[17],[20] | 8% | [21],[23],[24] | 8% | [21],[23],[24] | 8% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (25) | [16],[17],[20] | (27) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (29) | [16],[17],[20] | $ (35) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[17],[20] | 8% | [16],[17],[20] | 8% | [16],[17],[20] | 8% | [23],[24] | 8% | [23],[24] | 8% | [23],[24] | |||
Investment, interest rate | [23],[24],[25] | 13.42% | 13.42% | 13.42% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 17,444 | [23],[24],[27] | |||||||||||
Investment, cost | (50) | [16],[17],[20] | 17,276 | [23],[24] | |||||||||||
Investments at fair value | $ (59) | [16],[17],[20] | $ 17,096 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[20] | 8% | [16],[20] | 8% | [16],[20] | 8% | [21],[23],[24] | 8% | [21],[23],[24] | 8% | [21],[23],[24] | |||
Investment, interest rate | [16],[19],[20] | 13.46% | 13.46% | 13.46% | |||||||||||
Investment, principal | $ 17,400 | [16],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 17,244 | [16],[20] | (54) | [21],[23],[24] | |||||||||||
Investments at fair value | $ 17,112 | [16],[20] | $ (70) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [20] | 5.25% | [20] | 5.25% | [20] | 5.25% | [23] | 5.25% | [23] | 5.25% | [23] | |||
Investment, interest rate | 10.71% | [19],[20] | 10.71% | [19],[20] | 10.71% | [19],[20] | 10.67% | [23],[25] | 10.67% | [23],[25] | 10.67% | [23],[25] | |||
Investment, principal | $ 8,538 | [20],[26] | $ 14,347 | [23],[27] | |||||||||||
Investment, cost | 8,257 | [20] | 13,871 | [23] | |||||||||||
Investments at fair value | $ 8,396 | [20] | $ 13,618 | [23] | |||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [16],[20],[28] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [16],[19],[20],[28] | 12% | 12% | 12% | |||||||||||
Investment, principal | [16],[20],[26],[28] | $ 7,448 | |||||||||||||
Investment, cost | [16],[20],[28] | 7,313 | |||||||||||||
Investments at fair value | [16],[20],[28] | $ 7,355 | |||||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[17],[20],[28] | 6.50% | [16],[17],[20],[28] | 6.50% | [16],[17],[20],[28] | 6.50% | [23],[24],[30] | 6.50% | [23],[24],[30] | 6.50% | [23],[24],[30] | |||
Investment, interest rate | [23],[24],[25],[30] | 11.89% | 11.89% | 11.89% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26],[28] | $ 7,448 | [23],[24],[27],[30] | |||||||||||
Investment, cost | (73) | [16],[17],[20],[28] | 7,296 | [23],[24],[30] | |||||||||||
Investments at fair value | $ (50) | [16],[17],[20],[28] | $ 7,301 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20],[28] | 6.50% | [16],[20],[28] | 6.50% | [16],[20],[28] | 6.50% | [21],[23],[24],[30] | 6.50% | [21],[23],[24],[30] | 6.50% | [21],[23],[24],[30] | |||
Investment, interest rate | [19],[20] | 12% | 12% | 12% | |||||||||||
Investment, principal | $ 1,432 | [16],[20],[26],[28] | $ 0 | [21],[23],[24],[27],[30] | |||||||||||
Investment, cost | 1,403 | [16],[20],[28] | (82) | [21],[23],[24],[30] | |||||||||||
Investments at fair value | $ 1,414 | [16],[20],[28] | $ (79) | [21],[23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24],[30] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [23],[24],[25],[30] | 12.04% | 12.04% | 12.04% | |||||||||||
Investment, principal | [23],[24],[27],[30] | $ 1,432 | |||||||||||||
Investment, cost | [23],[24],[30] | 1,399 | |||||||||||||
Investments at fair value | [23],[24],[30] | $ 1,404 | |||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | |||||||||||||||
Investment, interest rate | 4.46% | [19],[20],[28] | 4.46% | [19],[20],[28] | 4.46% | [19],[20],[28] | 4.46% | [23],[24],[25],[30] | 4.46% | [23],[24],[25],[30] | 4.46% | [23],[24],[25],[30] | |||
Investment, principal | $ 9,406 | [26],[28] | $ 6,808 | [24],[27],[30] | |||||||||||
Investment, cost | 7,727 | [28] | 5,490 | [24],[30] | |||||||||||
Investments at fair value | $ 8,155 | [28] | $ 5,873 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.25% | [23],[24],[30] | 8.25% | [23],[24],[30] | 8.25% | [23],[24],[30] | |||
Investment, interest rate | 13.63% | [16],[19],[20],[28] | 13.63% | [16],[19],[20],[28] | 13.63% | [16],[19],[20],[28] | 13.62% | [23],[24],[25],[30] | 13.62% | [23],[24],[25],[30] | 13.62% | [23],[24],[25],[30] | |||
Investment, principal | $ 23,975 | [16],[20],[26],[28] | $ 23,975 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 23,347 | [16],[20],[28] | 23,310 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 23,519 | [16],[20],[28] | $ 23,328 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | [16],[20] | 5.75% | [16],[20] | 5.75% | [16],[20] | 5.75% | [23],[24] | 5.75% | [23],[24] | 5.75% | [23],[24] | |||
Investment, interest rate | 11.36% | [16],[19],[20] | 11.36% | [16],[19],[20] | 11.36% | [16],[19],[20] | 11.40% | [23],[24],[25] | 11.40% | [23],[24],[25] | 11.40% | [23],[24],[25] | |||
Investment, principal | $ 43,931 | [16],[20],[26] | $ 44,550 | [23],[24],[27] | |||||||||||
Investment, cost | 42,440 | [16],[20] | 42,918 | [23],[24] | |||||||||||
Investments at fair value | $ 35,145 | [16],[20] | $ 35,046 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 12.06% | [16],[19],[20] | 12.06% | [16],[19],[20] | 12.06% | [16],[19],[20] | 11.92% | [23],[24],[25] | 11.92% | [23],[24],[25] | 11.92% | [23],[24],[25] | |||
Investment, principal | $ 40,587 | [16],[20],[26] | $ 40,587 | [23],[24],[27] | |||||||||||
Investment, cost | 39,991 | [16],[20] | 39,935 | [23],[24] | |||||||||||
Investments at fair value | $ 38,963 | [16],[20] | $ 38,963 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 10.75% | [16],[32] | 10.75% | [16],[32] | 10.75% | [16],[32] | 10.75% | [23],[24] | 10.75% | [23],[24] | 10.75% | [23],[24] | |||
Investment, interest rate, paid in kind | [23],[24] | 16.06% | 16.06% | 16.06% | |||||||||||
Investment, principal | $ 1,001 | [16],[26],[32] | $ 26,613 | [23],[24],[27] | |||||||||||
Investment, cost | 983 | [16],[32] | 26,492 | [23],[24] | |||||||||||
Investments at fair value | $ 793 | [16],[32] | $ 24,484 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 10.75% | [16],[20],[32] | 10.75% | [16],[20],[32] | 10.75% | [16],[20],[32] | 10.75% | [23],[24] | 10.75% | [23],[24] | 10.75% | [23],[24] | |||
Investment, interest rate, paid in kind | [23],[24] | 16.05% | 16.05% | 16.05% | |||||||||||
Investment, principal | $ 2,232 | [16],[20],[26],[32] | $ 787 | [23],[24],[27] | |||||||||||
Investment, cost | 2,163 | [16],[20],[32] | 771 | [23],[24] | |||||||||||
Investments at fair value | $ 1,768 | [16],[20],[32] | $ 787 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 10.75% | [16],[20],[32] | 10.75% | [16],[20],[32] | 10.75% | [16],[20],[32] | 10.75% | [21],[23],[24] | 10.75% | [21],[23],[24] | 10.75% | [21],[23],[24] | |||
Investment, interest rate, paid in kind | [21],[23],[24] | 16.06% | 16.06% | 16.06% | |||||||||||
Investment, principal | $ 839 | [16],[20],[26],[32] | $ 688 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 785 | [16],[20],[32] | 688 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 664 | [16],[20],[32] | $ 688 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | [16],[20],[32] | 10.75% | 10.75% | 10.75% | |||||||||||
Investment, principal | [16],[20],[26],[32] | $ 28,010 | |||||||||||||
Investment, cost | [16],[20],[32] | 26,687 | |||||||||||||
Investments at fair value | [16],[20],[32] | $ 14,817 | |||||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 350,241 | 350,241 | 350,241 | 350,241 | 350,241 | 350,241 | |||||||||
Investment, cost | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 0 | $ 147 | |||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24],[30] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [23],[24],[25],[30] | 11.14% | 11.14% | 11.14% | |||||||||||
Investment, interest rate, paid in kind | [23],[24],[30] | 2.75% | 2.75% | 2.75% | |||||||||||
Investment, principal | [23],[24],[27],[30] | $ 7,179 | |||||||||||||
Investment, cost | [23],[24],[30] | 6,969 | |||||||||||||
Investments at fair value | [23],[24],[30] | $ 6,568 | |||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 112,990 | [16],[28] | 112,990 | [16],[28] | 112,990 | [16],[28] | 112,990 | [24],[30] | 112,990 | [24],[30] | 112,990 | [24],[30] | |||
Investment, cost | $ 300 | [16],[28] | $ 300 | [24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[28] | $ 105 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,078,284 | [16] | 1,078,284 | [16] | 1,078,284 | [16] | 1,078,284 | [24] | 1,078,284 | [24] | 1,078,284 | [24] | |||
Investment, cost | $ 113 | [16] | $ 113 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (85) | [16],[17],[20] | (99) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (86) | [16],[17],[20] | $ (86) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [23],[24] | 7.50% | [23],[24] | 7.50% | [23],[24] | |||
Investment, interest rate | 12.97% | [16],[19],[20] | 12.97% | [16],[19],[20] | 12.97% | [16],[19],[20] | 12.93% | [23],[24],[25] | 12.93% | [23],[24],[25] | 12.93% | [23],[24],[25] | |||
Investment, principal | $ 33,331 | [16],[20],[26] | $ 33,414 | [23],[24],[27] | |||||||||||
Investment, cost | 32,585 | [16],[20] | 32,539 | [23],[24] | |||||||||||
Investments at fair value | $ 32,577 | [16],[20] | $ 32,659 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [20] | 7.25% | [20] | 7.25% | [20] | 7.25% | [23] | 7.25% | [23] | 7.25% | [23] | |||
Investment, interest rate | 12.91% | [19],[20] | 12.91% | [19],[20] | 12.91% | [19],[20] | 12.78% | [23],[25] | 12.78% | [23],[25] | 12.78% | [23],[25] | |||
Investment, principal | $ 13,939 | [20],[26] | $ 13,939 | [23],[27] | |||||||||||
Investment, cost | 12,721 | [20] | 12,661 | [23] | |||||||||||
Investments at fair value | 11,314 | [20] | 10,094 | [23] | |||||||||||
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares | |||||||||||||||
Investment, cost | 8,722 | 83,262 | |||||||||||||
Investments at fair value | $ 8,722 | $ 83,262 | |||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | |||
Investment, interest rate | [21],[23],[24],[25] | 11.84% | 11.84% | 11.84% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 272 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (44) | [16],[17],[20] | 246 | [21],[23],[24] | |||||||||||
Investments at fair value | $ (47) | [16],[17],[20] | $ 238 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (26) | [16],[17],[20] | (47) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (35) | [16],[17],[20] | $ (47) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 11.99% | [19],[20] | 11.99% | [19],[20] | 11.99% | [19],[20] | 11.84% | [23],[24],[25] | 11.84% | [23],[24],[25] | 11.84% | [23],[24],[25] | |||
Investment, principal | $ 38,015 | [16],[20],[26] | $ 16,752 | [23],[24],[27] | |||||||||||
Investment, cost | 37,482 | [16],[20] | 16,623 | [23],[24] | |||||||||||
Investments at fair value | $ 37,445 | [16],[20] | $ 16,500 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 11.84% | [16],[19],[20] | 11.84% | [16],[19],[20] | 11.84% | [16],[19],[20] | 11.80% | [23],[24],[25] | 11.80% | [23],[24],[25] | 11.80% | [23],[24],[25] | |||
Investment, principal | $ 16,722 | [16],[20],[26] | $ 38,015 | [23],[24],[27] | |||||||||||
Investment, cost | 16,593 | [16],[20] | 37,447 | [23],[24] | |||||||||||
Investments at fair value | $ 16,471 | [16],[20] | $ 37,445 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (39) | [16],[17],[20] | (41) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (199) | [16],[17],[20] | $ (172) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.46% | [16],[19],[20] | 11.46% | [16],[19],[20] | 11.46% | [16],[19],[20] | 11.42% | [23],[24],[25] | 11.42% | [23],[24],[25] | 11.42% | [23],[24],[25] | |||
Investment, principal | $ 2,729 | [16],[20],[26] | $ 2,736 | [23],[24],[27] | |||||||||||
Investment, cost | 2,597 | [16],[20] | 2,595 | [23],[24] | |||||||||||
Investments at fair value | $ 2,524 | [16],[20] | $ 2,558 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.46% | [19],[20] | 11.46% | [19],[20] | 11.46% | [19],[20] | 11.42% | [23],[24],[25] | 11.42% | [23],[24],[25] | 11.42% | [23],[24],[25] | |||
Investment, principal | $ 23,435 | [16],[20],[26] | $ 23,494 | [23],[24],[27] | |||||||||||
Investment, cost | 23,091 | [16],[20] | 23,128 | [23],[24] | |||||||||||
Investments at fair value | $ 21,677 | [16],[20] | $ 21,967 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [20],[28] | 9.50% | [20],[28] | 9.50% | [20],[28] | 9.50% | [23],[30] | 9.50% | [23],[30] | 9.50% | [23],[30] | |||
Investment, interest rate | 15.08% | [19],[20],[28] | 15.08% | [19],[20],[28] | 15.08% | [19],[20],[28] | 14.95% | [23],[25],[30] | 14.95% | [23],[25],[30] | 14.95% | [23],[25],[30] | |||
Investment, principal | $ 26,356 | [20],[26],[28] | $ 26,422 | [23],[27],[30] | |||||||||||
Investment, cost | 24,952 | [20],[28] | 24,920 | [23],[30] | |||||||||||
Investments at fair value | $ 27,163 | [20],[28] | $ 27,512 | [23],[30] | |||||||||||
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | [24] | 2,000,000 | 2,000,000 | 2,000,000 | |||||||||||
Investment, cost | [24] | $ 1,399 | |||||||||||||
Investments at fair value | [24] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[20] | 5% | [16],[20] | 5% | [16],[20] | 5% | [23],[24] | 5% | [23],[24] | 5% | [23],[24] | |||
Investment, interest rate | 10.61% | [16],[19],[20] | 10.61% | [16],[19],[20] | 10.61% | [16],[19],[20] | 10.65% | [23],[24],[25] | 10.65% | [23],[24],[25] | 10.65% | [23],[24],[25] | |||
Investment, principal | $ 45,125 | [16],[20],[26] | $ 45,243 | [23],[24],[27] | |||||||||||
Investment, cost | 44,652 | [16],[20] | 44,717 | [23],[24] | |||||||||||
Investments at fair value | $ 43,771 | [16],[20] | $ 43,886 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 559 | [16] | 559 | [16] | 559 | [16] | 559 | [24] | 559 | [24] | 559 | [24] | |||
Investment, principal | [24],[27] | ||||||||||||||
Investment, cost | $ 563 | [16] | 563 | [24] | |||||||||||
Investments at fair value | $ 268 | [16] | $ 372 | [24] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [16],[20] | 9.50% | [16],[20] | 9.50% | [16],[20] | 8.50% | [23],[24] | 8.50% | [23],[24] | 8.50% | [23],[24] | |||
Investment, interest rate | 5% | [16],[19],[20] | 5% | [16],[19],[20] | 5% | [16],[19],[20] | 13.99% | [23],[24],[25] | 13.99% | [23],[24],[25] | 13.99% | [23],[24],[25] | |||
Investment, interest rate, paid in kind | 9.95% | 9.95% | 9.95% | ||||||||||||
Investment, principal | $ 3,012 | [16],[20],[26] | $ 5,403 | [23],[24],[27] | |||||||||||
Investment, cost | 2,968 | [16],[20] | 5,348 | [23],[24] | |||||||||||
Investments at fair value | $ 2,846 | [16],[20] | $ 5,160 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [16],[20] | 9.50% | [16],[20] | 9.50% | [16],[20] | 8.50% | [21],[23],[24] | 8.50% | [21],[23],[24] | 8.50% | [21],[23],[24] | |||
Investment, interest rate | 5% | [16],[19],[20] | 5% | [16],[19],[20] | 5% | [16],[19],[20] | 13.99% | [21],[23],[24],[25] | 13.99% | [21],[23],[24],[25] | 13.99% | [21],[23],[24],[25] | |||
Investment, interest rate, paid in kind | 9.95% | 9.95% | 9.95% | ||||||||||||
Investment, principal | $ 5,536 | [16],[20],[26] | $ 2,939 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 5,486 | [16],[20] | 2,884 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 5,232 | [16],[20] | $ 2,745 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | 6% | [21],[23],[24] | |||
Investment, interest rate | [21],[23],[24],[25] | 11.42% | 11.42% | 11.42% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 964 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (26) | [16],[17],[20] | 936 | [21],[23],[24] | |||||||||||
Investments at fair value | $ (27) | [16],[17],[20] | $ 938 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.53% | [16],[19],[20] | 11.53% | [16],[19],[20] | 11.53% | [16],[19],[20] | 11.52% | [23],[24],[25] | 11.52% | [23],[24],[25] | 11.52% | [23],[24],[25] | |||
Investment, principal | $ 2,624 | [16],[20],[26] | $ 20,125 | [23],[24],[27] | |||||||||||
Investment, cost | 2,581 | [16],[20] | 19,912 | [23],[24] | |||||||||||
Investments at fair value | $ 2,585 | [16],[20] | $ 19,823 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [16],[17],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.53% | [19],[20] | 11.53% | [19],[20] | 11.53% | [19],[20] | 11.52% | [23],[24],[25] | 11.52% | [23],[24],[25] | 11.52% | [23],[24],[25] | |||
Investment, principal | $ 11,802 | [16],[17],[20],[26] | $ 2,631 | [23],[24],[27] | |||||||||||
Investment, cost | 11,685 | [16],[17],[20] | 2,587 | [23],[24] | |||||||||||
Investments at fair value | $ 11,625 | [16],[17],[20] | $ 2,591 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [16],[17],[20] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | 7.50% | [21],[23],[24] | |||
Investment, interest rate | 12.86% | [16],[17],[19],[20] | 12.86% | [16],[17],[19],[20] | 12.86% | [16],[17],[19],[20] | 12.83% | [21],[23],[24],[25] | 12.83% | [21],[23],[24],[25] | 12.83% | [21],[23],[24],[25] | |||
Investment, principal | $ 8,308 | [16],[17],[20],[26] | $ 1,466 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 8,070 | [16],[17],[20] | 1,215 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 8,308 | [16],[17],[20] | $ 1,282 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [16],[20] | 7.50% | [23],[24] | 7.50% | [23],[24] | 7.50% | [23],[24] | |||
Investment, interest rate | 12.89% | [16],[19],[20] | 12.89% | [16],[19],[20] | 12.89% | [16],[19],[20] | 12.89% | [23],[24],[25] | 12.89% | [23],[24],[25] | 12.89% | [23],[24],[25] | |||
Investment, principal | $ 40,538 | [16],[20],[26] | $ 40,538 | [23],[24],[27] | |||||||||||
Investment, cost | 39,910 | [16],[20] | 39,873 | [23],[24] | |||||||||||
Investments at fair value | $ 40,944 | [16],[20] | $ 39,833 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [16],[17],[20] | 5.50% | [16],[17],[20] | 5.50% | [16],[17],[20] | 5.50% | [21],[23],[24] | 5.50% | [21],[23],[24] | 5.50% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (55) | [16],[17],[20] | (28) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (27) | [16],[17],[20] | $ (47) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [16],[20] | 5.50% | [16],[20] | 5.50% | [16],[20] | 5.50% | [23],[24] | 5.50% | [23],[24] | 5.50% | [23],[24] | |||
Investment, interest rate | 10.95% | [19],[20] | 10.95% | [19],[20] | 10.95% | [19],[20] | 10.99% | [23],[24],[25] | 10.99% | [23],[24],[25] | 10.99% | [23],[24],[25] | |||
Investment, principal | $ 21,272 | [16],[20],[26] | $ 13,973 | [23],[24],[27] | |||||||||||
Investment, cost | 20,949 | [16],[20] | 13,936 | [23],[24] | |||||||||||
Investments at fair value | $ 21,060 | [16],[20] | $ 13,685 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [16],[20] | 5.50% | [16],[20] | 5.50% | [16],[20] | 5.50% | [23],[24] | 5.50% | [23],[24] | 5.50% | [23],[24] | |||
Investment, interest rate | 10.95% | [16],[19],[20] | 10.95% | [16],[19],[20] | 10.95% | [16],[19],[20] | 10.99% | [23],[24],[25] | 10.99% | [23],[24],[25] | 10.99% | [23],[24],[25] | |||
Investment, principal | $ 13,937 | [16],[20],[26] | $ 21,328 | [23],[24],[27] | |||||||||||
Investment, cost | 13,897 | [16],[20] | 21,021 | [23],[24] | |||||||||||
Investments at fair value | $ 13,797 | [16],[20] | $ 20,888 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | 0 | |||||||||||||
Investments at fair value | [16],[17],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 11.50% | [16],[19],[20],[28] | 11.50% | [16],[19],[20],[28] | 11.50% | [16],[19],[20],[28] | 11.50% | [23],[24],[25],[30] | 11.50% | [23],[24],[25],[30] | 11.50% | [23],[24],[25],[30] | |||
Investment, principal | $ 8,568 | [16],[26],[28] | $ 8,568 | [24],[27],[30] | |||||||||||
Investment, cost | 8,502 | [16],[28] | 8,495 | [24],[30] | |||||||||||
Investments at fair value | $ 8,139 | [16],[28] | $ 8,132 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | 11.50% | [16],[19],[20],[28] | 11.50% | [16],[19],[20],[28] | 11.50% | [16],[19],[20],[28] | 11.50% | [23],[24],[25],[30] | 11.50% | [23],[24],[25],[30] | 11.50% | [23],[24],[25],[30] | |||
Investment, principal | $ 8,568 | [16],[26],[28] | $ 4,284 | [24],[27],[30] | |||||||||||
Investment, cost | 8,502 | [16],[28] | 4,247 | [24],[30] | |||||||||||
Investments at fair value | $ 8,139 | [16],[28] | $ 4,066 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | 11.50% | [16],[19],[20],[28] | 11.50% | [16],[19],[20],[28] | 11.50% | [16],[19],[20],[28] | 11.50% | [23],[24],[25],[30] | 11.50% | [23],[24],[25],[30] | 11.50% | [23],[24],[25],[30] | |||
Investment, principal | $ 4,284 | [16],[26],[28] | $ 8,568 | [24],[27],[30] | |||||||||||
Investment, cost | 4,251 | [16],[28] | 8,495 | [24],[30] | |||||||||||
Investments at fair value | $ 4,070 | [16],[28] | $ 8,132 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 8% | [16],[19],[20],[28] | 8% | [16],[19],[20],[28] | 8% | [16],[19],[20],[28] | 8% | [23],[24],[25],[30] | 8% | [23],[24],[25],[30] | 8% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 1.75% | [16],[28] | 1.75% | [16],[28] | 1.75% | [16],[28] | 1.75% | [24],[30] | 1.75% | [24],[30] | 1.75% | [24],[30] | |||
Investment, principal | $ 9,129 | [16],[26],[28] | $ 9,106 | [24],[27],[30] | |||||||||||
Investment, cost | 8,644 | [16],[28] | 8,580 | [24],[30] | |||||||||||
Investments at fair value | $ 8,147 | [16],[28] | $ 8,013 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,817 | [16],[28] | 66,817 | [16],[28] | 66,817 | [16],[28] | 259,877 | [24],[30] | 259,877 | [24],[30] | 259,877 | [24],[30] | |||
Investment, principal | [24],[27],[30] | ||||||||||||||
Investment, cost | $ 23 | [16],[28] | 545 | [24],[30] | |||||||||||
Investments at fair value | $ 27 | [16],[28] | $ 78 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 259,877 | [16],[28] | 259,877 | [16],[28] | 259,877 | [16],[28] | 66,817 | [24],[30] | 66,817 | [24],[30] | 66,817 | [24],[30] | |||
Investment, principal | [24],[27],[30] | ||||||||||||||
Investment, cost | $ 545 | [16],[28] | 23 | [24],[30] | |||||||||||
Investments at fair value | $ 65 | [16],[28] | $ 33 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (35) | [16],[17],[20] | (43) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (67) | [16],[17],[20] | $ (76) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate | 12.53% | [19],[20] | 12.53% | [19],[20] | 12.53% | [19],[20] | 12.52% | [23],[24],[25] | 12.52% | [23],[24],[25] | 12.52% | [23],[24],[25] | |||
Investment, principal | $ 46,687 | [16],[20],[26] | $ 5,248 | [23],[24],[27] | |||||||||||
Investment, cost | 46,322 | [16],[20] | 5,220 | [23],[24] | |||||||||||
Investments at fair value | $ 46,033 | [16],[20] | $ 5,164 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate | 12.53% | [16],[19],[20] | 12.53% | [16],[19],[20] | 12.53% | [16],[19],[20] | 12.52% | [23],[24],[25] | 12.52% | [23],[24],[25] | 12.52% | [23],[24],[25] | |||
Investment, principal | $ 5,248 | [16],[20],[26] | $ 46,687 | [23],[24],[27] | |||||||||||
Investment, cost | 5,225 | [16],[20] | 46,239 | [23],[24] | |||||||||||
Investments at fair value | $ 5,175 | [16],[20] | $ 45,940 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [16],[20] | 6.75% | [16],[20] | 6.75% | [16],[20] | 6.75% | [23],[24] | 6.75% | [23],[24] | 6.75% | [23],[24] | |||
Investment, interest rate | 13.60% | [16],[19],[20] | 13.60% | [16],[19],[20] | 13.60% | [16],[19],[20] | 12.51% | [23],[24],[25] | 12.51% | [23],[24],[25] | 12.51% | [23],[24],[25] | |||
Investment, principal | $ 49,266 | [16],[20],[26] | $ 54,559 | [23],[24],[27] | |||||||||||
Investment, cost | 49,001 | [16],[20] | 54,236 | [23],[24] | |||||||||||
Investments at fair value | $ 48,034 | [16],[20] | $ 53,168 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 6.88% | [19],[20] | 6.88% | [19],[20] | 6.88% | [19],[20] | 6.88% | [23],[25] | 6.88% | [23],[25] | 6.88% | [23],[25] | |||
Investment, principal | $ 10,191 | [26] | $ 10,191 | [27] | |||||||||||
Investment, cost | 9,846 | 9,831 | |||||||||||||
Investments at fair value | $ 10,368 | $ 8,743 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.88% | [16],[20],[28] | 6.88% | [16],[20],[28] | 6.88% | [16],[20],[28] | 6.88% | [23],[24],[30] | 6.88% | [23],[24],[30] | 6.88% | [23],[24],[30] | |||
Investment, interest rate | 12.33% | [16],[19],[20],[28] | 12.33% | [16],[19],[20],[28] | 12.33% | [16],[19],[20],[28] | 12.29% | [23],[24],[25],[30] | 12.29% | [23],[24],[25],[30] | 12.29% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 2% | [16],[20],[28] | 2% | [16],[20],[28] | 2% | [16],[20],[28] | 2% | [23],[24],[30] | 2% | [23],[24],[30] | 2% | [23],[24],[30] | |||
Investment, principal | $ 73,547 | [16],[20],[26],[28] | $ 73,362 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 72,724 | [16],[20],[28] | 72,459 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 70,201 | [16],[20],[28] | $ 69,694 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | [28] | 487,870 | [28] | 487,870 | [28] | 487,870 | [30] | 487,870 | [30] | 487,870 | [30] | |||
Investment, cost | $ 0 | [28] | $ 0 | [30] | |||||||||||
Investments at fair value | $ 1,947 | [28] | $ 903 | [30] | |||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | [28] | 487,870 | [28] | 487,870 | [28] | 487,870 | [30] | 487,870 | [30] | 487,870 | [30] | |||
Investment, cost | $ 0 | [28] | $ 0 | [30] | |||||||||||
Investments at fair value | $ 1,947 | [28] | $ 903 | [30] | |||||||||||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [16],[20] | 8.50% | [23],[24] | 8.50% | [23],[24] | 8.50% | [23],[24] | |||
Investment, interest rate | 13.93% | [16],[19],[20] | 13.93% | [16],[19],[20] | 13.93% | [16],[19],[20] | 13.99% | [23],[24],[25] | 13.99% | [23],[24],[25] | 13.99% | [23],[24],[25] | |||
Investment, principal | $ 30,339 | [16],[20],[26] | $ 30,339 | [23],[24],[27] | |||||||||||
Investment, cost | 30,040 | [16],[20] | 30,021 | [23],[24] | |||||||||||
Investments at fair value | $ 30,166 | [16],[20] | $ 29,007 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [16],[20] | 9.50% | [16],[20] | 9.50% | [16],[20] | 9.50% | [23],[24] | 9.50% | [23],[24] | 9.50% | [23],[24] | |||
Investment, interest rate | 14.83% | [16],[19],[20] | 14.83% | [16],[19],[20] | 14.83% | [16],[19],[20] | 14.89% | [23],[24],[25] | 14.89% | [23],[24],[25] | 14.89% | [23],[24],[25] | |||
Investment, principal | $ 64,606 | [16],[20],[26] | $ 64,606 | [23],[24],[27] | |||||||||||
Investment, cost | 64,689 | [16],[20] | 64,720 | [23],[24] | |||||||||||
Investments at fair value | $ 63,185 | [16],[20] | $ 63,185 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (28) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (23) | |||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [16],[19],[20] | 11.37% | 11.37% | 11.37% | |||||||||||
Investment, principal | [16],[20],[26] | $ 19,995 | |||||||||||||
Investment, cost | [16],[20] | 19,695 | |||||||||||||
Investments at fair value | [16],[20] | $ 19,751 | |||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (38) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (38) | |||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment owned, ownership percentage | 87.50% | [17],[28],[37],[38] | 87.50% | [17],[28],[37],[38] | 87.50% | [17],[28],[37],[38] | 87.50% | [21],[30],[39],[40] | 87.50% | [21],[30],[39],[40] | 87.50% | [21],[30],[39],[40] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | $ 0 | [17],[28],[37],[38] | $ 0 | [21],[30],[39],[40] | |||||||||||
Investments at fair value | $ 0 | [17],[28],[37],[38] | $ 0 | [21],[30],[39],[40] | $ 0 | 0 | |||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [16],[17],[20],[28],[37] | 4.50% | [16],[17],[20],[28],[37] | 4.50% | [16],[17],[20],[28],[37] | 4.50% | [21],[24],[30],[39] | 4.50% | [21],[24],[30],[39] | 4.50% | [21],[24],[30],[39] | 4.50% | ||
Investment, interest rate | 9.94% | [16],[17],[19],[20],[28],[37] | 9.94% | [16],[17],[19],[20],[28],[37] | 9.94% | [16],[17],[19],[20],[28],[37] | 9.76% | [21],[23],[24],[25],[30],[39] | 9.76% | [21],[23],[24],[25],[30],[39] | 9.76% | [21],[23],[24],[25],[30],[39] | 7.67% | ||
Investment, principal | $ 58,349 | [16],[17],[20],[26],[28],[37] | $ 58,349 | [21],[24],[27],[30],[39] | $ 59,049 | ||||||||||
Investment, cost | 50,621 | [16],[17],[20],[28],[37] | 50,330 | [21],[24],[30],[39] | |||||||||||
Investments at fair value | $ 50,957 | [16],[17],[20],[28],[37] | $ 50,017 | [21],[24],[30],[39] | $ 49,536 | 50,283 | |||||||||
Investment owned, percent of net assets | 3.40% | 3.40% | 3.40% | 4.10% | |||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate | 12.46% | [16],[19],[20] | 12.46% | [16],[19],[20] | 12.46% | [16],[19],[20] | 12.49% | [23],[24],[25] | 12.49% | [23],[24],[25] | 12.49% | [23],[24],[25] | |||
Investment, principal | $ 9,323 | [16],[20],[26] | $ 9,323 | [23],[24],[27] | |||||||||||
Investment, cost | 9,216 | [16],[20] | 9,210 | [23],[24] | |||||||||||
Investments at fair value | $ 9,183 | [16],[20] | $ 9,183 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 10% | [16],[20],[32] | 10% | [16],[20],[32] | 10% | [16],[20],[32] | 10% | [23],[24] | 10% | [23],[24] | 10% | [23],[24] | |||
Investment, interest rate, paid in kind | [23],[24] | 15.67% | 15.67% | 15.67% | |||||||||||
Investment, principal | $ 1,303 | [16],[20],[26],[32] | $ 25,712 | [23],[24],[27] | |||||||||||
Investment, cost | 1,202 | [16],[20],[32] | 25,615 | [23],[24] | |||||||||||
Investments at fair value | $ 1,074 | [16],[20],[32] | $ 25,069 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 10% | [16],[20],[32] | 10% | [16],[20],[32] | 10% | [16],[20],[32] | 10% | [21],[23],[24] | 10% | [21],[23],[24] | 10% | [21],[23],[24] | |||
Investment, principal | $ 31,515 | [16],[20],[26],[32] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 26,979 | [16],[20],[32] | (11) | [21],[23],[24] | |||||||||||
Investments at fair value | $ 25,959 | [16],[20],[32] | $ (69) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 12% | [16],[17],[20],[32] | 12% | [16],[17],[20],[32] | 12% | [16],[17],[20],[32] | 10% | [21],[23],[24] | 10% | [21],[23],[24] | 10% | [21],[23],[24] | |||
Investment, interest rate, paid in kind | [21],[23],[24] | 15.64% | 15.64% | 15.64% | |||||||||||
Investment, principal | $ 233 | [16],[17],[20],[26],[32] | $ 1,210 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 233 | [16],[17],[20],[32] | 1,193 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 233 | [16],[17],[20],[32] | $ 1,169 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [16],[17],[20] | 7.75% | [16],[17],[20] | 7.75% | [16],[17],[20] | 7.75% | [21],[23],[24] | 7.75% | [21],[23],[24] | 7.75% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (40) | [16],[17],[20] | (42) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (29) | [16],[17],[20] | $ (36) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [16],[20] | 7.75% | [16],[20] | 7.75% | [16],[20] | 7.75% | [23],[24] | 7.75% | [23],[24] | 7.75% | [23],[24] | |||
Investment, interest rate | 13.13% | [16],[19],[20] | 13.13% | [16],[19],[20] | 13.13% | [16],[19],[20] | 13.12% | [23],[24],[25] | 13.12% | [23],[24],[25] | 13.12% | [23],[24],[25] | |||
Investment, principal | $ 15,231 | [16],[20],[26] | $ 15,231 | [23],[24],[27] | |||||||||||
Investment, cost | 14,908 | [16],[20] | 14,892 | [23],[24] | |||||||||||
Investments at fair value | 15,003 | [16],[20] | 14,945 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Other cash accounts | |||||||||||||||
Investment, cost | 122,975 | 62,277 | |||||||||||||
Investments at fair value | $ 122,975 | $ 62,277 | |||||||||||||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [23],[25] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [27] | $ 4,519 | |||||||||||||
Investment, cost | 4,550 | ||||||||||||||
Investments at fair value | $ 3,305 | ||||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [16],[17],[20] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | 7% | [21],[23],[24] | |||
Investment, interest rate | [16],[17],[19],[20] | 12.35% | 12.35% | 12.35% | |||||||||||
Investment, principal | $ 98 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 48 | [16],[17],[20] | (53) | [21],[23],[24] | |||||||||||
Investments at fair value | $ 44 | [16],[17],[20] | $ (54) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate | 12.36% | [16],[19],[20] | 12.36% | [16],[19],[20] | 12.36% | [16],[19],[20] | 12.32% | [23],[24],[25] | 12.32% | [23],[24],[25] | 12.32% | [23],[24],[25] | |||
Investment, principal | $ 10,868 | [16],[20],[26] | $ 10,895 | [23],[24],[27] | |||||||||||
Investment, cost | 10,497 | [16],[20] | 10,505 | [23],[24] | |||||||||||
Investments at fair value | $ 10,469 | [16],[20] | $ 10,495 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 100,000 | [16] | 100,000 | [16] | 100,000 | [16] | 100,000 | [24] | 100,000 | [24] | 100,000 | [24] | |||
Investment, cost | $ 109 | [16] | $ 109 | [24] | |||||||||||
Investments at fair value | $ 300 | [16] | $ 248 | [24] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (30) | [16],[17],[20] | (34) | [21],[23],[24] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[20] | $ (3) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 12.04% | [16],[19],[20] | 12.04% | [16],[19],[20] | 12.04% | [16],[19],[20] | 12.01% | [23],[24],[25] | 12.01% | [23],[24],[25] | 12.01% | [23],[24],[25] | |||
Investment, principal | $ 38,308 | [16],[20],[26] | $ 38,414 | [23],[24],[27] | |||||||||||
Investment, cost | 37,902 | [16],[20] | 37,960 | [23],[24] | |||||||||||
Investments at fair value | $ 38,308 | [16],[20] | $ 38,380 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [20] | 5% | [20] | 5% | [20] | 5% | [23] | 5% | [23] | 5% | [23] | |||
Investment, interest rate | 10.46% | [19],[20] | 10.46% | [19],[20] | 10.46% | [19],[20] | 10.42% | [23],[25] | 10.42% | [23],[25] | 10.42% | [23],[25] | |||
Investment, principal | $ 9,651 | [20],[26] | $ 9,676 | [23],[27] | |||||||||||
Investment, cost | 9,500 | [20] | 9,518 | [23] | |||||||||||
Investments at fair value | $ 9,630 | [20] | $ 9,551 | [23] | |||||||||||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | [16],[20] | 5.75% | [16],[20] | 5.75% | [16],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.32% | [16],[19],[20] | 11.32% | [16],[19],[20] | 11.32% | [16],[19],[20] | 11.57% | [23],[24],[25] | 11.57% | [23],[24],[25] | 11.57% | [23],[24],[25] | |||
Investment, principal | $ 22,375 | [16],[20],[26] | $ 22,375 | [23],[24],[27] | |||||||||||
Investment, cost | 22,201 | [16],[20] | 22,189 | [23],[24] | |||||||||||
Investments at fair value | $ 21,928 | [16],[20] | $ 21,896 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (134) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (133) | |||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [16],[19],[20] | 11.36% | 11.36% | 11.36% | |||||||||||
Investment, principal | [16],[20],[26] | $ 52,639 | |||||||||||||
Investment, cost | [16],[20] | 51,606 | |||||||||||||
Investments at fair value | [16],[20] | $ 51,618 | |||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (69) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (69) | |||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | [16] | 4,531,000 | 4,531,000 | 4,531,000 | |||||||||||
Investment, cost | [16] | $ 4,440 | |||||||||||||
Investments at fair value | [16] | $ 4,444 | |||||||||||||
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [26] | $ 2,300 | |||||||||||||
Investment, cost | 2,122 | ||||||||||||||
Investments at fair value | $ 2,192 | ||||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [23],[24] | 7.25% | [23],[24] | 7.25% | [23],[24] | |||
Investment, interest rate | 12.70% | [16],[19],[20] | 12.70% | [16],[19],[20] | 12.70% | [16],[19],[20] | 12.74% | [23],[24],[25] | 12.74% | [23],[24],[25] | 12.74% | [23],[24],[25] | |||
Investment, principal | $ 36,499 | [16],[20],[26] | $ 36,499 | [23],[24],[27] | |||||||||||
Investment, cost | 35,490 | [16],[20] | 35,458 | [23],[24] | |||||||||||
Investments at fair value | $ 33,397 | [16],[20] | $ 33,214 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[17],[20] | 8% | [16],[17],[20] | 8% | [16],[17],[20] | 8% | [21],[23],[24] | 8% | [21],[23],[24] | 8% | [21],[23],[24] | |||
Investment, interest rate | 13.56% | [16],[17],[19],[20] | 13.56% | [16],[17],[19],[20] | 13.56% | [16],[17],[19],[20] | 13.45% | [21],[23],[24],[25] | 13.45% | [21],[23],[24],[25] | 13.45% | [21],[23],[24],[25] | |||
Investment, principal | $ 3,722 | [16],[17],[20],[26] | $ 3,003 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 3,649 | [16],[17],[20] | 2,926 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 3,540 | [16],[17],[20] | $ 2,801 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[20] | 8% | [16],[20] | 8% | [16],[20] | 8% | [23],[24] | 8% | [23],[24] | 8% | [23],[24] | |||
Investment, interest rate | 13.56% | [16],[19],[20] | 13.56% | [16],[19],[20] | 13.56% | [16],[19],[20] | 13.45% | [23],[24],[25] | 13.45% | [23],[24],[25] | 13.45% | [23],[24],[25] | |||
Investment, principal | $ 67,244 | [16],[20],[26] | $ 67,244 | [23],[24],[27] | |||||||||||
Investment, cost | 66,418 | [16],[20] | 66,353 | [23],[24] | |||||||||||
Investments at fair value | $ 64,689 | [16],[20] | $ 64,406 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond | |||||||||||||||
Investment, basis spread, variable rate | [16],[20],[28] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [16],[19],[20],[28] | 12.60% | 12.60% | 12.60% | |||||||||||
Investment, principal | [16],[20],[26],[28] | $ 28,818 | |||||||||||||
Investment, cost | [16],[20],[28] | 28,530 | |||||||||||||
Investments at fair value | [16],[20],[28] | $ 28,530 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.78% | 12.78% | 12.78% | |||||||||||
Investment, principal | [23],[24],[27] | $ 24,503 | |||||||||||||
Investment, cost | [23],[24] | 24,255 | |||||||||||||
Investments at fair value | [23],[24] | $ 24,081 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.78% | 12.78% | 12.78% | |||||||||||
Investment, principal | [23],[24],[27] | $ 2,819 | |||||||||||||
Investment, cost | [23],[24] | 2,797 | |||||||||||||
Investments at fair value | [23],[24] | $ 2,771 | |||||||||||||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [16],[20],[28] | 5.50% | [16],[20],[28] | 5.50% | [16],[20],[28] | 5.75% | [23],[24],[30] | 5.75% | [23],[24],[30] | 5.75% | [23],[24],[30] | |||
Investment, interest rate | 10.96% | [16],[19],[20],[28] | 10.96% | [16],[19],[20],[28] | 10.96% | [16],[19],[20],[28] | 11.21% | [23],[24],[25],[30] | 11.21% | [23],[24],[25],[30] | 11.21% | [23],[24],[25],[30] | |||
Investment, principal | £ | £ 6,136 | [16],[20],[26],[28] | £ 4,626 | [23],[24],[27],[30] | |||||||||||
Investment, cost | $ 7,677 | [16],[20],[28] | $ 5,897 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 7,353 | [16],[20],[28] | $ 5,166 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 64,887,669 | [16] | 64,887,669 | [16] | 64,887,669 | [16] | 64,887,669 | [24] | 64,887,669 | [24] | 64,887,669 | [24] | |||
Investment, cost | $ 375 | [16] | $ 375 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [16],[17],[20] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | 6.50% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (40) | [16],[17],[20] | (43) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (35) | [16],[17],[20] | $ (47) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [16],[20] | 6.50% | [23],[24] | 6.50% | [23],[24] | 6.50% | [23],[24] | |||
Investment, interest rate | 11.96% | [16],[19],[20] | 11.96% | [16],[19],[20] | 11.96% | [16],[19],[20] | 11.92% | [23],[24],[25] | 11.92% | [23],[24],[25] | 11.92% | [23],[24],[25] | |||
Investment, principal | $ 32,329 | [16],[20],[26] | $ 32,329 | [23],[24],[27] | |||||||||||
Investment, cost | 32,089 | [16],[20] | 32,070 | [23],[24] | |||||||||||
Investments at fair value | $ 31,915 | [16],[20] | $ 31,779 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.25% | [23],[24],[30] | 8.25% | [23],[24],[30] | 8.25% | [23],[24],[30] | |||
Investment, interest rate | 13.86% | [16],[19],[20],[28] | 13.86% | [16],[19],[20],[28] | 13.86% | [16],[19],[20],[28] | 13.90% | [23],[24],[25],[30] | 13.90% | [23],[24],[25],[30] | 13.90% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 0.50% | [16],[20],[28] | 0.50% | [16],[20],[28] | 0.50% | [16],[20],[28] | 0.50% | [23],[24],[30] | 0.50% | [23],[24],[30] | 0.50% | [23],[24],[30] | |||
Investment, principal | $ 9,697 | [16],[20],[26],[28] | $ 36,707 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 9,405 | [16],[20],[28] | 35,548 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 9,115 | [16],[20],[28] | $ 34,505 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.25% | [23],[24],[30] | 8.25% | [23],[24],[30] | 8.25% | [23],[24],[30] | |||
Investment, interest rate | 13.86% | [16],[19],[20],[28] | 13.86% | [16],[19],[20],[28] | 13.86% | [16],[19],[20],[28] | 13.90% | [23],[24],[25],[30] | 13.90% | [23],[24],[25],[30] | 13.90% | [23],[24],[25],[30] | |||
Investment, interest rate, paid in kind | 0.50% | [16],[20],[28] | 0.50% | [16],[20],[28] | 0.50% | [16],[20],[28] | 0.50% | [23],[24],[30] | 0.50% | [23],[24],[30] | 0.50% | [23],[24],[30] | |||
Investment, principal | $ 32,133 | [16],[20],[26],[28] | $ 13,504 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 31,203 | [16],[20],[28] | 13,058 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 30,205 | [16],[20],[28] | $ 12,694 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 204,454 | [16],[28] | 204,454 | [16],[28] | 204,454 | [16],[28] | 204,454 | [24],[30] | 204,454 | [24],[30] | 204,454 | [24],[30] | |||
Investment, cost | $ 1,202 | [16],[28] | $ 1,202 | [24],[30] | |||||||||||
Investments at fair value | $ 1,073 | [16],[28] | $ 756 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 4.88% | 4.88% | 4.88% | |||||||||||
Investment, principal | [26] | $ 1,680 | |||||||||||||
Investment, cost | 1,539 | ||||||||||||||
Investments at fair value | $ 1,573 | ||||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,037 | [16] | 1,037 | [16] | 1,037 | [16] | 1,037 | [24] | 1,037 | [24] | 1,037 | [24] | |||
Investment, cost | $ 1,037 | [16] | $ 1,037 | [24] | |||||||||||
Investments at fair value | $ 1,024 | [16] | $ 951 | [24] | |||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [16],[17],[20] | 8.75% | [16],[17],[20] | 8.75% | [16],[17],[20] | 8.75% | [23],[24] | 8.75% | [23],[24] | 8.75% | [23],[24] | |||
Investment, interest rate | 14.20% | [16],[17],[19],[20] | 14.20% | [16],[17],[19],[20] | 14.20% | [16],[17],[19],[20] | 14.18% | [23],[24],[25] | 14.18% | [23],[24],[25] | 14.18% | [23],[24],[25] | |||
Investment, principal | $ 990 | [16],[17],[20],[26] | $ 8,010 | [23],[24],[27] | |||||||||||
Investment, cost | 954 | [16],[17],[20] | 7,799 | [23],[24] | |||||||||||
Investments at fair value | $ 921 | [16],[17],[20] | $ 7,778 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [16],[20] | 8.75% | [16],[20] | 8.75% | [16],[20] | 8.75% | [21],[23],[24] | 8.75% | [21],[23],[24] | 8.75% | [21],[23],[24] | |||
Investment, interest rate | [16],[19],[20] | 14.21% | 14.21% | 14.21% | |||||||||||
Investment, principal | $ 8,010 | [16],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 7,807 | [16],[20] | (35) | [21],[23],[24] | |||||||||||
Investments at fair value | $ 7,778 | [16],[20] | $ (68) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,184,630 | [16] | 1,184,630 | [16] | 1,184,630 | [16] | 1,184,630 | [24] | 1,184,630 | [24] | 1,184,630 | [24] | |||
Investment, cost | $ 40,094 | [16] | $ 40,093 | [24] | |||||||||||
Investments at fair value | $ 36,226 | [16] | $ 36,226 | [24] | |||||||||||
Investment owned, percent of net assets | 2.40% | 2.40% | 2.40% | ||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate, paid in kind | 12% | [16] | 12% | [16] | 12% | [16] | 12% | [24] | 12% | [24] | 12% | [24] | |||
Investment, principal | $ 16,355 | [16],[26] | $ 15,874 | [24],[27] | |||||||||||
Investment, cost | 14,634 | [16] | 14,100 | [24] | |||||||||||
Investments at fair value | $ 16,355 | [16] | $ 15,874 | [24] | |||||||||||
Investment owned, percent of net assets | 1.10% | 1.10% | 1.10% | ||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate, paid in kind | 12% | [16],[17] | 12% | [16],[17] | 12% | [16],[17] | 12% | [21],[24] | 12% | [21],[24] | 12% | [21],[24] | |||
Investment, principal | $ 3,005 | [16],[17],[26] | $ 1,359 | [21],[24],[27] | |||||||||||
Investment, cost | 2,951 | [16],[17] | 1,337 | [21],[24] | |||||||||||
Investments at fair value | $ 3,005 | [16],[17] | $ 1,359 | [21],[24] | |||||||||||
Investment owned, percent of net assets | 0.20% | 0.20% | 0.20% | ||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,686 | [16] | 66,686 | [16] | 66,686 | [16] | 66,686 | [24] | 66,686 | [24] | 66,686 | [24] | |||
Investment, cost | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | ||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | [16],[20] | 4.75% | [16],[20] | 4.75% | [16],[20] | 4.75% | [23],[24] | 4.75% | [23],[24] | 4.75% | [23],[24] | |||
Investment, interest rate | 10.39% | [16],[19],[20] | 10.39% | [16],[19],[20] | 10.39% | [16],[19],[20] | 10.38% | [23],[24],[25] | 10.38% | [23],[24],[25] | 10.38% | [23],[24],[25] | |||
Investment, principal | $ 4,440 | [16],[20],[26] | $ 4,452 | [23],[24],[27] | |||||||||||
Investment, cost | 3,833 | [16],[20] | 3,806 | [23],[24] | |||||||||||
Investments at fair value | $ 4,307 | [16],[20] | $ 4,184 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[20] | 8% | [16],[20] | 8% | [16],[20] | 8% | [23],[24] | 8% | [23],[24] | 8% | [23],[24] | |||
Investment, interest rate | 13.64% | [16],[19],[20] | 13.64% | [16],[19],[20] | 13.64% | [16],[19],[20] | 13.63% | [23],[24],[25] | 13.63% | [23],[24],[25] | 13.63% | [23],[24],[25] | |||
Investment, principal | $ 12,034 | [16],[20],[26] | $ 12,034 | [23],[24],[27] | |||||||||||
Investment, cost | 11,280 | [16],[20] | 11,250 | [23],[24] | |||||||||||
Investments at fair value | $ 10,169 | [16],[20] | $ 9,928 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [26] | $ 1,590 | |||||||||||||
Investment, cost | 1,531 | ||||||||||||||
Investments at fair value | $ 1,592 | ||||||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [16],[20],[32] | 6.75% | [16],[20],[32] | 6.75% | [16],[20],[32] | 6.75% | [23],[24] | 6.75% | [23],[24] | 6.75% | [23],[24] | |||
Investment, interest rate | [23],[24],[25] | 12.40% | 12.40% | 12.40% | |||||||||||
Investment, principal | $ 25,462 | [16],[20],[26],[32] | $ 25,527 | [23],[24],[27] | |||||||||||
Investment, cost | 23,085 | [16],[20],[32] | 23,859 | [23],[24] | |||||||||||
Investments at fair value | $ 14,131 | [16],[20],[32] | $ 19,954 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 10% | [16],[17],[20] | 10% | [16],[17],[20] | 10% | [16],[17],[20] | 10% | [21],[23],[24] | 10% | [21],[23],[24] | 10% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (87) | [16],[17],[20] | (95) | [21],[23],[24] | |||||||||||
Investments at fair value | $ (85) | [16],[17],[20] | $ (93) | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 10% | [16],[20] | 10% | [16],[20] | 10% | [16],[20] | 10% | [23],[24] | 10% | [23],[24] | 10% | [23],[24] | |||
Investment, interest rate | 15.36% | [16],[19],[20] | 15.36% | [16],[19],[20] | 15.36% | [16],[19],[20] | 15.24% | [23],[24],[25] | 15.24% | [23],[24],[25] | 15.24% | [23],[24],[25] | |||
Investment, principal | $ 25,418 | [16],[20],[26] | $ 25,558 | [23],[24],[27] | |||||||||||
Investment, cost | 24,707 | [16],[20] | 24,777 | [23],[24] | |||||||||||
Investments at fair value | $ 24,719 | [16],[20] | $ 24,791 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 991,019 | [16] | 991,019 | [16] | 991,019 | [16] | 991,019 | [24] | 991,019 | [24] | 991,019 | [24] | |||
Investment, cost | $ 327 | [16] | $ 327 | [24] | |||||||||||
Investments at fair value | $ 1,536 | [16] | $ 1,625 | [24] | |||||||||||
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 9,307 | [28] | 9,307 | [28] | 9,307 | [28] | 9,307 | [30] | 9,307 | [30] | 9,307 | [30] | |||
Investment, cost | $ 78 | [28] | $ 78 | [30] | |||||||||||
Investments at fair value | $ 19 | [28] | $ 13 | [30] | |||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment owned, ownership percentage | 87.50% | [17],[28],[36],[37],[38] | 87.50% | [17],[28],[36],[37],[38] | 87.50% | [17],[28],[36],[37],[38] | 87.50% | [21],[30],[39],[40],[41] | 87.50% | [21],[30],[39],[40],[41] | 87.50% | [21],[30],[39],[40],[41] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | $ 54,791 | [17],[28],[36],[37],[38] | $ 54,791 | [21],[30],[39],[40],[41] | |||||||||||
Investments at fair value | $ 29,587 | [17],[28],[36],[37],[38] | $ 28,878 | [21],[30],[39],[40],[41] | $ 24,108 | 20,715 | |||||||||
Investment owned, percent of net assets | 2% | 2% | 2% | 2% | |||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[17],[20],[28],[37] | 7% | [16],[17],[20],[28],[37] | 7% | [16],[17],[20],[28],[37] | 7% | [21],[24],[30],[39] | 7% | [21],[24],[30],[39] | 7% | [21],[24],[30],[39] | 7% | ||
Investment, interest rate | 12.44% | [16],[17],[19],[20],[28],[37] | 12.44% | [16],[17],[19],[20],[28],[37] | 12.44% | [16],[17],[19],[20],[28],[37] | 12.26% | [21],[23],[24],[25],[30],[39] | 12.26% | [21],[23],[24],[25],[30],[39] | 12.26% | [21],[23],[24],[25],[30],[39] | 10.17% | ||
Investment, principal | $ 112,656 | [16],[17],[20],[26],[28],[37] | $ 112,656 | [21],[24],[27],[30],[39] | $ 112,656 | ||||||||||
Investment, cost | 112,656 | [16],[17],[20],[28],[37] | 112,656 | [21],[24],[30],[39] | |||||||||||
Investments at fair value | $ 112,656 | [16],[17],[20],[28],[37] | $ 112,656 | [21],[24],[30],[39] | $ 112,656 | $ 96,250 | |||||||||
Investment owned, percent of net assets | 7.50% | 7.50% | 7.50% | 9.40% | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [16],[17],[20],[28] | 7.88% | [16],[17],[20],[28] | 7.88% | [16],[17],[20],[28] | 7.88% | [23],[24],[30] | 7.88% | [23],[24],[30] | 7.88% | [23],[24],[30] | |||
Investment, interest rate | [23],[24],[25],[30] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26],[28] | $ 7,191 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 0 | [16],[17],[20],[28] | 6,934 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[20],[28] | $ 6,937 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [16],[17],[20],[28] | 7.88% | [16],[17],[20],[28] | 7.88% | [16],[17],[20],[28] | 7.88% | [23],[24],[30] | 7.88% | [23],[24],[30] | 7.88% | [23],[24],[30] | |||
Investment, interest rate | [23],[24],[25],[30] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26],[28] | $ 2,697 | [23],[24],[27],[30] | |||||||||||
Investment, cost | 0 | [16],[17],[20],[28] | 2,601 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[20],[28] | $ 2,602 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [16],[20],[28] | 7.88% | [16],[20],[28] | 7.88% | [16],[20],[28] | 7.88% | [21],[23],[24],[30] | 7.88% | [21],[23],[24],[30] | 7.88% | [21],[23],[24],[30] | |||
Investment, interest rate | [16],[19],[20],[28] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 7,191 | [16],[20],[26],[28] | $ 0 | [21],[23],[24],[27],[30] | |||||||||||
Investment, cost | 6,946 | [16],[20],[28] | 0 | [21],[23],[24],[30] | |||||||||||
Investments at fair value | $ 6,880 | [16],[20],[28] | $ 0 | [21],[23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [16],[20],[28] | 7.88% | [16],[20],[28] | 7.88% | [16],[20],[28] | 7.88% | [21],[23],[24],[30] | 7.88% | [21],[23],[24],[30] | 7.88% | [21],[23],[24],[30] | |||
Investment, interest rate | [16],[19],[20],[28] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 2,697 | [16],[20],[26],[28] | $ 0 | [21],[23],[24],[27],[30] | |||||||||||
Investment, cost | 2,605 | [16],[20],[28] | 0 | [21],[23],[24],[30] | |||||||||||
Investments at fair value | $ 2,580 | [16],[20],[28] | $ 0 | [21],[23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 58,210 | [16],[28] | 58,210 | [16],[28] | 58,210 | [16],[28] | 58,210 | [24],[30] | 58,210 | [24],[30] | 58,210 | [24],[30] | |||
Investment, cost | $ 182 | [16],[28] | $ 182 | [24],[30] | |||||||||||
Investments at fair value | $ 44 | [16],[28] | $ 87 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 345,452 | [16] | 345,452 | [16] | 345,452 | [16] | 345,452 | [24] | 345,452 | [24] | 345,452 | [24] | |||
Investment, cost | $ 367 | [16] | $ 367 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [23],[24],[25] | 13.04% | 13.04% | 13.04% | |||||||||||
Investment, principal | [23],[24],[27] | $ 821 | |||||||||||||
Investment, cost | [23],[24] | 813 | |||||||||||||
Investments at fair value | [23],[24] | $ 776 | |||||||||||||
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,000 | [28] | 66,000 | [28] | 66,000 | [28] | 66,000 | [30] | 66,000 | [30] | 66,000 | [30] | |||
Investment, cost | $ 139 | [28] | $ 139 | [30] | |||||||||||
Investments at fair value | $ 8 | [28] | $ 6 | [30] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5% | [16],[17],[20] | 5% | [16],[17],[20] | 5% | [16],[17],[20] | 5% | [21],[23],[24] | 5% | [21],[23],[24] | 5% | [21],[23],[24] | |||
Investment, interest rate | [21],[23],[24],[25] | 10.42% | 10.42% | 10.42% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 618 | [21],[23],[24],[27] | |||||||||||
Investment, cost | (40) | [16],[17],[20] | 576 | [21],[23],[24] | |||||||||||
Investments at fair value | $ (19) | [16],[17],[20] | $ 577 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [16],[20] | 5.25% | [16],[20] | 5.25% | [16],[20] | 5.25% | [23],[24] | 5.25% | [23],[24] | 5.25% | [23],[24] | |||
Investment, interest rate | 10.71% | [19],[20] | 10.71% | [19],[20] | 10.71% | [19],[20] | 10.67% | [23],[24],[25] | 10.67% | [23],[24],[25] | 10.67% | [23],[24],[25] | |||
Investment, principal | $ 4,477 | [16],[20],[26] | $ 4,488 | [23],[24],[27] | |||||||||||
Investment, cost | 4,415 | [16],[20] | 4,423 | [23],[24] | |||||||||||
Investments at fair value | $ 4,438 | [16],[20] | $ 4,425 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [26] | $ 4,700 | |||||||||||||
Investment, cost | 4,162 | ||||||||||||||
Investments at fair value | $ 4,377 | ||||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.25% | [16],[20],[28] | 8.50% | [23],[24],[30] | 8.50% | [23],[24],[30] | 8.50% | [23],[24],[30] | |||
Investment, interest rate | 12.21% | [16],[19],[20],[28] | 12.21% | [16],[19],[20],[28] | 12.21% | [16],[19],[20],[28] | 12.32% | [23],[24],[25],[30] | 12.32% | [23],[24],[25],[30] | 12.32% | [23],[24],[25],[30] | |||
Investment, principal | € | € 23,731 | [16],[20],[26],[28] | € 23,731 | [23],[24],[27],[30] | |||||||||||
Investment, cost | $ 26,702 | [16],[20],[28] | $ 26,772 | [23],[24],[30] | |||||||||||
Investments at fair value | $ 26,149 | [16],[20],[28] | $ 24,937 | [23],[24],[30] | |||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[20] | 8% | [16],[20] | 8% | [16],[20] | 8% | [23],[24] | 8% | [23],[24] | 8% | [23],[24] | |||
Investment, interest rate | 13.36% | [16],[19],[20] | 13.36% | [16],[19],[20] | 13.36% | [16],[19],[20] | 13.32% | [23],[24],[25] | 13.32% | [23],[24],[25] | 13.32% | [23],[24],[25] | |||
Investment, principal | $ 49,395 | [16],[20],[26] | $ 49,520 | [23],[24],[27] | |||||||||||
Investment, cost | 48,462 | [16],[20] | 48,536 | [23],[24] | |||||||||||
Investments at fair value | $ 48,901 | [16],[20] | $ 49,148 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24],[42] | 7% | [23],[24],[42] | 7% | [23],[24],[42] | |||
Investment, interest rate | 12.66% | [16],[19],[20] | 12.66% | [16],[19],[20] | 12.66% | [16],[19],[20] | 12.44% | [23],[24],[25],[42] | 12.44% | [23],[24],[25],[42] | 12.44% | [23],[24],[25],[42] | |||
Investment, principal | $ 1,552 | [16],[20],[26] | $ 1,552 | [23],[24],[27],[42] | |||||||||||
Investment, cost | 1,541 | [16],[20] | 1,540 | [23],[24],[42] | |||||||||||
Investments at fair value | $ 1,476 | [16],[20] | $ 1,478 | [23],[24],[42] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [21],[23],[24],[42] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [21],[23],[24],[25],[42] | 12.51% | 12.51% | 12.51% | |||||||||||
Investment, principal | [21],[23],[24],[27],[42] | $ 1,099 | |||||||||||||
Investment, cost | [21],[23],[24],[42] | 1,062 | |||||||||||||
Investments at fair value | [21],[23],[24],[42] | $ 943 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7% | [16],[20] | 7% | [16],[20] | 7% | [16],[20] | 7% | [23],[24],[42] | 7% | [23],[24],[42] | 7% | [23],[24],[42] | |||
Investment, interest rate | 12.66% | [16],[19],[20] | 12.66% | [16],[19],[20] | 12.66% | [16],[19],[20] | 12.51% | [23],[24],[25],[42] | 12.51% | [23],[24],[25],[42] | 12.51% | [23],[24],[25],[42] | |||
Investment, principal | $ 2,742 | [16],[20],[26] | $ 32,104 | [23],[24],[27],[42] | |||||||||||
Investment, cost | 2,721 | [16],[20] | 31,861 | [23],[24],[42] | |||||||||||
Investments at fair value | $ 2,608 | [16],[20] | $ 30,579 | [23],[24],[42] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 7% | [23],[24],[42] | 7% | [23],[24],[42] | 7% | [23],[24],[42] | |||
Investment, interest rate | 14.50% | [16],[19],[20] | 14.50% | [16],[19],[20] | 14.50% | [16],[19],[20] | 12.51% | [23],[24],[25],[42] | 12.51% | [23],[24],[25],[42] | 12.51% | [23],[24],[25],[42] | |||
Investment, principal | $ 3,298 | [16],[20],[26] | $ 2,749 | [23],[24],[27],[42] | |||||||||||
Investment, cost | 3,175 | [16],[20] | 2,726 | [23],[24],[42] | |||||||||||
Investments at fair value | $ 3,137 | [16],[20] | $ 2,618 | [23],[24],[42] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [16],[19],[20] | 12.66% | 12.66% | 12.66% | |||||||||||
Investment, principal | [16],[20],[26] | $ 32,022 | |||||||||||||
Investment, cost | [16],[20] | 31,799 | |||||||||||||
Investments at fair value | [16],[20] | $ 30,456 | |||||||||||||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | |||||||||||||||
Investment, interest rate | [22],[23],[24],[25],[30] | 11.50% | 11.50% | 11.50% | |||||||||||
Investment, principal | [22],[24],[27],[30] | $ 4,984 | |||||||||||||
Investment, cost | [22],[24],[30] | 4,894 | |||||||||||||
Investments at fair value | [22],[24],[30] | $ 4,785 | |||||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 13% | [16],[19],[20],[28] | 13% | [16],[19],[20],[28] | 13% | [16],[19],[20],[28] | 13% | [23],[24],[25],[30] | 13% | [23],[24],[25],[30] | 13% | [23],[24],[25],[30] | |||
Investment, principal | $ 50,419 | [16],[26],[28] | $ 50,419 | [24],[27],[30] | |||||||||||
Investment, cost | 49,898 | [16],[28] | 49,842 | [24],[30] | |||||||||||
Investments at fair value | $ 49,869 | [16],[28] | $ 49,869 | [24],[30] | |||||||||||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [16],[20] | 8% | [16],[20] | 8% | [16],[20] | 8% | [23] | 8% | [23] | 8% | [23] | |||
Investment, interest rate | 13.47% | [16],[19],[20] | 13.47% | [16],[19],[20] | 13.47% | [16],[19],[20] | 13.43% | [23],[25] | 13.43% | [23],[25] | 13.43% | [23],[25] | |||
Investment, principal | $ 12,843 | [16],[20],[26] | $ 12,843 | [23],[27] | |||||||||||
Investment, cost | 12,617 | [16],[20] | 12,603 | [23] | |||||||||||
Investments at fair value | $ 12,847 | [16],[20] | $ 12,464 | [23] | |||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [21],[23],[24],[30] | 6% | 6% | 6% | |||||||||||
Investment, principal | [21],[23],[24],[27],[30] | $ 0 | |||||||||||||
Investment, cost | [21],[23],[24],[30] | (29) | |||||||||||||
Investments at fair value | [21],[23],[24],[30] | $ (22) | |||||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24],[30] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [23],[24],[25],[30] | 11.42% | 11.42% | 11.42% | |||||||||||
Investment, principal | [23],[24],[27],[30] | $ 28,826 | |||||||||||||
Investment, cost | [23],[24],[30] | 28,595 | |||||||||||||
Investments at fair value | [23],[24],[30] | $ 28,537 | |||||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [16],[17],[20] | 9.75% | [16],[17],[20] | 9.75% | [16],[17],[20] | 9.75% | [21],[23],[24] | 9.75% | [21],[23],[24] | 9.75% | [21],[23],[24] | |||
Investment, interest rate | 15.21% | [16],[17],[19],[20] | 15.21% | [16],[17],[19],[20] | 15.21% | [16],[17],[19],[20] | 15.17% | [21],[23],[24],[25] | 15.17% | [21],[23],[24],[25] | 15.17% | [21],[23],[24],[25] | |||
Investment, principal | $ 2,119 | [16],[17],[20],[26] | $ 1,861 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 2,105 | [16],[17],[20] | 1,845 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 2,040 | [16],[17],[20] | $ 1,802 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [16],[20] | 9.75% | [16],[20] | 9.75% | [16],[20] | 9.75% | [23],[24] | 9.75% | [23],[24] | 9.75% | [23],[24] | |||
Investment, interest rate | 15.28% | [16],[19],[20] | 15.28% | [16],[19],[20] | 15.28% | [16],[19],[20] | 15.26% | [23],[24],[25] | 15.26% | [23],[24],[25] | 15.26% | [23],[24],[25] | |||
Investment, principal | $ 23,363 | [16],[20],[26] | $ 23,423 | [23],[24],[27] | |||||||||||
Investment, cost | 23,174 | [16],[20] | 23,207 | [23],[24] | |||||||||||
Investments at fair value | $ 22,545 | [16],[20] | $ 22,814 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.36% | [16],[19],[20] | 11.36% | [16],[19],[20] | 11.36% | [16],[19],[20] | 11.32% | [23],[24],[25] | 11.32% | [23],[24],[25] | 11.32% | [23],[24],[25] | |||
Investment, principal | $ 19,894 | [16],[20],[26] | $ 19,947 | [23],[24],[27] | |||||||||||
Investment, cost | 19,014 | [16],[20] | 19,013 | [23],[24] | |||||||||||
Investments at fair value | $ 19,211 | [16],[20] | $ 19,199 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24],[33] | 7.30% | 7.30% | 7.30% | |||||||||||
Investment, principal | [23],[24],[27],[33] | $ 19,163 | |||||||||||||
Investment, cost | [23],[24],[33] | 19,163 | |||||||||||||
Investments at fair value | [23],[24],[33] | 18,340 | |||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate, paid in kind | [16],[32] | 10% | 10% | 10% | |||||||||||
Investment, principal | [16],[26],[32] | $ 5,065 | |||||||||||||
Investment, cost | [16],[32] | 4,657 | |||||||||||||
Investments at fair value | $ 4,290 | [16],[32] | 0 | ||||||||||||
Investment owned, percent of net assets | 0.30% | 0.30% | 0.30% | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate, paid in kind | [16],[32] | 10% | 10% | 10% | |||||||||||
Investment, principal | [16],[26],[32] | $ 20,871 | |||||||||||||
Investment, cost | [16],[32] | 19,217 | |||||||||||||
Investments at fair value | $ 18,723 | [16],[32] | 0 | ||||||||||||
Investment owned, percent of net assets | 1.20% | 1.20% | 1.20% | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest | |||||||||||||||
Investment owned, ownership percentage | [16] | 6.40% | 6.40% | 6.40% | |||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | [16] | 0 | |||||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24],[33] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [23],[24],[27],[33] | $ 4,641 | |||||||||||||
Investment, cost | [23],[24],[33] | 4,641 | |||||||||||||
Investments at fair value | [23],[24],[33] | $ 4,170 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 9% | [16],[20],[32] | 9% | [16],[20],[32] | 9% | [16],[20],[32] | 7% | [23],[24] | 7% | [23],[24] | 7% | [23],[24] | |||
Investment, interest rate, paid in kind | [23],[24] | 12.65% | 12.65% | 12.65% | |||||||||||
Investment, principal | $ 46,832 | [16],[20],[26],[32] | $ 46,832 | [23],[24],[27] | |||||||||||
Investment, cost | 45,698 | [16],[20],[32] | 45,698 | [23],[24] | |||||||||||
Investments at fair value | $ 28,099 | [16],[20],[32] | $ 37,231 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 358,299 | [16] | 358,299 | [16] | 358,299 | [16] | 10,616 | [24] | 10,616 | [24] | 10,616 | [24] | |||
Investment, cost | $ 2,912 | [16] | $ 120 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 10,616 | [16] | 10,616 | [16] | 10,616 | [16] | 358,299 | [24] | 358,299 | [24] | 358,299 | [24] | |||
Investment, cost | $ 120 | [16] | $ 2,912 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 0 | [24] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3 | |||||||||||||||
Investment owned, balance (in shares) | shares | 60,862 | [16] | 60,862 | [16] | 60,862 | [16] | 60,862 | [24] | 60,862 | [24] | 60,862 | [24] | |||
Investment, cost | $ 1,207 | [16] | $ 1,207 | [24] | |||||||||||
Investments at fair value | $ 0 | [16] | $ 108 | [24] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4 | |||||||||||||||
Investment owned, balance (in shares) | shares | 32,447 | [16] | 32,447 | [16] | 32,447 | [16] | 32,447 | [24] | 32,447 | [24] | 32,447 | [24] | |||
Investment, cost | $ 33,353 | [16],[20] | $ 33,353 | [24] | |||||||||||
Investments at fair value | $ 11,131 | [16],[20] | $ 31,701 | [24] | |||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [16],[20] | 6% | [16],[20] | 6% | [16],[20] | 6% | [23],[24] | 6% | [23],[24] | 6% | [23],[24] | |||
Investment, interest rate | 11.48% | [16],[19],[20] | 11.48% | [16],[19],[20] | 11.48% | [16],[19],[20] | 11.42% | [23],[24],[25] | 11.42% | [23],[24],[25] | 11.42% | [23],[24],[25] | |||
Investment, principal | $ 11,642 | [16],[20],[26] | $ 11,671 | [23],[24],[27] | |||||||||||
Investment, cost | 11,618 | [16],[20] | 11,646 | [23],[24] | |||||||||||
Investments at fair value | $ 11,321 | [16],[20] | $ 11,363 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment, basis spread, variable rate | 7.71% | [20],[28] | 7.71% | [20],[28] | 7.71% | [20],[28] | 7.71% | [23],[30] | 7.71% | [23],[30] | 7.71% | [23],[30] | |||
Investment, interest rate | 13.12% | [19],[20],[28] | 13.12% | [19],[20],[28] | 13.12% | [19],[20],[28] | 13.06% | [23],[25],[30] | 13.06% | [23],[25],[30] | 13.06% | [23],[25],[30] | |||
Investment, principal | $ 1,000 | [20],[26],[28] | $ 1,000 | [23],[27],[30] | |||||||||||
Investment, cost | 818 | [20],[28] | 816 | [23],[30] | |||||||||||
Investments at fair value | $ 930 | [20],[28] | $ 917 | [23],[30] | |||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | 4.75% | [19],[20],[28] | 4.75% | [19],[20],[28] | 4.75% | [19],[20],[28] | 6.50% | [23],[25],[30] | 6.50% | [23],[25],[30] | 6.50% | [23],[25],[30] | |||
Investment, principal | $ 300 | [26],[28] | $ 4,500 | [27],[30] | |||||||||||
Investment, cost | 266 | [28] | 4,115 | [30] | |||||||||||
Investments at fair value | $ 259 | [28] | $ 2,953 | [30] | |||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | 6.50% | [19],[20],[28] | 6.50% | [19],[20],[28] | 6.50% | [19],[20],[28] | 4.75% | [23],[25],[30] | 4.75% | [23],[25],[30] | 4.75% | [23],[25],[30] | |||
Investment, principal | $ 4,500 | [26],[28] | $ 300 | [27],[30] | |||||||||||
Investment, cost | 4,129 | [28] | 264 | [30] | |||||||||||
Investments at fair value | $ 3,252 | [28] | $ 245 | [30] | |||||||||||
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, principal | [20],[26] | $ 6,620 | |||||||||||||
Investment, cost | [20] | 6,620 | |||||||||||||
Investments at fair value | [20] | $ 7,009 | |||||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.68% | 12.68% | 12.68% | |||||||||||
Investment, principal | [23],[24],[27] | $ 1,140 | |||||||||||||
Investment, cost | [23],[24] | 927 | |||||||||||||
Investments at fair value | [23],[24] | $ 1,139 | |||||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [16],[19],[20] | 21.66% | 21.66% | 21.66% | |||||||||||
Investment, principal | [16],[20],[26] | $ 1,290 | |||||||||||||
Investment, cost | [16],[20] | 1,278 | |||||||||||||
Investments at fair value | [16],[20] | $ 1,203 | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [16],[17],[20] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, principal | [16],[17],[20],[26] | $ 0 | |||||||||||||
Investment, cost | [16],[17],[20] | (81) | |||||||||||||
Investments at fair value | [16],[17],[20] | $ (82) | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [16],[20] | 6.75% | [16],[20] | 6.75% | [16],[20] | 3.75% | [23] | 3.75% | [23] | 3.75% | [23] | |||
Investment, interest rate | 12.06% | [16],[19],[20] | 12.06% | [16],[19],[20] | 12.06% | [16],[19],[20] | 9.27% | [23],[25] | 9.27% | [23],[25] | 9.27% | [23],[25] | |||
Investment, principal | $ 29,838 | [16],[20],[26] | $ 11,792 | [23],[27] | |||||||||||
Investment, cost | 29,105 | [16],[20] | 11,281 | [23] | |||||||||||
Investments at fair value | $ 29,092 | [16],[20] | $ 11,127 | [23] | |||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [23],[24],[25] | 12.65% | 12.65% | 12.65% | |||||||||||
Investment, principal | [23],[24],[27] | $ 5,000 | |||||||||||||
Investment, cost | [23],[24] | 4,925 | |||||||||||||
Investments at fair value | [23],[24] | $ 4,263 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [16],[20] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [16],[19],[20] | 21.66% | 21.66% | 21.66% | |||||||||||
Investment, principal | [16],[20],[26] | $ 1,543 | |||||||||||||
Investment, cost | [16],[20] | 1,530 | |||||||||||||
Investments at fair value | [16],[20] | $ 1,439 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [23],[24],[25] | 21.68% | 21.68% | 21.68% | |||||||||||
Investment, principal | [23],[24],[27] | $ 1,565 | |||||||||||||
Investment, cost | [23],[24] | 1,551 | |||||||||||||
Investments at fair value | [23],[24] | $ 1,464 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [23],[24] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [23],[24],[25] | 21.68% | 21.68% | 21.68% | |||||||||||
Investment, principal | [23],[24],[27] | $ 1,323 | |||||||||||||
Investment, cost | [23],[24] | 1,311 | |||||||||||||
Investments at fair value | [23],[24] | $ 1,237 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 4,871 | [16] | 4,871 | [16] | 4,871 | [16] | 4,871 | [24] | 4,871 | [24] | 4,871 | [24] | |||
Investment, cost | $ 46 | [16] | $ 46 | [24] | |||||||||||
Investments at fair value | $ 42 | [16] | $ 107 | [24] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 127,452 | [16] | 127,452 | [16] | 127,452 | [16] | 127,452 | [24] | 127,452 | [24] | 127,452 | [24] | |||
Investment, cost | $ 2,057 | [16] | $ 2,057 | [24] | |||||||||||
Investments at fair value | $ 1,485 | [16] | $ 1,319 | [24] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [20] | 6.25% | [20] | 6.25% | [20] | 6.25% | [23] | 6.25% | [23] | 6.25% | [23] | |||
Investment, interest rate | 11.71% | [19],[20] | 11.71% | [19],[20] | 11.71% | [19],[20] | 11.67% | [23],[25] | 11.67% | [23],[25] | 11.67% | [23],[25] | |||
Investment, principal | $ 4,664 | [20],[26] | $ 8,983 | [23],[27] | |||||||||||
Investment, cost | 4,526 | [20] | 8,698 | [23] | |||||||||||
Investments at fair value | $ 4,425 | [20] | $ 8,678 | [23] | |||||||||||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 4% | [16],[20] | 4% | [16],[20] | 4% | [16],[20] | 4% | [23],[24] | 4% | [23],[24] | 4% | [23],[24] | |||
Investment, interest rate | 9.35% | [16],[19],[20] | 9.35% | [16],[19],[20] | 9.35% | [16],[19],[20] | 9.32% | [23],[24],[25] | 9.32% | [23],[24],[25] | 9.32% | [23],[24],[25] | |||
Investment, principal | $ 19,578 | [16],[20],[26] | $ 19,578 | [23],[24],[27] | |||||||||||
Investment, cost | 19,556 | [16],[20] | 19,568 | [23],[24] | |||||||||||
Investments at fair value | $ 19,577 | [16],[20] | $ 19,489 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [23],[24],[30] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [23],[24],[25],[30] | 12.72% | 12.72% | 12.72% | |||||||||||
Investment, principal | £ | [23],[24],[27],[30] | £ 20,000 | |||||||||||||
Investment, cost | [23],[24],[30] | $ 25,841 | |||||||||||||
Investments at fair value | [23],[24],[30] | $ 22,914 | |||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [19],[20] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [26] | $ 4,960 | |||||||||||||
Investment, cost | 4,379 | ||||||||||||||
Investments at fair value | $ 4,506 | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 21,523 | [16] | 21,523 | [16] | 21,523 | [16] | 21,523 | [24] | 21,523 | [24] | 21,523 | [24] | |||
Investment, cost | $ 20,789 | [16] | $ 20,789 | [24] | |||||||||||
Investments at fair value | $ 20,542 | [16] | $ 20,074 | [24] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [16],[17],[20] | 6.75% | [16],[17],[20] | 6.75% | [16],[17],[20] | 6.75% | [21],[23],[24] | 6.75% | [21],[23],[24] | 6.75% | [21],[23],[24] | |||
Investment, interest rate | 12.10% | [19],[20] | 12.10% | [19],[20] | 12.10% | [19],[20] | 12.14% | [21],[23],[24],[25] | 12.14% | [21],[23],[24],[25] | 12.14% | [21],[23],[24],[25] | |||
Investment, principal | $ 377 | [16],[17],[20],[26] | $ 377 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 336 | [16],[17],[20] | 334 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 276 | [16],[17],[20] | $ 296 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [23],[24] | 7.25% | [23],[24] | 7.25% | [23],[24] | |||
Investment, interest rate | 12.62% | [16],[19],[20] | 12.62% | [16],[19],[20] | 12.62% | [16],[19],[20] | 12.63% | [23],[24],[25] | 12.63% | [23],[24],[25] | 12.63% | [23],[24],[25] | |||
Investment, interest rate, paid in kind | [23],[24] | ||||||||||||||
Investment, principal | $ 24,427 | [16],[20],[26] | $ 24,427 | [23],[24],[27] | |||||||||||
Investment, cost | 24,151 | [16],[20] | 24,135 | [23],[24] | |||||||||||
Investments at fair value | $ 23,531 | [16],[20] | $ 23,548 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [16],[20] | 7.25% | [23],[24] | 7.25% | [23],[24] | 7.25% | [23],[24] | |||
Investment, interest rate | 12.62% | [16],[19],[20] | 12.62% | [16],[19],[20] | 12.62% | [16],[19],[20] | 12.63% | [23],[24],[25] | 12.63% | [23],[24],[25] | 12.63% | [23],[24],[25] | |||
Investment, principal | $ 3,636 | [16],[20],[26] | $ 3,636 | [23],[24],[27] | |||||||||||
Investment, cost | 3,604 | [16],[20] | 3,602 | [23],[24] | |||||||||||
Investments at fair value | $ 3,537 | [16],[20] | $ 3,574 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [16],[17],[20] | 7.25% | [16],[17],[20] | 7.25% | [16],[17],[20] | 7.25% | [21],[23],[24] | 7.25% | [21],[23],[24] | 7.25% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 0 | [16],[17],[20] | 0 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[20] | $ 0 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [16],[17],[20] | 8.75% | [16],[17],[20] | 8.75% | [16],[17],[20] | 8.75% | [23],[24] | 8.75% | [23],[24] | 8.75% | [23],[24] | |||
Investment, interest rate | [23],[24],[25] | 11.75% | 11.75% | 11.75% | |||||||||||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 5,212 | [23],[24],[27] | |||||||||||
Investment, cost | 0 | [16],[17],[20] | 4,987 | [23],[24] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[20] | $ 4,990 | [23],[24] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [16],[17],[20] | 8.75% | [16],[17],[20] | 8.75% | [16],[17],[20] | 8.75% | [21],[23],[24] | 8.75% | [21],[23],[24] | 8.75% | [21],[23],[24] | |||
Investment, principal | $ 0 | [16],[17],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 0 | [16],[17],[20] | 0 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 0 | [16],[17],[20] | $ 0 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [16],[20] | 8.75% | [16],[20] | 8.75% | [16],[20] | 8.75% | [21],[23],[24] | 8.75% | [21],[23],[24] | 8.75% | [21],[23],[24] | |||
Investment, interest rate | [16],[19],[20] | 11.75% | 11.75% | 11.75% | |||||||||||
Investment, principal | $ 5,212 | [16],[20],[26] | $ 0 | [21],[23],[24],[27] | |||||||||||
Investment, cost | 5,001 | [16],[20] | 0 | [21],[23],[24] | |||||||||||
Investments at fair value | $ 5,043 | [16],[20] | $ 0 | [21],[23],[24] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 53,700 | [16] | 53,700 | [16] | 53,700 | [16] | 53,700 | [24] | 53,700 | [24] | 53,700 | [24] | |||
Investment, principal | [26] | $ 0 | |||||||||||||
Investment, cost | 175 | [16] | $ 175 | [24] | |||||||||||
Investments at fair value | $ 212 | [16] | $ 258 | [24] | |||||||||||
[1] All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted. Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Equity ownership may be held in shares or units of companies related to the portfolio companies. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region. All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted. Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Equity ownership may be held in shares or units of companies related to the portfolio companies. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. ten twenty ten twenty ten twenty ten twenty Income producing through payment of dividends or distributions. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. Income producing through payment of dividends or distributions. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC. |
Consolidated Schedule of Inve_2
Consolidated Schedule of Investments - Derivatives € in Thousands, £ in Thousands, $ in Thousands | Dec. 31, 2023 USD ($) | Dec. 31, 2023 EUR (€) | Dec. 31, 2023 GBP (£) | Sep. 30, 2023 USD ($) | Sep. 30, 2023 EUR (€) | Sep. 30, 2023 GBP (£) |
Schedule of Investments [Line Items] | ||||||
Derivative assets | $ 0 | $ 4,910 | ||||
Derivative liability at fair value | (29,316) | (47,519) | ||||
Foreign currency forward contract | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative assets | 0 | 4,910 | ||||
Derivative liability at fair value | (2,914) | 0 | ||||
Interest rate swap | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative assets | 4,013 | 0 | ||||
Derivative liability at fair value | (30,415) | (47,519) | ||||
Derivative assets (liability) | (26,402) | |||||
Interest Rate Swap Maturing 2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative assets | $ (30,415) | |||||
Derivative liability at fair value | $ (40,519) | |||||
Interest rate | 2.70% | 2.70% | 2.70% | 2.70% | 2.70% | 2.70% |
Floating interest rate | 1.658% | 1.658% | 1.658% | 1.658% | 1.658% | 1.658% |
Notional amount | $ 350,000 | $ 350,000 | ||||
Interest Rate Swap Maturing 2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative assets | $ 4,013 | |||||
Derivative liability at fair value | $ (7,000) | |||||
Interest rate | 7.10% | 7.10% | 7.10% | 7.10% | 7.10% | 7.10% |
Floating interest rate | 3.1255% | 3.1255% | 3.1255% | 3.1255% | 3.1255% | 3.1255% |
Notional amount | $ 300,000 | $ 300,000 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 8, 2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 36,775 | |||||
Notional Amount to be Sold | € | € 34,350 | |||||
Derivative assets | 0 | |||||
Derivative liability at fair value | (1,227) | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 42,182 | |||||
Notional Amount to be Sold | € | € 34,350 | € 38,026 | ||||
Derivative assets | 1,857 | |||||
Derivative liability at fair value | (1,227) | 0 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 8, 2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 47,403 | |||||
Notional Amount to be Sold | £ | £ 38,500 | |||||
Derivative assets | 0 | |||||
Derivative liability at fair value | (1,687) | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 72,098 | |||||
Notional Amount to be Sold | £ | £ 56,556 | |||||
Derivative assets | 3,053 | |||||
Derivative liability at fair value | (1,687) | 0 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative assets | 4,013 | 0 | ||||
Derivative liability at fair value | 0 | (7,000) | ||||
Notional amount | 300,000 | 300,000 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative assets | 0 | 0 | ||||
Derivative liability at fair value | (30,415) | (40,519) | ||||
Notional amount | $ 350,000 | $ 350,000 |
Consolidated Schedule of Inve_3
Consolidated Schedule of Investments - Parenthetical | 12 Months Ended |
Sep. 30, 2023 $ / shares | |
Schedule of Investments [Line Items] | |
Percentage of total assets representing qualifying assets | 74.30% |
Percentage of total assets representing non-qualifying assets | 25.70% |
Minimum | |
Schedule of Investments [Line Items] | |
Debt instrument, floor interest rate | 0% |
Maximum | |
Schedule of Investments [Line Items] | |
Debt instrument, floor interest rate | 2.75% |
Share-Based Payment Arrangement, Tranche One | |
Schedule of Investments [Line Items] | |
Investment owned, balance, shares, VWAP threshold (in dollars per share) | $ 15 |
Investment owned, balance, shares, VWAP number of trading days | 10 days |
Investment owned, balance, shares, VWAP, number of consecutive trading days | 20 days |
Share-Based Payment Arrangement, Tranche Two | |
Schedule of Investments [Line Items] | |
Investment owned, balance, shares, VWAP threshold (in dollars per share) | $ 20 |
Investment owned, balance, shares, VWAP number of trading days | 10 days |
Investment owned, balance, shares, VWAP, number of consecutive trading days | 20 days |
Organization
Organization | 3 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | Organization Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in Oaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with their own product offerings and investment, marketing and support teams. On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into the Company in a two-step transaction, with the Company as the surviving company (the "OCSI Merger”). |
Significant Accounting Policies
Significant Accounting Policies | 3 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value. Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2023 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities. Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of December 31, 2023, there were seven investments on non-accrual status that in aggregate represented 5.9% and 4.2% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of December 31, 2023, included in restricted cash was $19.3 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $19.3 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility. As of September 30, 2023, included in restricted cash was $9.1 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility. Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date). Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months. |
Portfolio Investments
Portfolio Investments | 3 Months Ended |
Dec. 31, 2023 | |
Schedule of Investments [Abstract] | |
Portfolio Investments | Portfolio Investments As of December 31, 2023, 199.7% of net assets at fair value, or $3.0 billion, was invested in 146 portfolio companies, including (i) $142.2 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $51.0 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of December 31, 2023, 8.7% of net assets at fair value, or $131.7 million, was invested in cash and cash equivalents (including $19.3 million of restricted cash). In comparison, as of September 30, 2023, 190.8% of net assets at fair value, or $2.9 billion, was invested in 143 portfolio investments, including (i) $141.5 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $50.0 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2023, 9.6% of net assets at fair value, or $145.5 million, was invested in cash and cash equivalents (including $9.1 million of restricted cash). As of December 31, 2023, 86.3% of the Company's portfolio at fair value consisted of senior secured debt investments and 7.9% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2023, 86.5% of the Company's portfolio at fair value consisted of senior secured debt investments and 7.5% consisted of subordinated debt investments, including the debt investments in the JVs. The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain. During the three months ended December 31, 2023 and 2022, the Company recorded net realized losses of $8.5 million and $3.2 million, respectively. During the three months ended December 31, 2023 and 2022, the Company recorded net unrealized depreciation of $25.0 million and $23.0 million, respectively. The composition of the Company's investments as of December 31, 2023 and September 30, 2023 at cost and fair value was as follows: December 31, 2023 September 30, 2023 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,779,477 $ 2,680,454 $ 2,654,484 $ 2,557,102 Investments in equity securities 190,205 144,898 171,858 143,767 Debt investments in the JVs 163,277 163,613 162,986 162,673 Equity investments in the JVs 54,791 29,587 54,791 28,878 Total $ 3,187,750 $ 3,018,552 $ 3,044,119 $ 2,892,420 The following table presents the composition of the Company's debt investments as of December 31, 2023 and September 30, 2023 at fixed rates and floating rates: December 31, 2023 September 30, 2023 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,397,664 84.30 % $ 2,345,205 86.23 % Fixed rate debt securities 446,403 15.70 374,570 13.77 Total $ 2,844,067 100.00 % $ 2,719,775 100.00 % The following table presents the financial instruments carried at fair value as of December 31, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 212,113 $ 2,393,175 $ — $ 2,605,288 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 42,419 196,360 — 238,779 Investments in equity securities (preferred) — — 69,261 — 69,261 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,416 3,894 67,327 29,587 105,224 Total investments at fair value 4,416 258,426 2,726,123 29,587 3,018,552 Cash equivalents 8,722 — — — 8,722 Total assets at fair value $ 13,138 $ 258,426 $ 2,726,123 $ 29,587 $ 3,027,274 Derivative liability $ — $ 29,316 $ — $ — $ 29,316 Total liabilities at fair value $ — $ 29,316 $ — $ — $ 29,316 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 208,694 $ 2,292,691 $ — $ 2,501,385 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 28,666 189,724 — 218,390 Investments in equity securities (preferred) — — 86,057 — 86,057 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,317 1,953 51,440 28,878 86,588 Total investments at fair value 4,317 239,313 2,619,912 28,878 2,892,420 Cash equivalents 83,262 — — — 83,262 Derivative assets — 4,910 — — 4,910 Total assets at fair value $ 87,579 $ 244,223 $ 2,619,912 $ 28,878 $ 2,980,592 Derivative liability $ — $ 47,519 $ — $ — $ 47,519 Total liabilities at fair value $ — $ 47,519 $ — $ — $ 47,519 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period. The following table provides a roll-forward in the changes in fair value from September 30, 2023 to December 31, 2023 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2023 $ 2,292,691 $ 189,724 $ 86,057 $ 51,440 $ 2,619,912 Purchases 281,278 14,639 4,440 — 300,357 Sales and repayments (172,647) (4,932) — (786) (178,365) Transfers in (a)(b) 17,121 — — 17,330 34,451 Transfers out (b) (16,172) (4,657) (1,159) — (21,988) Capitalized PIK interest income 3,835 13 — — 3,848 Accretion of OID 4,005 298 — — 4,303 Net unrealized appreciation (depreciation) (7,904) 1,229 (20,077) 662 (26,090) Net realized gains (losses) (9,032) 46 — (1,319) (10,305) Fair value as of December 31, 2023 $ 2,393,175 $ 196,360 $ 69,261 $ 67,327 $ 2,726,123 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2023 $ (18,446) $ 648 $ (20,231) $ (1,444) $ (39,473) __________ (a) There was a $12.4 million transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) There were investment restructurings during the three months ended December 31, 2023 in which (1) $16.2 million of Level 3 senior secured debt was exchanged for Level 3 common equity, (2) $4.7 million of Level 3 subordinated debt was exchanged for Level 3 senior secured debt and (3) $1.2 million of Level 3 preferred equity was exchanged for Level 3 common equity. The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases 177,599 21,104 2,579 2,181 203,463 Sales and repayments (55,885) (699) — (48) (56,632) Transfers in (a) 19,075 — — — 19,075 Capitalized PIK interest income 5,763 6 — — 5,769 Accretion of OID 4,114 398 — — 4,512 Net unrealized appreciation (depreciation) (12,271) (566) (1,477) 4,505 (9,809) Net realized gains (losses) (1,159) — — 46 (1,113) Fair value as of December 31, 2022 $ 2,047,842 $ 179,631 $ 80,625 $ 26,642 $ 2,334,740 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022 $ (12,398) $ (566) $ (1,477) $ 4,505 $ (9,936) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. Significant Unobservable Inputs for Level 3 Investments The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,966,262 Market Yield Market Yield (b) 9.0% - 40.0% 14.3% 18,042 Enterprise Value Revenue Multiple (c) 0.2x - 0.4x 0.3x 77,424 Enterprise Value EBITDA Multiple (c) 2.3x - 9.8x 6.0x 132,614 Transaction Precedent Transaction Price (d) N/A - N/A N/A 198,833 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 32,747 Market Yield Market Yield (b) 10.0% - 23.0% 10.3% Debt Investments in the JVs 163,613 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 42,156 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.6x 88,566 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 6.3x 1,001 Enterprise Value Asset Multiple (c) 1.0x - 1.5x 1.4x 4,865 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,726,123 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,904,140 Market Yield Market Yield (b) 9.0% - 32.0% 14.7% 64,802 Enterprise Value EBITDA Multiple (c) 3.0x - 6.0x 4.6x 33,816 Transaction Precedent Transaction Price (d) N/A - N/A N/A 289,933 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 22,881 Market Yield Market Yield (b) 10.0% - 22.0% 11.2% 4,170 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,673 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 32,318 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.5x 103,661 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 8.8x 1,097 Enterprise Value Asset Multiple (c) 1.0x - 1.4x 1.4x 421 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,619,912 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively. Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. Financial Instruments Disclosed, But Not Carried, At Fair Value The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,554 291,204 — 291,204 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 316,745 315,147 — 315,147 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 297,418 310,425 — 310,425 — Total $ 1,622,717 $ 1,626,776 $ — $ 916,776 $ 710,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,241 286,437 — 286,437 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 306,412 301,784 — 301,784 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 286,078 289,980 — 289,980 — Total $ 1,600,731 $ 1,588,201 $ — $ 878,201 $ 710,000 The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. Oaktree used market quotes as of the valuation date to estimate the fair value of the Company's 3.500% notes due 2025 (the "2025 Notes"), 2.700% notes due 2027 (the "2027 Notes") and 7.100% notes due 2029 (the "2029 Notes"), which are included in Level 2 of the hierarchy. Portfolio Composition Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,703,890 84.82 % $ 2,594,640 85.24 % Debt investments in the JVs 163,277 5.12 % 162,986 5.35 % Preferred equity 102,877 3.23 % 99,597 3.27 % Common equity and warrants 87,328 2.74 % 72,261 2.37 % Subordinated debt 75,587 2.37 % 59,844 1.97 % LLC equity interests of the JVs 54,791 1.72 % 54,791 1.80 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,605,288 86.31 % 172.36 % $ 2,501,385 86.47 % 165.01 % Debt investments in the JVs 163,613 5.42 % 10.82 % 162,673 5.62 % 10.73 % Common equity and warrants 75,637 2.51 % 5.00 % 57,710 2.00 % 3.81 % Subordinated debt 75,166 2.49 % 4.97 % 55,717 1.93 % 3.68 % Preferred equity 69,261 2.29 % 4.58 % 86,057 2.98 % 5.68 % LLC equity interests of the JVs 29,587 0.98 % 1.96 % 28,878 1.00 % 1.91 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Northeast $ 1,054,445 33.08 % $ 1,012,955 33.27 % West 417,364 13.09 % 393,390 12.92 % Southeast 412,397 12.94 % 375,247 12.33 % International 370,987 11.64 % 418,595 13.75 % Midwest 365,262 11.46 % 360,506 11.84 % South 222,299 6.97 % 202,374 6.65 % Southwest 216,429 6.79 % 153,318 5.04 % Northwest 128,567 4.03 % 127,734 4.20 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 964,560 31.95 % 63.80 % $ 945,422 32.69 % 62.37 % West 398,128 13.19 % 26.34 % 384,055 13.28 % 25.34 % Southeast 385,269 12.76 % 25.49 % 354,444 12.25 % 23.38 % International 374,156 12.40 % 24.75 % 414,079 14.32 % 27.32 % Midwest 357,502 11.84 % 23.65 % 350,620 12.12 % 23.13 % South 216,121 7.16 % 14.30 % 188,541 6.52 % 12.44 % Southwest 196,779 6.52 % 13.02 % 130,455 4.51 % 8.61 % Northwest 126,037 4.18 % 8.34 % 124,804 4.31 % 8.23 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Application Software $ 472,016 14.82 % $ 468,483 15.39 % Multi-Sector Holdings (1) 219,766 6.89 219,469 7.21 Health Care Services 137,713 4.32 81,560 2.68 Data Processing & Outsourced Services 133,399 4.18 133,410 4.38 Health Care Technology 130,701 4.10 106,915 3.51 Biotechnology 127,672 4.01 126,349 4.15 Industrial Machinery & Supplies & Components 102,785 3.22 99,511 3.27 Real Estate Operating Companies 85,374 2.68 83,754 2.75 Broadline Retail 83,290 2.61 83,290 2.74 Pharmaceuticals 74,100 2.32 84,948 2.79 Other Specialty Retail 68,033 2.13 41,088 1.35 Personal Care Products 67,619 2.12 68,146 2.24 Interactive Media & Services 66,109 2.07 19,013 0.62 Fertilizers & Agricultural Chemicals 64,689 2.03 64,720 2.13 Aerospace & Defense 63,768 2.00 51,797 1.70 Diversified Support Services 63,265 1.98 23,435 0.77 Environmental & Facilities Services 63,022 1.98 63,064 2.07 Health Care Distributors 62,010 1.95 62,044 2.04 Diversified Financial Services 61,608 1.93 61,725 2.03 Internet Services & Infrastructure 61,012 1.91 60,934 2.00 Airport Services 57,897 1.82 55,961 1.84 Metal, Glass & Plastic Containers 57,679 1.81 55,530 1.82 Insurance Brokers 52,472 1.65 52,856 1.74 Diversified Metals & Mining 49,898 1.57 49,842 1.64 Automotive Retail 49,603 1.56 57,596 1.89 Home Improvement Retail 49,001 1.54 54,236 1.78 Auto Parts & Equipment 48,462 1.52 48,536 1.59 Systems Software 45,509 1.43 23,111 0.76 Real Estate Services 44,652 1.40 44,717 1.47 Specialized Finance 42,215 1.32 73,035 2.40 Soft Drinks & Non-alcoholic Beverages 42,158 1.32 42,628 1.40 Leisure Facilities 39,724 1.25 39,076 1.28 Specialty Chemicals 37,622 1.18 38,640 1.27 Electrical Components & Equipment 32,500 1.02 32,440 1.07 Distributors 32,189 1.01 37,666 1.24 Advertising 25,597 0.80 25,597 0.84 Passenger Airlines 24,952 0.78 24,920 0.82 Real Estate Development 24,198 0.76 23,965 0.79 Gold 23,347 0.73 23,310 0.77 Home Furnishings 23,085 0.72 23,859 0.78 Health Care Equipment 22,509 0.71 22,441 0.74 Construction & Engineering 21,668 0.68 22,102 0.73 Hotels, Resorts & Cruise Lines 17,169 0.54 17,195 0.56 Oil & Gas Storage & Transportation 16,172 0.51 22,042 0.72 Integrated Telecommunication Services 14,657 0.46 18,801 0.62 Restaurants 12,617 0.40 12,603 0.41 Health Care Supplies 11,618 0.36 11,646 0.38 Cable & Satellite 8,946 0.28 4,619 0.15 Education Services 8,257 0.26 13,871 0.46 Food Distributors 7,677 0.24 5,897 0.19 Oil & Gas Refining & Marketing 6,620 0.21 — — Research & Consulting Services 4,862 0.15 4,871 0.16 Other Specialized REITs 4,395 0.14 4,379 0.14 Apparel Retail 4,375 0.14 4,999 0.16 Office Services & Supplies 4,162 0.13 — — Paper & Plastic Packaging Products & Materials 3,247 0.10 3,254 0.11 Housewares & Specialties 2,854 0.09 2,908 0.10 Leisure Products 2,070 0.06 2,055 0.07 Alternative Carriers 1,625 0.05 — — Diversified Chemicals 1,539 0.05 — — Consumer Finance — — 16,440 0.54 Movies & Entertainment — — 12,188 0.40 Air Freight & Logistics — — 4,925 0.16 Integrated Oil & Gas — — 4,894 0.16 Technology Distributors — — 813 0.03 $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 460,072 15.23 % 30.41 % $ 455,719 15.73 % 30.03 % Multi-Sector Holdings (1) 195,163 6.47 12.91 193,431 6.69 12.76 Biotechnology 127,586 4.23 8.44 125,678 4.35 8.29 Data Processing & Outsourced Services 126,731 4.20 8.38 125,259 4.33 8.26 Health Care Services 122,076 4.04 8.08 66,683 2.31 4.40 Health Care Technology 107,574 3.56 7.12 95,404 3.30 6.29 Industrial Machinery & Supplies & Components 104,217 3.45 6.89 98,352 3.40 6.49 Real Estate Operating Companies 84,517 2.80 5.59 82,463 2.85 5.44 Pharmaceuticals 71,320 2.36 4.72 80,455 2.78 5.31 Other Specialty Retail 69,533 2.30 4.60 41,115 1.42 2.71 Interactive Media & Services 66,304 2.20 4.39 19,199 0.66 1.27 Aerospace & Defense 63,981 2.12 4.23 51,862 1.79 3.42 Fertilizers & Agricultural Chemicals 63,185 2.09 4.18 63,185 2.18 4.17 Diversified Financial Services 62,687 2.08 4.15 60,003 2.07 3.96 Diversified Support Services 62,669 2.08 4.15 23,352 0.81 1.54 Environmental & Facilities Services 62,180 2.06 4.11 62,413 2.16 4.12 Internet Services & Infrastructure 60,771 2.01 4.02 60,579 2.09 4.00 Health Care Distributors 60,654 2.01 4.01 60,865 2.10 4.02 Personal Care Products 59,562 1.97 3.94 59,928 2.07 3.95 Metal, Glass & Plastic Containers 55,586 1.84 3.68 53,459 1.85 3.53 Airport Services 55,577 1.84 3.68 54,453 1.88 3.59 Insurance Brokers 54,927 1.82 3.63 53,050 1.83 3.50 Diversified Metals & Mining 49,869 1.65 3.30 49,869 1.72 3.29 Auto Parts & Equipment 48,901 1.62 3.23 49,148 1.70 3.24 Automotive Retail 48,109 1.59 3.18 55,805 1.93 3.68 Home Improvement Retail 48,034 1.59 3.18 53,168 1.84 3.51 Systems Software 45,148 1.50 2.99 21,968 0.76 1.45 Real Estate Services 43,771 1.45 2.90 43,886 1.52 2.90 Soft Drinks & Non-alcoholic Beverages 41,868 1.39 2.77 42,391 1.47 2.80 Specialized Finance 41,677 1.38 2.76 69,590 2.41 4.59 Broadline Retail 39,230 1.30 2.60 69,040 2.39 4.55 Leisure Facilities 39,022 1.29 2.58 36,963 1.28 2.44 Specialty Chemicals 37,692 1.25 2.49 38,615 1.34 2.55 Electrical Components & Equipment 32,491 1.08 2.15 32,573 1.13 2.15 Distributors 31,221 1.03 2.07 37,311 1.29 2.46 Passenger Airlines 27,163 0.90 1.80 27,512 0.95 1.82 Real Estate Development 23,881 0.79 1.58 23,679 0.82 1.56 Gold 23,519 0.78 1.56 23,328 0.81 1.54 Health Care Equipment 21,410 0.71 1.42 22,436 0.78 1.48 Construction & Engineering 21,347 0.71 1.41 21,903 0.76 1.45 Hotels, Resorts & Cruise Lines 17,024 0.56 1.13 16,991 0.59 1.12 Oil & Gas Storage & Transportation 16,173 0.54 1.07 16,040 0.55 1.06 Home Furnishings 14,131 0.47 0.93 19,954 0.69 1.32 Integrated Telecommunication Services 13,261 0.44 0.88 16,492 0.57 1.09 Restaurants 12,847 0.43 0.85 12,464 0.43 0.82 Advertising 12,140 0.40 0.80 11,955 0.41 0.79 Health Care Supplies 11,321 0.38 0.75 11,363 0.39 0.75 Cable & Satellite 9,309 0.31 0.62 4,546 0.16 0.30 Education Services 8,396 0.28 0.56 13,618 0.47 0.90 Food Distributors 7,353 0.24 0.49 5,166 0.18 0.34 Oil & Gas Refining & Marketing 7,009 0.23 0.46 — — — Research & Consulting Services 4,893 0.16 0.32 4,831 0.17 0.32 Apparel Retail 4,419 0.15 0.29 5,002 0.17 0.33 Office Services & Supplies 4,377 0.15 0.29 — — — Other Specialized REITs 3,511 0.12 0.23 3,198 0.11 0.21 Paper & Plastic Packaging Products & Materials 3,048 0.10 0.20 3,061 0.11 0.20 Housewares & Specialties 2,684 0.09 0.18 2,808 0.10 0.19 Leisure Products 2,197 0.07 0.15 2,063 0.07 0.14 Alternative Carriers 1,661 0.06 0.11 — — — Diversified Chemicals 1,573 0.05 0.10 — — — Consumer Finance — — — 15,087 0.52 1.00 Movies & Entertainment — — — 11,865 0.41 0.78 Integrated Oil & Gas — — — 4,785 0.17 0.32 Air Freight & Logistics — — — 4,263 0.15 0.28 Technology Distributors — — — 776 0.03 0.05 Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % ___________________ (1) This industry includes the Company's investments in the JVs. As of December 31, 2023 and September 30, 2023, the Company had no single investment that represented greater than 10% of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments. Senior Loan Fund JV I, LLC In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of December 31, 2023 and September 30, 2023, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I has a revolving credit facility with Bank of America, N.A. (the "SLF JV I Facility"), which permitted up to $270.0 million of borrowings (subject to borrowing base and other limitations) as of December 31, 2023. Borrowings under the SLF JV I Facility are secured by all of the assets of SLF JV I Funding II LLC, a special purpose financing subsidiary of SLF JV I. As of December 31, 2023, the revolving period of the SLF JV I Facility was scheduled to expire August 12, 2026 and the maturity date was August 17, 2026. As of December 31, 2023, borrowings under the SLF JV I Facility accrued interest at a rate equal to daily SOFR plus 2.00% per annum. $149.0 million of borrowings were outstanding under the SLF JV I Facility as of each of December 31, 2023 and September 30, 2023. As of December 31, 2023 and September 30, 2023, SLF JV I had total assets of $372.8 million and $376.1 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 52 and 48 portfolio companies as of December 31, 2023 and September 30, 2023, respectively. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of December 31, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $142.2 million in aggregate, at fair value. As of September 30, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $141.5 million in aggregate, at fair value. As of each of December 31, 2023 and September 30, 2023, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of each of December 31, 2023 and September 30, 2023, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $334,754 $332,637 Weighted average interest rate on senior secured loans (2) 10.57% 10.62% Number of borrowers in SLF JV I 52 48 Largest exposure to a single borrower (1) $11,220 $11,286 Total of five largest loan exposures to borrowers (1) $51,354 $54,051 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. SLF JV I Portfolio as of December 31, 2023 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diver |
Fee Income
Fee Income | 3 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Fee Income | Fee Income For the three months ended December 31, 2023 and 2022, the Company recorded total fee income of $1.3 million and $2.0 million, respectively, of which $0.2 million and $0.2 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees. |
Share Data and Net Assets
Share Data and Net Assets | 3 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Share Data and Net Assets | Share Data and Net Assets The share and per share information for the three months ended December 31, 2022 disclosed in Note 5 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Earnings per Share The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three months ended December 31, 2023 and 2022: (Share amounts in thousands) Three months ended Three months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Weighted average common shares outstanding — basic and diluted 77,840 61,142 Earnings (loss) per common share — basic and diluted $ 0.14 $ 0.22 Changes in Net Assets The following table presents the changes in net assets for the three months ended December 31, 2023: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2023 77,225 $ 772 $ 2,166,330 $ (651,338) $ 1,515,764 Net investment income — — — 44,189 44,189 Net unrealized appreciation (depreciation) — — — (25,025) (25,025) Net realized gains (losses) — — — (8,453) (8,453) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (176) (176) Distributions to stockholders — — — (48,897) (48,897) Issuance of common stock in connection with the "at the market" offering 1,641 17 32,296 — 32,313 Issuance of common stock under dividend reinvestment plan 99 1 1,935 — 1,936 Balance as of December 31, 2023 78,965 $ 790 $ 2,200,561 $ (689,700) $ 1,511,651 The following table presents the changes in net assets for the three months ended December 31, 2022: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989 Distributions Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment. The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP. For income tax purposes, the Company has reported its distributions for the 2023 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 2023 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders. The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 2023 and 2022: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 8, 2023 December 15, 2023 December 29, 2023 $ 0.55 $ 41.7 million 87,472 (1) $ 1.7 million Special November 8, 2023 December 15, 2023 December 29, 2023 $ 0.07 $ 5.3 million 11,133 (1) $ 0.2 million Total for the three months ended December 31, 2023 $ 0.62 $ 47.0 million 98,605 $ 1.9 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 $ 0.42 $ 24.8 million 41,510 (1) $ 0.8 million Total for the three months ended December 31, 2022 $ 0.96 $ 56.8 million 94,879 $ 1.9 million __________ (1) New shares were issued and distributed. Common Stock Issuances During the three months ended December 31, 2023 and 2022, the Company issued 98,605 and 94,879 shares, respectively, of common stock as part of the DRIP. On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of the Company’s common stock having an aggregate offering price of up to $125 million under the Company’s current registration statement and on August 8, 2023 to add Jefferies LLC as an additional placement agent and to remove SMBC Nikko Securities America, Inc. as a placement agent. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices. In connection with the "at the market" offering, the Company issued and sold 1,641,416 shares of common stock during the three months ended December 31, 2023 for net proceeds of $32.3 million (net of offering costs). Number of Shares Issued Gross Proceeds Placement Agent Fees Net Proceeds (1) Average Sales Price per Share (2) "At the market" offering 1,641,416 $ 32,725 $ 327 $ 32,398 $ 19.94 (1) Net proceeds excludes offering costs of $0.1 million. (2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses. In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the three months ended December 31, 2022. |
Borrowings
Borrowings | 3 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC, or “OSI 2 SPV”) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of each of December 31, 2023 and September 30, 2023, the Company had $430.0 million of borrowings outstanding under the Syndicated Facility, which had a fair value of $430.0 million. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 7.621% and 5.849% for the three months ended December 31, 2023 and 2022, respectively. For the three months ended December 31, 2023 and 2022, the Company recorded interest expense (inclusive of fees) of $9.6 million and $10.0 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. As of December 31, 2023 and September 30, 2023, the Company did not have any borrowings outstanding under the Citibank Facility. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% for the three months ended December 31, 2022. For the three months ended December 31, 2022, the Company recorded interest expense (inclusive of fees) of $2.7 million related to the Citibank Facility. OSI2 Citibank Facility On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. As of December 31, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. As of each of December 31, 2023 and September 30, 2023, the Company had $280.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $280.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 8.204% for the three months ended December 31, 2023. For the three months ended December 31, 2023, the Company recorded interest expense (inclusive of fees) of $6.1 million related to the OSI2 Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month SOFR plus 1.658% plus a SOFR adjustment of 0.26161% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. 2029 Notes On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes. The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2029 Notes is paid semi-annually on February 15 and August 15, beginning February 15, 2024, at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2029 Notes in the open market. The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture. In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of December 31, 2023 and September 30, 2023: As of December 31, 2023 As of September 30, 2023 ($ in millions) 2025 Notes 2027 Notes 2029 Notes 2025 Notes 2027 Notes 2029 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 300.0 $ 350.0 $ 300.0 Unamortized financing costs (0.9) (2.3) (3.4) (1.1) (2.5) (3.5) Unaccreted discount (0.6) (0.5) (3.2) (0.7) (0.6) (3.4) Interest rate swap fair value adjustment — (30.4) 4.0 — (40.5) (7.0) Net carrying value $ 298.5 $ 316.8 $ 297.4 $ 298.2 $ 306.4 $ 286.1 Fair Value $ 291.2 $ 315.1 $ 310.4 $ 286.4 $ 301.8 $ 290.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the three months ended December 31, 2023: ($ in millions) 2025 Notes 2027 Notes 2029 Notes Coupon interest $ 2.6 $ 2.4 $ 5.3 Amortization of financing costs and discount 0.3 0.2 0.3 Effect of interest rate swap — 4.2 1.2 Total interest expense $ 2.9 $ 6.8 $ 6.8 Coupon interest rate (net of effect of interest rate swaps) 3.500 % 7.455 % 8.679 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — 2.5 Total interest expense $ 2.9 $ 5.1 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 5.586 % |
Taxable_Distributable Income an
Taxable/Distributable Income and Dividend Distributions | 3 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Taxable/Distributable Income and Dividend Distributions | Taxable/Distributable Income and Dividend Distributions Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans. As of September 30, 2023, the Company had net capital loss carryforwards of $558.3 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $70.3 million are available to offset future short-term capital gains and $488.0 million are available to offset future long-term capital gains. A portion of such net capital loss carryforwards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations. Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2023 and 2022. Three months ended Three months ended Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Net unrealized (appreciation) depreciation 25,025 22,982 Book/tax difference due to capital losses suspended (utilized) 6,540 8,013 Other book/tax differences (7,178) (12,910) Taxable/Distributable Income (1) $ 34,922 $ 31,257 __________ (1) The Company's taxable income for the three months ended December 31, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2024. Therefore, the final taxable income may be different than the estimate. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of December 31, 2023, $8.2 million of the $8.2 million deferred tax assets would not more likely than not be realized in future periods. For the three months ended December 31, 2023, the Company recognized a total expense for income tax related to realized and unrealized gains (losses) of $0.2 million, which was composed primarily of a current income tax expense. For the three months ended December 31, 2022, the Company recognized a total benefit for income tax related to realized and unrealized losses of $0.5 million, which was primarily all current income tax benefit. As of September 30, 2023, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ 33,525 Net realized capital losses (509,832) Unrealized losses, net (175,031) Accumulated overdistributed earnings $ (651,338) The aggregate cost of investments for U.S. federal income tax purposes was $3,070.0 million as of September 30, 2023. As of September 30, 2023, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $529.5 million. As of September 30, 2023, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was $704.5 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $175.0 million. |
Realized Gains or Losses and Ne
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation | 3 Months Ended |
Dec. 31, 2023 | |
Investment Company [Abstract] | |
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation | Realized Gains or Losses and Net Unrealized Appreciation or Depreciation Realized Gains or Losses Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules. During the three months ended December 31, 2023, the Company recorded an aggregate net realized loss of $8.5 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Continental Intermodal Group LP $ (6.8) P&L Development LLC (1.9) Zephyr Bidco Limited (1) (1.7) Lift Brands Holdings, Inc. (1.4) Foreign currency forward contracts 4.1 Other, net (0.8) Total, net $ (8.5) __________ (1) This investment was denominated in British Pounds and the realized loss shown in this table includes losses due to foreign currency translation, which was offset by gains on foreign currency forward contracts. During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 4.4 Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) Global Medical Response Inc. (1.0) Other, net (1.7) Total, net $ (3.2) Net Unrealized Appreciation or Depreciation Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation. During the three months ended December 31, 2023 and 2022, the Company recorded net unrealized depreciation of $25.0 million and $23.0 million, respectively. For the three months ended December 31, 2023, this consisted of $18.8 million of net unrealized depreciation on equity investments, $13.7 million of net unrealized depreciation on debt investments and $7.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $15.3 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses). For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. |
Concentration of Credit Risks
Concentration of Credit Risks | 3 Months Ended |
Dec. 31, 2023 | |
Risks and Uncertainties [Abstract] | |
Concentration of Credit Risks | Concentration of Credit Risks The Company deposits its cash with financial institutions and at times such balances are in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions As of December 31, 2023 and September 30, 2023, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $19.0 million and $19.5 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree. Investment Advisory Agreement The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company. The investment advisory agreement with Oaktree was amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the closing of OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree. Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company. Base Management Fee Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger. For the three months ended December 31, 2023 and 2022, the base management fee incurred under the Investment Advisory Agreement was $10.0 million (net of waiver) and $9.2 million (net of waiver), respectively. Incentive Fee The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income. Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows: • No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets; • 100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and • For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved. There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle. For the three months ended December 31, 2023 and 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $9.0 million and $7.7 million, respectively. Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of December 31, 2023, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2023 under the Investment Advisory Agreement, no Part II incentive fees would be payable. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three months ended December 31, 2023 and 2022, there were no accrued capital gains incentive fees. As of December 31, 2023, the total accrued capital gains incentive fee liability was zero. Indemnification The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser. Administrative Services The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation. Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies. For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities. For the three months ended December 31, 2023 and 2022, the Company accrued administrative expenses of $0.4 million and $0.4 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. As of December 31, 2023 and September 30, 2023, $3.8 million and $4.3 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator. |
Financial Highlights
Financial Highlights | 3 Months Ended |
Dec. 31, 2023 | |
Investment Company [Abstract] | |
Financial Highlights | Financial Highlights (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $19.63 $20.38 Net investment income (1) 0.57 0.63 Net unrealized appreciation (depreciation) (1) (0.33) (0.38) Net realized gains (losses) (1) (0.11) (0.05) (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — 0.01 Distributions of net investment income to stockholders (0.62) (0.96) Net asset value per share at end of period $19.14 $19.63 Per share market value at beginning of period $20.12 $18.00 Per share market value at end of period $20.42 $20.61 Total return (2) 4.70% 19.90% Common shares outstanding at beginning of period 77,225 61,125 Common shares outstanding at end of period 78,965 61,220 Net assets at beginning of period $1,515,764 $1,245,563 Net assets at end of period $1,511,651 $1,201,989 Average net assets (3) $1,524,243 $1,241,806 Ratio of net investment income to average net assets (7) 11.50% 12.40% Ratio of total expenses to average net assets (7) 14.39% 13.11% Ratio of net expenses to average net assets (7) 14.00% 12.87% Ratio of portfolio turnover to average investments at fair value 7.36% 4.24% Weighted average outstanding debt (4) $1,660,435 $1,441,326 Average debt per share (1) $21.33 $23.57 Asset coverage ratio at end of period (5) 188.66% 176.31% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Calculated based upon the weighted average of principal debt outstanding for the period. (5) Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively. (6) The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (7) Interim periods are annualized. |
Derivative Instruments
Derivative Instruments | 3 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | Derivative Instruments The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of December 31, 2023, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts. Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 36,775 € 34,350 2/8/2024 $ — $ 1,227 Derivative liability Foreign currency forward contract $ 47,403 £ 38,500 2/8/2024 — 1,687 Derivative liability $ — $ 2,914 Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 42,182 € 38,026 11/9/2023 $ 1,857 $ — Derivative asset Foreign currency forward contract $ 72,098 £ 56,556 11/9/2023 3,053 — Derivative asset $ 4,910 $ — In connection with the issuance of the 2027 Notes and 2029 Notes, the Company entered into interest rate swap agreements with the Royal Bank of Canada pursuant to ISDA Master Agreements. As of December 31, 2023, the Company paid $26.5 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreements, which is included in due from broker on the Consolidated Statement of Assets and Liabilities. Certain information related to the Company’s interest rate swaps is presented below as of December 31, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 30,415 Derivative liability Interest rate swap 300,000 2/15/2029 4,013 — Derivative liability $ 4,013 $ 30,415 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 40,519 Derivative liability Interest rate swap 300,000 2/15/2029 — 7,000 Derivative liability $ — $ 47,519 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Off-Balance Sheet Arrangements The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of December 31, 2023, the Company's only off-balance sheet arrangements consisted of $226.6 million of unfunded commitments, which was comprised of $199.5 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $199.5 million, approximately $165.9 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. As of September 30, 2023, the Company's only off-balance sheet arrangements consisted of $232.7 million of unfunded commitments, which was comprised of $205.6 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $205.6 million, approximately $154.2 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities. A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components and subordinated notes and LLC equity interests in the JVs) as of December 31, 2023 and September 30, 2023 is shown in the table below: December 31, 2023 September 30, 2023 107-109 Beech OAK22 LLC $ 26,969 $ 26,969 OCSI Glick JV LLC 13,998 13,998 PetVet Care Centers, LLC 13,732 — Senior Loan Fund JV I, LLC 13,125 13,125 Fairbridge Strategic Capital Funding LLC 9,465 13,090 BioXcel Therapeutics, Inc. 9,383 14,547 Amspec Parent LLC 9,372 — Seres Therapeutics, Inc. 8,090 8,090 MRI Software LLC 7,260 2,261 Next Holdco, LLC 7,051 — iCIMs, Inc. 6,924 7,466 Kings Buyer, LLC 5,462 5,189 Grove Hotel Parcel Owner, LLC 5,286 5,286 scPharmaceuticals Inc. 5,212 5,212 Avalara, Inc. 5,047 5,047 Mindbody, Inc. 4,762 4,762 Accupac, Inc. 4,500 4,500 107 Fair Street LLC 4,227 4,227 Harrow, Inc. 4,011 4,011 Inventus Power, Inc. 3,792 3,792 Dominion Diagnostics, LLC 3,484 3,484 Establishment Labs Holdings Inc. 3,384 3,384 WP CPP Holdings, LLC 3,272 — Enverus Holdings, Inc. 3,135 — PRGX Global, Inc. 3,127 3,127 Salus Workers' Compensation, LLC 3,102 3,102 Spanx, LLC 3,092 2,473 ADC Therapeutics SA 3,020 3,020 Relativity ODA LLC 2,762 2,762 LSL Holdco, LLC 2,650 2,650 Galileo Parent, Inc. 2,484 2,061 MND Holdings III Corp 2,280 9,122 Crewline Buyer, Inc. 2,180 — 112-126 Van Houten Real22 LLC 2,139 2,343 Coupa Holdings, LLC 2,075 2,075 Berner Food & Beverage, LLC 2,005 1,622 Oranje Holdco, Inc. 1,904 1,904 MHE Intermediate Holdings, LLC 1,786 821 Evergreen IX Borrower 2023, LLC 1,626 1,626 Acquia Inc. 1,376 1,376 PPW Aero Buyer, Inc. 1,368 1,466 SCP Eye Care Services, LLC 1,366 2,356 Coyote Buyer, LLC 1,333 400 Pluralsight, LLC 1,068 1,787 Finastra USA, Inc. 896 960 Digital.AI Software Holdings, Inc. 782 1,078 OTG Management, LLC 467 3,190 ASP-R-PAC Acquisition Co LLC 396 396 SIO2 Medical Products, Inc. 238 1,821 Telestream Holdings Corporation 148 407 Delta Leasing SPV II LLC — 14,639 Assembled Brands Capital LLC — 7,514 Impel Pharmaceuticals Inc. — 2,458 Supreme Fitness Group NY Holdings, LLC — 2,199 Tahoe Bidco B.V. — 2,162 Liquid Environmental Solutions Corporation — 1,383 Total $ 226,613 $ 232,740 |
Subsequent Events
Subsequent Events | 3 Months Ended |
Dec. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three months ended December 31, 2023, except as discussed below. Distribution Declaration On January 26, 2024, the Company’s Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on March 29, 2024 to stockholders of record on March 15, 2024. |
Schedule_12-14
Schedule 12-14 | 3 Months Ended |
Dec. 31, 2023 | |
Investments in and Advances to Affiliates [Abstract] | |
Schedule 12-14 | Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Three months ended December 31, 2023 Portfolio Company (1) Industry Investment Type Index Spread Cash PIK Rate Maturity Date Shares Principal Net Realized Gain (Loss) Amount of Interest, Fees or Dividends Credited in Income (2) Fair Value at October 1, 2023 Gross Additions (3) Gross Reductions (4) Fair Value at December 31, 2023 % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 829 $ — $ — $ — $ — $ — $ — — % C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 34,984,460 — — 27,638 — — 27,638 1.8 % Continental Intermodal Group LP Oil & Gas Storage & Transportation Common Stock 22,267,661 — — — 16,173 — 16,173 1.1 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan SOFR+ 5.00 % 10.50 % 8/28/2025 $ 14,033 — 391 14,068 — (35) 14,033 0.9 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan SOFR+ 5.00 % 10.46 % 8/28/2025 1,393 — 58 2,090 — (696) 1,394 0.1 % Dominion Diagnostics, LLC Health Care Services First Lien Revolver SOFR+ 5.00 % 10.50 % 8/28/2025 5,574 — 150 5,574 — — 5,574 0.4 % Dominion Diagnostics, LLC Health Care Services Common Stock 30,031 — — 2,711 — — 2,711 0.2 % First Star Speir Aviation Limited Airlines Equity Interest 786 — — — — — — % OCSI Glick JV LLC (5) Multi-Sector Holdings Subordinated Debt SOFR+ 4.50 % 9.94 % 10/20/2028 58,349 — 1,773 50,017 940 — 50,957 3.4 % OCSI Glick JV LLC (5) Multi-Sector Holdings Membership Interest 87.50 % — — — — — — — % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Subordinated Debt SOFR+ 7.00 % 12.44 % 12/29/2028 112,656 — 3,581 112,656 — — 112,656 7.5 % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Membership Interest 87.50 % — 1,400 28,878 709 — 29,587 2.0 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers First Lien Term Loan 12.00 % 8/3/2028 16,355 — 540 15,874 534 (53) 16,355 1.1 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers First Lien Term Loan 12.00 % 8/3/2028 3,005 — 69 1,359 1,646 — 3,005 0.2 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers Common Stock 1,184,630 — — 36,226 — — 36,226 2.4 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers Warrants 66,686 — — — — — — — % Total Control Investments $ 211,365 $ 786 $ 7,962 $ 297,091 $ 20,002 $ (784) $ 316,309 20.9 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver — 329 21,823 33 (21,856) — — % Assembled Brands Capital LLC Specialized Finance Common Stock 12,463,242 — — 89 1,159 (251) 997 0.1 % Assembled Brands Capital LLC Specialized Finance Preferred Equity — — 1,005 154 (1,159) — — % Assembled Brands Capital LLC Specialized Finance Warrants 78,045 — — — — — — — % The Avery Real Estate Operating Companies First Lien Term Loan 10.00 % 12/15/2024 5,065 — — — 4,657 (367) 4,290 0.3 % The Avery Real Estate Operating Companies First Lien Term Loan 10.00 % 12/15/2024 20,871 — — — 19,217 (494) 18,723 1.2 % The Avery Real Estate Operating Companies Membership Interest 6.40 % — — — — — — — — % Caregiver Services, Inc. Health Care Services Preferred Equity 1,080,398 — — 432 — — 432 — % Total Affiliate Investments $ 25,936 $ — $ 329 $ 23,349 $ 25,220 $ (24,127) $ 24,442 1.6 % Total Control & Affiliate Investments $ 237,301 $ 786 $ 8,291 $ 320,440 $ 45,222 $ (24,911) $ 340,751 22.5 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (6) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required). Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Three months ended December 31, 2022 Portfolio Company (1) Industry Investment Type Index Spread Cash PIK Rate Maturity Date Shares Principal Net Realized Gain (Loss) Amount of Interest, Fees or Dividends Credited in Income (2) Fair Value at October 1, 2022 Gross Additions (3) Gross Reductions (4) Fair Value at December 31, 2022 % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 829 $ — $ — $ — $ — $ — $ — $ — — % C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 34,984,460 — — — 27,638 — — 27,638 2.3 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan LIBOR+ 5.00 % 9.73 % 2/28/2024 14,297 — 331 14,333 — (36) 14,297 1.2 % Dominion Diagnostics, LLC Health Care Services First Lien Revolver LIBOR+ 5.00 % 2/28/2024 — — 14 — — — — — % Dominion Diagnostics, LLC Health Care Services Common Stock 30,031 — — — 4,946 — (719) 4,227 0.4 % OCSI Glick JV LLC (5) Multi-Sector Holdings Subordinated Debt LIBOR+ 4.50 % 7.67 % 10/20/2028 59,049 — 1,624 50,283 380 (1,127) 49,536 4.1 % OCSI Glick JV LLC (5) Multi-Sector Holdings Membership Interest 87.50 % — — — — — — — — % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Subordinated Debt LIBOR+ 7.00 % 10.17 % 12/29/2028 112,656 — 2,611 96,250 16,406 — 112,656 9.4 % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Membership Interest 87.50 % — — 1,050 20,715 5,469 (2,076) 24,108 2.0 % Total Control Investments $ 186,002 $ — $ 5,630 $ 214,165 $ 22,255 $ (3,958) $ 232,462 19.3 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver LIBOR+ 6.75 % 11.48 % 10/17/2023 21,464 — 646 24,225 55 (3,028) 21,252 1.8 % Assembled Brands Capital LLC Specialized Finance Common Stock 1,609,201 — — — 370 — (16) 354 — % Assembled Brands Capital LLC Specialized Finance Preferred Equity 1,019,169 — — — 1,223 20 — 1,243 0.1 % Assembled Brands Capital LLC Specialized Finance Warrants 70,425 — — — — — — — — % Caregiver Services, Inc. Health Care Services Preferred Equity 1,080,399 — — — 378 — (54) 324 — % Total Affiliate Investments $ 21,464 $ — $ 646 $ 26,196 $ 75 $ (3,098) $ 23,173 1.9 % Total Control & Affiliate Investments $ 207,466 $ — $ 6,276 $ 240,361 $ 22,330 $ (7,056) $ 255,635 21.2 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments, included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2022. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (6) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required). |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Pay vs Performance Disclosure | ||
Net increase (decrease) in net assets resulting from operations | $ 10,535 | $ 13,172 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
N-2
N-2 - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |||||
Dec. 31, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | |||
Cover [Abstract] | ||||||
Entity Central Index Key | 0001414932 | |||||
Amendment Flag | false | |||||
Securities Act File Number | 1-33901 | |||||
Document Type | 10-Q | |||||
Entity Registrant Name | Oaktree Specialty Lending Corporation | |||||
Entity Address, Address Line One | 333 South Grand Avenue | |||||
Entity Address, Address Line Two | 28th Floor | |||||
Entity Address, City or Town | Los Angeles | |||||
Entity Address, State or Province | CA | |||||
Entity Address, Postal Zip Code | 90071 | |||||
City Area Code | 213 | |||||
Local Phone Number | 830-6300 | |||||
Entity Emerging Growth Company | false | |||||
Financial Highlights [Abstract] | ||||||
Senior Securities Amount | $ 1,662.9 | $ 1,514.4 | ||||
General Description of Registrant [Abstract] | ||||||
Investment Objectives and Practices [Text Block] | Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital and (4) public credit, where we seek discounted, high quality public debt investments particularly in times of market dislocation. | |||||
NAV Per Share | $ 19.14 | [1] | $ 19.63 | $ 19.63 | [1] | $ 20.38 |
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||
Long Term Debt [Table Text Block] | Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC, or “OSI 2 SPV”) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of each of December 31, 2023 and September 30, 2023, the Company had $430.0 million of borrowings outstanding under the Syndicated Facility, which had a fair value of $430.0 million. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 7.621% and 5.849% for the three months ended December 31, 2023 and 2022, respectively. For the three months ended December 31, 2023 and 2022, the Company recorded interest expense (inclusive of fees) of $9.6 million and $10.0 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. As of December 31, 2023 and September 30, 2023, the Company did not have any borrowings outstanding under the Citibank Facility. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% for the three months ended December 31, 2022. For the three months ended December 31, 2022, the Company recorded interest expense (inclusive of fees) of $2.7 million related to the Citibank Facility. OSI2 Citibank Facility On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. As of December 31, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. As of each of December 31, 2023 and September 30, 2023, the Company had $280.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $280.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 8.204% for the three months ended December 31, 2023. For the three months ended December 31, 2023, the Company recorded interest expense (inclusive of fees) of $6.1 million related to the OSI2 Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month SOFR plus 1.658% plus a SOFR adjustment of 0.26161% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. 2029 Notes On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes. The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2029 Notes is paid semi-annually on February 15 and August 15, beginning February 15, 2024, at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2029 Notes in the open market. The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture. In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. | |||||
2025 Notes [Member] | ||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||
Long Term Debt, Title [Text Block] | 2025 Notes | |||||
Long Term Debt, Structuring [Text Block] | On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. | |||||
Long Term Debt, Dividends and Covenants [Text Block] | The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. | |||||
2027 Notes [Member] | ||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||
Long Term Debt, Title [Text Block] | 2027 Notes | |||||
Long Term Debt, Structuring [Text Block] | On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. | |||||
Long Term Debt, Dividends and Covenants [Text Block] | The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. | |||||
2029 Notes [Member] | ||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||
Long Term Debt, Structuring [Text Block] | On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes. The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2029 Notes is paid semi-annually on February 15 and August 15, beginning February 15, 2024, at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2029 Notes in the open market. | |||||
Long Term Debt, Dividends and Covenants [Text Block] | The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture. In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. | |||||
Syndicated Facility [Member] | ||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||
Long Term Debt, Title [Text Block] | Syndicated Facility | |||||
Long Term Debt, Structuring [Text Block] | On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. | |||||
Long Term Debt, Dividends and Covenants [Text Block] | The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. | |||||
Citibank Facility [Member] | ||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||
Long Term Debt, Title [Text Block] | Citibank Facility | |||||
Long Term Debt, Structuring [Text Block] | On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. | |||||
OSI2 Citibank Facility [Member] | ||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||
Long Term Debt, Title [Text Block] | OSI2 Citibank Facility | |||||
Long Term Debt, Structuring [Text Block] | On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. | |||||
Long Term Debt, Dividends and Covenants [Text Block] | As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. | |||||
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 3 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. |
Use of Estimates | Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. |
Consolidation | Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. |
Fair Value Measurements | Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2023 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities. |
Foreign Currency Translation | Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. |
Derivative Instruments | Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. |
Investment Income | Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of December 31, 2023, there were seven investments on non-accrual status that in aggregate represented 5.9% and 4.2% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. |
Cash and Cash Equivalents and Restricted Cash | Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. |
Due From Portfolio Companies | Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date). |
Receivables/Payables from Unsettled Transactions | Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. |
Deferred Financing Costs | Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. |
Deferred Offering Costs | Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. |
Income Taxes | Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months. |
Portfolio Investments (Tables)
Portfolio Investments (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Schedule of Investments [Abstract] | |
Composition of Investments | The composition of the Company's investments as of December 31, 2023 and September 30, 2023 at cost and fair value was as follows: December 31, 2023 September 30, 2023 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,779,477 $ 2,680,454 $ 2,654,484 $ 2,557,102 Investments in equity securities 190,205 144,898 171,858 143,767 Debt investments in the JVs 163,277 163,613 162,986 162,673 Equity investments in the JVs 54,791 29,587 54,791 28,878 Total $ 3,187,750 $ 3,018,552 $ 3,044,119 $ 2,892,420 The following table presents the composition of the Company's debt investments as of December 31, 2023 and September 30, 2023 at fixed rates and floating rates: December 31, 2023 September 30, 2023 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,397,664 84.30 % $ 2,345,205 86.23 % Fixed rate debt securities 446,403 15.70 374,570 13.77 Total $ 2,844,067 100.00 % $ 2,719,775 100.00 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Application Software $ 472,016 14.82 % $ 468,483 15.39 % Multi-Sector Holdings (1) 219,766 6.89 219,469 7.21 Health Care Services 137,713 4.32 81,560 2.68 Data Processing & Outsourced Services 133,399 4.18 133,410 4.38 Health Care Technology 130,701 4.10 106,915 3.51 Biotechnology 127,672 4.01 126,349 4.15 Industrial Machinery & Supplies & Components 102,785 3.22 99,511 3.27 Real Estate Operating Companies 85,374 2.68 83,754 2.75 Broadline Retail 83,290 2.61 83,290 2.74 Pharmaceuticals 74,100 2.32 84,948 2.79 Other Specialty Retail 68,033 2.13 41,088 1.35 Personal Care Products 67,619 2.12 68,146 2.24 Interactive Media & Services 66,109 2.07 19,013 0.62 Fertilizers & Agricultural Chemicals 64,689 2.03 64,720 2.13 Aerospace & Defense 63,768 2.00 51,797 1.70 Diversified Support Services 63,265 1.98 23,435 0.77 Environmental & Facilities Services 63,022 1.98 63,064 2.07 Health Care Distributors 62,010 1.95 62,044 2.04 Diversified Financial Services 61,608 1.93 61,725 2.03 Internet Services & Infrastructure 61,012 1.91 60,934 2.00 Airport Services 57,897 1.82 55,961 1.84 Metal, Glass & Plastic Containers 57,679 1.81 55,530 1.82 Insurance Brokers 52,472 1.65 52,856 1.74 Diversified Metals & Mining 49,898 1.57 49,842 1.64 Automotive Retail 49,603 1.56 57,596 1.89 Home Improvement Retail 49,001 1.54 54,236 1.78 Auto Parts & Equipment 48,462 1.52 48,536 1.59 Systems Software 45,509 1.43 23,111 0.76 Real Estate Services 44,652 1.40 44,717 1.47 Specialized Finance 42,215 1.32 73,035 2.40 Soft Drinks & Non-alcoholic Beverages 42,158 1.32 42,628 1.40 Leisure Facilities 39,724 1.25 39,076 1.28 Specialty Chemicals 37,622 1.18 38,640 1.27 Electrical Components & Equipment 32,500 1.02 32,440 1.07 Distributors 32,189 1.01 37,666 1.24 Advertising 25,597 0.80 25,597 0.84 Passenger Airlines 24,952 0.78 24,920 0.82 Real Estate Development 24,198 0.76 23,965 0.79 Gold 23,347 0.73 23,310 0.77 Home Furnishings 23,085 0.72 23,859 0.78 Health Care Equipment 22,509 0.71 22,441 0.74 Construction & Engineering 21,668 0.68 22,102 0.73 Hotels, Resorts & Cruise Lines 17,169 0.54 17,195 0.56 Oil & Gas Storage & Transportation 16,172 0.51 22,042 0.72 Integrated Telecommunication Services 14,657 0.46 18,801 0.62 Restaurants 12,617 0.40 12,603 0.41 Health Care Supplies 11,618 0.36 11,646 0.38 Cable & Satellite 8,946 0.28 4,619 0.15 Education Services 8,257 0.26 13,871 0.46 Food Distributors 7,677 0.24 5,897 0.19 Oil & Gas Refining & Marketing 6,620 0.21 — — Research & Consulting Services 4,862 0.15 4,871 0.16 Other Specialized REITs 4,395 0.14 4,379 0.14 Apparel Retail 4,375 0.14 4,999 0.16 Office Services & Supplies 4,162 0.13 — — Paper & Plastic Packaging Products & Materials 3,247 0.10 3,254 0.11 Housewares & Specialties 2,854 0.09 2,908 0.10 Leisure Products 2,070 0.06 2,055 0.07 Alternative Carriers 1,625 0.05 — — Diversified Chemicals 1,539 0.05 — — Consumer Finance — — 16,440 0.54 Movies & Entertainment — — 12,188 0.40 Air Freight & Logistics — — 4,925 0.16 Integrated Oil & Gas — — 4,894 0.16 Technology Distributors — — 813 0.03 $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 460,072 15.23 % 30.41 % $ 455,719 15.73 % 30.03 % Multi-Sector Holdings (1) 195,163 6.47 12.91 193,431 6.69 12.76 Biotechnology 127,586 4.23 8.44 125,678 4.35 8.29 Data Processing & Outsourced Services 126,731 4.20 8.38 125,259 4.33 8.26 Health Care Services 122,076 4.04 8.08 66,683 2.31 4.40 Health Care Technology 107,574 3.56 7.12 95,404 3.30 6.29 Industrial Machinery & Supplies & Components 104,217 3.45 6.89 98,352 3.40 6.49 Real Estate Operating Companies 84,517 2.80 5.59 82,463 2.85 5.44 Pharmaceuticals 71,320 2.36 4.72 80,455 2.78 5.31 Other Specialty Retail 69,533 2.30 4.60 41,115 1.42 2.71 Interactive Media & Services 66,304 2.20 4.39 19,199 0.66 1.27 Aerospace & Defense 63,981 2.12 4.23 51,862 1.79 3.42 Fertilizers & Agricultural Chemicals 63,185 2.09 4.18 63,185 2.18 4.17 Diversified Financial Services 62,687 2.08 4.15 60,003 2.07 3.96 Diversified Support Services 62,669 2.08 4.15 23,352 0.81 1.54 Environmental & Facilities Services 62,180 2.06 4.11 62,413 2.16 4.12 Internet Services & Infrastructure 60,771 2.01 4.02 60,579 2.09 4.00 Health Care Distributors 60,654 2.01 4.01 60,865 2.10 4.02 Personal Care Products 59,562 1.97 3.94 59,928 2.07 3.95 Metal, Glass & Plastic Containers 55,586 1.84 3.68 53,459 1.85 3.53 Airport Services 55,577 1.84 3.68 54,453 1.88 3.59 Insurance Brokers 54,927 1.82 3.63 53,050 1.83 3.50 Diversified Metals & Mining 49,869 1.65 3.30 49,869 1.72 3.29 Auto Parts & Equipment 48,901 1.62 3.23 49,148 1.70 3.24 Automotive Retail 48,109 1.59 3.18 55,805 1.93 3.68 Home Improvement Retail 48,034 1.59 3.18 53,168 1.84 3.51 Systems Software 45,148 1.50 2.99 21,968 0.76 1.45 Real Estate Services 43,771 1.45 2.90 43,886 1.52 2.90 Soft Drinks & Non-alcoholic Beverages 41,868 1.39 2.77 42,391 1.47 2.80 Specialized Finance 41,677 1.38 2.76 69,590 2.41 4.59 Broadline Retail 39,230 1.30 2.60 69,040 2.39 4.55 Leisure Facilities 39,022 1.29 2.58 36,963 1.28 2.44 Specialty Chemicals 37,692 1.25 2.49 38,615 1.34 2.55 Electrical Components & Equipment 32,491 1.08 2.15 32,573 1.13 2.15 Distributors 31,221 1.03 2.07 37,311 1.29 2.46 Passenger Airlines 27,163 0.90 1.80 27,512 0.95 1.82 Real Estate Development 23,881 0.79 1.58 23,679 0.82 1.56 Gold 23,519 0.78 1.56 23,328 0.81 1.54 Health Care Equipment 21,410 0.71 1.42 22,436 0.78 1.48 Construction & Engineering 21,347 0.71 1.41 21,903 0.76 1.45 Hotels, Resorts & Cruise Lines 17,024 0.56 1.13 16,991 0.59 1.12 Oil & Gas Storage & Transportation 16,173 0.54 1.07 16,040 0.55 1.06 Home Furnishings 14,131 0.47 0.93 19,954 0.69 1.32 Integrated Telecommunication Services 13,261 0.44 0.88 16,492 0.57 1.09 Restaurants 12,847 0.43 0.85 12,464 0.43 0.82 Advertising 12,140 0.40 0.80 11,955 0.41 0.79 Health Care Supplies 11,321 0.38 0.75 11,363 0.39 0.75 Cable & Satellite 9,309 0.31 0.62 4,546 0.16 0.30 Education Services 8,396 0.28 0.56 13,618 0.47 0.90 Food Distributors 7,353 0.24 0.49 5,166 0.18 0.34 Oil & Gas Refining & Marketing 7,009 0.23 0.46 — — — Research & Consulting Services 4,893 0.16 0.32 4,831 0.17 0.32 Apparel Retail 4,419 0.15 0.29 5,002 0.17 0.33 Office Services & Supplies 4,377 0.15 0.29 — — — Other Specialized REITs 3,511 0.12 0.23 3,198 0.11 0.21 Paper & Plastic Packaging Products & Materials 3,048 0.10 0.20 3,061 0.11 0.20 Housewares & Specialties 2,684 0.09 0.18 2,808 0.10 0.19 Leisure Products 2,197 0.07 0.15 2,063 0.07 0.14 Alternative Carriers 1,661 0.06 0.11 — — — Diversified Chemicals 1,573 0.05 0.10 — — — Consumer Finance — — — 15,087 0.52 1.00 Movies & Entertainment — — — 11,865 0.41 0.78 Integrated Oil & Gas — — — 4,785 0.17 0.32 Air Freight & Logistics — — — 4,263 0.15 0.28 Technology Distributors — — — 776 0.03 0.05 Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % ___________________ (1) This industry includes the Company's investments in the JVs. SLF JV I Portfolio as of December 31, 2023 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan SOFR+ 5.00% 12.11% 8/18/2028 $ 8,575 $ 8,486 $ 8,600 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 1,124 1,112 1,098 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 6,631 6,571 6,479 (4) Altice France S.A. Integrated Telecommunication Services First Lien Term Loan L+ 4.00% 9.64% 8/14/2026 1,786 1,722 1,670 Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 13.00% 6/30/2025 8,681 8,629 8,117 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.47% 6/9/2028 1,596 1,488 1,513 American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.47% 6/9/2028 4,944 4,734 4,688 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.91% 10/20/2028 4,811 4,751 4,050 (4) Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.36% 8/11/2025 1,519 1,187 929 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (7) (30) (4)(5) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.64% 12/29/2027 4,124 4,069 3,876 (4) Astra Acquisition Corp. Application Software First Lien Term Loan SOFR+ 5.25% 10.86% 10/25/2028 5,052 4,895 3,294 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.46% 8/19/2028 5,920 5,734 5,904 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.46% 8/19/2028 613 589 612 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.71% 8/19/2028 1,985 1,884 1,981 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.61% 2/15/2029 2,394 2,364 2,387 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.61% 2/15/2029 4,309 4,081 4,296 Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan SOFR+ 7.00% 8.45% 4.00% 12/24/2026 6,351 6,284 6,033 (4) Bausch + Lomb Corp Health Care Supplies First Lien Term Loan SOFR+ 3.25% 8.71% 5/10/2027 3,990 3,884 3,957 BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 1,749 1,737 1,684 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 6,290 6,231 6,057 (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 171 — — (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 7,193,540 7,194 5,683 (4) Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.53% 8/10/2027 2,348 2,318 2,125 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.53% 8/10/2027 1,978 1,951 1,790 Centerline Communications, LLC Wireless Telecommunication Services First Lien Revolver SOFR+ 6.00% 11.54% 8/10/2027 600 593 543 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.53% 8/10/2027 1,955 1,932 1,769 Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.35% 10/13/2029 6,327 5,985 6,332 (4) Curium Bidco S.à.r.l. Pharmaceuticals First Lien Term Loan SOFR+ 4.50% 9.85% 7/31/2029 8,708 8,621 8,714 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.65% 8/2/2027 7,196 7,110 7,209 (4) DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 10.13% 4/26/2029 8,698 8,563 8,619 (4) Eagle Parent Corp. Diversified Support Services First Lien Term Loan SOFR+ 4.25% 9.60% 4/2/2029 2,992 2,948 2,971 Frontier Communications Holdings, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 3.75% 9.22% 10/8/2027 2,992 2,955 2,981 Gibson Brands, Inc. Leisure Products First Lien Term Loan SOFR+ 5.00% 10.66% 8/11/2028 7,350 7,277 6,590 (4) Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 10.71% 4/9/2029 $ 7,900 $ 7,720 $ 7,769 (4) Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan SOFR+ 5.25% 10.86% 6/30/2026 7,313 7,238 7,313 INW Manufacturing, LLC Personal Care Products First Lien Term Loan SOFR+ 5.75% 11.36% 3/25/2027 8,875 8,728 7,100 (4) KDC/ONE Development Corp Inc Personal Care Products First Lien Term Loan SOFR+ 5.00% 10.36% 8/15/2028 7,910 7,658 7,857 LABL, Inc. Office Services & Supplies First Lien Term Loan SOFR+ 5.00% 10.46% 10/29/2028 3,952 3,813 3,801 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan SOFR+ 5.75% 11.41% 10/14/2027 7,350 7,257 7,267 Lightbox Intermediate, L.P. Real Estate Services First Lien Term Loan SOFR+ 5.00% 10.61% 5/9/2026 11,220 11,091 10,883 (4) McAfee Corp. Systems Software First Lien Term Loan SOFR+ 3.75% 9.19% 3/1/2029 5,925 5,653 5,916 Mindbody, Inc. Internet Services & Infrastructure First Lien Revolver SOFR+ 7.00% 2/14/2025 — (2) (7) (4)(5) Mindbody, Inc. Internet Services & Infrastructure First Lien Term Loan SOFR+ 7.00% 12.53% 2/14/2025 4,669 4,652 4,603 (4) Mitchell International, Inc. Application Software First Lien Term Loan SOFR+ 3.75% 9.40% 10/15/2028 2,977 2,845 2,980 MRI Software LLC Application Software First Lien Revolver SOFR+ 5.50% 2/10/2027 — (3) (2) (4)(5) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.95% 2/10/2027 8,297 8,143 8,215 (4) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.95% 2/10/2027 2,205 2,205 2,183 (4) OEConnection LLC Application Software First Lien Term Loan SOFR+ 4.00% 9.46% 9/25/2026 10,958 10,810 10,954 Park Place Technologies, LLC Internet Services & Infrastructure First Lien Term Loan SOFR+ 5.00% 10.46% 11/10/2027 9,799 9,488 9,778 (4) Peraton Corp. Aerospace & Defense First Lien Term Loan SOFR+ 3.75% 9.21% 2/1/2028 1,995 1,994 2,002 PetSmart LLC Other Specialty Retail First Lien Term Loan SOFR+ 3.75% 9.21% 2/11/2028 4,000 3,930 3,962 Planview Parent, Inc. Application Software First Lien Term Loan SOFR+ 4.00% 9.61% 12/17/2027 2,410 2,299 2,395 Planview Parent, Inc. Application Software Second Lien Term Loan SOFR+ 7.25% 12.70% 12/18/2028 4,503 4,435 4,120 (4) Pluralsight, LLC Application Software First Lien Revolver SOFR+ 8.00% 13.56% 4/6/2027 394 379 375 (4)(5) Pluralsight, LLC Application Software First Lien Term Loan SOFR+ 8.00% 13.56% 4/6/2027 8,116 7,869 7,807 (4) Renaissance Holding Corp. Education Services First Lien Term Loan SOFR+ 4.75% 10.11% 4/5/2030 4,988 4,853 5,012 SCIH Salt Holdings Inc. Diversified Chemicals First Lien Term Loan SOFR+ 4.00% 9.47% 3/16/2027 2,991 2,991 2,999 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.23% 10.61% 4/27/2024 158 158 107 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.25% 10.63% 4/27/2024 8,091 8,090 5,482 SM Wellness Holdings, Inc. Health Care Services First Lien Term Loan SOFR+ 4.75% 10.39% 4/17/2028 2,970 2,595 2,881 (4) Southern Veterinary Partners, LLC Health Care Facilities First Lien Term Loan SOFR+ 4.00% 9.47% 10/5/2027 7,661 7,622 7,646 Spanx, LLC Apparel Retail First Lien Term Loan SOFR+ 5.25% 10.71% 11/20/2028 8,820 8,697 8,743 (4) SPX Flow, Inc. Industrial Machinery & Supplies & Components First Lien Term Loan SOFR+ 4.50% 9.96% 4/5/2029 8,801 8,459 8,842 Star Parent, Inc. Life Sciences Tools & Services First Lien Term Loan SOFR+ 4.00% 9.35% 9/27/2030 8,000 7,880 7,926 TIBCO Software Inc. Application Software First Lien Term Loan SOFR+ 4.50% 9.95% 3/30/2029 8,194 7,570 8,025 Touchstone Acquisition, Inc. Health Care Supplies First Lien Term Loan SOFR+ 6.00% 11.48% 12/29/2028 7,194 7,091 6,996 (4) Trident TPI Holdings, Inc. Metal, Glass & Plastic Containers First Lien Term Loan SOFR+ 4.00% 9.61% 9/15/2028 2,992 2,944 2,987 Veritas US Inc. Application Software First Lien Term Loan SOFR+ 5.00% 10.47% 9/1/2025 6,289 6,247 5,248 Windstream Services II, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 6.25% 11.71% 9/21/2027 3,249 3,180 3,083 (4) Total Portfolio Investments $ 334,754 $ 334,451 $ 325,769 _________ (1) Represents the interest rate as of December 31, 2023. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR and/or LIBOR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of December 31, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35% and the 90-day LIBOR at 5.64%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of December 31, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of December 31, 2023. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. SLF JV I Portfolio as of September 30, 2023 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan SOFR+ 5.00% 10.32% 8/18/2028 $ 8,596 $ 8,503 $ 8,499 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 11.90% 12/18/2025 1,149 1,135 1,128 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.15% 12/18/2025 6,771 6,701 6,648 (4) Altice France S.A. Integrated Telecommunication Services First Lien Term Loan L+ 4.00% 9.63% 8/14/2026 2,969 2,853 2,810 Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 13.04% 6/30/2025 8,798 8,737 8,218 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.43% 6/9/2028 4,957 4,734 4,614 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.81% 10/20/2028 4,824 4,763 4,239 (4) Amplify Finco Pty Ltd. Movies & Entertainment First Lien Term Loan SOFR+ 4.15% 9.54% 11/26/2026 7,720 7,643 7,720 Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.40% 8/11/2025 1,523 1,191 1,099 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (7) (29) (4)(5) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.63% 12/29/2027 4,134 4,076 3,892 (4) Astra Acquisition Corp. Application Software First Lien Term Loan SOFR+ 5.25% 10.90% 10/25/2028 5,052 4,888 3,817 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.42% 8/19/2028 4,950 4,747 4,809 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.67% 8/19/2028 1,990 1,884 1,937 Asurion, LLC Property & Casualty Insurance Second Lien Term Loan SOFR+ 5.25% 10.68% 1/20/2029 4,346 4,036 3,871 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.57% 2/15/2029 4,320 4,080 4,251 Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan SOFR+ 6.00% 11.49% 12/24/2026 6,289 6,216 6,028 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.65% 6/11/2027 1,753 1,742 1,711 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.65% 6/11/2027 6,306 6,247 6,155 (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 171 — — (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 7,193,540 7,194 5,683 (4) Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.55% 8/10/2027 2,354 2,322 2,281 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.55% 8/10/2027 1,983 1,954 1,921 Centerline Communications, LLC Wireless Telecommunication Services First Lien Revolver SOFR+ 6.00% 11.57% 8/10/2027 600 592 581 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.55% 8/10/2027 1,960 1,935 1,899 Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.39% 10/13/2029 6,343 5,983 6,285 (4) Curium Bidco S.à.r.l. Biotechnology First Lien Term Loan SOFR+ 4.50% 9.89% 7/31/2029 8,730 8,642 8,730 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.43% 8/2/2027 5,799 5,715 5,681 (4) DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 10.12% 4/26/2029 7,920 7,792 7,729 (4) Gibson Brands, Inc. Leisure Products First Lien Term Loan SOFR+ 5.00% 10.57% 8/11/2028 7,369 7,295 6,190 (4) Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 10.67% 4/9/2029 7,920 7,731 7,517 (4) Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan SOFR+ 5.25% 10.90% 6/30/2026 7,331 7,249 7,340 INW Manufacturing, LLC Personal Care Products First Lien Term Loan SOFR+ 5.75% 11.40% 3/25/2027 9,000 8,839 7,080 (4) KDC/ONE Development Corp Inc Personal Care Products First Lien Term Loan SOFR+ 5.00% 10.32% 8/15/2028 10,000 9,666 9,665 LABL, Inc. Office Services & Supplies First Lien Term Loan SOFR+ 5.00% 10.42% 10/29/2028 $ 3,962 $ 3,815 $ 3,955 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan SOFR+ 5.75% 11.32% 10/14/2027 7,369 7,269 7,267 Lightbox Intermediate, L.P. Real Estate Services First Lien Term Loan SOFR+ 5.00% 10.65% 5/9/2026 11,249 11,106 10,912 (4) McAfee Corp. Systems Software First Lien Term Loan SOFR+ 3.75% 9.18% 3/1/2029 5,940 5,654 5,812 Mindbody, Inc. Internet Services & Infrastructure First Lien Revolver SOFR+ 7.00% 2/14/2025 — (2) (8) (4)(5) Mindbody, Inc. Internet Services & Infrastructure First Lien Term Loan SOFR+ 7.00% 12.52% 2/14/2025 4,669 4,648 4,594 (4) Mitchell International, Inc. Application Software First Lien Term Loan SOFR+ 3.75% 9.18% 10/15/2028 2,985 2,845 2,941 MRI Software LLC Application Software First Lien Revolver SOFR+ 5.50% 2/10/2026 — (3) (7) (4)(5) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.99% 2/10/2026 8,319 8,164 8,147 (4) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.99% 2/10/2026 2,211 2,210 2,165 (4) Northern Star Industries Inc. Electrical Components & Equipment First Lien Term Loan SOFR+ 4.76% 10.15% 3/31/2025 6,615 6,608 6,565 OEConnection LLC Application Software First Lien Term Loan SOFR+ 4.00% 9.43% 9/25/2026 10,987 10,827 10,971 Park Place Technologies, LLC Internet Services & Infrastructure First Lien Term Loan SOFR+ 5.00% 10.42% 11/10/2027 9,825 9,492 9,698 (4) Planview Parent, Inc. Application Software First Lien Term Loan SOFR+ 4.00% 9.65% 12/17/2027 2,416 2,298 2,390 Planview Parent, Inc. Application Software Second Lien Term Loan SOFR+ 7.25% 12.74% 12/18/2028 4,503 4,435 4,098 (4) Pluralsight, LLC Application Software First Lien Revolver SOFR+ 8.00% 13.45% 4/6/2027 318 301 297 (4)(5) Pluralsight, LLC Application Software First Lien Term Loan SOFR+ 8.00% 13.45% 4/6/2027 8,116 7,850 7,773 (4) Renaissance Holding Corp. Education Services First Lien Term Loan SOFR+ 4.75% 9.99% 4/5/2030 5,000 4,860 4,969 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.23% 10.86% 4/27/2024 138 138 94 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.25% 10.88% 4/27/2024 8,113 8,111 5,531 SM Wellness Holdings, Inc. Health Care Services First Lien Term Loan SOFR+ 4.75% 10.38% 4/17/2028 2,977 2,580 2,799 (4) Southern Veterinary Partners, LLC Health Care Facilities First Lien Term Loan SOFR+ 4.00% 9.43% 10/5/2027 7,680 7,642 7,643 Spanx, LLC Apparel Retail First Lien Term Loan SOFR+ 5.25% 10.67% 11/20/2028 8,843 8,713 8,717 (4) SPX Flow, Inc. Industrial Machinery & Supplies & Components First Lien Term Loan SOFR+ 4.50% 9.92% 4/5/2029 8,801 8,442 8,794 Star Parent, Inc. Life Sciences Tools & Services First Lien Term Loan SOFR+ 4.00% 9.33% 9/19/2030 8,000 7,880 7,834 TIBCO Software Inc. Application Software First Lien Term Loan SOFR+ 4.50% 9.99% 3/30/2029 8,215 7,559 7,913 Touchstone Acquisition, Inc. Health Care Supplies First Lien Term Loan SOFR+ 6.00% 11.42% 12/29/2028 7,212 7,103 7,022 (4) Veritas US Inc. Application Software First Lien Term Loan SOFR+ 5.00% 10.43% 9/1/2025 6,305 6,257 5,500 Windstream Services II, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 6.25% 11.67% 9/21/2027 6,148 6,008 5,939 (4) WP CPP Holdings, LLC Aerospace & Defense First Lien Term Loan SOFR+ 3.75% 9.27% 4/30/2025 1,965 1,920 1,855 (4) Total Portfolio Investments $ 332,637 $ 331,808 $ 322,179 _________ (1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR and/or LIBOR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39% and the 30-day LIBOR at 5.43%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of September 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of September 30, 2023. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. Glick JV Portfolio as of December 31, 2023 Portfolio Company Industry Investment Type Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan SOFR+ 5.00% 10.39% 8/18/2028 $ 1,995 $ 1,957 $ 2,001 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 562 557 549 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 3,669 3,637 3,585 (4) Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 13.00% 6/30/2025 6,147 6,110 5,747 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.47% 6/9/2028 3,270 3,111 3,100 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.91% 10/20/2028 2,853 2,818 2,402 (4) Amynta Agency Borrower Inc. Property & Casualty Insurance First Lien Term Loan SOFR+ 5.00% 10.45% 2/28/2028 2,993 2,917 3,000 Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.36% 8/11/2025 905 703 554 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.64% 12/29/2027 1,712 1,689 1,609 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (3) (12) (4)(5) Astra Acquisition Corp. Application Software First Lien Term Loan SOFR+ 5.25% 10.86% 10/25/2028 2,078 2,040 1,355 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.71% 8/19/2028 993 942 990 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.46% 8/19/2028 2,773 2,687 2,765 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.61% 2/15/2029 2,965 2,856 2,956 Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan SOFR+ 7.00% 8.45% 4.00% 12/24/2026 3,664 3,625 3,481 (4) Bausch + Lomb Corp Health Care Supplies First Lien Term Loan SOFR+ 3.25% 8.71% 5/10/2027 1,995 1,942 1,979 BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 3,355 3,323 3,230 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 798 793 768 (4) Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.35% 10/13/2029 2,759 2,607 2,762 (4) Curium Bidco S.à.r.l. Pharmaceuticals First Lien Term Loan SOFR+ 4.50% 9.85% 7/31/2029 2,834 2,813 2,836 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.65% 8/2/2027 3,171 3,144 3,176 (4) DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 10.13% 4/26/2029 3,361 3,309 3,331 (4) Portfolio Company Industry Investment Type Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Principal Cost Fair Value (3) Notes Eagle Parent Corp. Diversified Support Services First Lien Term Loan SOFR+ 4.25% 9.60% 4/2/2029 $ 1,496 $ 1,474 $ 1,486 Frontier Communications Holdings, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 3.75% 9.22% 10/8/2027 1,496 1,477 1,491 Gibson Brands, Inc. Leisure Products First Lien Term Loan SOFR+ 5.00% 10.66% 8/11/2028 3,920 3,881 3,515 (4) Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 10.71% 4/9/2029 3,950 3,860 3,884 (4) Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan SOFR+ 5.25% 10.86% 6/30/2026 3,900 3,860 3,900 INW Manufacturing, LLC Personal Care Products First Lien Term Loan SOFR+ 5.75% 11.36% 3/25/2027 2,219 2,182 1,775 (4) KDC/ONE Development Corp Inc Personal Care Products First Lien Term Loan SOFR+ 5.00% 10.36% 8/15/2028 3,560 3,447 3,536 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan SOFR+ 5.75% 11.41% 10/14/2027 3,920 3,870 3,876 MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.95% 2/10/2027 1,625 1,612 1,609 (4) MRI Software LLC Application Software First Lien Revolver SOFR+ 5.50% 2/10/2027 — (1) (1) (4)(5) OEConnection LLC Application Software First Lien Term Loan SOFR+ 4.00% 9.46% 9/25/2026 3,839 3,821 3,837 Peraton Corp. Aerospace & Defense First Lien Term Loan SOFR+ 3.75% 9.21% 2/1/2028 997 997 1,001 PetSmart LLC Other Specialty Retail First Lien Term Loan SOFR+ 3.75% 9.21% 2/11/2028 2,000 1,965 1,981 Planview Parent, Inc. Application Software First Lien Term Loan SOFR+ 4.00% 9.61% 12/17/2027 681 650 677 Planview Parent, Inc. Application Software Second Lien Term Loan SOFR+ 7.25% 12.70% 12/18/2028 2,842 2,799 2,600 (4) Pluralsight, LLC Application Software First Lien Term Loan SOFR+ 8.00% 13.56% 4/6/2027 5,182 5,040 4,985 (4) Pluralsight, LLC Application Software First Lien Revolver SOFR+ 8.00% 13.56% 4/6/2027 281 271 266 (4)(5) SCIH Salt Holdings Inc. Diversified Chemicals First Lien Term Loan SOFR+ 4.00% 9.47% 3/16/2027 1,495 1,495 1,500 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.25% 10 |
Schedule of Financial Instruments Carried at Fair Value | The following table presents the financial instruments carried at fair value as of December 31, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 212,113 $ 2,393,175 $ — $ 2,605,288 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 42,419 196,360 — 238,779 Investments in equity securities (preferred) — — 69,261 — 69,261 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,416 3,894 67,327 29,587 105,224 Total investments at fair value 4,416 258,426 2,726,123 29,587 3,018,552 Cash equivalents 8,722 — — — 8,722 Total assets at fair value $ 13,138 $ 258,426 $ 2,726,123 $ 29,587 $ 3,027,274 Derivative liability $ — $ 29,316 $ — $ — $ 29,316 Total liabilities at fair value $ — $ 29,316 $ — $ — $ 29,316 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 208,694 $ 2,292,691 $ — $ 2,501,385 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 28,666 189,724 — 218,390 Investments in equity securities (preferred) — — 86,057 — 86,057 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,317 1,953 51,440 28,878 86,588 Total investments at fair value 4,317 239,313 2,619,912 28,878 2,892,420 Cash equivalents 83,262 — — — 83,262 Derivative assets — 4,910 — — 4,910 Total assets at fair value $ 87,579 $ 244,223 $ 2,619,912 $ 28,878 $ 2,980,592 Derivative liability $ — $ 47,519 $ — $ — $ 47,519 Total liabilities at fair value $ — $ 47,519 $ — $ — $ 47,519 __________ (a) |
Schedule of Roll-Forward in the Changes in Fair Value | The following table provides a roll-forward in the changes in fair value from September 30, 2023 to December 31, 2023 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2023 $ 2,292,691 $ 189,724 $ 86,057 $ 51,440 $ 2,619,912 Purchases 281,278 14,639 4,440 — 300,357 Sales and repayments (172,647) (4,932) — (786) (178,365) Transfers in (a)(b) 17,121 — — 17,330 34,451 Transfers out (b) (16,172) (4,657) (1,159) — (21,988) Capitalized PIK interest income 3,835 13 — — 3,848 Accretion of OID 4,005 298 — — 4,303 Net unrealized appreciation (depreciation) (7,904) 1,229 (20,077) 662 (26,090) Net realized gains (losses) (9,032) 46 — (1,319) (10,305) Fair value as of December 31, 2023 $ 2,393,175 $ 196,360 $ 69,261 $ 67,327 $ 2,726,123 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2023 $ (18,446) $ 648 $ (20,231) $ (1,444) $ (39,473) __________ (a) There was a $12.4 million transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) There were investment restructurings during the three months ended December 31, 2023 in which (1) $16.2 million of Level 3 senior secured debt was exchanged for Level 3 common equity, (2) $4.7 million of Level 3 subordinated debt was exchanged for Level 3 senior secured debt and (3) $1.2 million of Level 3 preferred equity was exchanged for Level 3 common equity. The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases 177,599 21,104 2,579 2,181 203,463 Sales and repayments (55,885) (699) — (48) (56,632) Transfers in (a) 19,075 — — — 19,075 Capitalized PIK interest income 5,763 6 — — 5,769 Accretion of OID 4,114 398 — — 4,512 Net unrealized appreciation (depreciation) (12,271) (566) (1,477) 4,505 (9,809) Net realized gains (losses) (1,159) — — 46 (1,113) Fair value as of December 31, 2022 $ 2,047,842 $ 179,631 $ 80,625 $ 26,642 $ 2,334,740 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022 $ (12,398) $ (566) $ (1,477) $ 4,505 $ (9,936) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. |
Schedule of Significant Unobservable Inputs for Level 3 Investments | The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,966,262 Market Yield Market Yield (b) 9.0% - 40.0% 14.3% 18,042 Enterprise Value Revenue Multiple (c) 0.2x - 0.4x 0.3x 77,424 Enterprise Value EBITDA Multiple (c) 2.3x - 9.8x 6.0x 132,614 Transaction Precedent Transaction Price (d) N/A - N/A N/A 198,833 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 32,747 Market Yield Market Yield (b) 10.0% - 23.0% 10.3% Debt Investments in the JVs 163,613 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 42,156 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.6x 88,566 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 6.3x 1,001 Enterprise Value Asset Multiple (c) 1.0x - 1.5x 1.4x 4,865 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,726,123 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,904,140 Market Yield Market Yield (b) 9.0% - 32.0% 14.7% 64,802 Enterprise Value EBITDA Multiple (c) 3.0x - 6.0x 4.6x 33,816 Transaction Precedent Transaction Price (d) N/A - N/A N/A 289,933 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 22,881 Market Yield Market Yield (b) 10.0% - 22.0% 11.2% 4,170 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,673 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 32,318 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.5x 103,661 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 8.8x 1,097 Enterprise Value Asset Multiple (c) 1.0x - 1.4x 1.4x 421 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,619,912 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. |
Schedule of Fair Value Disclosure of Asset and Liability Not Measured at Fair Value | The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,554 291,204 — 291,204 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 316,745 315,147 — 315,147 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 297,418 310,425 — 310,425 — Total $ 1,622,717 $ 1,626,776 $ — $ 916,776 $ 710,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,241 286,437 — 286,437 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 306,412 301,784 — 301,784 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 286,078 289,980 — 289,980 — Total $ 1,600,731 $ 1,588,201 $ — $ 878,201 $ 710,000 |
Schedule of Portfolio Composition | Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,703,890 84.82 % $ 2,594,640 85.24 % Debt investments in the JVs 163,277 5.12 % 162,986 5.35 % Preferred equity 102,877 3.23 % 99,597 3.27 % Common equity and warrants 87,328 2.74 % 72,261 2.37 % Subordinated debt 75,587 2.37 % 59,844 1.97 % LLC equity interests of the JVs 54,791 1.72 % 54,791 1.80 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,605,288 86.31 % 172.36 % $ 2,501,385 86.47 % 165.01 % Debt investments in the JVs 163,613 5.42 % 10.82 % 162,673 5.62 % 10.73 % Common equity and warrants 75,637 2.51 % 5.00 % 57,710 2.00 % 3.81 % Subordinated debt 75,166 2.49 % 4.97 % 55,717 1.93 % 3.68 % Preferred equity 69,261 2.29 % 4.58 % 86,057 2.98 % 5.68 % LLC equity interests of the JVs 29,587 0.98 % 1.96 % 28,878 1.00 % 1.91 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Northeast $ 1,054,445 33.08 % $ 1,012,955 33.27 % West 417,364 13.09 % 393,390 12.92 % Southeast 412,397 12.94 % 375,247 12.33 % International 370,987 11.64 % 418,595 13.75 % Midwest 365,262 11.46 % 360,506 11.84 % South 222,299 6.97 % 202,374 6.65 % Southwest 216,429 6.79 % 153,318 5.04 % Northwest 128,567 4.03 % 127,734 4.20 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 964,560 31.95 % 63.80 % $ 945,422 32.69 % 62.37 % West 398,128 13.19 % 26.34 % 384,055 13.28 % 25.34 % Southeast 385,269 12.76 % 25.49 % 354,444 12.25 % 23.38 % International 374,156 12.40 % 24.75 % 414,079 14.32 % 27.32 % Midwest 357,502 11.84 % 23.65 % 350,620 12.12 % 23.13 % South 216,121 7.16 % 14.30 % 188,541 6.52 % 12.44 % Southwest 196,779 6.52 % 13.02 % 130,455 4.51 % 8.61 % Northwest 126,037 4.18 % 8.34 % 124,804 4.31 % 8.23 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $334,754 $332,637 Weighted average interest rate on senior secured loans (2) 10.57% 10.62% Number of borrowers in SLF JV I 52 48 Largest exposure to a single borrower (1) $11,220 $11,286 Total of five largest loan exposures to borrowers (1) $51,354 $54,051 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $130,946 $130,589 Weighted average current interest rate on senior secured loans (2) 10.58% 10.77% Number of borrowers in the Glick JV 42 38 Largest loan exposure to a single borrower (1) $6,147 $6,230 Total of five largest loan exposures to borrowers (1) $27,867 $28,396 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $19.63 $20.38 Net investment income (1) 0.57 0.63 Net unrealized appreciation (depreciation) (1) (0.33) (0.38) Net realized gains (losses) (1) (0.11) (0.05) (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — 0.01 Distributions of net investment income to stockholders (0.62) (0.96) Net asset value per share at end of period $19.14 $19.63 Per share market value at beginning of period $20.12 $18.00 Per share market value at end of period $20.42 $20.61 Total return (2) 4.70% 19.90% Common shares outstanding at beginning of period 77,225 61,125 Common shares outstanding at end of period 78,965 61,220 Net assets at beginning of period $1,515,764 $1,245,563 Net assets at end of period $1,511,651 $1,201,989 Average net assets (3) $1,524,243 $1,241,806 Ratio of net investment income to average net assets (7) 11.50% 12.40% Ratio of total expenses to average net assets (7) 14.39% 13.11% Ratio of net expenses to average net assets (7) 14.00% 12.87% Ratio of portfolio turnover to average investments at fair value 7.36% 4.24% Weighted average outstanding debt (4) $1,660,435 $1,441,326 Average debt per share (1) $21.33 $23.57 Asset coverage ratio at end of period (5) 188.66% 176.31% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Calculated based upon the weighted average of principal debt outstanding for the period. (5) Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively. (6) The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (7) Interim periods are annualized. |
Summarized Financial Information | Below is certain summarized financial information for SLF JV I as of December 31, 2023 and September 30, 2023 and for the three months ended December 31, 2023 and 2022: December 31, 2023 September 30, 2023 Selected Balance Sheet Information: Investments at fair value (cost December 31, 2023: $334,451; cost September 30, 2023: $331,808) $ 325,769 $ 322,179 Cash and cash equivalents 35,218 31,950 Restricted cash 363 2,987 Other assets 11,408 18,988 Total assets $ 372,758 $ 376,104 Senior credit facility payable $ 149,000 $ 149,000 Secured borrowings 30,760 38,845 SLF JV I Notes payable at fair value (proceeds December 31, 2023: $128,750; proceeds September 30, 2023: $128,750) 128,750 128,750 Other liabilities 30,648 26,630 Total liabilities $ 339,158 $ 343,225 Members' equity 33,600 32,879 Total liabilities and members' equity $ 372,758 $ 376,104 Three months ended December 31, 2023 Three months ended December 31, 2022 Selected Statements of Operations Information: Interest income $ 9,708 $ 8,781 Other income 57 — Total investment income 9,765 8,781 Senior credit facility and secured borrowing interest expense 3,906 3,709 SLF JV I Notes interest expense 4,093 2,982 Other expenses 71 69 Total expenses (1) 8,070 6,760 Net investment income 1,695 2,021 Net unrealized appreciation (depreciation) 947 (2,207) Net realized gains (losses) (322) (992) Net income (loss) $ 2,320 $ (1,178) __________ (1) There are no management fees or incentive fees charged at SLF JV I. Below is certain summarized financial information for the Glick JV as of December 31, 2023 and September 30, 2023 and for the three months ended December 31, 2023 and 2022: December 31, 2023 September 30, 2023 Selected Balance Sheet Information: Investments at fair value (cost December 31, 2023: $128,333; cost September 30, 2023: $127,788) $ 124,492 $ 123,343 Cash and cash equivalents 8,953 12,119 Restricted cash 194 184 Other assets 5,537 5,521 Total assets $ 139,176 $ 141,167 Senior credit facility payable $ 53,000 $ 53,000 Glick JV Notes payable at fair value (proceeds December 31, 2023: $66,685; proceeds September 30, 2023: $66,685) 58,259 57,201 Secured borrowings 12,965 18,106 Other liabilities 14,952 12,860 Total liabilities $ 139,176 $ 141,167 Members' equity — — Total liabilities and members' equity $ 139,176 $ 141,167 Three months ended December 31, 2023 Three months ended December 31, 2022 Selected Statements of Operations Information: Interest income $ 3,798 $ 3,403 Fee income 25 — Total investment income 3,823 3,403 Senior credit facility and secured borrowing interest expense 1,452 1,285 Glick JV Notes interest expense 1,694 1,324 Other expenses 37 53 Total expenses (1) 3,183 2,662 Net investment income 640 741 Net unrealized appreciation (depreciation) (453) (651) Realized gain (loss) (187) (90) Net income (loss) $ — $ — __________ (1) There are no management fees or incentive fees charged at the Glick JV. |
Share Data and Net Assets (Tabl
Share Data and Net Assets (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three months ended December 31, 2023 and 2022: (Share amounts in thousands) Three months ended Three months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Weighted average common shares outstanding — basic and diluted 77,840 61,142 Earnings (loss) per common share — basic and diluted $ 0.14 $ 0.22 |
Schedule of Changes in Net Assets | The following table presents the changes in net assets for the three months ended December 31, 2023: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2023 77,225 $ 772 $ 2,166,330 $ (651,338) $ 1,515,764 Net investment income — — — 44,189 44,189 Net unrealized appreciation (depreciation) — — — (25,025) (25,025) Net realized gains (losses) — — — (8,453) (8,453) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (176) (176) Distributions to stockholders — — — (48,897) (48,897) Issuance of common stock in connection with the "at the market" offering 1,641 17 32,296 — 32,313 Issuance of common stock under dividend reinvestment plan 99 1 1,935 — 1,936 Balance as of December 31, 2023 78,965 $ 790 $ 2,200,561 $ (689,700) $ 1,511,651 The following table presents the changes in net assets for the three months ended December 31, 2022: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989 |
Schedule of Distributions | The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 2023 and 2022: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 8, 2023 December 15, 2023 December 29, 2023 $ 0.55 $ 41.7 million 87,472 (1) $ 1.7 million Special November 8, 2023 December 15, 2023 December 29, 2023 $ 0.07 $ 5.3 million 11,133 (1) $ 0.2 million Total for the three months ended December 31, 2023 $ 0.62 $ 47.0 million 98,605 $ 1.9 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 $ 0.42 $ 24.8 million 41,510 (1) $ 0.8 million Total for the three months ended December 31, 2022 $ 0.96 $ 56.8 million 94,879 $ 1.9 million __________ (1) New shares were issued and distributed. |
Schedule of Common Stock Issued and Sold | In connection with the "at the market" offering, the Company issued and sold 1,641,416 shares of common stock during the three months ended December 31, 2023 for net proceeds of $32.3 million (net of offering costs). Number of Shares Issued Gross Proceeds Placement Agent Fees Net Proceeds (1) Average Sales Price per Share (2) "At the market" offering 1,641,416 $ 32,725 $ 327 $ 32,398 $ 19.94 (1) Net proceeds excludes offering costs of $0.1 million. (2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses. |
Borrowings (Tables)
Borrowings (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Components of Debt | The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of December 31, 2023 and September 30, 2023: As of December 31, 2023 As of September 30, 2023 ($ in millions) 2025 Notes 2027 Notes 2029 Notes 2025 Notes 2027 Notes 2029 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 300.0 $ 350.0 $ 300.0 Unamortized financing costs (0.9) (2.3) (3.4) (1.1) (2.5) (3.5) Unaccreted discount (0.6) (0.5) (3.2) (0.7) (0.6) (3.4) Interest rate swap fair value adjustment — (30.4) 4.0 — (40.5) (7.0) Net carrying value $ 298.5 $ 316.8 $ 297.4 $ 298.2 $ 306.4 $ 286.1 Fair Value $ 291.2 $ 315.1 $ 310.4 $ 286.4 $ 301.8 $ 290.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the three months ended December 31, 2023: ($ in millions) 2025 Notes 2027 Notes 2029 Notes Coupon interest $ 2.6 $ 2.4 $ 5.3 Amortization of financing costs and discount 0.3 0.2 0.3 Effect of interest rate swap — 4.2 1.2 Total interest expense $ 2.9 $ 6.8 $ 6.8 Coupon interest rate (net of effect of interest rate swaps) 3.500 % 7.455 % 8.679 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — 2.5 Total interest expense $ 2.9 $ 5.1 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 5.586 % |
Taxable_Distributable Income _2
Taxable/Distributable Income and Dividend Distributions (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations | Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2023 and 2022. Three months ended Three months ended Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Net unrealized (appreciation) depreciation 25,025 22,982 Book/tax difference due to capital losses suspended (utilized) 6,540 8,013 Other book/tax differences (7,178) (12,910) Taxable/Distributable Income (1) $ 34,922 $ 31,257 __________ (1) The Company's taxable income for the three months ended December 31, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2024. Therefore, the final taxable income may be different than the estimate. |
Components of Accumulated Overdistributed Earnings | As of September 30, 2023, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ 33,525 Net realized capital losses (509,832) Unrealized losses, net (175,031) Accumulated overdistributed earnings $ (651,338) |
Realized Gains or Losses and _2
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Investment Company [Abstract] | |
Schedule of Aggregate Net Realized Gains | During the three months ended December 31, 2023, the Company recorded an aggregate net realized loss of $8.5 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Continental Intermodal Group LP $ (6.8) P&L Development LLC (1.9) Zephyr Bidco Limited (1) (1.7) Lift Brands Holdings, Inc. (1.4) Foreign currency forward contracts 4.1 Other, net (0.8) Total, net $ (8.5) __________ (1) This investment was denominated in British Pounds and the realized loss shown in this table includes losses due to foreign currency translation, which was offset by gains on foreign currency forward contracts. During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 4.4 Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) Global Medical Response Inc. (1.0) Other, net (1.7) Total, net $ (3.2) |
Financial Highlights (Tables)
Financial Highlights (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Investment Company [Abstract] | |
Schedule of Financial Highlights | Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,703,890 84.82 % $ 2,594,640 85.24 % Debt investments in the JVs 163,277 5.12 % 162,986 5.35 % Preferred equity 102,877 3.23 % 99,597 3.27 % Common equity and warrants 87,328 2.74 % 72,261 2.37 % Subordinated debt 75,587 2.37 % 59,844 1.97 % LLC equity interests of the JVs 54,791 1.72 % 54,791 1.80 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,605,288 86.31 % 172.36 % $ 2,501,385 86.47 % 165.01 % Debt investments in the JVs 163,613 5.42 % 10.82 % 162,673 5.62 % 10.73 % Common equity and warrants 75,637 2.51 % 5.00 % 57,710 2.00 % 3.81 % Subordinated debt 75,166 2.49 % 4.97 % 55,717 1.93 % 3.68 % Preferred equity 69,261 2.29 % 4.58 % 86,057 2.98 % 5.68 % LLC equity interests of the JVs 29,587 0.98 % 1.96 % 28,878 1.00 % 1.91 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Northeast $ 1,054,445 33.08 % $ 1,012,955 33.27 % West 417,364 13.09 % 393,390 12.92 % Southeast 412,397 12.94 % 375,247 12.33 % International 370,987 11.64 % 418,595 13.75 % Midwest 365,262 11.46 % 360,506 11.84 % South 222,299 6.97 % 202,374 6.65 % Southwest 216,429 6.79 % 153,318 5.04 % Northwest 128,567 4.03 % 127,734 4.20 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 964,560 31.95 % 63.80 % $ 945,422 32.69 % 62.37 % West 398,128 13.19 % 26.34 % 384,055 13.28 % 25.34 % Southeast 385,269 12.76 % 25.49 % 354,444 12.25 % 23.38 % International 374,156 12.40 % 24.75 % 414,079 14.32 % 27.32 % Midwest 357,502 11.84 % 23.65 % 350,620 12.12 % 23.13 % South 216,121 7.16 % 14.30 % 188,541 6.52 % 12.44 % Southwest 196,779 6.52 % 13.02 % 130,455 4.51 % 8.61 % Northwest 126,037 4.18 % 8.34 % 124,804 4.31 % 8.23 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $334,754 $332,637 Weighted average interest rate on senior secured loans (2) 10.57% 10.62% Number of borrowers in SLF JV I 52 48 Largest exposure to a single borrower (1) $11,220 $11,286 Total of five largest loan exposures to borrowers (1) $51,354 $54,051 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $130,946 $130,589 Weighted average current interest rate on senior secured loans (2) 10.58% 10.77% Number of borrowers in the Glick JV 42 38 Largest loan exposure to a single borrower (1) $6,147 $6,230 Total of five largest loan exposures to borrowers (1) $27,867 $28,396 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $19.63 $20.38 Net investment income (1) 0.57 0.63 Net unrealized appreciation (depreciation) (1) (0.33) (0.38) Net realized gains (losses) (1) (0.11) (0.05) (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — 0.01 Distributions of net investment income to stockholders (0.62) (0.96) Net asset value per share at end of period $19.14 $19.63 Per share market value at beginning of period $20.12 $18.00 Per share market value at end of period $20.42 $20.61 Total return (2) 4.70% 19.90% Common shares outstanding at beginning of period 77,225 61,125 Common shares outstanding at end of period 78,965 61,220 Net assets at beginning of period $1,515,764 $1,245,563 Net assets at end of period $1,511,651 $1,201,989 Average net assets (3) $1,524,243 $1,241,806 Ratio of net investment income to average net assets (7) 11.50% 12.40% Ratio of total expenses to average net assets (7) 14.39% 13.11% Ratio of net expenses to average net assets (7) 14.00% 12.87% Ratio of portfolio turnover to average investments at fair value 7.36% 4.24% Weighted average outstanding debt (4) $1,660,435 $1,441,326 Average debt per share (1) $21.33 $23.57 Asset coverage ratio at end of period (5) 188.66% 176.31% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Calculated based upon the weighted average of principal debt outstanding for the period. (5) Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively. (6) The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (7) Interim periods are annualized. |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Foreign Currency Forward Contracts and Interest Rate Swap | Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 36,775 € 34,350 2/8/2024 $ — $ 1,227 Derivative liability Foreign currency forward contract $ 47,403 £ 38,500 2/8/2024 — 1,687 Derivative liability $ — $ 2,914 Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 42,182 € 38,026 11/9/2023 $ 1,857 $ — Derivative asset Foreign currency forward contract $ 72,098 £ 56,556 11/9/2023 3,053 — Derivative asset $ 4,910 $ — Certain information related to the Company’s interest rate swaps is presented below as of December 31, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 30,415 Derivative liability Interest rate swap 300,000 2/15/2029 4,013 — Derivative liability $ 4,013 $ 30,415 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 40,519 Derivative liability Interest rate swap 300,000 2/15/2029 — 7,000 Derivative liability $ — $ 47,519 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Unfunded Commitments | A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components and subordinated notes and LLC equity interests in the JVs) as of December 31, 2023 and September 30, 2023 is shown in the table below: December 31, 2023 September 30, 2023 107-109 Beech OAK22 LLC $ 26,969 $ 26,969 OCSI Glick JV LLC 13,998 13,998 PetVet Care Centers, LLC 13,732 — Senior Loan Fund JV I, LLC 13,125 13,125 Fairbridge Strategic Capital Funding LLC 9,465 13,090 BioXcel Therapeutics, Inc. 9,383 14,547 Amspec Parent LLC 9,372 — Seres Therapeutics, Inc. 8,090 8,090 MRI Software LLC 7,260 2,261 Next Holdco, LLC 7,051 — iCIMs, Inc. 6,924 7,466 Kings Buyer, LLC 5,462 5,189 Grove Hotel Parcel Owner, LLC 5,286 5,286 scPharmaceuticals Inc. 5,212 5,212 Avalara, Inc. 5,047 5,047 Mindbody, Inc. 4,762 4,762 Accupac, Inc. 4,500 4,500 107 Fair Street LLC 4,227 4,227 Harrow, Inc. 4,011 4,011 Inventus Power, Inc. 3,792 3,792 Dominion Diagnostics, LLC 3,484 3,484 Establishment Labs Holdings Inc. 3,384 3,384 WP CPP Holdings, LLC 3,272 — Enverus Holdings, Inc. 3,135 — PRGX Global, Inc. 3,127 3,127 Salus Workers' Compensation, LLC 3,102 3,102 Spanx, LLC 3,092 2,473 ADC Therapeutics SA 3,020 3,020 Relativity ODA LLC 2,762 2,762 LSL Holdco, LLC 2,650 2,650 Galileo Parent, Inc. 2,484 2,061 MND Holdings III Corp 2,280 9,122 Crewline Buyer, Inc. 2,180 — 112-126 Van Houten Real22 LLC 2,139 2,343 Coupa Holdings, LLC 2,075 2,075 Berner Food & Beverage, LLC 2,005 1,622 Oranje Holdco, Inc. 1,904 1,904 MHE Intermediate Holdings, LLC 1,786 821 Evergreen IX Borrower 2023, LLC 1,626 1,626 Acquia Inc. 1,376 1,376 PPW Aero Buyer, Inc. 1,368 1,466 SCP Eye Care Services, LLC 1,366 2,356 Coyote Buyer, LLC 1,333 400 Pluralsight, LLC 1,068 1,787 Finastra USA, Inc. 896 960 Digital.AI Software Holdings, Inc. 782 1,078 OTG Management, LLC 467 3,190 ASP-R-PAC Acquisition Co LLC 396 396 SIO2 Medical Products, Inc. 238 1,821 Telestream Holdings Corporation 148 407 Delta Leasing SPV II LLC — 14,639 Assembled Brands Capital LLC — 7,514 Impel Pharmaceuticals Inc. — 2,458 Supreme Fitness Group NY Holdings, LLC — 2,199 Tahoe Bidco B.V. — 2,162 Liquid Environmental Solutions Corporation — 1,383 Total $ 226,613 $ 232,740 |
Significant Accounting Polici_3
Significant Accounting Policies (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2023 USD ($) investment | Dec. 31, 2022 USD ($) | Sep. 30, 2023 USD ($) investment | Dec. 31, 2022 USD ($) | |
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Restricted cash | $ 19,328 | $ 9,089 | ||
Excise tax | 0 | $ 78 | $ 100 | |
Deutsche Bank Trust Company Americas | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Restricted cash | $ 19,300 | |||
Wells Fargo Bank, N.A. | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Restricted cash | $ 9,100 | |||
Investment Owned, Cost | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Concentration risk | 5.90% | 2.40% | ||
Investment Owned, Fair Value | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Number of investments | investment | 7 | 4 | ||
Concentration risk | 4.20% | 1.80% |
Portfolio Investments - Narrati
Portfolio Investments - Narrative (Details) | 3 Months Ended | 12 Months Ended | ||||||
Dec. 31, 2023 USD ($) member borrower | Dec. 31, 2022 USD ($) | Sep. 30, 2023 USD ($) borrower | Aug. 15, 2023 | Sep. 30, 2021 USD ($) | May 18, 2021 | Mar. 19, 2021 member | Feb. 25, 2020 | |
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investment owned, percent of net assets | 199.69% | 190.82% | ||||||
Investments at fair value | $ 3,018,552,000 | $ 2,892,420,000 | ||||||
Number of borrowers | borrower | 146 | 143 | ||||||
Money market funds, percent of net assets | 8.70% | 9.60% | ||||||
Cash, cash equivalents and restricted cash | $ 131,697,000 | $ 19,245,000 | $ 145,539,000 | $ 26,364,000 | ||||
Restricted cash | 19,328,000 | 9,089,000 | ||||||
Net realized gains (losses) | (8,453,000) | (3,203,000) | ||||||
Net unrealized appreciation (depreciation) | (25,025,000) | (22,982,000) | ||||||
Credit facilities payable | 710,000,000 | 710,000,000 | ||||||
Assets | 3,266,195,000 | 3,217,839,000 | ||||||
Unfunded commitments | 226,613,000 | 232,740,000 | ||||||
Investment owned, at cost | 3,187,750,000 | 3,044,119,000 | ||||||
SLF JV I, LLC | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | 142,200,000 | 141,500,000 | ||||||
OCSI Glick JV LLC | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 51,000,000 | $ 50,000,000 | ||||||
Investment Owned, At Fair Value | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investment owned, percent of net assets | 199.69% | 190.82% | ||||||
Investments at fair value | $ 3,018,552,000 | $ 2,892,420,000 | ||||||
Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Concentration risk | 100% | 100% | ||||||
Senior secured debt | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investment owned, percent of net assets | 172.36% | 165.01% | ||||||
Investments at fair value | $ 2,605,288,000 | $ 2,501,385,000 | ||||||
Investment owned, at cost | $ 2,703,890,000 | $ 2,594,640,000 | ||||||
Senior secured debt | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Concentration risk | 86.31% | 86.47% | ||||||
Subordinated debt securities, including JV debt instruments | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 238,779,000 | $ 218,390,000 | ||||||
Subordinated debt securities, including JV debt instruments | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Concentration risk | 7.90% | 7.50% | ||||||
SLF JV I | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 142,200,000 | $ 141,500,000 | ||||||
SLF JV I Notes | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | 112,700,000 | |||||||
Investment owned, at cost | 112,700,000 | |||||||
Interest income | $ 3,600,000 | 2,600,000 | ||||||
Investment, basis spread, variable rate | 7% | |||||||
Investment, interest rate, floor | 1% | |||||||
SLF JV I, LLC | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 29,600,000 | 28,900,000 | ||||||
Investment owned, at cost | 54,800,000 | 54,800,000 | ||||||
Dividend income | 1,400,000 | 1,100,000 | ||||||
OCSI Glick JV LLC | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | 51,000,000 | 50,000,000 | ||||||
Investment owned, at cost | 50,600,000 | 50,300,000 | ||||||
Glick JV Notes | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Interest income | $ 1,800,000 | 1,600,000 | ||||||
Investment, basis spread, variable rate | 4.50% | |||||||
2025 Notes | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Interest rate, percentage | 3.50% | 3.50% | ||||||
2027 Notes | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Interest rate, percentage | 2.70% | 2.70% | ||||||
2029 Notes | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Interest rate, percentage | 7.10% | 7.10% | ||||||
The JVs | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Money market funds, percent of net assets | 8.70% | |||||||
Cash, cash equivalents and restricted cash | $ 131,700,000 | |||||||
Restricted cash | 19,300,000 | |||||||
SLF JV I | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 325,769,000 | $ 322,179,000 | ||||||
Number of borrowers | borrower | 52 | 48 | ||||||
Restricted cash | $ 363,000 | $ 2,987,000 | ||||||
Number of board of directors | member | 4 | |||||||
Number of board of directors selected by company | member | 2 | |||||||
Number of board of directors selected by counterparty | member | 2 | |||||||
Number of investment committee members selected by company | member | 1 | |||||||
Number of investment committee members selected by counterparty | member | 1 | |||||||
Investment owned, ownership percentage | 87.50% | 87.50% | ||||||
Credit facilities payable | $ 149,000,000 | $ 149,000,000 | ||||||
Assets | 372,758,000 | 376,104,000 | ||||||
Financial support funded by company and counterparty | 190,500,000 | 190,500,000 | ||||||
Financial support funded by company for investee | 166,700,000 | 166,700,000 | ||||||
Unfunded commitments | 13,100,000 | 13,100,000 | ||||||
Investment owned, at cost | 334,451,000 | 331,808,000 | ||||||
Interest income | 9,708,000 | 8,781,000 | ||||||
Investments sold | 13,500,000 | |||||||
Proceeds from sale of investments | 12,900,000 | |||||||
Gain (loss) on sale of investments | 100,000 | |||||||
SLF JV I | SLF JV I Notes | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Unfunded commitments | 9,800,000 | 9,800,000 | ||||||
SLF JV I | SLF JV I, LLC | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Unfunded commitments | 3,300,000 | 3,300,000 | ||||||
SLF JV I | SLF JV I Facility | Revolving Credit Facility | Line of Credit | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Borrowing capacity | 270,000,000 | |||||||
Credit facilities payable | $ 149,000,000 | $ 149,000,000 | ||||||
SLF JV I | SLF JV I Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Debt instrument, basis spread, variable rate | 2% | |||||||
SLF JV I | Kemper | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investment owned, ownership percentage | 12.50% | 12.50% | ||||||
OCSI Glick JV LLC | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 124,492,000 | $ 123,343,000 | ||||||
Number of borrowers | borrower | 42 | 38 | ||||||
Restricted cash | $ 194,000 | $ 184,000 | ||||||
Number of board of directors | member | 4 | |||||||
Number of board of directors selected by company | member | 2 | |||||||
Number of board of directors selected by counterparty | member | 2 | |||||||
Number of investment committee members selected by company | member | 1 | |||||||
Number of investment committee members selected by counterparty | member | 1 | |||||||
Credit facilities payable | 53,000,000 | 53,000,000 | ||||||
Assets | 139,176,000 | 141,167,000 | ||||||
Financial support funded by company and counterparty | 84,000,000 | 84,000,000 | ||||||
Financial support funded by company for investee | 73,500,000 | 73,500,000 | ||||||
Investment owned, at cost | 128,333,000 | 127,788,000 | ||||||
Interest income | 3,798,000 | $ 3,403,000 | ||||||
Financial commitment to investee by company and counterparty, aggregate amount | 100,000,000 | 100,000,000 | ||||||
Financial commitment to investee, aggregate amount | 87,500,000 | 87,500,000 | ||||||
Financial commitment to investee by counterparty, aggregate amount | 12,500,000 | $ 12,500,000 | ||||||
OCSI Glick JV LLC | Glick JV LLC | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 51,000,000 | |||||||
Investment owned, ownership percentage | 87.50% | 12.50% | ||||||
Unfunded commitments | $ 1,600,000 | $ 1,600,000 | ||||||
Investment owned, at cost | 51,000,000 | |||||||
Financial commitment to investee, aggregate amount | $ 8,700,000 | 8,700,000 | ||||||
OCSI Glick JV LLC | Glick JV Notes | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Investments at fair value | $ 50,000,000 | |||||||
Investment owned, ownership percentage | 87.50% | 12.50% | ||||||
Unfunded commitments | $ 12,400,000 | $ 12,400,000 | ||||||
Investment owned, at cost | 50,000,000 | |||||||
Financial commitment to investee, aggregate amount | 78,800,000 | 78,800,000 | ||||||
OCSI Glick JV LLC | Glick JV Facility | Revolving Credit Facility | Line of Credit | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Borrowing capacity | 80,000,000 | |||||||
Credit facilities payable | $ 53,000,000 | $ 53,000,000 | ||||||
OCSI Glick JV LLC | Glick JV Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate | ||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||
Debt instrument, basis spread, variable rate | 2% |
Portfolio Investments - Composi
Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 |
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,187,750 | $ 3,044,119 |
Investments at fair value | 3,018,552 | 2,892,420 |
Debt investments, fair value | $ 2,844,067 | $ 2,719,775 |
% of Debt Portfolio | 100% | 100% |
Investments in debt securities | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,779,477 | $ 2,654,484 |
Investments at fair value | 2,680,454 | 2,557,102 |
Investments in equity securities | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | 190,205 | 171,858 |
Investments at fair value | 144,898 | 143,767 |
Debt investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | 163,277 | 162,986 |
Investments at fair value | 163,613 | 162,673 |
Equity investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | 54,791 | 54,791 |
Investments at fair value | 29,587 | 28,878 |
Floating rate debt securities, including the debt investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Debt investments, fair value | $ 2,397,664 | $ 2,345,205 |
% of Debt Portfolio | 84.30% | 86.23% |
Fixed rate debt securities | ||
Schedule of Investments [Line Items] | ||
Debt investments, fair value | $ 446,403 | $ 374,570 |
% of Debt Portfolio | 15.70% | 13.77% |
Portfolio Investments - Schedul
Portfolio Investments - Schedule of Financial Instruments Carried at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 |
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,018,552 | $ 2,892,420 |
Cash equivalents | 8,722 | 83,262 |
Derivative assets | 0 | 4,910 |
Total assets at fair value | 3,027,274 | 2,980,592 |
Derivative liability | 29,316 | 47,519 |
Total liabilities at fair value | 29,316 | 47,519 |
Carrying Value | 1,622,717 | 1,600,731 |
Fair Value | 1,626,776 | 1,588,201 |
Senior secured debt | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 2,605,288 | 2,501,385 |
Subordinated debt securities, including JV debt instruments CLO Notes | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 238,779 | 218,390 |
Preferred equity | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 69,261 | 86,057 |
Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 105,224 | 86,588 |
2027 Notes | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 316,745 | 306,412 |
Fair Value | 315,147 | 301,784 |
Level 1 | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 4,416 | 4,317 |
Cash equivalents | 8,722 | 83,262 |
Derivative assets | 0 | |
Total assets at fair value | 13,138 | 87,579 |
Derivative liability | 0 | 0 |
Total liabilities at fair value | 0 | 0 |
Fair Value | 0 | 0 |
Level 1 | Senior secured debt | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 1 | Subordinated debt securities, including JV debt instruments CLO Notes | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 1 | Preferred equity | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 1 | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 4,416 | 4,317 |
Level 1 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 258,426 | 239,313 |
Cash equivalents | 0 | 0 |
Derivative assets | 4,910 | |
Total assets at fair value | 258,426 | 244,223 |
Derivative liability | 29,316 | 47,519 |
Total liabilities at fair value | 29,316 | 47,519 |
Fair Value | 916,776 | 878,201 |
Level 2 | Senior secured debt | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 212,113 | 208,694 |
Level 2 | Subordinated debt securities, including JV debt instruments CLO Notes | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 42,419 | 28,666 |
Level 2 | Preferred equity | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 2 | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 3,894 | 1,953 |
Level 2 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 315,147 | 301,784 |
Level 3 | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 2,726,123 | 2,619,912 |
Cash equivalents | 0 | 0 |
Derivative assets | 0 | |
Total assets at fair value | 2,726,123 | 2,619,912 |
Derivative liability | 0 | 0 |
Total liabilities at fair value | 0 | 0 |
Fair Value | 710,000 | 710,000 |
Level 3 | Senior secured debt | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 2,393,175 | 2,292,691 |
Level 3 | Subordinated debt securities, including JV debt instruments CLO Notes | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 196,360 | 189,724 |
Level 3 | Preferred equity | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 69,261 | 86,057 |
Level 3 | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 67,327 | 51,440 |
Level 3 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 29,587 | 28,878 |
Cash equivalents | 0 | 0 |
Derivative assets | 0 | |
Total assets at fair value | 29,587 | 28,878 |
Derivative liability | 0 | 0 |
Total liabilities at fair value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | Senior secured debt | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | Subordinated debt securities, including JV debt instruments CLO Notes | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | Preferred equity | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 29,587 | $ 28,878 |
Portfolio Investments - Roll-Fo
Portfolio Investments - Roll-Forward in the Changes in Fair Value (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Fair value, beginning balance | $ 2,619,912 | $ 2,169,475 |
Purchases | 300,357 | 203,463 |
Sales and repayments | (178,365) | (56,632) |
Transfers in | 34,451 | 19,075 |
Transfers out | (21,988) | |
Capitalized PIK interest income | 3,848 | 5,769 |
Accretion of OID | 4,303 | 4,512 |
Fair value, ending balance | $ 2,726,123 | 2,334,740 |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax | |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations | $ (39,473) | (9,936) |
Transfers in | $ 34,451 | 19,075 |
Net unrealized appreciation (depreciation) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Net unrealized appreciation (depreciation) | |
Total gains or losses included in earnings | $ (26,090) | (9,809) |
Net realized gains (losses) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Realized gain (loss) | |
Total gains or losses included in earnings | $ (10,305) | (1,113) |
Senior secured debt | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Fair value, beginning balance | 2,292,691 | 1,910,606 |
Purchases | 281,278 | 177,599 |
Sales and repayments | (172,647) | (55,885) |
Transfers in | 17,121 | 19,075 |
Transfers out | (16,172) | |
Capitalized PIK interest income | 3,835 | 5,763 |
Accretion of OID | 4,005 | 4,114 |
Fair value, ending balance | 2,393,175 | 2,047,842 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations | (18,446) | (12,398) |
Transfers in | 17,121 | 19,075 |
Investment exchanged, cost | 16,200 | |
Senior secured debt | Net unrealized appreciation (depreciation) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | (7,904) | (12,271) |
Senior secured debt | Net realized gains (losses) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | (9,032) | (1,159) |
Subordinated debt | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Fair value, beginning balance | 189,724 | 159,388 |
Purchases | 14,639 | 21,104 |
Sales and repayments | (4,932) | (699) |
Transfers in | 0 | 0 |
Transfers out | (4,657) | |
Capitalized PIK interest income | 13 | 6 |
Accretion of OID | 298 | 398 |
Fair value, ending balance | 196,360 | 179,631 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations | 648 | (566) |
Transfers in | 0 | 0 |
Investment exchanged, cost | 4,700 | |
Subordinated debt | Net unrealized appreciation (depreciation) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | 1,229 | (566) |
Subordinated debt | Net realized gains (losses) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | 46 | 0 |
Preferred equity | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Fair value, beginning balance | 86,057 | 79,523 |
Purchases | 4,440 | 2,579 |
Sales and repayments | 0 | 0 |
Transfers in | 0 | 0 |
Transfers out | (1,159) | |
Capitalized PIK interest income | 0 | 0 |
Accretion of OID | 0 | 0 |
Fair value, ending balance | 69,261 | 80,625 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations | (20,231) | (1,477) |
Transfers in | 0 | 0 |
Investment exchanged, cost | 1,200 | |
Preferred equity | Net unrealized appreciation (depreciation) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | (20,077) | (1,477) |
Preferred equity | Net realized gains (losses) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | 0 | 0 |
Common equity and warrants | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Fair value, beginning balance | 51,440 | 19,958 |
Purchases | 0 | 2,181 |
Sales and repayments | (786) | (48) |
Transfers in | 17,330 | 0 |
Transfers out | 0 | |
Capitalized PIK interest income | 0 | 0 |
Accretion of OID | 0 | 0 |
Fair value, ending balance | 67,327 | 26,642 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations | (1,444) | 4,505 |
Transfers in | 17,330 | 0 |
Common equity and warrants | Net unrealized appreciation (depreciation) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | 662 | 4,505 |
Common equity and warrants | Net realized gains (losses) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Total gains or losses included in earnings | (1,319) | $ 46 |
Investment, Change in Market Quotes or Liquidity | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Transfers in | 12,400 | |
Transfers in | $ 12,400 |
Portfolio Investments - Signifi
Portfolio Investments - Significant Unobservable Inputs for Level 3 Investments (Details) $ in Thousands | Dec. 31, 2023 USD ($) | Sep. 30, 2023 USD ($) |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 3,018,552 | $ 2,892,420 |
Senior secured debt | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 2,605,288 | 2,501,385 |
Debt investments in the JVs | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 163,613 | 162,673 |
Level 3 | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 2,726,123 | 2,619,912 |
Level 3 | Senior secured debt | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 2,393,175 | 2,292,691 |
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 1,966,262 | $ 1,904,140 |
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.090 | 0.090 |
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.400 | 0.320 |
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.143 | 0.147 |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 18,042 | |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.2 | |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.4 | |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.3 | |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 77,424 | $ 64,802 |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 2.3 | 3 |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 9.8 | 6 |
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 6 | 4.6 |
Level 3 | Senior secured debt | Valuation, Transaction Precedent | Measurement Input, Transaction Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 132,614 | $ 33,816 |
Level 3 | Senior secured debt | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 198,833 | 289,933 |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 32,747 | $ 22,881 |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.100 | 0.100 |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.230 | 0.220 |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.103 | 0.112 |
Level 3 | Subordinated Debt | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 4,170 | |
Level 3 | Debt investments in the JVs | Valuation, Enterprise Value | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 163,613 | 162,673 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 42,156 | $ 32,318 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.4 | 0.4 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 3.2 | 3.2 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 0.6 | 0.5 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 88,566 | $ 103,661 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 1.7 | 1.7 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 15.1 | 15.1 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 6.3 | 8.8 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 1,001 | $ 1,097 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 1 | 1 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 1.5 | 1.4 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investment Company, Investment Owned, Measurement Input | 1.4 | 1.4 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Transaction Precedent | Measurement Input, Transaction Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 4,865 | $ 421 |
Portfolio Investments - Sched_2
Portfolio Investments - Schedule of Financial Instruments Disclosed, but Carried at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 |
Schedule of Investments [Line Items] | ||
Carrying Value | $ 1,622,717 | $ 1,600,731 |
Fair Value | 1,626,776 | 1,588,201 |
Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 430,000 | 430,000 |
Fair Value | 430,000 | 430,000 |
OSI2 Citibank Facility payable | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 280,000 | 280,000 |
Fair Value | 280,000 | 280,000 |
2025 Notes | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 298,554 | 298,241 |
Fair Value | 291,204 | 286,437 |
2027 Notes | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 316,745 | 306,412 |
Fair Value | 315,147 | 301,784 |
2029 Notes | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 297,418 | 286,078 |
Fair Value | 310,425 | 289,980 |
Level 1 | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | OSI2 Citibank Facility payable | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | 2025 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | 2029 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | ||
Schedule of Investments [Line Items] | ||
Fair Value | 916,776 | 878,201 |
Level 2 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | OSI2 Citibank Facility payable | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | 2025 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 291,204 | 286,437 |
Level 2 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 315,147 | 301,784 |
Level 2 | 2029 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 310,425 | 289,980 |
Level 3 | ||
Schedule of Investments [Line Items] | ||
Fair Value | 710,000 | 710,000 |
Level 3 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 430,000 | 430,000 |
Level 3 | OSI2 Citibank Facility payable | ||
Schedule of Investments [Line Items] | ||
Fair Value | 280,000 | 280,000 |
Level 3 | 2025 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 3 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 3 | 2029 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | $ 0 | $ 0 |
Portfolio Investments - Portfol
Portfolio Investments - Portfolio Composition (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Dec. 31, 2023 | Sep. 30, 2023 | |
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,187,750 | $ 3,044,119 |
Investments at fair value | $ 3,018,552 | $ 2,892,420 |
Investment owned, percent of net assets | 199.69% | 190.82% |
Northeast | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 1,054,445 | $ 1,012,955 |
Investments at fair value | $ 964,560 | $ 945,422 |
Investment owned, percent of net assets | 63.80% | 62.37% |
West | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 417,364 | $ 393,390 |
Investments at fair value | $ 398,128 | $ 384,055 |
Investment owned, percent of net assets | 26.34% | 25.34% |
Southeast | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 412,397 | $ 375,247 |
Investments at fair value | $ 385,269 | $ 354,444 |
Investment owned, percent of net assets | 25.49% | 23.38% |
International | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 370,987 | $ 418,595 |
Investments at fair value | $ 374,156 | $ 414,079 |
Investment owned, percent of net assets | 24.75% | 27.32% |
Midwest | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 365,262 | $ 360,506 |
Investments at fair value | $ 357,502 | $ 350,620 |
Investment owned, percent of net assets | 23.65% | 23.13% |
South | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 222,299 | $ 202,374 |
Investments at fair value | $ 216,121 | $ 188,541 |
Investment owned, percent of net assets | 14.30% | 12.44% |
Southwest | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 216,429 | $ 153,318 |
Investments at fair value | $ 196,779 | $ 130,455 |
Investment owned, percent of net assets | 13.02% | 8.61% |
Northwest | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 128,567 | $ 127,734 |
Investments at fair value | $ 126,037 | $ 124,804 |
Investment owned, percent of net assets | 8.34% | 8.23% |
Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Cost | Geographic Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Cost | Geographic Concentration Risk | Northeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 33.08% | 33.27% |
Investment Owned, At Cost | Geographic Concentration Risk | West | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.09% | 12.92% |
Investment Owned, At Cost | Geographic Concentration Risk | Southeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 12.94% | 12.33% |
Investment Owned, At Cost | Geographic Concentration Risk | International | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 11.64% | 13.75% |
Investment Owned, At Cost | Geographic Concentration Risk | Midwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 11.46% | 11.84% |
Investment Owned, At Cost | Geographic Concentration Risk | South | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6.97% | 6.65% |
Investment Owned, At Cost | Geographic Concentration Risk | Southwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6.79% | 5.04% |
Investment Owned, At Cost | Geographic Concentration Risk | Northwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.03% | 4.20% |
Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,018,552 | $ 2,892,420 |
Investment owned, percent of net assets | 199.69% | 190.82% |
Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Fair Value | Geographic Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Northeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 31.95% | 32.69% |
Investment Owned, At Fair Value | Geographic Concentration Risk | West | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.19% | 13.28% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Southeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 12.76% | 12.25% |
Investment Owned, At Fair Value | Geographic Concentration Risk | International | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 12.40% | 14.32% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Midwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 11.84% | 12.12% |
Investment Owned, At Fair Value | Geographic Concentration Risk | South | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 7.16% | 6.52% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Southwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6.52% | 4.51% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Northwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.18% | 4.31% |
Senior secured debt | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,703,890 | $ 2,594,640 |
Investments at fair value | $ 2,605,288 | $ 2,501,385 |
Investment owned, percent of net assets | 172.36% | 165.01% |
Senior secured debt | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 84.82% | 85.24% |
Senior secured debt | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 86.31% | 86.47% |
Debt investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 163,277 | $ 162,986 |
Investments at fair value | $ 163,613 | $ 162,673 |
Investment owned, percent of net assets | 10.82% | 10.73% |
Debt investments in the JVs | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 5.12% | 5.35% |
Debt investments in the JVs | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 5.42% | 5.62% |
Preferred equity | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 102,877 | $ 99,597 |
Investments at fair value | $ 69,261 | $ 86,057 |
Investment owned, percent of net assets | 4.58% | 5.68% |
Preferred equity | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.23% | 3.27% |
Preferred equity | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.29% | 2.98% |
Common equity and warrants | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 87,328 | $ 72,261 |
Investments at fair value | $ 75,637 | $ 57,710 |
Investment owned, percent of net assets | 5% | 3.81% |
Common equity and warrants | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.74% | 2.37% |
Common equity and warrants | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.51% | 2% |
Subordinated debt | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 75,587 | $ 59,844 |
Investments at fair value | $ 75,166 | $ 55,717 |
Investment owned, percent of net assets | 4.97% | 3.68% |
Subordinated debt | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.37% | 1.97% |
Subordinated debt | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.49% | 1.93% |
LLC equity interests of the JVs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 54,791 | $ 54,791 |
Investments at fair value | $ 29,587 | $ 28,878 |
Investment owned, percent of net assets | 1.96% | 1.91% |
LLC equity interests of the JVs | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.72% | 1.80% |
LLC equity interests of the JVs | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.98% | 1% |
Portfolio Investments - Portf_2
Portfolio Investments - Portfolio of Investments by Industry (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Dec. 31, 2023 | Sep. 30, 2023 | |
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,187,750 | $ 3,044,119 |
Investments at fair value | $ 3,018,552 | $ 2,892,420 |
Investment owned, percent of net assets | 199.69% | 190.82% |
Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,018,552 | $ 2,892,420 |
Investment owned, percent of net assets | 199.69% | 190.82% |
Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Application Software | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 472,016 | $ 468,483 |
Application Software | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 14.82% | 15.39% |
Application Software | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 460,072 | $ 455,719 |
Investment owned, percent of net assets | 30.41% | 30.03% |
Application Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 15.23% | 15.73% |
Multi-Sector Holdings | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 219,766 | $ 219,469 |
Multi-Sector Holdings | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6.89% | 7.21% |
Multi-Sector Holdings | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 195,163 | $ 193,431 |
Investment owned, percent of net assets | 12.91% | 12.76% |
Multi-Sector Holdings | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6.47% | 6.69% |
Health Care Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 137,713 | $ 81,560 |
Health Care Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.32% | 2.68% |
Health Care Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 122,076 | $ 66,683 |
Investment owned, percent of net assets | 8.08% | 4.40% |
Health Care Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.04% | 2.31% |
Data Processing & Outsourced Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 133,399 | $ 133,410 |
Data Processing & Outsourced Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.18% | 4.38% |
Data Processing & Outsourced Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 126,731 | $ 125,259 |
Investment owned, percent of net assets | 8.38% | 8.26% |
Data Processing & Outsourced Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.20% | 4.33% |
Health Care Technology | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 130,701 | $ 106,915 |
Health Care Technology | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.10% | 3.51% |
Health Care Technology | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 107,574 | $ 95,404 |
Investment owned, percent of net assets | 7.12% | 6.29% |
Health Care Technology | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.56% | 3.30% |
Biotechnology | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 127,672 | $ 126,349 |
Biotechnology | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.01% | 4.15% |
Biotechnology | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 127,586 | $ 125,678 |
Investment owned, percent of net assets | 8.44% | 8.29% |
Biotechnology | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.23% | 4.35% |
Industrial Machinery & Supplies & Components | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 102,785 | $ 99,511 |
Industrial Machinery & Supplies & Components | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.22% | 3.27% |
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 104,217 | $ 98,352 |
Investment owned, percent of net assets | 6.89% | 6.49% |
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.45% | 3.40% |
Real Estate Operating Companies | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 85,374 | $ 83,754 |
Real Estate Operating Companies | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.68% | 2.75% |
Real Estate Operating Companies | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 84,517 | $ 82,463 |
Investment owned, percent of net assets | 5.59% | 5.44% |
Real Estate Operating Companies | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.80% | 2.85% |
Broadline Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 83,290 | $ 83,290 |
Broadline Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.61% | 2.74% |
Broadline Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 39,230 | $ 69,040 |
Investment owned, percent of net assets | 2.60% | 4.55% |
Broadline Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.30% | 2.39% |
Pharmaceuticals | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 74,100 | $ 84,948 |
Pharmaceuticals | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.32% | 2.79% |
Pharmaceuticals | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 71,320 | $ 80,455 |
Investment owned, percent of net assets | 4.72% | 5.31% |
Pharmaceuticals | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.36% | 2.78% |
Other Specialty Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 68,033 | $ 41,088 |
Other Specialty Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.13% | 1.35% |
Other Specialty Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 69,533 | $ 41,115 |
Investment owned, percent of net assets | 4.60% | 2.71% |
Other Specialty Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.30% | 1.42% |
Personal Care Products | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 67,619 | $ 68,146 |
Personal Care Products | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.12% | 2.24% |
Personal Care Products | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 59,562 | $ 59,928 |
Investment owned, percent of net assets | 3.94% | 3.95% |
Personal Care Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.97% | 2.07% |
Interactive Media & Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 66,109 | $ 19,013 |
Interactive Media & Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.07% | 0.62% |
Interactive Media & Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 66,304 | $ 19,199 |
Investment owned, percent of net assets | 4.39% | 1.27% |
Interactive Media & Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.20% | 0.66% |
Fertilizers & Agricultural Chemicals | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 64,689 | $ 64,720 |
Fertilizers & Agricultural Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.03% | 2.13% |
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 63,185 | $ 63,185 |
Investment owned, percent of net assets | 4.18% | 4.17% |
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.09% | 2.18% |
Aerospace & Defense | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 63,768 | $ 51,797 |
Aerospace & Defense | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2% | 1.70% |
Aerospace & Defense | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 63,981 | $ 51,862 |
Investment owned, percent of net assets | 4.23% | 3.42% |
Aerospace & Defense | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.12% | 1.79% |
Diversified Support Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 63,265 | $ 23,435 |
Diversified Support Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.98% | 0.77% |
Diversified Support Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 62,669 | $ 23,352 |
Investment owned, percent of net assets | 4.15% | 1.54% |
Diversified Support Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.08% | 0.81% |
Environmental & Facilities Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 63,022 | $ 63,064 |
Environmental & Facilities Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.98% | 2.07% |
Environmental & Facilities Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 62,180 | $ 62,413 |
Investment owned, percent of net assets | 4.11% | 4.12% |
Environmental & Facilities Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.06% | 2.16% |
Health Care Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 62,010 | $ 62,044 |
Health Care Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.95% | 2.04% |
Health Care Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 60,654 | $ 60,865 |
Investment owned, percent of net assets | 4.01% | 4.02% |
Health Care Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.01% | 2.10% |
Diversified Financial Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 61,608 | $ 61,725 |
Diversified Financial Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.93% | 2.03% |
Diversified Financial Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 62,687 | $ 60,003 |
Investment owned, percent of net assets | 4.15% | 3.96% |
Diversified Financial Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.08% | 2.07% |
Internet Services & Infrastructure | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 61,012 | $ 60,934 |
Internet Services & Infrastructure | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.91% | 2% |
Internet Services & Infrastructure | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 60,771 | $ 60,579 |
Investment owned, percent of net assets | 4.02% | 4% |
Internet Services & Infrastructure | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.01% | 2.09% |
Airport Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 57,897 | $ 55,961 |
Airport Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.82% | 1.84% |
Airport Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 55,577 | $ 54,453 |
Investment owned, percent of net assets | 3.68% | 3.59% |
Airport Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.84% | 1.88% |
Metal, Glass & Plastic Containers | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 57,679 | $ 55,530 |
Metal, Glass & Plastic Containers | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.81% | 1.82% |
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 55,586 | $ 53,459 |
Investment owned, percent of net assets | 3.68% | 3.53% |
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.84% | 1.85% |
Insurance Brokers | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 52,472 | $ 52,856 |
Insurance Brokers | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.65% | 1.74% |
Insurance Brokers | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 54,927 | $ 53,050 |
Investment owned, percent of net assets | 3.63% | 3.50% |
Insurance Brokers | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.82% | 1.83% |
Diversified Metals & Mining | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 49,898 | $ 49,842 |
Diversified Metals & Mining | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.57% | 1.64% |
Diversified Metals & Mining | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 49,869 | $ 49,869 |
Investment owned, percent of net assets | 3.30% | 3.29% |
Diversified Metals & Mining | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.65% | 1.72% |
Automotive Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 49,603 | $ 57,596 |
Automotive Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.56% | 1.89% |
Automotive Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 48,109 | $ 55,805 |
Investment owned, percent of net assets | 3.18% | 3.68% |
Automotive Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.59% | 1.93% |
Home Improvement Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 49,001 | $ 54,236 |
Home Improvement Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.54% | 1.78% |
Home Improvement Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 48,034 | $ 53,168 |
Investment owned, percent of net assets | 3.18% | 3.51% |
Home Improvement Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.59% | 1.84% |
Auto Parts & Equipment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 48,462 | $ 48,536 |
Auto Parts & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.52% | 1.59% |
Auto Parts & Equipment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 48,901 | $ 49,148 |
Investment owned, percent of net assets | 3.23% | 3.24% |
Auto Parts & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.62% | 1.70% |
Systems Software | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 45,509 | $ 23,111 |
Systems Software | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.43% | 0.76% |
Systems Software | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 45,148 | $ 21,968 |
Investment owned, percent of net assets | 2.99% | 1.45% |
Systems Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.50% | 0.76% |
Real Estate Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 44,652 | $ 44,717 |
Real Estate Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.40% | 1.47% |
Real Estate Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 43,771 | $ 43,886 |
Investment owned, percent of net assets | 2.90% | 2.90% |
Real Estate Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.45% | 1.52% |
Specialized Finance | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 42,215 | $ 73,035 |
Specialized Finance | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.32% | 2.40% |
Specialized Finance | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 41,677 | $ 69,590 |
Investment owned, percent of net assets | 2.76% | 4.59% |
Specialized Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.38% | 2.41% |
Soft Drinks & Non-alcoholic Beverages | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 42,158 | $ 42,628 |
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.32% | 1.40% |
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 41,868 | $ 42,391 |
Investment owned, percent of net assets | 2.77% | 2.80% |
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.39% | 1.47% |
Leisure Facilities | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 39,724 | $ 39,076 |
Leisure Facilities | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.25% | 1.28% |
Leisure Facilities | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 39,022 | $ 36,963 |
Investment owned, percent of net assets | 2.58% | 2.44% |
Leisure Facilities | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.29% | 1.28% |
Specialty Chemicals | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 37,622 | $ 38,640 |
Specialty Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.18% | 1.27% |
Specialty Chemicals | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 37,692 | $ 38,615 |
Investment owned, percent of net assets | 2.49% | 2.55% |
Specialty Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.25% | 1.34% |
Electrical Components & Equipment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 32,500 | $ 32,440 |
Electrical Components & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.02% | 1.07% |
Electrical Components & Equipment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 32,491 | $ 32,573 |
Investment owned, percent of net assets | 2.15% | 2.15% |
Electrical Components & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.08% | 1.13% |
Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 32,189 | $ 37,666 |
Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.01% | 1.24% |
Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 31,221 | $ 37,311 |
Investment owned, percent of net assets | 2.07% | 2.46% |
Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.03% | 1.29% |
Advertising | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 25,597 | $ 25,597 |
Advertising | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.80% | 0.84% |
Advertising | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 12,140 | $ 11,955 |
Investment owned, percent of net assets | 0.80% | 0.79% |
Advertising | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.40% | 0.41% |
Passenger Airlines | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 24,952 | $ 24,920 |
Passenger Airlines | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.78% | 0.82% |
Passenger Airlines | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 27,163 | $ 27,512 |
Investment owned, percent of net assets | 1.80% | 1.82% |
Passenger Airlines | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.90% | 0.95% |
Real Estate Development | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 24,198 | $ 23,965 |
Real Estate Development | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.76% | 0.79% |
Real Estate Development | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 23,881 | $ 23,679 |
Investment owned, percent of net assets | 1.58% | 1.56% |
Real Estate Development | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.79% | 0.82% |
Gold | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 23,347 | $ 23,310 |
Gold | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.73% | 0.77% |
Gold | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 23,519 | $ 23,328 |
Investment owned, percent of net assets | 1.56% | 1.54% |
Gold | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.78% | 0.81% |
Home Furnishings | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 23,085 | $ 23,859 |
Home Furnishings | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.72% | 0.78% |
Home Furnishings | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 14,131 | $ 19,954 |
Investment owned, percent of net assets | 0.93% | 1.32% |
Home Furnishings | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.47% | 0.69% |
Health Care Equipment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 22,509 | $ 22,441 |
Health Care Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.71% | 0.74% |
Health Care Equipment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 21,410 | $ 22,436 |
Investment owned, percent of net assets | 1.42% | 1.48% |
Health Care Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.71% | 0.78% |
Construction & Engineering | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 21,668 | $ 22,102 |
Construction & Engineering | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.68% | 0.73% |
Construction & Engineering | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 21,347 | $ 21,903 |
Investment owned, percent of net assets | 1.41% | 1.45% |
Construction & Engineering | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.71% | 0.76% |
Hotels, Resorts & Cruise Lines | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 17,169 | $ 17,195 |
Hotels, Resorts & Cruise Lines | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.54% | 0.56% |
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 17,024 | $ 16,991 |
Investment owned, percent of net assets | 1.13% | 1.12% |
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.56% | 0.59% |
Oil & Gas Storage & Transportation | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 16,172 | $ 22,042 |
Oil & Gas Storage & Transportation | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.51% | 0.72% |
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 16,173 | $ 16,040 |
Investment owned, percent of net assets | 1.07% | 1.06% |
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.54% | 0.55% |
Integrated Telecommunication Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 14,657 | $ 18,801 |
Integrated Telecommunication Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.46% | 0.62% |
Integrated Telecommunication Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 13,261 | $ 16,492 |
Investment owned, percent of net assets | 0.88% | 1.09% |
Integrated Telecommunication Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.44% | 0.57% |
Restaurants | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 12,617 | $ 12,603 |
Restaurants | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.40% | 0.41% |
Restaurants | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 12,847 | $ 12,464 |
Investment owned, percent of net assets | 0.85% | 0.82% |
Restaurants | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.43% | 0.43% |
Health Care Supplies | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 11,618 | $ 11,646 |
Health Care Supplies | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.36% | 0.38% |
Health Care Supplies | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 11,321 | $ 11,363 |
Investment owned, percent of net assets | 0.75% | 0.75% |
Health Care Supplies | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.38% | 0.39% |
Cable & Satellite | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 8,946 | $ 4,619 |
Cable & Satellite | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.28% | 0.15% |
Cable & Satellite | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 9,309 | $ 4,546 |
Investment owned, percent of net assets | 0.62% | 0.30% |
Cable & Satellite | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.31% | 0.16% |
Education Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 8,257 | $ 13,871 |
Education Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.26% | 0.46% |
Education Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 8,396 | $ 13,618 |
Investment owned, percent of net assets | 0.56% | 0.90% |
Education Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.28% | 0.47% |
Food Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 7,677 | $ 5,897 |
Food Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.24% | 0.19% |
Food Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 7,353 | $ 5,166 |
Investment owned, percent of net assets | 0.49% | 0.34% |
Food Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.24% | 0.18% |
Oil & Gas Refining & Marketing | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 6,620 | $ 0 |
Oil & Gas Refining & Marketing | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.21% | 0% |
Oil & Gas Refining & Marketing | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 7,009 | $ 0 |
Investment owned, percent of net assets | 0.46% | 0% |
Oil & Gas Refining & Marketing | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.23% | 0% |
Research & Consulting Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,862 | $ 4,871 |
Research & Consulting Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.16% |
Research & Consulting Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 4,893 | $ 4,831 |
Investment owned, percent of net assets | 0.32% | 0.32% |
Research & Consulting Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.16% | 0.17% |
Other Specialized REITs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,395 | $ 4,379 |
Other Specialized REITs | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.14% | 0.14% |
Other Specialized REITs | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,511 | $ 3,198 |
Investment owned, percent of net assets | 0.23% | 0.21% |
Other Specialized REITs | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.12% | 0.11% |
Apparel Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,375 | $ 4,999 |
Apparel Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.14% | 0.16% |
Apparel Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 4,419 | $ 5,002 |
Investment owned, percent of net assets | 0.29% | 0.33% |
Apparel Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.17% |
Office Services & Supplies | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,162 | $ 0 |
Office Services & Supplies | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.13% | 0% |
Office Services & Supplies | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 4,377 | $ 0 |
Investment owned, percent of net assets | 0.29% | 0% |
Office Services & Supplies | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0% |
Paper & Plastic Packaging Products & Materials | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,247 | $ 3,254 |
Paper & Plastic Packaging Products & Materials | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.10% | 0.11% |
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,048 | $ 3,061 |
Investment owned, percent of net assets | 0.20% | 0.20% |
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.10% | 0.11% |
Housewares & Specialties | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,854 | $ 2,908 |
Housewares & Specialties | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.09% | 0.10% |
Housewares & Specialties | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 2,684 | $ 2,808 |
Investment owned, percent of net assets | 0.18% | 0.19% |
Housewares & Specialties | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.09% | 0.10% |
Leisure Products | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,070 | $ 2,055 |
Leisure Products | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.06% | 0.07% |
Leisure Products | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 2,197 | $ 2,063 |
Investment owned, percent of net assets | 0.15% | 0.14% |
Leisure Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.07% | 0.07% |
Alternative Carriers | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 1,625 | $ 0 |
Alternative Carriers | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.05% | 0% |
Alternative Carriers | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 1,661 | $ 0 |
Investment owned, percent of net assets | 0.11% | 0% |
Alternative Carriers | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.06% | 0% |
Diversified Chemicals | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 1,539 | $ 0 |
Diversified Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.05% | 0% |
Diversified Chemicals | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 1,573 | $ 0 |
Investment owned, percent of net assets | 0.10% | 0% |
Diversified Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.05% | 0% |
Consumer Finance | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 16,440 |
Consumer Finance | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.54% |
Consumer Finance | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 15,087 |
Investment owned, percent of net assets | 0% | 1% |
Consumer Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.52% |
Movies & Entertainment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 12,188 |
Movies & Entertainment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.40% |
Movies & Entertainment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 11,865 |
Investment owned, percent of net assets | 0% | 0.78% |
Movies & Entertainment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.41% |
Air Freight & Logistics | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 4,925 |
Air Freight & Logistics | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.16% |
Air Freight & Logistics | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 4,263 |
Investment owned, percent of net assets | 0% | 0.28% |
Air Freight & Logistics | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.15% |
Integrated Oil & Gas | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 4,894 |
Integrated Oil & Gas | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.16% |
Integrated Oil & Gas | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 4,785 |
Investment owned, percent of net assets | 0% | 0.32% |
Integrated Oil & Gas | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.17% |
Technology Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 813 |
Technology Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.03% |
Technology Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 776 |
Investment owned, percent of net assets | 0% | 0.05% |
Technology Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.03% |
Portfolio Investments - Summary
Portfolio Investments - Summary of Portfolio (Details) € in Thousands, £ in Thousands, $ in Thousands | Dec. 31, 2023 USD ($) borrower | Dec. 31, 2023 EUR (€) borrower | Dec. 31, 2023 GBP (£) borrower | Sep. 30, 2023 USD ($) borrower | Sep. 30, 2023 EUR (€) borrower | Sep. 30, 2023 GBP (£) borrower | Dec. 31, 2022 USD ($) | |||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Number of borrowers | borrower | 146 | 146 | 146 | 143 | 143 | 143 | ||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,269 | [1],[2],[3],[4] | $ 1,269 | [5],[6],[7],[8] | ||||||||||
Investment, interest rate | 12.50% | [1],[2],[3],[9],[10] | 12.50% | [1],[2],[3],[9],[10] | 12.50% | [1],[2],[3],[9],[10] | 12.50% | [5],[6],[8],[11],[12] | 12.50% | [5],[6],[8],[11],[12] | 12.50% | [5],[6],[8],[11],[12] | ||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 18,869 | [1],[2],[4] | $ 18,869 | [5],[7],[8] | ||||||||||
Investment, interest rate | 11% | [1],[2],[9],[10] | 11% | [1],[2],[9],[10] | 11% | [1],[2],[9],[10] | 11% | [5],[8],[11],[12] | 11% | [5],[8],[11],[12] | 11% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,274 | [1],[2],[3],[4] | $ 4,070 | [5],[6],[7],[8] | ||||||||||
Investment, interest rate | 12% | [1],[2],[3],[9],[10] | 12% | [1],[2],[3],[9],[10] | 12% | [1],[2],[3],[9],[10] | 12% | [5],[6],[8],[11],[12] | 12% | [5],[6],[8],[11],[12] | 12% | [5],[6],[8],[11],[12] | ||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 21,434 | [1],[4],[13],[14] | $ 21,434 | [7],[8],[15],[16] | ||||||||||
Investment, interest rate | 14.25% | [1],[9],[10],[13],[14] | 14.25% | [1],[9],[10],[13],[14] | 14.25% | [1],[9],[10],[13],[14] | 14.25% | [8],[11],[12],[15],[16] | 14.25% | [8],[11],[12],[15],[16] | 14.25% | [8],[11],[12],[15],[16] | ||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,329 | [1],[4],[13] | $ 6,021 | [7],[8],[15] | ||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,373 | [1],[4],[10] | $ 3,446 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.11% | [1],[9],[10] | 12.11% | [1],[9],[10] | 12.11% | [1],[9],[10] | 11.90% | [8],[11],[12] | 11.90% | [8],[11],[12] | 11.90% | [8],[11],[12] | ||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 944 | [1],[4],[10] | $ 17,901 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.14% | [1],[9],[10] | 12.14% | [1],[9],[10] | 12.14% | [1],[9],[10] | 12.15% | [8],[11],[12] | 12.15% | [8],[11],[12] | 12.15% | [8],[11],[12] | ||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,532 | [1],[4],[10] | $ 963 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.11% | [1],[9],[10] | 12.11% | [1],[9],[10] | 12.11% | [1],[9],[10] | 12.13% | [8],[11],[12] | 12.13% | [8],[11],[12] | 12.13% | [8],[11],[12] | ||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10],[13] | $ 6,589 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | [8],[11],[12],[15] | 13.04% | 13.04% | 13.04% | ||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,589 | [1],[4],[10],[13] | $ 0 | [5],[7],[8],[11],[15] | ||||||||||
Investment, interest rate | [9],[10] | 13% | 13% | 13% | ||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | [7],[11],[15] | € 5,500 | ||||||||||||
Investment, interest rate | [11],[12],[15] | 8.86% | 8.86% | 8.86% | ||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 16,032 | [1],[4],[10] | $ 17,873 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13.21% | [1],[9],[10] | 13.21% | [1],[9],[10] | 13.21% | [1],[9],[10] | 13.17% | [8],[11],[12] | 13.17% | [8],[11],[12] | 13.17% | [8],[11],[12] | ||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10],[13] | $ 0 | [5],[7],[8],[11],[15] | ||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,268 | [1],[4],[10],[13] | $ 3,276 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 11.64% | [9],[10] | 11.64% | [9],[10] | 11.64% | [9],[10] | 11.63% | [8],[11],[12],[15] | 11.63% | [8],[11],[12],[15] | 11.63% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,583 | [1],[4],[13],[14] | $ 12,222 | [7],[8],[15],[16] | ||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,033 | [1],[2],[4],[10] | $ 2,033 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 11.52% | [1],[2],[9],[10] | 11.52% | [1],[2],[9],[10] | 11.52% | [1],[2],[9],[10] | 11.55% | [5],[8],[11],[12] | 11.55% | [5],[8],[11],[12] | 11.55% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 20,234 | [7],[8],[11] | ||||||||||
Investment, interest rate | [8],[11],[12] | 11.55% | 11.55% | 11.55% | ||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 20,182 | [1],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 11.52% | [1],[9],[10] | 11.52% | [1],[9],[10] | 11.52% | [1],[9],[10] | [5],[8],[11],[12] | [5],[8],[11],[12] | [5],[8],[11],[12] | |||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,333 | [1],[2],[4],[10] | $ 1,333 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 12.72% | [1],[2],[9],[10] | 12.72% | [1],[2],[9],[10] | 12.72% | [1],[2],[9],[10] | 12.72% | [5],[8],[11],[12] | 12.72% | [5],[8],[11],[12] | 12.72% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,400 | [1],[4],[10] | $ 6,400 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.74% | [1],[9],[10] | 12.74% | [1],[9],[10] | 12.74% | [1],[9],[10] | 12.34% | [8],[11],[12] | 12.34% | [8],[11],[12] | 12.34% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 25,332 | [1],[2],[4],[10] | $ 25,332 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.74% | [1],[2],[9],[10] | 12.74% | [1],[2],[9],[10] | 12.74% | [1],[2],[9],[10] | 12.34% | [8],[11],[12] | 12.34% | [8],[11],[12] | 12.34% | [8],[11],[12] | ||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 23,562 | [1],[4],[10],[17] | $ 23,562 | [7],[8],[11],[18] | ||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,050 | [4],[13] | $ 4,050 | [7],[15] | ||||||||||
Investment, interest rate | 5.50% | [9],[10],[13] | 5.50% | [9],[10],[13] | 5.50% | [9],[10],[13] | 5.50% | [11],[12],[15] | 5.50% | [11],[12],[15] | 5.50% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,331 | [1],[4],[10] | $ 9,057 | [7],[8],[11] | ||||||||||
Investment, interest rate | 5% | [1],[9],[10] | 5% | [1],[9],[10] | 5% | [1],[9],[10] | 5% | [8],[11],[12] | 5% | [8],[11],[12] | 5% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 16,825 | [1],[4],[10] | $ 17,053 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13% | [1],[9],[10] | 13% | [1],[9],[10] | 13% | [1],[9],[10] | 13.04% | [8],[11],[12] | 13.04% | [8],[11],[12] | 13.04% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 28,964 | [1],[4],[13] | $ 28,464 | [7],[8],[15] | ||||||||||
Investment, interest rate | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 28,178 | [1],[4],[13] | $ 2,121 | [7],[8],[15] | ||||||||||
Investment, interest rate | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,159 | [1],[4],[13] | $ 27,692 | [7],[8],[15] | ||||||||||
Investment, interest rate | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,100 | [1],[4],[13] | $ 2,064 | [7],[8],[15] | ||||||||||
Investment, interest rate | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [1],[9],[10],[13] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | 8.50% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 17,048 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 14.14% | 14.14% | 14.14% | ||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 17,048 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 14.25% | 14.25% | 14.25% | ||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 14,907 | [4],[10] | $ 19,115 | [7],[11] | ||||||||||
Investment, interest rate | 11.91% | [9],[10] | 11.91% | [9],[10] | 11.91% | [9],[10] | 11.81% | [11],[12] | 11.81% | [11],[12] | 11.81% | [11],[12] | ||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[11],[15] | $ 12,500 | ||||||||||||
Investment, interest rate | [11],[12],[15] | 13.54% | 13.54% | 13.54% | ||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 33,558 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 11.10% | 11.10% | 11.10% | ||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,691 | [4],[10] | $ 3,700 | [7],[11] | ||||||||||
Investment, interest rate | 9.36% | [9],[10] | 9.36% | [9],[10] | 9.36% | [9],[10] | 9.40% | [11],[12] | 9.40% | [11],[12] | 9.40% | [11],[12] | ||
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 47,810 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 10.86% | 10.86% | 10.86% | ||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | € 4,949 | [1],[4],[10],[13] | € 3,017 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 12.71% | [1],[9],[10],[13] | 12.71% | [1],[9],[10],[13] | 12.71% | [1],[9],[10],[13] | 10.95% | [8],[11],[12],[15] | 10.95% | [8],[11],[12],[15] | 10.95% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,519 | [1],[4],[10],[13] | $ 10,519 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 11.82% | [1],[9],[10],[13] | 11.82% | [1],[9],[10],[13] | 11.82% | [1],[9],[10],[13] | 11.57% | [8],[11],[12],[15] | 11.57% | [8],[11],[12],[15] | 11.57% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | £ 3,649 | [1],[4],[10],[13] | £ 4,949 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 9.95% | [1],[9],[10],[13] | 9.95% | [1],[9],[10],[13] | 9.95% | [1],[9],[10],[13] | 12.46% | [8],[11],[12],[15] | 12.46% | [8],[11],[12],[15] | 12.46% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | £ 3,017 | [1],[4],[10],[13] | £ 23,675 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 11.20% | [1],[9],[10],[13] | 11.20% | [1],[9],[10],[13] | 11.20% | [1],[9],[10],[13] | 12.46% | [8],[11],[12],[15] | 12.46% | [8],[11],[12],[15] | 12.46% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | £ 23,675 | [1],[4],[10],[13] | £ 3,649 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 12.71% | [1],[9],[10],[13] | 12.71% | [1],[9],[10],[13] | 12.71% | [1],[9],[10],[13] | 9.70% | [8],[11],[12],[15] | 9.70% | [8],[11],[12],[15] | 9.70% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 21,852 | [5],[7],[8],[11] | $ 21,464 | |||||||||||
Investment, interest rate | 12.14% | [5],[8],[11],[12] | 12.14% | [5],[8],[11],[12] | 12.14% | [5],[8],[11],[12] | 11.48% | |||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 15,688 | [4],[10] | $ 8,490 | [7],[11] | ||||||||||
Investment, interest rate | 10.86% | [9],[10] | 10.86% | [9],[10] | 10.86% | [9],[10] | 10.90% | [11],[12] | 10.90% | [11],[12] | 10.90% | [11],[12] | ||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 29,801 | [1],[4],[10],[13] | $ 29,509 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 8.45% | [1],[9],[10],[13] | 8.45% | [1],[9],[10],[13] | 8.45% | [1],[9],[10],[13] | 11.49% | [8],[11],[12],[15] | 11.49% | [8],[11],[12],[15] | 11.49% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 50,470 | [1],[4],[10] | $ 50,470 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.60% | [9],[10] | 12.60% | [9],[10] | 12.60% | [9],[10] | 12.64% | [8],[11],[12] | 12.64% | [8],[11],[12] | 12.64% | [8],[11],[12] | ||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,239 | [1],[4],[10] | $ 3,247 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.61% | [1],[9],[10] | 10.61% | [1],[9],[10] | 10.61% | [1],[9],[10] | 10.65% | [8],[11],[12] | 10.65% | [8],[11],[12] | 10.65% | [8],[11],[12] | ||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,258 | [1],[4],[10] | $ 1,261 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.61% | [1],[9],[10] | 10.61% | [1],[9],[10] | 10.61% | [1],[9],[10] | 10.65% | [8],[11],[12] | 10.65% | [8],[11],[12] | 10.65% | [8],[11],[12] | ||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,091 | [1],[4],[10] | $ 8,920 | [7],[8],[11] | ||||||||||
Investment, interest rate | 14.15% | [1],[9],[10] | 14.15% | [1],[9],[10] | 14.15% | [1],[9],[10] | 14.15% | [8],[11],[12] | 14.15% | [8],[11],[12] | 14.15% | [8],[11],[12] | ||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,361 | [1],[4],[10] | $ 2,091 | [7],[8],[11] | ||||||||||
Investment, interest rate | 14.11% | [1],[9],[10] | 14.11% | [1],[9],[10] | 14.11% | [1],[9],[10] | 14.15% | [8],[11],[12] | 14.15% | [8],[11],[12] | 14.15% | [8],[11],[12] | ||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,920 | [1],[4],[10] | $ 4,361 | [7],[8],[11] | ||||||||||
Investment, interest rate | 14.11% | [1],[9],[10] | 14.11% | [1],[9],[10] | 14.11% | [1],[9],[10] | 14.15% | [8],[11],[12] | 14.15% | [8],[11],[12] | 14.15% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,836 | [1],[2],[4],[10] | $ 2,221 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 13% | [1],[2],[9],[10] | 13% | [1],[2],[9],[10] | 13% | [1],[2],[9],[10] | 13% | [5],[8],[11],[12] | 13% | [5],[8],[11],[12] | 13% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 40,557 | [1],[4],[10] | $ 40,660 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.03% | [1],[9],[10] | 11.03% | [1],[9],[10] | 11.03% | [1],[9],[10] | 11.02% | [8],[11],[12] | 11.02% | [8],[11],[12] | 11.02% | [8],[11],[12] | ||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10],[13] | $ 6,757 | [7],[8],[15] | ||||||||||
Investment, interest rate | [8],[11],[12],[15] | 8% | 8% | 8% | ||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,815 | [1],[4],[10],[13] | $ 3,316 | [5],[7],[8],[15],[16] | ||||||||||
Investment, interest rate | [1],[9],[10],[13] | 12.89% | 12.89% | 12.89% | ||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[13] | $ 0 | [5],[7],[8],[15] | ||||||||||
Investment, interest rate | 8% | [1],[2],[9],[10],[13] | 8% | [1],[2],[9],[10],[13] | 8% | [1],[2],[9],[10],[13] | 8% | [5],[8],[11],[12],[15] | 8% | [5],[8],[11],[12],[15] | 8% | [5],[8],[11],[12],[15] | ||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[13] | $ 0 | [5],[7],[8],[15] | ||||||||||
Investment, interest rate | 8% | [1],[2],[9],[10],[13] | 8% | [1],[2],[9],[10],[13] | 8% | [1],[2],[9],[10],[13] | 8% | [5],[8],[11],[12],[15] | 8% | [5],[8],[11],[12],[15] | 8% | [5],[8],[11],[12],[15] | ||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,785 | [1],[4],[13] | $ 0 | [5],[7],[8],[15],[16] | ||||||||||
Investment, interest rate | [1],[9],[10],[13] | 8% | 8% | 8% | ||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [5],[7],[8],[15],[16] | 0 | ||||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 30,625 | [4],[10] | $ 30,625 | [7],[11] | ||||||||||
Investment, interest rate | 12.46% | [9],[10] | 12.46% | [9],[10] | 12.46% | [9],[10] | 12.43% | [11],[12] | 12.43% | [11],[12] | 12.43% | [11],[12] | ||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,257 | [1],[4] | $ 5,257 | [7],[8] | ||||||||||
Investment, interest rate | 9% | [1],[9],[10] | 9% | [1],[9],[10] | 9% | [1],[9],[10] | 9% | [8],[11],[12] | 9% | [8],[11],[12] | 9% | [8],[11],[12] | ||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4],[10],[13] | $ 16,185 | ||||||||||||
Investment, interest rate | [9],[10],[13] | 11.29% | 11.29% | 11.29% | ||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 727 | [1],[4],[10],[17] | $ 727 | [7],[8],[11],[18] | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 37 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 3,031 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 1,557 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 1,024 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,632 | [4],[13] | $ 2,632 | [7],[15] | ||||||||||
Investment, interest rate | 7.50% | [9],[10],[13] | 7.50% | [9],[10],[13] | 7.50% | [9],[10],[13] | 7.50% | [11],[12],[15] | 7.50% | [11],[12],[15] | 7.50% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 176 | [4],[13] | $ 176 | [7],[15] | ||||||||||
Investment, interest rate | 7.75% | [9],[10],[13] | 7.75% | [9],[10],[13] | 7.75% | [9],[10],[13] | 7.75% | [11],[12],[15] | 7.75% | [11],[12],[15] | 7.75% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,720 | [4] | $ 8,420 | [7] | ||||||||||
Investment, interest rate | 7.38% | [9],[10] | 7.38% | [9],[10] | 7.38% | [9],[10] | 7.38% | [11],[12] | 7.38% | [11],[12] | 7.38% | [11],[12] | ||
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4],[13] | $ 1,670 | ||||||||||||
Investment, interest rate | [9],[10],[13] | 6.75% | 6.75% | 6.75% | ||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11],[18] | $ 22,084 | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | $ 13,157 | [7],[8],[11] | ||||||||||
Investment, interest rate | [8],[11],[12] | 12.82% | 12.82% | 12.82% | ||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 13,157 | [1],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [1],[9],[10] | 12.86% | 12.86% | 12.86% | ||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 14,713 | [4],[10] | $ 14,750 | [7],[11] | ||||||||||
Investment, interest rate | 10.35% | [9],[10] | 10.35% | [9],[10] | 10.35% | [9],[10] | 10.39% | [11],[12] | 10.39% | [11],[12] | 10.39% | [11],[12] | ||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[4],[10] | $ 933 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [5],[8],[11],[12] | 11.47% | 11.47% | 11.47% | ||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,967 | [1],[4],[10] | $ 18,013 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.53% | [9],[10] | 11.53% | [9],[10] | 11.53% | [9],[10] | 11.52% | [8],[11],[12] | 11.52% | [8],[11],[12] | 11.52% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4] | $ 20,924 | ||||||||||||
Investment, interest rate | [9],[10] | 12.10% | 12.10% | 12.10% | ||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,938 | [4],[10] | $ 4,950 | [7],[11] | ||||||||||
Investment, interest rate | 10.13% | [9],[10] | 10.13% | [9],[10] | 10.13% | [9],[10] | 10.12% | [11],[12] | 10.12% | [11],[12] | 10.12% | [11],[12] | ||
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 440 | ||||||||||||
Investment, interest rate | [9],[10] | 8% | 8% | 8% | ||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 32,104 | [1],[4],[13] | $ 17,465 | [5],[7],[8],[15] | ||||||||||
Investment, interest rate | 3% | [1],[9],[10],[13] | 3% | [1],[9],[10],[13] | 3% | [1],[9],[10],[13] | 3% | [5],[8],[11],[12],[15] | 3% | [5],[8],[11],[12],[15] | 3% | [5],[8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 20,757 | [1],[4],[10] | $ 20,757 | [7],[8],[11] | ||||||||||
Investment, interest rate | 14.50% | [1],[9],[10] | 14.50% | [1],[9],[10] | 14.50% | [1],[9],[10] | 14.54% | [8],[11],[12] | 14.54% | [8],[11],[12] | 14.54% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 667 | [1],[4] | $ 654 | [7],[8] | ||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 578 | [1],[2],[4],[10] | $ 284 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 12.45% | [1],[2],[9],[10] | 12.45% | [1],[2],[9],[10] | 12.45% | [1],[2],[9],[10] | 12.49% | [5],[8],[11],[12] | 12.49% | [5],[8],[11],[12] | 12.49% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,355 | [1],[4],[10] | $ 12,386 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.45% | [1],[9],[10] | 12.45% | [1],[9],[10] | 12.45% | [1],[9],[10] | 12.49% | [8],[11],[12] | 12.49% | [8],[11],[12] | 12.49% | [8],[11],[12] | ||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,514 | [4],[10] | $ 4,641 | [7],[11] | ||||||||||
Investment, interest rate | 10.65% | [9],[10] | 10.65% | [9],[10] | 10.65% | [9],[10] | 10.43% | [11],[12] | 10.43% | [11],[12] | 10.43% | [11],[12] | ||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 5,090 | ||||||||||||
Investment, interest rate | [9],[10] | 5.88% | 5.88% | 5.88% | ||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,574 | [1],[4],[10] | $ 5,574 | [7],[8],[11] | 0 | |||||||||
Investment, interest rate | 10.50% | [1],[9],[10] | 10.50% | [1],[9],[10] | 10.50% | [1],[9],[10] | 10.54% | [8],[11],[12] | 10.54% | [8],[11],[12] | 10.54% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 14,297 | |||||||||||||
Investment, interest rate | 9.73% | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 14,033 | [1],[4],[10] | $ 14,068 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.50% | [1],[9],[10] | 10.50% | [1],[9],[10] | 10.50% | [1],[9],[10] | 10.54% | [8],[11],[12] | 10.54% | [8],[11],[12] | 10.54% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,393 | [1],[2],[4],[10] | $ 2,090 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 10.46% | [1],[2],[9],[10] | 10.46% | [1],[2],[9],[10] | 10.46% | [1],[2],[9],[10] | 10.42% | [5],[8],[11],[12] | 10.42% | [5],[8],[11],[12] | 10.42% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,974 | [1],[4],[10] | $ 8,974 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13% | [1],[9],[10] | 13% | [1],[9],[10] | 13% | [1],[9],[10] | 13.04% | [8],[11],[12] | 13.04% | [8],[11],[12] | 13.04% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 24,865 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 10.84% | 10.84% | 10.84% | ||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,799 | [1],[4],[13] | $ 11,065 | [7],[8],[15] | ||||||||||
Investment, interest rate | 3% | [1],[9],[10],[13] | 3% | [1],[9],[10],[13] | 3% | [1],[9],[10],[13] | 3% | [8],[11],[12],[15] | 3% | [8],[11],[12],[15] | 3% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[13] | $ 1,772 | [7],[8],[15] | ||||||||||
Investment, interest rate | 3% | [1],[2],[9],[10],[13] | 3% | [1],[2],[9],[10],[13] | 3% | [1],[2],[9],[10],[13] | 3% | [8],[11],[12],[15] | 3% | [8],[11],[12],[15] | 3% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[13] | $ 0 | [5],[7],[8],[15] | ||||||||||
Investment, interest rate | 3% | [1],[2],[9],[10],[13] | 3% | [1],[2],[9],[10],[13] | 3% | [1],[2],[9],[10],[13] | 3% | [5],[8],[11],[12],[15] | 3% | [5],[8],[11],[12],[15] | 3% | [5],[8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,232 | [1],[4],[13] | $ 0 | [5],[7],[8],[15] | ||||||||||
Investment, interest rate | 3% | [1],[9],[10],[13] | 3% | [1],[9],[10],[13] | 3% | [1],[9],[10],[13] | 3% | [5],[8],[11],[12],[15] | 3% | [5],[8],[11],[12],[15] | 3% | [5],[8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 14,736 | [1],[2],[4],[10] | $ 14,736 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.35% | [9],[10] | 11.35% | [9],[10] | 11.35% | [9],[10] | 11.32% | [8],[11],[12] | 11.32% | [8],[11],[12] | 11.32% | [8],[11],[12] | ||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4],[10] | $ 4,324 | ||||||||||||
Investment, interest rate | [9],[10] | 9.47% | 9.47% | 9.47% | ||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 31,074 | [4],[10] | $ 31,074 | [7],[11],[15] | ||||||||||
Investment, interest rate | 12.22% | [9],[10] | 12.22% | [9],[10] | 12.22% | [9],[10] | 12.18% | [11],[12],[15] | 12.18% | [11],[12],[15] | 12.18% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 61,500 | [1],[2],[4] | $ 59,950 | [5],[7],[8] | ||||||||||
Investment, interest rate | 9% | [1],[2],[9],[10] | 9% | [1],[2],[9],[10] | 9% | [1],[2],[9],[10] | 9% | [5],[8],[11],[12] | 9% | [5],[8],[11],[12] | 9% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 322 | [1],[2],[4],[10],[13] | $ 258 | [5],[7],[8],[11],[15] | ||||||||||
Investment, interest rate | 12.61% | [1],[2],[9],[10],[13] | 12.61% | [1],[2],[9],[10],[13] | 12.61% | [1],[2],[9],[10],[13] | 12.55% | [5],[8],[11],[12],[15] | 12.55% | [5],[8],[11],[12],[15] | 12.55% | [5],[8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,742 | [1],[4],[10],[13] | $ 11,742 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 12.71% | [1],[9],[10],[13] | 12.71% | [1],[9],[10],[13] | 12.71% | [1],[9],[10],[13] | 12.55% | [8],[11],[12],[15] | 12.55% | [8],[11],[12],[15] | 12.55% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,918 | [1],[4],[13] | $ 11,918 | [7],[8],[15] | ||||||||||
Investment, interest rate | 11% | [1],[9],[10],[13] | 11% | [1],[9],[10],[13] | 11% | [1],[9],[10],[13] | 11% | [8],[11],[12],[15] | 11% | [8],[11],[12],[15] | 11% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,881 | [4],[13] | $ 4,881 | [7],[15] | ||||||||||
Investment, interest rate | 6% | [9],[10],[13] | 6% | [9],[10],[13] | 6% | [9],[10],[13] | 6% | [11],[12],[15] | 6% | [11],[12],[15] | 6% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,215 | [1],[2],[4],[10] | $ 1,638 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 12.60% | [1],[2],[9],[10] | 12.60% | [1],[2],[9],[10] | 12.60% | [1],[2],[9],[10] | 12.64% | [5],[8],[11],[12] | 12.64% | [5],[8],[11],[12] | 12.64% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 23,714 | [1],[4],[10] | $ 23,774 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.60% | [1],[9],[10] | 12.60% | [1],[9],[10] | 12.60% | [1],[9],[10] | 12.64% | [8],[11],[12] | 12.64% | [8],[11],[12] | 12.64% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,450 | [1],[4],[10] | $ 2,456 | [7],[11] | ||||||||||
Investment, interest rate | 10.66% | [1],[9],[10] | 10.66% | [1],[9],[10] | 10.66% | [1],[9],[10] | 10.57% | [11],[12] | 10.57% | [11],[12] | 10.57% | [11],[12] | ||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | € 1,000 | [4],[10],[13] | € 1,000 | [7],[11],[15] | ||||||||||
Investment, interest rate | 6.84% | [9],[10],[13] | 6.84% | [9],[10],[13] | 6.84% | [9],[10],[13] | 6.56% | [11],[12],[15] | 6.56% | [11],[12],[15] | 6.56% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | $ 17,444 | [7],[8],[11] | ||||||||||
Investment, interest rate | [8],[11],[12] | 13.42% | 13.42% | 13.42% | ||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,400 | [1],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [1],[9],[10] | 13.46% | 13.46% | 13.46% | ||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,538 | [4],[10] | $ 14,347 | [7],[11] | ||||||||||
Investment, interest rate | 10.71% | [9],[10] | 10.71% | [9],[10] | 10.71% | [9],[10] | 10.67% | [11],[12] | 10.67% | [11],[12] | 10.67% | [11],[12] | ||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10],[13] | $ 7,448 | ||||||||||||
Investment, interest rate | [1],[9],[10],[13] | 12% | 12% | 12% | ||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10],[13] | $ 7,448 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | [8],[11],[12],[15] | 11.89% | 11.89% | 11.89% | ||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,432 | [1],[4],[10],[13] | $ 0 | [5],[7],[8],[11],[15] | ||||||||||
Investment, interest rate | [9],[10] | 12% | 12% | 12% | ||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11],[15] | $ 1,432 | ||||||||||||
Investment, interest rate | [8],[11],[12],[15] | 12.04% | 12.04% | 12.04% | ||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,406 | [4],[13] | $ 6,808 | [7],[8],[15] | ||||||||||
Investment, interest rate | 4.46% | [9],[10],[13] | 4.46% | [9],[10],[13] | 4.46% | [9],[10],[13] | 4.46% | [8],[11],[12],[15] | 4.46% | [8],[11],[12],[15] | 4.46% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 23,975 | [1],[4],[10],[13] | $ 23,975 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 13.63% | [1],[9],[10],[13] | 13.63% | [1],[9],[10],[13] | 13.63% | [1],[9],[10],[13] | 13.62% | [8],[11],[12],[15] | 13.62% | [8],[11],[12],[15] | 13.62% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 43,931 | [1],[4],[10] | $ 44,550 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.36% | [1],[9],[10] | 11.36% | [1],[9],[10] | 11.36% | [1],[9],[10] | 11.40% | [8],[11],[12] | 11.40% | [8],[11],[12] | 11.40% | [8],[11],[12] | ||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 40,587 | [1],[4],[10] | $ 40,587 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.06% | [1],[9],[10] | 12.06% | [1],[9],[10] | 12.06% | [1],[9],[10] | 11.92% | [8],[11],[12] | 11.92% | [8],[11],[12] | 11.92% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,001 | [1],[4],[17] | $ 26,613 | [7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 2,232 | [1],[4],[10],[17] | 787 | [7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 839 | [1],[4],[10],[17] | 688 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10],[17] | 28,010 | ||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11],[15] | $ 7,179 | ||||||||||||
Investment, interest rate | [8],[11],[12],[15] | 11.14% | 11.14% | 11.14% | ||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 33,331 | [1],[4],[10] | $ 33,414 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.97% | [1],[9],[10] | 12.97% | [1],[9],[10] | 12.97% | [1],[9],[10] | 12.93% | [8],[11],[12] | 12.93% | [8],[11],[12] | 12.93% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 13,939 | [4],[10] | $ 13,939 | [7],[11] | ||||||||||
Investment, interest rate | 12.91% | [9],[10] | 12.91% | [9],[10] | 12.91% | [9],[10] | 12.78% | [11],[12] | 12.78% | [11],[12] | 12.78% | [11],[12] | ||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 272 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [5],[8],[11],[12] | 11.84% | 11.84% | 11.84% | ||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 38,015 | [1],[4],[10] | $ 16,752 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.99% | [9],[10] | 11.99% | [9],[10] | 11.99% | [9],[10] | 11.84% | [8],[11],[12] | 11.84% | [8],[11],[12] | 11.84% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 16,722 | [1],[4],[10] | $ 38,015 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.84% | [1],[9],[10] | 11.84% | [1],[9],[10] | 11.84% | [1],[9],[10] | 11.80% | [8],[11],[12] | 11.80% | [8],[11],[12] | 11.80% | [8],[11],[12] | ||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,729 | [1],[4],[10] | $ 2,736 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.46% | [1],[9],[10] | 11.46% | [1],[9],[10] | 11.46% | [1],[9],[10] | 11.42% | [8],[11],[12] | 11.42% | [8],[11],[12] | 11.42% | [8],[11],[12] | ||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 23,435 | [1],[4],[10] | $ 23,494 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.46% | [9],[10] | 11.46% | [9],[10] | 11.46% | [9],[10] | 11.42% | [8],[11],[12] | 11.42% | [8],[11],[12] | 11.42% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 26,356 | [4],[10],[13] | $ 26,422 | [7],[11],[15] | ||||||||||
Investment, interest rate | 15.08% | [9],[10],[13] | 15.08% | [9],[10],[13] | 15.08% | [9],[10],[13] | 14.95% | [11],[12],[15] | 14.95% | [11],[12],[15] | 14.95% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 45,125 | [1],[4],[10] | $ 45,243 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.61% | [1],[9],[10] | 10.61% | [1],[9],[10] | 10.61% | [1],[9],[10] | 10.65% | [8],[11],[12] | 10.65% | [8],[11],[12] | 10.65% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8] | |||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,012 | [1],[4],[10] | $ 5,403 | [7],[8],[11] | ||||||||||
Investment, interest rate | 5% | [1],[9],[10] | 5% | [1],[9],[10] | 5% | [1],[9],[10] | 13.99% | [8],[11],[12] | 13.99% | [8],[11],[12] | 13.99% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,536 | [1],[4],[10] | $ 2,939 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 5% | [1],[9],[10] | 5% | [1],[9],[10] | 5% | [1],[9],[10] | 13.99% | [5],[8],[11],[12] | 13.99% | [5],[8],[11],[12] | 13.99% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 964 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [5],[8],[11],[12] | 11.42% | 11.42% | 11.42% | ||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,624 | [1],[4],[10] | $ 20,125 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.53% | [1],[9],[10] | 11.53% | [1],[9],[10] | 11.53% | [1],[9],[10] | 11.52% | [8],[11],[12] | 11.52% | [8],[11],[12] | 11.52% | [8],[11],[12] | ||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,802 | [1],[2],[4],[10] | $ 2,631 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.53% | [9],[10] | 11.53% | [9],[10] | 11.53% | [9],[10] | 11.52% | [8],[11],[12] | 11.52% | [8],[11],[12] | 11.52% | [8],[11],[12] | ||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,308 | [1],[2],[4],[10] | $ 1,466 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 12.86% | [1],[2],[9],[10] | 12.86% | [1],[2],[9],[10] | 12.86% | [1],[2],[9],[10] | 12.83% | [5],[8],[11],[12] | 12.83% | [5],[8],[11],[12] | 12.83% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 40,538 | [1],[4],[10] | $ 40,538 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.89% | [1],[9],[10] | 12.89% | [1],[9],[10] | 12.89% | [1],[9],[10] | 12.89% | [8],[11],[12] | 12.89% | [8],[11],[12] | 12.89% | [8],[11],[12] | ||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 21,272 | [1],[4],[10] | $ 13,973 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.95% | [9],[10] | 10.95% | [9],[10] | 10.95% | [9],[10] | 10.99% | [8],[11],[12] | 10.99% | [8],[11],[12] | 10.99% | [8],[11],[12] | ||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 13,937 | [1],[4],[10] | $ 21,328 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.95% | [1],[9],[10] | 10.95% | [1],[9],[10] | 10.95% | [1],[9],[10] | 10.99% | [8],[11],[12] | 10.99% | [8],[11],[12] | 10.99% | [8],[11],[12] | ||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,568 | [1],[4],[13] | $ 8,568 | [7],[8],[15] | ||||||||||
Investment, interest rate | 11.50% | [1],[9],[10],[13] | 11.50% | [1],[9],[10],[13] | 11.50% | [1],[9],[10],[13] | 11.50% | [8],[11],[12],[15] | 11.50% | [8],[11],[12],[15] | 11.50% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,568 | [1],[4],[13] | $ 4,284 | [7],[8],[15] | ||||||||||
Investment, interest rate | 11.50% | [1],[9],[10],[13] | 11.50% | [1],[9],[10],[13] | 11.50% | [1],[9],[10],[13] | 11.50% | [8],[11],[12],[15] | 11.50% | [8],[11],[12],[15] | 11.50% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,284 | [1],[4],[13] | $ 8,568 | [7],[8],[15] | ||||||||||
Investment, interest rate | 11.50% | [1],[9],[10],[13] | 11.50% | [1],[9],[10],[13] | 11.50% | [1],[9],[10],[13] | 11.50% | [8],[11],[12],[15] | 11.50% | [8],[11],[12],[15] | 11.50% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,129 | [1],[4],[13] | $ 9,106 | [7],[8],[15] | ||||||||||
Investment, interest rate | 8% | [1],[9],[10],[13] | 8% | [1],[9],[10],[13] | 8% | [1],[9],[10],[13] | 8% | [8],[11],[12],[15] | 8% | [8],[11],[12],[15] | 8% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[15] | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[15] | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 46,687 | [1],[4],[10] | $ 5,248 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.53% | [9],[10] | 12.53% | [9],[10] | 12.53% | [9],[10] | 12.52% | [8],[11],[12] | 12.52% | [8],[11],[12] | 12.52% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,248 | [1],[4],[10] | $ 46,687 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.53% | [1],[9],[10] | 12.53% | [1],[9],[10] | 12.53% | [1],[9],[10] | 12.52% | [8],[11],[12] | 12.52% | [8],[11],[12] | 12.52% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 49,266 | [1],[4],[10] | $ 54,559 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13.60% | [1],[9],[10] | 13.60% | [1],[9],[10] | 13.60% | [1],[9],[10] | 12.51% | [8],[11],[12] | 12.51% | [8],[11],[12] | 12.51% | [8],[11],[12] | ||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,191 | [4] | $ 10,191 | [7] | ||||||||||
Investment, interest rate | 6.88% | [9],[10] | 6.88% | [9],[10] | 6.88% | [9],[10] | 6.88% | [11],[12] | 6.88% | [11],[12] | 6.88% | [11],[12] | ||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 73,547 | [1],[4],[10],[13] | $ 73,362 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 12.33% | [1],[9],[10],[13] | 12.33% | [1],[9],[10],[13] | 12.33% | [1],[9],[10],[13] | 12.29% | [8],[11],[12],[15] | 12.29% | [8],[11],[12],[15] | 12.29% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 30,339 | [1],[4],[10] | $ 30,339 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13.93% | [1],[9],[10] | 13.93% | [1],[9],[10] | 13.93% | [1],[9],[10] | 13.99% | [8],[11],[12] | 13.99% | [8],[11],[12] | 13.99% | [8],[11],[12] | ||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 64,606 | [1],[4],[10] | $ 64,606 | [7],[8],[11] | ||||||||||
Investment, interest rate | 14.83% | [1],[9],[10] | 14.83% | [1],[9],[10] | 14.83% | [1],[9],[10] | 14.89% | [8],[11],[12] | 14.89% | [8],[11],[12] | 14.89% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 19,995 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 11.37% | 11.37% | 11.37% | ||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 58,349 | [1],[2],[4],[10],[13],[19] | $ 58,349 | [5],[7],[8],[15],[20] | $ 59,049 | |||||||||
Investment, interest rate | 9.94% | [1],[2],[9],[10],[13],[19] | 9.94% | [1],[2],[9],[10],[13],[19] | 9.94% | [1],[2],[9],[10],[13],[19] | 9.76% | [5],[8],[11],[12],[15],[20] | 9.76% | [5],[8],[11],[12],[15],[20] | 9.76% | [5],[8],[11],[12],[15],[20] | 7.67% | |
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,323 | [1],[4],[10] | $ 9,323 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.46% | [1],[9],[10] | 12.46% | [1],[9],[10] | 12.46% | [1],[9],[10] | 12.49% | [8],[11],[12] | 12.49% | [8],[11],[12] | 12.49% | [8],[11],[12] | ||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,303 | [1],[4],[10],[17] | $ 25,712 | [7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 31,515 | [1],[4],[10],[17] | 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 233 | [1],[2],[4],[10],[17] | 1,210 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 15,231 | [1],[4],[10] | $ 15,231 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13.13% | [1],[9],[10] | 13.13% | [1],[9],[10] | 13.13% | [1],[9],[10] | 13.12% | [8],[11],[12] | 13.12% | [8],[11],[12] | 13.12% | [8],[11],[12] | ||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7] | $ 4,519 | ||||||||||||
Investment, interest rate | [11],[12] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 98 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [1],[2],[9],[10] | 12.35% | 12.35% | 12.35% | ||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,868 | [1],[4],[10] | $ 10,895 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.36% | [1],[9],[10] | 12.36% | [1],[9],[10] | 12.36% | [1],[9],[10] | 12.32% | [8],[11],[12] | 12.32% | [8],[11],[12] | 12.32% | [8],[11],[12] | ||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 38,308 | [1],[4],[10] | $ 38,414 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.04% | [1],[9],[10] | 12.04% | [1],[9],[10] | 12.04% | [1],[9],[10] | 12.01% | [8],[11],[12] | 12.01% | [8],[11],[12] | 12.01% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,651 | [4],[10] | $ 9,676 | [7],[11] | ||||||||||
Investment, interest rate | 10.46% | [9],[10] | 10.46% | [9],[10] | 10.46% | [9],[10] | 10.42% | [11],[12] | 10.42% | [11],[12] | 10.42% | [11],[12] | ||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 22,375 | [1],[4],[10] | $ 22,375 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.32% | [1],[9],[10] | 11.32% | [1],[9],[10] | 11.32% | [1],[9],[10] | 11.57% | [8],[11],[12] | 11.57% | [8],[11],[12] | 11.57% | [8],[11],[12] | ||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 52,639 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 11.36% | 11.36% | 11.36% | ||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 2,300 | ||||||||||||
Investment, interest rate | [9],[10] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 36,499 | [1],[4],[10] | $ 36,499 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.70% | [1],[9],[10] | 12.70% | [1],[9],[10] | 12.70% | [1],[9],[10] | 12.74% | [8],[11],[12] | 12.74% | [8],[11],[12] | 12.74% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,722 | [1],[2],[4],[10] | $ 3,003 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 13.56% | [1],[2],[9],[10] | 13.56% | [1],[2],[9],[10] | 13.56% | [1],[2],[9],[10] | 13.45% | [5],[8],[11],[12] | 13.45% | [5],[8],[11],[12] | 13.45% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 67,244 | [1],[4],[10] | $ 67,244 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13.56% | [1],[9],[10] | 13.56% | [1],[9],[10] | 13.56% | [1],[9],[10] | 13.45% | [8],[11],[12] | 13.45% | [8],[11],[12] | 13.45% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10],[13] | $ 28,818 | ||||||||||||
Investment, interest rate | [1],[9],[10],[13] | 12.60% | 12.60% | 12.60% | ||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 24,503 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.78% | 12.78% | 12.78% | ||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 2,819 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.78% | 12.78% | 12.78% | ||||||||||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | £ 6,136 | [1],[4],[10],[13] | £ 4,626 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 10.96% | [1],[9],[10],[13] | 10.96% | [1],[9],[10],[13] | 10.96% | [1],[9],[10],[13] | 11.21% | [8],[11],[12],[15] | 11.21% | [8],[11],[12],[15] | 11.21% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 32,329 | [1],[4],[10] | $ 32,329 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.96% | [1],[9],[10] | 11.96% | [1],[9],[10] | 11.96% | [1],[9],[10] | 11.92% | [8],[11],[12] | 11.92% | [8],[11],[12] | 11.92% | [8],[11],[12] | ||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,697 | [1],[4],[10],[13] | $ 36,707 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 13.86% | [1],[9],[10],[13] | 13.86% | [1],[9],[10],[13] | 13.86% | [1],[9],[10],[13] | 13.90% | [8],[11],[12],[15] | 13.90% | [8],[11],[12],[15] | 13.90% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 32,133 | [1],[4],[10],[13] | $ 13,504 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 13.86% | [1],[9],[10],[13] | 13.86% | [1],[9],[10],[13] | 13.86% | [1],[9],[10],[13] | 13.90% | [8],[11],[12],[15] | 13.90% | [8],[11],[12],[15] | 13.90% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 1,680 | ||||||||||||
Investment, interest rate | [9],[10] | 4.88% | 4.88% | 4.88% | ||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 990 | [1],[2],[4],[10] | $ 8,010 | [7],[8],[11] | ||||||||||
Investment, interest rate | 14.20% | [1],[2],[9],[10] | 14.20% | [1],[2],[9],[10] | 14.20% | [1],[2],[9],[10] | 14.18% | [8],[11],[12] | 14.18% | [8],[11],[12] | 14.18% | [8],[11],[12] | ||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,010 | [1],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [1],[9],[10] | 14.21% | 14.21% | 14.21% | ||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 16,355 | [1],[4] | 15,874 | [7],[8] | ||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 3,005 | [1],[2],[4] | 1,359 | [5],[7],[8] | ||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,440 | [1],[4],[10] | $ 4,452 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.39% | [1],[9],[10] | 10.39% | [1],[9],[10] | 10.39% | [1],[9],[10] | 10.38% | [8],[11],[12] | 10.38% | [8],[11],[12] | 10.38% | [8],[11],[12] | ||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,034 | [1],[4],[10] | $ 12,034 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13.64% | [1],[9],[10] | 13.64% | [1],[9],[10] | 13.64% | [1],[9],[10] | 13.63% | [8],[11],[12] | 13.63% | [8],[11],[12] | 13.63% | [8],[11],[12] | ||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 1,590 | ||||||||||||
Investment, interest rate | [9],[10] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 25,462 | [1],[4],[10],[17] | $ 25,527 | [7],[8],[11] | ||||||||||
Investment, interest rate | [8],[11],[12] | 12.40% | 12.40% | 12.40% | ||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 25,418 | [1],[4],[10] | $ 25,558 | [7],[8],[11] | ||||||||||
Investment, interest rate | 15.36% | [1],[9],[10] | 15.36% | [1],[9],[10] | 15.36% | [1],[9],[10] | 15.24% | [8],[11],[12] | 15.24% | [8],[11],[12] | 15.24% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 112,656 | [1],[2],[4],[10],[13],[19] | $ 112,656 | [5],[7],[8],[15],[20] | $ 112,656 | |||||||||
Investment, interest rate | 12.44% | [1],[2],[9],[10],[13],[19] | 12.44% | [1],[2],[9],[10],[13],[19] | 12.44% | [1],[2],[9],[10],[13],[19] | 12.26% | [5],[8],[11],[12],[15],[20] | 12.26% | [5],[8],[11],[12],[15],[20] | 12.26% | [5],[8],[11],[12],[15],[20] | 10.17% | |
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10],[13] | $ 7,191 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | [8],[11],[12],[15] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10],[13] | $ 2,697 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | [8],[11],[12],[15] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,191 | [1],[4],[10],[13] | $ 0 | [5],[7],[8],[11],[15] | ||||||||||
Investment, interest rate | [1],[9],[10],[13] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,697 | [1],[4],[10],[13] | 0 | [5],[7],[8],[11],[15] | ||||||||||
Investment, interest rate | [1],[9],[10],[13] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 821 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 13.04% | 13.04% | 13.04% | ||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 618 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [5],[8],[11],[12] | 10.42% | 10.42% | 10.42% | ||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,477 | [1],[4],[10] | $ 4,488 | [7],[8],[11] | ||||||||||
Investment, interest rate | 10.71% | [9],[10] | 10.71% | [9],[10] | 10.71% | [9],[10] | 10.67% | [8],[11],[12] | 10.67% | [8],[11],[12] | 10.67% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 4,700 | ||||||||||||
Investment, interest rate | [9],[10] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | € 23,731 | [1],[4],[10],[13] | € 23,731 | [7],[8],[11],[15] | ||||||||||
Investment, interest rate | 12.21% | [1],[9],[10],[13] | 12.21% | [1],[9],[10],[13] | 12.21% | [1],[9],[10],[13] | 12.32% | [8],[11],[12],[15] | 12.32% | [8],[11],[12],[15] | 12.32% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 49,395 | [1],[4],[10] | $ 49,520 | [7],[8],[11] | ||||||||||
Investment, interest rate | 13.36% | [1],[9],[10] | 13.36% | [1],[9],[10] | 13.36% | [1],[9],[10] | 13.32% | [8],[11],[12] | 13.32% | [8],[11],[12] | 13.32% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,552 | [1],[4],[10] | $ 1,552 | [7],[8],[11],[21] | ||||||||||
Investment, interest rate | 12.66% | [1],[9],[10] | 12.66% | [1],[9],[10] | 12.66% | [1],[9],[10] | 12.44% | [8],[11],[12],[21] | 12.44% | [8],[11],[12],[21] | 12.44% | [8],[11],[12],[21] | ||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [5],[7],[8],[11],[21] | $ 1,099 | ||||||||||||
Investment, interest rate | [5],[8],[11],[12],[21] | 12.51% | 12.51% | 12.51% | ||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,742 | [1],[4],[10] | $ 32,104 | [7],[8],[11],[21] | ||||||||||
Investment, interest rate | 12.66% | [1],[9],[10] | 12.66% | [1],[9],[10] | 12.66% | [1],[9],[10] | 12.51% | [8],[11],[12],[21] | 12.51% | [8],[11],[12],[21] | 12.51% | [8],[11],[12],[21] | ||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,298 | [1],[4],[10] | $ 2,749 | [7],[8],[11],[21] | ||||||||||
Investment, interest rate | 14.50% | [1],[9],[10] | 14.50% | [1],[9],[10] | 14.50% | [1],[9],[10] | 12.51% | [8],[11],[12],[21] | 12.51% | [8],[11],[12],[21] | 12.51% | [8],[11],[12],[21] | ||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 32,022 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 12.66% | 12.66% | 12.66% | ||||||||||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [6],[7],[8],[15] | $ 4,984 | ||||||||||||
Investment, interest rate | [6],[8],[11],[12],[15] | 11.50% | 11.50% | 11.50% | ||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 50,419 | [1],[4],[13] | $ 50,419 | [7],[8],[15] | ||||||||||
Investment, interest rate | 13% | [1],[9],[10],[13] | 13% | [1],[9],[10],[13] | 13% | [1],[9],[10],[13] | 13% | [8],[11],[12],[15] | 13% | [8],[11],[12],[15] | 13% | [8],[11],[12],[15] | ||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,843 | [1],[4],[10] | $ 12,843 | [7],[11] | ||||||||||
Investment, interest rate | 13.47% | [1],[9],[10] | 13.47% | [1],[9],[10] | 13.47% | [1],[9],[10] | 13.43% | [11],[12] | 13.43% | [11],[12] | 13.43% | [11],[12] | ||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [5],[7],[8],[11],[15] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11],[15] | $ 28,826 | ||||||||||||
Investment, interest rate | [8],[11],[12],[15] | 11.42% | 11.42% | 11.42% | ||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,119 | [1],[2],[4],[10] | $ 1,861 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 15.21% | [1],[2],[9],[10] | 15.21% | [1],[2],[9],[10] | 15.21% | [1],[2],[9],[10] | 15.17% | [5],[8],[11],[12] | 15.17% | [5],[8],[11],[12] | 15.17% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 23,363 | [1],[4],[10] | $ 23,423 | [7],[8],[11] | ||||||||||
Investment, interest rate | 15.28% | [1],[9],[10] | 15.28% | [1],[9],[10] | 15.28% | [1],[9],[10] | 15.26% | [8],[11],[12] | 15.26% | [8],[11],[12] | 15.26% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 19,894 | [1],[4],[10] | $ 19,947 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.36% | [1],[9],[10] | 11.36% | [1],[9],[10] | 11.36% | [1],[9],[10] | 11.32% | [8],[11],[12] | 11.32% | [8],[11],[12] | 11.32% | [8],[11],[12] | ||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11],[18] | $ 19,163 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[17] | $ 5,065 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[17] | 20,871 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11],[18] | 4,641 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 46,832 | [1],[4],[10],[17] | 46,832 | [7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,642 | [1],[4],[10] | $ 11,671 | [7],[8],[11] | ||||||||||
Investment, interest rate | 11.48% | [1],[9],[10] | 11.48% | [1],[9],[10] | 11.48% | [1],[9],[10] | 11.42% | [8],[11],[12] | 11.42% | [8],[11],[12] | 11.42% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,000 | [4],[10],[13] | $ 1,000 | [7],[11],[15] | ||||||||||
Investment, interest rate | 13.12% | [9],[10],[13] | 13.12% | [9],[10],[13] | 13.12% | [9],[10],[13] | 13.06% | [11],[12],[15] | 13.06% | [11],[12],[15] | 13.06% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 300 | [4],[13] | $ 4,500 | [7],[15] | ||||||||||
Investment, interest rate | 4.75% | [9],[10],[13] | 4.75% | [9],[10],[13] | 4.75% | [9],[10],[13] | 6.50% | [11],[12],[15] | 6.50% | [11],[12],[15] | 6.50% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,500 | [4],[13] | $ 300 | [7],[15] | ||||||||||
Investment, interest rate | 6.50% | [9],[10],[13] | 6.50% | [9],[10],[13] | 6.50% | [9],[10],[13] | 4.75% | [11],[12],[15] | 4.75% | [11],[12],[15] | 4.75% | [11],[12],[15] | ||
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4],[10] | $ 6,620 | ||||||||||||
Investment, interest rate | [9],[10] | 9.50% | 9.50% | 9.50% | ||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 1,140 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.68% | 12.68% | 12.68% | ||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 1,290 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 21.66% | 21.66% | 21.66% | ||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 29,838 | [1],[4],[10] | $ 11,792 | [7],[11] | ||||||||||
Investment, interest rate | 12.06% | [1],[9],[10] | 12.06% | [1],[9],[10] | 12.06% | [1],[9],[10] | 9.27% | [11],[12] | 9.27% | [11],[12] | 9.27% | [11],[12] | ||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 5,000 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 12.65% | 12.65% | 12.65% | ||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[10] | $ 1,543 | ||||||||||||
Investment, interest rate | [1],[9],[10] | 21.66% | 21.66% | 21.66% | ||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 1,565 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 21.68% | 21.68% | 21.68% | ||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [7],[8],[11] | $ 1,323 | ||||||||||||
Investment, interest rate | [8],[11],[12] | 21.68% | 21.68% | 21.68% | ||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,664 | [4],[10] | $ 8,983 | [7],[11] | ||||||||||
Investment, interest rate | 11.71% | [9],[10] | 11.71% | [9],[10] | 11.71% | [9],[10] | 11.67% | [11],[12] | 11.67% | [11],[12] | 11.67% | [11],[12] | ||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 19,578 | [1],[4],[10] | $ 19,578 | [7],[8],[11] | ||||||||||
Investment, interest rate | 9.35% | [1],[9],[10] | 9.35% | [1],[9],[10] | 9.35% | [1],[9],[10] | 9.32% | [8],[11],[12] | 9.32% | [8],[11],[12] | 9.32% | [8],[11],[12] | ||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | [7],[8],[11],[15] | £ 20,000 | ||||||||||||
Investment, interest rate | [8],[11],[12],[15] | 12.72% | 12.72% | 12.72% | ||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 4,960 | ||||||||||||
Investment, interest rate | [9],[10] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 377 | [1],[2],[4],[10] | $ 377 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | 12.10% | [9],[10] | 12.10% | [9],[10] | 12.10% | [9],[10] | 12.14% | [5],[8],[11],[12] | 12.14% | [5],[8],[11],[12] | 12.14% | [5],[8],[11],[12] | ||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 24,427 | [1],[4],[10] | $ 24,427 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.62% | [1],[9],[10] | 12.62% | [1],[9],[10] | 12.62% | [1],[9],[10] | 12.63% | [8],[11],[12] | 12.63% | [8],[11],[12] | 12.63% | [8],[11],[12] | ||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,636 | [1],[4],[10] | $ 3,636 | [7],[8],[11] | ||||||||||
Investment, interest rate | 12.62% | [1],[9],[10] | 12.62% | [1],[9],[10] | 12.62% | [1],[9],[10] | 12.63% | [8],[11],[12] | 12.63% | [8],[11],[12] | 12.63% | [8],[11],[12] | ||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | $ 5,212 | [7],[8],[11] | ||||||||||
Investment, interest rate | [8],[11],[12] | 11.75% | 11.75% | 11.75% | ||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[4],[10] | $ 0 | [5],[7],[8],[11] | ||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,212 | [1],[4],[10] | 0 | [5],[7],[8],[11] | ||||||||||
Investment, interest rate | [1],[9],[10] | 11.75% | 11.75% | 11.75% | ||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [4] | $ 0 | ||||||||||||
SLF JV I | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 334,754 | $ 332,637 | ||||||||||||
Number of borrowers | borrower | 52 | 52 | 52 | 48 | 48 | 48 | ||||||||
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,124 | $ 1,149 | ||||||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 11.90% | 11.90% | 11.90% | ||||||||
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,631 | $ 6,771 | ||||||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 12.15% | 12.15% | 12.15% | ||||||||
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,124 | $ 4,134 | ||||||||||||
Investment, interest rate | 11.64% | 11.64% | 11.64% | 11.63% | 11.63% | 11.63% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,575 | $ 8,596 | ||||||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 10.32% | 10.32% | 10.32% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,786 | $ 2,969 | ||||||||||||
Investment, interest rate | 9.64% | 9.64% | 9.64% | 9.63% | 9.63% | 9.63% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,681 | $ 8,798 | ||||||||||||
Investment, interest rate | 13% | 13% | 13% | 13.04% | 13.04% | 13.04% | ||||||||
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,957 | |||||||||||||
Investment, interest rate | 9.43% | 9.43% | 9.43% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,596 | |||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,944 | |||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,811 | $ 4,824 | ||||||||||||
Investment, interest rate | 11.91% | 11.91% | 11.91% | 11.81% | 11.81% | 11.81% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,720 | |||||||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,519 | $ 1,523 | ||||||||||||
Investment, interest rate | 9.36% | 9.36% | 9.36% | 9.40% | 9.40% | 9.40% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,052 | $ 5,052 | ||||||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,920 | $ 4,950 | ||||||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.42% | 9.42% | 9.42% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 613 | $ 1,990 | ||||||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.67% | 9.67% | 9.67% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,985 | |||||||||||||
Investment, interest rate | 9.71% | 9.71% | 9.71% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,346 | |||||||||||||
Investment, interest rate | 10.68% | 10.68% | 10.68% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,351 | $ 6,289 | ||||||||||||
Investment, interest rate | 8.45% | 8.45% | 8.45% | 11.49% | 11.49% | 11.49% | ||||||||
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,749 | $ 1,753 | ||||||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | ||||||||
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,290 | $ 6,306 | ||||||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,990 | |||||||||||||
Investment, interest rate | 8.71% | 8.71% | 8.71% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 600 | $ 600 | ||||||||||||
Investment, interest rate | 11.54% | 11.54% | 11.54% | 11.57% | 11.57% | 11.57% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,348 | $ 2,354 | ||||||||||||
Investment, interest rate | 11.53% | 11.53% | 11.53% | 11.55% | 11.55% | 11.55% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,978 | $ 1,983 | ||||||||||||
Investment, interest rate | 11.53% | 11.53% | 11.53% | 11.55% | 11.55% | 11.55% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,955 | $ 1,960 | ||||||||||||
Investment, interest rate | 11.53% | 11.53% | 11.53% | 11.55% | 11.55% | 11.55% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,327 | $ 6,343 | ||||||||||||
Investment, interest rate | 10.35% | 10.35% | 10.35% | 10.39% | 10.39% | 10.39% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,708 | $ 8,730 | ||||||||||||
Investment, interest rate | 9.85% | 9.85% | 9.85% | 9.89% | 9.89% | 9.89% | ||||||||
SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,698 | $ 7,920 | ||||||||||||
Investment, interest rate | 10.13% | 10.13% | 10.13% | 10.12% | 10.12% | 10.12% | ||||||||
SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,196 | $ 5,799 | ||||||||||||
Investment, interest rate | 10.65% | 10.65% | 10.65% | 10.43% | 10.43% | 10.43% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,992 | |||||||||||||
Investment, interest rate | 9.60% | 9.60% | 9.60% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 51,354 | $ 54,051 | ||||||||||||
SLF JV I | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,992 | |||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,350 | $ 7,369 | ||||||||||||
Investment, interest rate | 10.66% | 10.66% | 10.66% | 10.57% | 10.57% | 10.57% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,900 | $ 7,920 | ||||||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | ||||||||
SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,875 | $ 9,000 | ||||||||||||
Investment, interest rate | 11.36% | 11.36% | 11.36% | 11.40% | 11.40% | 11.40% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,313 | $ 7,331 | ||||||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | ||||||||
SLF JV I | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,910 | $ 10,000 | ||||||||||||
Investment, interest rate | 10.36% | 10.36% | 10.36% | 10.32% | 10.32% | 10.32% | ||||||||
SLF JV I | Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,952 | $ 3,962 | ||||||||||||
Investment, interest rate | 10.46% | 10.46% | 10.46% | 10.42% | 10.42% | 10.42% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,220 | $ 11,286 | ||||||||||||
SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,350 | $ 7,369 | ||||||||||||
Investment, interest rate | 11.41% | 11.41% | 11.41% | 11.32% | 11.32% | 11.32% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,220 | $ 11,249 | ||||||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | ||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,297 | $ 8,319 | ||||||||||||
Investment, interest rate | 10.95% | 10.95% | 10.95% | 10.99% | 10.99% | 10.99% | ||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,205 | $ 2,211 | ||||||||||||
Investment, interest rate | 10.95% | 10.95% | 10.95% | 10.99% | 10.99% | 10.99% | ||||||||
SLF JV I | Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,925 | $ 5,940 | ||||||||||||
Investment, interest rate | 9.19% | 9.19% | 9.19% | 9.18% | 9.18% | 9.18% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,669 | $ 4,669 | ||||||||||||
Investment, interest rate | 12.53% | 12.53% | 12.53% | 12.52% | 12.52% | 12.52% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,977 | $ 2,985 | ||||||||||||
Investment, interest rate | 9.40% | 9.40% | 9.40% | 9.18% | 9.18% | 9.18% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,615 | |||||||||||||
Investment, interest rate | 10.15% | 10.15% | 10.15% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,958 | $ 10,987 | ||||||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.43% | 9.43% | 9.43% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,799 | $ 9,825 | ||||||||||||
Investment, interest rate | 10.46% | 10.46% | 10.46% | 10.42% | 10.42% | 10.42% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,995 | |||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,000 | |||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,410 | $ 2,416 | ||||||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | 9.65% | 9.65% | 9.65% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,503 | $ 4,503 | ||||||||||||
Investment, interest rate | 12.70% | 12.70% | 12.70% | 12.74% | 12.74% | 12.74% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 394 | $ 318 | ||||||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,116 | $ 8,116 | ||||||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,988 | $ 5,000 | ||||||||||||
Investment, interest rate | 10.11% | 10.11% | 10.11% | 9.99% | 9.99% | 9.99% | ||||||||
SLF JV I | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,991 | |||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 158 | $ 138 | ||||||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.86% | 10.86% | 10.86% | ||||||||
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,091 | $ 8,113 | ||||||||||||
Investment, interest rate | 10.63% | 10.63% | 10.63% | 10.88% | 10.88% | 10.88% | ||||||||
SLF JV I | Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,970 | $ 2,977 | ||||||||||||
Investment, interest rate | 10.39% | 10.39% | 10.39% | 10.38% | 10.38% | 10.38% | ||||||||
SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,801 | $ 8,801 | ||||||||||||
Investment, interest rate | 9.96% | 9.96% | 9.96% | 9.92% | 9.92% | 9.92% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,661 | $ 7,680 | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | 9.43% | 9.43% | 9.43% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,820 | $ 8,843 | ||||||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,000 | $ 8,000 | ||||||||||||
Investment, interest rate | 9.35% | 9.35% | 9.35% | 9.33% | 9.33% | 9.33% | ||||||||
SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,194 | $ 8,215 | ||||||||||||
Investment, interest rate | 9.95% | 9.95% | 9.95% | 9.99% | 9.99% | 9.99% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 332,637 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,194 | $ 7,212 | ||||||||||||
Investment, interest rate | 11.48% | 11.48% | 11.48% | 11.42% | 11.42% | 11.42% | ||||||||
SLF JV I | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,992 | |||||||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,289 | $ 6,305 | ||||||||||||
Investment, interest rate | 10.47% | 10.47% | 10.47% | 10.43% | 10.43% | 10.43% | ||||||||
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,965 | |||||||||||||
Investment, interest rate | 9.27% | 9.27% | 9.27% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,249 | $ 6,148 | ||||||||||||
Investment, interest rate | 11.71% | 11.71% | 11.71% | 11.67% | 11.67% | 11.67% | ||||||||
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,320 | |||||||||||||
Investment, interest rate | 8.57% | 8.57% | 8.57% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,394 | |||||||||||||
Investment, interest rate | 8.61% | 8.61% | 8.61% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,309 | |||||||||||||
Investment, interest rate | 8.61% | 8.61% | 8.61% | |||||||||||
SLF JV I | Weighted Average | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, interest rate | 10.57% | 10.57% | 10.57% | 10.62% | 10.62% | 10.62% | ||||||||
Glick JV LLC | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 130,946 | $ 130,589 | ||||||||||||
Number of borrowers | borrower | 42 | 42 | 42 | 38 | 38 | 38 | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 562 | $ 574 | ||||||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 11.90% | 11.90% | 11.90% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,669 | $ 3,746 | ||||||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 12.15% | 12.15% | 12.15% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,712 | $ 1,716 | ||||||||||||
Investment, interest rate | 11.64% | 11.64% | 11.64% | 11.63% | 11.63% | 11.63% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,995 | $ 2,000 | ||||||||||||
Investment, interest rate | 10.39% | 10.39% | 10.39% | 10.32% | 10.32% | 10.32% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,147 | $ 6,230 | ||||||||||||
Investment, interest rate | 13% | 13% | 13% | 13.04% | 13.04% | 13.04% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,270 | $ 2,478 | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | 9.43% | 9.43% | 9.43% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,853 | $ 2,860 | ||||||||||||
Investment, interest rate | 11.91% | 11.91% | 11.91% | 11.81% | 11.81% | 11.81% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,895 | |||||||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,993 | $ 2,993 | ||||||||||||
Investment, interest rate | 10.45% | 10.45% | 10.45% | 10.42% | 10.42% | 10.42% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 905 | $ 907 | ||||||||||||
Investment, interest rate | 9.36% | 9.36% | 9.36% | 9.40% | 9.40% | 9.40% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,078 | $ 2,078 | ||||||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 993 | $ 1,980 | ||||||||||||
Investment, interest rate | 9.71% | 9.71% | 9.71% | 9.42% | 9.42% | 9.42% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,773 | $ 995 | ||||||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.67% | 9.67% | 9.67% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,423 | |||||||||||||
Investment, interest rate | 10.68% | 10.68% | 10.68% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,664 | $ 3,628 | ||||||||||||
Investment, interest rate | 8.45% | 8.45% | 8.45% | 11.49% | 11.49% | 11.49% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,355 | $ 3,363 | ||||||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 798 | $ 800 | ||||||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,995 | |||||||||||||
Investment, interest rate | 8.71% | 8.71% | 8.71% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,759 | $ 2,766 | ||||||||||||
Investment, interest rate | 10.35% | 10.35% | 10.35% | 10.39% | 10.39% | 10.39% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,834 | $ 2,841 | ||||||||||||
Investment, interest rate | 9.85% | 9.85% | 9.85% | 9.89% | 9.89% | 9.89% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,361 | $ 2,970 | ||||||||||||
Investment, interest rate | 10.13% | 10.13% | 10.13% | 10.12% | 10.12% | 10.12% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,171 | $ 2,460 | ||||||||||||
Investment, interest rate | 10.65% | 10.65% | 10.65% | 10.43% | 10.43% | 10.43% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,496 | |||||||||||||
Investment, interest rate | 9.60% | 9.60% | 9.60% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 27,867 | $ 28,396 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,496 | |||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,920 | $ 3,930 | ||||||||||||
Investment, interest rate | 10.66% | 10.66% | 10.66% | 10.57% | 10.57% | 10.57% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,950 | $ 3,960 | ||||||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,219 | $ 2,250 | ||||||||||||
Investment, interest rate | 11.36% | 11.36% | 11.36% | 11.40% | 11.40% | 11.40% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,900 | $ 3,910 | ||||||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,560 | $ 4,500 | ||||||||||||
Investment, interest rate | 10.36% | 10.36% | 10.36% | 10.32% | 10.32% | 10.32% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,147 | $ 6,230 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,920 | $ 3,930 | ||||||||||||
Investment, interest rate | 11.41% | 11.41% | 11.41% | 11.32% | 11.32% | 11.32% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,625 | $ 1,630 | ||||||||||||
Investment, interest rate | 10.95% | 10.95% | 10.95% | 10.99% | 10.99% | 10.99% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,198 | |||||||||||||
Investment, interest rate | 10.15% | 10.15% | 10.15% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,839 | $ 3,849 | ||||||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.43% | 9.43% | 9.43% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 997 | |||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,000 | |||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 681 | $ 683 | ||||||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | 9.65% | 9.65% | 9.65% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,842 | $ 2,842 | ||||||||||||
Investment, interest rate | 12.70% | 12.70% | 12.70% | 12.74% | 12.74% | 12.74% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 281 | $ 226 | ||||||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,182 | $ 5,182 | ||||||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,495 | |||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,012 | $ 6,029 | ||||||||||||
Investment, interest rate | 10.63% | 10.63% | 10.63% | 10.88% | 10.88% | 10.88% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 117 | $ 103 | ||||||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.86% | 10.86% | 10.86% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,228 | $ 5,227 | ||||||||||||
Investment, interest rate | 9.96% | 9.96% | 9.96% | 9.92% | 9.92% | 9.92% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,283 | $ 3,292 | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | 9.43% | 9.43% | 9.43% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,900 | $ 4,913 | ||||||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,000 | $ 4,000 | ||||||||||||
Investment, interest rate | 9.35% | 9.35% | 9.35% | 9.33% | 9.33% | 9.33% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,634 | $ 2,641 | ||||||||||||
Investment, interest rate | 9.95% | 9.95% | 9.95% | 9.99% | 9.99% | 9.99% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,986 | $ 2,993 | ||||||||||||
Investment, interest rate | 11.48% | 11.48% | 11.48% | 11.42% | 11.42% | 11.42% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,496 | |||||||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 983 | |||||||||||||
Investment, interest rate | 9.27% | 9.27% | 9.27% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,035 | $ 3,843 | ||||||||||||
Investment, interest rate | 11.71% | 11.71% | 11.71% | 11.67% | 11.67% | 11.67% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,965 | $ 1,772 | ||||||||||||
Investment, interest rate | 8.61% | 8.61% | 8.61% | 8.57% | 8.57% | 8.57% | ||||||||
Glick JV LLC | Senior Secured Loans | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 130,946 | $ 130,589 | ||||||||||||
Glick JV LLC | Weighted Average | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, interest rate | 10.58% | 10.58% | 10.58% | 10.77% | 10.77% | 10.77% | ||||||||
[1] As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC. |
Portfolio Investments - Portf_3
Portfolio Investments - Portfolio Listing (Details) € in Thousands, £ in Thousands, $ in Thousands | Dec. 31, 2023 USD ($) shares | Dec. 31, 2023 EUR (€) shares | Dec. 31, 2023 GBP (£) shares | Sep. 30, 2023 USD ($) shares | Sep. 30, 2023 EUR (€) shares | Sep. 30, 2023 GBP (£) shares | Dec. 31, 2022 USD ($) shares | Sep. 30, 2022 USD ($) | |||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | $ 3,187,750 | $ 3,044,119 | |||||||||||||
Investments at fair value | $ 3,018,552 | $ 2,892,420 | |||||||||||||
Minimum | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Debt instrument, floor interest rate | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||
Maximum | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Debt instrument, floor interest rate | 2.75% | 2.75% | 2.75% | 2.75% | 2.75% | 2.75% | |||||||||
SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | $ 334,754 | $ 332,637 | |||||||||||||
Investment owned, at cost | 334,451 | 331,808 | |||||||||||||
Investments at fair value | $ 325,769 | $ 322,179 | |||||||||||||
SLF JV I | Minimum | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Debt instrument, floor interest rate | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||
SLF JV I | Maximum | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Debt instrument, floor interest rate | 1% | 1% | 1% | 1% | 1% | 1% | |||||||||
OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | $ 130,946 | $ 130,589 | |||||||||||||
Investment owned, at cost | 128,333 | 127,788 | |||||||||||||
Investments at fair value | $ 124,492 | $ 123,343 | |||||||||||||
OCSI Glick JV LLC | Minimum | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Debt instrument, floor interest rate | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||
OCSI Glick JV LLC | Maximum | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Debt instrument, floor interest rate | 1% | 1% | 1% | 1% | 1% | 1% | |||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 12.50% | [1],[2],[3],[4],[5] | 12.50% | [1],[2],[3],[4],[5] | 12.50% | [1],[2],[3],[4],[5] | 12.50% | [6],[7],[8],[9],[10] | 12.50% | [6],[7],[8],[9],[10] | 12.50% | [6],[7],[8],[9],[10] | |||
Investment, principal | $ 1,269 | [1],[2],[3],[11] | $ 1,269 | [6],[7],[9],[12] | |||||||||||
Investment owned, at cost | 1,251 | [1],[2],[3] | 1,240 | [6],[7],[9] | |||||||||||
Investments at fair value | $ 1,228 | [1],[2],[3] | $ 1,214 | [6],[7],[9] | |||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11% | [1],[2],[4],[5] | 11% | [1],[2],[4],[5] | 11% | [1],[2],[4],[5] | 11% | [6],[8],[9],[10] | 11% | [6],[8],[9],[10] | 11% | [6],[8],[9],[10] | |||
Investment, principal | $ 18,869 | [1],[2],[11] | $ 18,869 | [6],[9],[12] | |||||||||||
Investment owned, at cost | 18,691 | [1],[2] | 18,687 | [6],[9] | |||||||||||
Investments at fair value | $ 18,443 | [1],[2] | $ 18,443 | [6],[9] | |||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 12% | [1],[2],[3],[4],[5] | 12% | [1],[2],[3],[4],[5] | 12% | [1],[2],[3],[4],[5] | 12% | [6],[7],[8],[9],[10] | 12% | [6],[7],[8],[9],[10] | 12% | [6],[7],[8],[9],[10] | |||
Investment, principal | $ 4,274 | [1],[2],[3],[11] | $ 4,070 | [6],[7],[9],[12] | |||||||||||
Investment owned, at cost | 4,256 | [1],[2],[3] | 4,038 | [6],[7],[9] | |||||||||||
Investments at fair value | $ 4,210 | [1],[2],[3] | $ 4,022 | [6],[7],[9] | |||||||||||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 14.25% | [1],[4],[5],[13],[14] | 14.25% | [1],[4],[5],[13],[14] | 14.25% | [1],[4],[5],[13],[14] | 14.25% | [8],[9],[10],[15],[16] | 14.25% | [8],[9],[10],[15],[16] | 14.25% | [8],[9],[10],[15],[16] | |||
Investment, principal | $ 21,434 | [1],[11],[13],[14] | $ 21,434 | [9],[12],[15],[16] | |||||||||||
Investment owned, at cost | 21,604 | [1],[13],[14] | 21,612 | [9],[15],[16] | |||||||||||
Investments at fair value | $ 21,273 | [1],[13],[14] | $ 21,220 | [9],[15],[16] | |||||||||||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate, paid in kind | 22.50% | [1],[13] | 22.50% | [1],[13] | 22.50% | [1],[13] | 20% | [9],[15] | 20% | [9],[15] | 20% | [9],[15] | |||
Investment, principal | $ 6,329 | [1],[11],[13] | $ 6,021 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 6,295 | [1],[13] | 6,013 | [9],[15] | |||||||||||
Investments at fair value | $ 6,219 | [1],[13] | $ 5,900 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 12.11% | [1],[4],[5] | 12.11% | [1],[4],[5] | 12.11% | [1],[4],[5] | 11.90% | [8],[9],[10] | 11.90% | [8],[9],[10] | 11.90% | [8],[9],[10] | |||
Investment, principal | $ 3,373 | [1],[5],[11] | $ 3,446 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 3,343 | [1],[5] | 3,411 | [8],[9] | |||||||||||
Investments at fair value | $ 3,295 | [1],[5] | $ 3,383 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 12.14% | [1],[4],[5] | 12.14% | [1],[4],[5] | 12.14% | [1],[4],[5] | 12.15% | [8],[9],[10] | 12.15% | [8],[9],[10] | 12.15% | [8],[9],[10] | |||
Investment, principal | $ 944 | [1],[5],[11] | $ 17,901 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 931 | [1],[5] | 17,743 | [8],[9] | |||||||||||
Investments at fair value | $ 922 | [1],[5] | $ 17,575 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 12.11% | [1],[4],[5] | 12.11% | [1],[4],[5] | 12.11% | [1],[4],[5] | 12.13% | [8],[9],[10] | 12.13% | [8],[9],[10] | 12.13% | [8],[9],[10] | |||
Investment, principal | $ 17,532 | [1],[5],[11] | $ 963 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 17,394 | [1],[5] | 948 | [8],[9] | |||||||||||
Investments at fair value | $ 17,130 | [1],[5] | $ 945 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 11.90% | 11.90% | 11.90% | |||||||||
Investment, principal | $ 1,124 | $ 1,149 | |||||||||||||
Investment owned, at cost | 1,112 | 1,135 | |||||||||||||
Investments at fair value | $ 1,098 | $ 1,128 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 11.90% | 11.90% | 11.90% | |||||||||
Investment, principal | $ 562 | $ 574 | |||||||||||||
Investment owned, at cost | 557 | 568 | |||||||||||||
Investments at fair value | $ 549 | $ 564 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 12.15% | 12.15% | 12.15% | |||||||||
Investment, principal | $ 6,631 | $ 6,771 | |||||||||||||
Investment owned, at cost | 6,571 | 6,701 | |||||||||||||
Investments at fair value | $ 6,479 | $ 6,648 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 12.15% | 12.15% | 12.15% | |||||||||
Investment, principal | $ 3,669 | $ 3,746 | |||||||||||||
Investment owned, at cost | 3,637 | 3,709 | |||||||||||||
Investments at fair value | $ 3,585 | $ 3,678 | |||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[5],[13] | 7.50% | [1],[5],[13] | 7.50% | [1],[5],[13] | 7.50% | [8],[9],[15] | 7.50% | [8],[9],[15] | 7.50% | [8],[9],[15] | |||
Investment, interest rate | [8],[9],[10],[15] | 13.04% | 13.04% | 13.04% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11],[13] | $ 6,589 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | (38) | [1],[2],[5],[13] | 6,305 | [8],[9],[15] | |||||||||||
Investments at fair value | $ (38) | [1],[2],[5],[13] | $ 6,276 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[5],[13] | 7.50% | [1],[5],[13] | 7.50% | [1],[5],[13] | 7.50% | [6],[8],[9],[15] | 7.50% | [6],[8],[9],[15] | 7.50% | [6],[8],[9],[15] | |||
Investment, interest rate | [4],[5] | 13% | 13% | 13% | |||||||||||
Investment, principal | $ 6,589 | [1],[5],[11],[13] | $ 0 | [6],[8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 6,317 | [1],[5],[13] | (38) | [6],[8],[9],[15] | |||||||||||
Investments at fair value | $ 6,276 | [1],[5],[13] | $ (38) | [6],[8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 28,948 | [1],[13] | 28,948 | [1],[13] | 28,948 | [1],[13] | 28,948 | [9],[15] | 28,948 | [9],[15] | 28,948 | [9],[15] | |||
Investment owned, at cost | $ 174 | [1],[13] | $ 174 | [9],[15] | |||||||||||
Investments at fair value | $ 13 | [1],[13] | $ 6 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[15] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [8],[10],[15] | 8.86% | 8.86% | 8.86% | |||||||||||
Investment, principal | € | [8],[12],[15] | € 5,500 | |||||||||||||
Investment owned, at cost | [8],[15] | $ 6,024 | |||||||||||||
Investments at fair value | [8],[15] | $ 5,825 | |||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 17,870 | [1] | 17,870 | [1] | 17,870 | [1] | 17,870 | [9] | 17,870 | [9] | 17,870 | [9] | |||
Investment owned, at cost | $ 1,733 | [1] | $ 1,733 | [9] | |||||||||||
Investments at fair value | $ 2,494 | [1] | $ 2,826 | [9] | |||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [1],[5] | 7.75% | [1],[5] | 7.75% | [1],[5] | 7.75% | [8],[9] | 7.75% | [8],[9] | 7.75% | [8],[9] | |||
Investment, interest rate | 13.21% | [1],[4],[5] | 13.21% | [1],[4],[5] | 13.21% | [1],[4],[5] | 13.17% | [8],[9],[10] | 13.17% | [8],[9],[10] | 13.17% | [8],[9],[10] | |||
Investment, principal | $ 16,032 | [1],[5],[11] | $ 17,873 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 15,844 | [1],[5] | 17,655 | [8],[9] | |||||||||||
Investments at fair value | $ 15,743 | [1],[5] | $ 17,687 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investment owned, at cost | (7) | (7) | |||||||||||||
Investments at fair value | $ (30) | $ (29) | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investment owned, at cost | (3) | (3) | |||||||||||||
Investments at fair value | $ (12) | $ (12) | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.64% | 11.64% | 11.64% | 11.63% | 11.63% | 11.63% | |||||||||
Investment, principal | $ 4,124 | $ 4,134 | |||||||||||||
Investment owned, at cost | 4,069 | 4,076 | |||||||||||||
Investments at fair value | $ 3,876 | $ 3,892 | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.64% | 11.64% | 11.64% | 11.63% | 11.63% | 11.63% | |||||||||
Investment, principal | $ 1,712 | $ 1,716 | |||||||||||||
Investment owned, at cost | 1,689 | 1,692 | |||||||||||||
Investments at fair value | $ 1,609 | $ 1,616 | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5],[13] | 6% | [1],[2],[5],[13] | 6% | [1],[2],[5],[13] | 6% | [6],[8],[9],[15] | 6% | [6],[8],[9],[15] | 6% | [6],[8],[9],[15] | |||
Investment, principal | $ 0 | [1],[2],[5],[11],[13] | $ 0 | [6],[8],[9],[12],[15] | |||||||||||
Investment owned, at cost | (12) | [1],[2],[5],[13] | (13) | [6],[8],[9],[15] | |||||||||||
Investments at fair value | $ (24) | [1],[2],[5],[13] | $ (23) | [6],[8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5],[13] | 6% | [1],[5],[13] | 6% | [1],[5],[13] | 6% | [8],[9],[15] | 6% | [8],[9],[15] | 6% | [8],[9],[15] | |||
Investment, interest rate | 11.64% | [4],[5] | 11.64% | [4],[5] | 11.64% | [4],[5] | 11.63% | [8],[9],[10],[15] | 11.63% | [8],[9],[10],[15] | 11.63% | [8],[9],[10],[15] | |||
Investment, principal | $ 3,268 | [1],[5],[11],[13] | $ 3,276 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 3,259 | [1],[5],[13] | 3,267 | [8],[9],[15] | |||||||||||
Investments at fair value | 3,072 | [1],[5],[13] | 3,084 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 12,583 | [1],[11],[13],[14] | 12,222 | [9],[12],[15],[16] | |||||||||||
Investment owned, at cost | 12,618 | [1],[13],[14] | 12,260 | [9],[15],[16] | |||||||||||
Investments at fair value | $ 12,268 | [1],[13],[14] | $ 11,795 | [9],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 12.11% | 12.11% | 12.11% | 10.32% | 10.32% | 10.32% | |||||||||
Investment, principal | $ 8,575 | $ 8,596 | |||||||||||||
Investment owned, at cost | 8,486 | 8,503 | |||||||||||||
Investments at fair value | $ 8,600 | $ 8,499 | |||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.39% | 10.39% | 10.39% | 10.32% | 10.32% | 10.32% | |||||||||
Investment, principal | $ 1,995 | $ 2,000 | |||||||||||||
Investment owned, at cost | 1,957 | 1,960 | |||||||||||||
Investments at fair value | $ 2,001 | $ 1,978 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | |||
Investment, interest rate | 11.52% | [1],[2],[4],[5] | 11.52% | [1],[2],[4],[5] | 11.52% | [1],[2],[4],[5] | 11.55% | [6],[8],[9],[10] | 11.55% | [6],[8],[9],[10] | 11.55% | [6],[8],[9],[10] | |||
Investment, principal | $ 2,033 | [1],[2],[5],[11] | $ 2,033 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 2,015 | [1],[2],[5] | 2,013 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 2,027 | [1],[2],[5] | $ 2,027 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | [8],[9],[10] | 11.55% | 11.55% | 11.55% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 20,234 | [8],[9],[12] | |||||||||||
Investment owned, at cost | (2) | [1],[2],[5] | 20,150 | [8],[9] | |||||||||||
Investments at fair value | $ (8) | [1],[2],[5] | $ 20,194 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | |||
Investment, interest rate | 11.52% | [1],[4],[5] | 11.52% | [1],[4],[5] | 11.52% | [1],[4],[5] | [6],[8],[9],[10] | [6],[8],[9],[10] | [6],[8],[9],[10] | ||||||
Investment, principal | $ 20,182 | [1],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 20,107 | [1],[5] | (2) | [6],[8],[9] | |||||||||||
Investments at fair value | $ 20,141 | [1],[5] | $ (8) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | |||
Investment, interest rate | 12.72% | [1],[2],[4],[5] | 12.72% | [1],[2],[4],[5] | 12.72% | [1],[2],[4],[5] | 12.72% | [6],[8],[9],[10] | 12.72% | [6],[8],[9],[10] | 12.72% | [6],[8],[9],[10] | |||
Investment, principal | $ 1,333 | [1],[2],[5],[11] | $ 1,333 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 1,324 | [1],[2],[5] | 1,322 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 1,333 | [1],[2],[5] | $ 1,324 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate | 12.74% | [1],[4],[5] | 12.74% | [1],[4],[5] | 12.74% | [1],[4],[5] | 12.34% | [8],[9],[10] | 12.34% | [8],[9],[10] | 12.34% | [8],[9],[10] | |||
Investment, principal | $ 6,400 | [1],[5],[11] | $ 6,400 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 6,343 | [1],[5] | 6,335 | [8],[9] | |||||||||||
Investments at fair value | $ 6,406 | [1],[5] | $ 6,380 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate | 12.74% | [1],[2],[4],[5] | 12.74% | [1],[2],[4],[5] | 12.74% | [1],[2],[4],[5] | 12.34% | [8],[9],[10] | 12.34% | [8],[9],[10] | 12.34% | [8],[9],[10] | |||
Investment, principal | $ 25,332 | [1],[2],[5],[11] | $ 25,332 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 25,293 | [1],[2],[5] | 25,288 | [8],[9] | |||||||||||
Investments at fair value | $ 25,357 | [1],[2],[5] | $ 25,253 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 5,715 | [1] | 5,715 | [1] | 5,715 | [1] | 5,715 | [9] | 5,715 | [9] | 5,715 | [9] | |||
Investment owned, at cost | $ 90 | [1] | $ 90 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[5],[17] | 8.50% | [1],[5],[17] | 8.50% | [1],[5],[17] | 8.50% | [8],[9],[18] | 8.50% | [8],[9],[18] | 8.50% | [8],[9],[18] | |||
Investment, principal | $ 23,562 | [1],[5],[11],[17] | $ 23,562 | [8],[9],[12],[18] | |||||||||||
Investment owned, at cost | 22,795 | [1],[5],[17] | 22,795 | [8],[9],[18] | |||||||||||
Investments at fair value | $ 9,797 | [1],[5],[17] | $ 9,797 | [8],[9],[18] | |||||||||||
Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.64% | 9.64% | 9.64% | 9.63% | 9.63% | 9.63% | |||||||||
Investment, principal | $ 1,786 | $ 2,969 | |||||||||||||
Investment owned, at cost | 1,722 | 2,853 | |||||||||||||
Investments at fair value | $ 1,670 | $ 2,810 | |||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 5.50% | [4],[5],[13] | 5.50% | [4],[5],[13] | 5.50% | [4],[5],[13] | 5.50% | [8],[10],[15] | 5.50% | [8],[10],[15] | 5.50% | [8],[10],[15] | |||
Investment, principal | $ 4,050 | [11],[13] | $ 4,050 | [12],[15] | |||||||||||
Investment owned, at cost | 3,592 | [13] | 3,577 | [15] | |||||||||||
Investments at fair value | $ 3,181 | [13] | $ 2,918 | [15] | |||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 11.50% | [1],[5] | 11.50% | [1],[5] | 11.50% | [1],[5] | 11.50% | [8],[9] | 11.50% | [8],[9] | 11.50% | [8],[9] | |||
Investment, interest rate | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 5% | [8],[9],[10] | 5% | [8],[9],[10] | 5% | [8],[9],[10] | |||
Investment, interest rate, paid in kind | 11.95% | [1],[5] | 11.95% | [1],[5] | 11.95% | [1],[5] | 11.99% | [8],[9] | 11.99% | [8],[9] | 11.99% | [8],[9] | |||
Investment, principal | $ 9,331 | [1],[5],[11] | $ 9,057 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 8,748 | [1],[5] | 8,434 | [8],[9] | |||||||||||
Investments at fair value | $ 8,585 | [1],[5] | $ 8,332 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 598,283 | 598,283 | 598,283 | 598,283 | [9] | 598,283 | [9] | 598,283 | [9] | ||||||
Investment owned, at cost | $ 642 | [1],[5] | $ 642 | [9] | |||||||||||
Investments at fair value | $ 1,562 | [1],[5] | $ 1,915 | [9] | |||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | 7.50% | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||
Investment, interest rate | 13% | 13% | 13% | 13.04% | 13.04% | 13.04% | |||||||||
Investment, principal | $ 8,681 | $ 8,798 | |||||||||||||
Investment owned, at cost | 8,629 | 8,737 | |||||||||||||
Investments at fair value | $ 8,117 | $ 8,218 | |||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | 7.50% | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||
Investment, interest rate | 13% | 13% | 13% | 13.04% | 13.04% | 13.04% | |||||||||
Investment, principal | $ 6,147 | $ 6,230 | |||||||||||||
Investment owned, at cost | 6,110 | 6,185 | |||||||||||||
Investments at fair value | $ 5,747 | $ 5,819 | |||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [8],[9] | 7.50% | [8],[9] | 7.50% | [8],[9] | |||
Investment, interest rate | 13% | [1],[4],[5] | 13% | [1],[4],[5] | 13% | [1],[4],[5] | 13.04% | [8],[9],[10] | 13.04% | [8],[9],[10] | 13.04% | [8],[9],[10] | |||
Investment, principal | $ 16,825 | [1],[5],[11] | $ 17,053 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 16,766 | [1],[5] | 16,982 | [8],[9] | |||||||||||
Investments at fair value | $ 15,732 | [1],[5] | $ 15,929 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 382,275 | [13] | 382,275 | [13] | 382,275 | [13] | 471,253 | [15] | 471,253 | [15] | 471,253 | [15] | |||
Investment owned, at cost | $ 689 | [13] | $ 849 | [15] | |||||||||||
Investments at fair value | $ 4,389 | [13] | $ 4,298 | [15] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 141,640 | [1],[13],[19] | 141,640 | [1],[13],[19] | 141,640 | [1],[13],[19] | 141,640 | [9],[15],[20] | 141,640 | [9],[15],[20] | 141,640 | [9],[15],[20] | |||
Investment owned, at cost | $ 566 | [1],[13],[19] | $ 566 | [9],[15],[20] | |||||||||||
Investments at fair value | $ 446 | [1],[13],[19] | $ 368 | [9],[15],[20] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [9],[15] | 3.50% | [9],[15] | 3.50% | [9],[15] | |||
Investment, principal | $ 28,964 | [1],[11],[13] | $ 28,464 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 28,838 | [1],[13] | 28,329 | [9],[15] | |||||||||||
Investments at fair value | $ 28,167 | [1],[13] | $ 27,687 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [9],[15] | 3.50% | [9],[15] | 3.50% | [9],[15] | |||
Investment, principal | $ 28,178 | [1],[11],[13] | $ 2,121 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 28,076 | [1],[13] | 1,945 | [9],[15] | |||||||||||
Investments at fair value | $ 27,403 | [1],[13] | $ 2,063 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [9],[15] | 3.50% | [9],[15] | 3.50% | [9],[15] | |||
Investment, principal | $ 2,159 | [1],[11],[13] | $ 27,692 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 1,982 | [1],[13] | 27,582 | [9],[15] | |||||||||||
Investments at fair value | $ 2,099 | [1],[13] | $ 26,936 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [1],[4],[5],[13] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | 8.50% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [1],[13] | 3.50% | [9],[15] | 3.50% | [9],[15] | 3.50% | [9],[15] | |||
Investment, principal | $ 2,100 | [1],[11],[13] | $ 2,064 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 1,927 | [1],[13] | 1,891 | [9],[15] | |||||||||||
Investments at fair value | $ 2,042 | [1],[13] | $ 2,007 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [8],[9],[10] | 14.14% | 14.14% | 14.14% | |||||||||||
Investment, principal | [8],[9],[12] | $ 17,048 | |||||||||||||
Investment owned, at cost | [8],[9] | 16,440 | |||||||||||||
Investments at fair value | [8],[9] | $ 15,087 | |||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [1],[4],[5] | 14.25% | 14.25% | 14.25% | |||||||||||
Investment, principal | [1],[5],[11] | $ 17,048 | |||||||||||||
Investment owned, at cost | [1],[5] | 16,469 | |||||||||||||
Investments at fair value | [1],[5] | $ 15,940 | |||||||||||||
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.43% | 9.43% | 9.43% | ||||||||||||
Investment, principal | $ 4,957 | ||||||||||||||
Investment owned, at cost | 4,734 | ||||||||||||||
Investments at fair value | $ 4,614 | ||||||||||||||
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | 9.43% | 9.43% | 9.43% | |||||||||
Investment, principal | $ 3,270 | $ 2,478 | |||||||||||||
Investment owned, at cost | 3,111 | 2,367 | |||||||||||||
Investments at fair value | $ 3,100 | $ 2,307 | |||||||||||||
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | ||||||||||||
Investment, principal | $ 1,596 | ||||||||||||||
Investment owned, at cost | 1,488 | ||||||||||||||
Investments at fair value | $ 1,513 | ||||||||||||||
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | ||||||||||||
Investment, principal | $ 4,944 | ||||||||||||||
Investment owned, at cost | 4,734 | ||||||||||||||
Investments at fair value | $ 4,688 | ||||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [5] | 6.25% | [5] | 6.25% | [5] | 6.25% | [8] | 6.25% | [8] | 6.25% | [8] | |||
Investment, interest rate | 11.91% | [4],[5] | 11.91% | [4],[5] | 11.91% | [4],[5] | 11.81% | [8],[10] | 11.81% | [8],[10] | 11.81% | [8],[10] | |||
Investment, principal | $ 14,907 | [5],[11] | $ 19,115 | [8],[12] | |||||||||||
Investment owned, at cost | 14,189 | [5] | 18,278 | [8] | |||||||||||
Investments at fair value | $ 12,548 | [5] | $ 16,798 | [8] | |||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||
Investment, interest rate | 11.91% | 11.91% | 11.91% | 11.81% | 11.81% | 11.81% | |||||||||
Investment, principal | $ 4,811 | $ 4,824 | |||||||||||||
Investment owned, at cost | 4,751 | 4,763 | |||||||||||||
Investments at fair value | $ 4,050 | $ 4,239 | |||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||
Investment, interest rate | 11.91% | 11.91% | 11.91% | 11.81% | 11.81% | 11.81% | |||||||||
Investment, principal | $ 2,853 | $ 2,860 | |||||||||||||
Investment owned, at cost | 2,818 | 2,825 | |||||||||||||
Investments at fair value | $ 2,402 | $ 2,514 | |||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.15% | 4.15% | 4.15% | ||||||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | ||||||||||||
Investment, principal | $ 7,720 | ||||||||||||||
Investment owned, at cost | 7,643 | ||||||||||||||
Investments at fair value | $ 7,720 | ||||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.15% | 4.15% | 4.15% | ||||||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | ||||||||||||
Investment, principal | $ 2,895 | ||||||||||||||
Investment owned, at cost | 2,866 | ||||||||||||||
Investments at fair value | $ 2,895 | ||||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[15] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [8],[10],[15] | 13.54% | 13.54% | 13.54% | |||||||||||
Investment, principal | [8],[12],[15] | $ 12,500 | |||||||||||||
Investment owned, at cost | [8],[15] | 12,188 | |||||||||||||
Investments at fair value | [8],[15] | $ 11,865 | |||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (112) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (113) | |||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [1],[4],[5] | 11.10% | 11.10% | 11.10% | |||||||||||
Investment, principal | [1],[5],[11] | $ 33,558 | |||||||||||||
Investment owned, at cost | [1],[5] | 32,728 | |||||||||||||
Investments at fair value | [1],[5] | $ 32,719 | |||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (60) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (60) | |||||||||||||
Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.45% | 10.45% | 10.45% | 10.42% | 10.42% | 10.42% | |||||||||
Investment, principal | $ 2,993 | $ 2,993 | |||||||||||||
Investment owned, at cost | 2,917 | 2,913 | |||||||||||||
Investments at fair value | $ 3,000 | $ 2,997 | |||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||
Investment, interest rate | 9.36% | 9.36% | 9.36% | 9.40% | 9.40% | 9.40% | |||||||||
Investment, principal | $ 1,519 | $ 1,523 | |||||||||||||
Investment owned, at cost | 1,187 | 1,191 | |||||||||||||
Investments at fair value | $ 929 | $ 1,099 | |||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||
Investment, interest rate | 9.36% | 9.36% | 9.36% | 9.40% | 9.40% | 9.40% | |||||||||
Investment, principal | $ 905 | $ 907 | |||||||||||||
Investment owned, at cost | 703 | 705 | |||||||||||||
Investments at fair value | $ 554 | $ 654 | |||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | [5] | 3.75% | [5] | 3.75% | [5] | 3.75% | [8] | 3.75% | [8] | 3.75% | [8] | |||
Investment, interest rate | 9.36% | [4],[5] | 9.36% | [4],[5] | 9.36% | [4],[5] | 9.40% | [8],[10] | 9.40% | [8],[10] | 9.40% | [8],[10] | |||
Investment, principal | $ 3,691 | [5],[11] | $ 3,700 | [8],[12] | |||||||||||
Investment owned, at cost | 3,059 | [5] | 3,067 | [8] | |||||||||||
Investments at fair value | $ 2,257 | [5] | $ 2,669 | [8] | |||||||||||
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[4],[5] | 10.86% | 10.86% | 10.86% | |||||||||||
Investment, principal | [1],[5],[11] | $ 47,810 | |||||||||||||
Investment owned, at cost | [1],[5] | 47,095 | |||||||||||||
Investments at fair value | [1],[5] | $ 47,093 | |||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 7% | [8],[9],[15] | 7% | [8],[9],[15] | 7% | [8],[9],[15] | |||
Investment, interest rate | 12.71% | [1],[4],[5],[13] | 12.71% | [1],[4],[5],[13] | 12.71% | [1],[4],[5],[13] | 10.95% | [8],[9],[10],[15] | 10.95% | [8],[9],[10],[15] | 10.95% | [8],[9],[10],[15] | |||
Investment, principal | € | € 4,949 | [1],[5],[11],[13] | € 3,017 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | $ 6,253 | [1],[5],[13] | $ 3,331 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 6,372 | [1],[5],[13] | $ 3,226 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5],[13] | 6% | [1],[5],[13] | 6% | [1],[5],[13] | 5.75% | [8],[9],[15] | 5.75% | [8],[9],[15] | 5.75% | [8],[9],[15] | |||
Investment, interest rate | 11.82% | [1],[4],[5],[13] | 11.82% | [1],[4],[5],[13] | 11.82% | [1],[4],[5],[13] | 11.57% | [8],[9],[10],[15] | 11.57% | [8],[9],[10],[15] | 11.57% | [8],[9],[10],[15] | |||
Investment, principal | $ 10,519 | [1],[5],[11],[13] | $ 10,519 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 10,411 | [1],[5],[13] | 10,400 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 10,624 | [1],[5],[13] | $ 10,624 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5],[13] | 6% | [1],[5],[13] | 6% | [1],[5],[13] | 7% | [8],[9],[15] | 7% | [8],[9],[15] | 7% | [8],[9],[15] | |||
Investment, interest rate | 9.95% | [1],[4],[5],[13] | 9.95% | [1],[4],[5],[13] | 9.95% | [1],[4],[5],[13] | 12.46% | [8],[9],[10],[15] | 12.46% | [8],[9],[10],[15] | 12.46% | [8],[9],[10],[15] | |||
Investment, principal | £ | £ 3,649 | [1],[5],[11],[13] | £ 4,949 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | $ 4,094 | [1],[5],[13] | $ 6,318 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 4,083 | [1],[5],[13] | $ 6,101 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 7% | [8],[9],[15] | 7% | [8],[9],[15] | 7% | [8],[9],[15] | |||
Investment, interest rate | 11.20% | [1],[4],[5],[13] | 11.20% | [1],[4],[5],[13] | 11.20% | [1],[4],[5],[13] | 12.46% | [8],[9],[10],[15] | 12.46% | [8],[9],[10],[15] | 12.46% | [8],[9],[10],[15] | |||
Investment, principal | £ | £ 3,017 | [1],[5],[11],[13] | £ 23,675 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | $ 3,319 | [1],[5],[13] | $ 28,713 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 3,366 | [1],[5],[13] | $ 29,185 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 5.75% | [8],[9],[15] | 5.75% | [8],[9],[15] | 5.75% | [8],[9],[15] | |||
Investment, interest rate | 12.71% | [1],[4],[5],[13] | 12.71% | [1],[4],[5],[13] | 12.71% | [1],[4],[5],[13] | 9.70% | [8],[9],[10],[15] | 9.70% | [8],[9],[10],[15] | 9.70% | [8],[9],[10],[15] | |||
Investment, principal | £ | £ 23,675 | [1],[5],[11],[13] | £ 3,649 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | $ 28,395 | [1],[5],[13] | $ 4,094 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 30,482 | [1],[5],[13] | $ 3,914 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 12,463,242 | [1] | 12,463,242 | [1] | 12,463,242 | [1] | 1,783,332 | [9] | 1,783,332 | [9] | 1,783,332 | [9] | 1,609,201 | ||
Investment owned, at cost | $ 1,963 | [1] | $ 804 | [9] | |||||||||||
Investments at fair value | 997 | [1] | $ 89 | [9] | $ 354 | $ 370 | |||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [6],[8],[9] | 6.75% | [6],[8],[9] | 6.75% | [6],[8],[9] | 6.75% | ||||||||
Investment, interest rate | 12.14% | [6],[8],[9],[10] | 12.14% | [6],[8],[9],[10] | 12.14% | [6],[8],[9],[10] | 11.48% | ||||||||
Investment, principal | $ 21,852 | [6],[8],[9],[12] | $ 21,464 | ||||||||||||
Investment owned, at cost | [6],[8],[9] | 21,855 | |||||||||||||
Investments at fair value | 0 | $ 21,823 | [6],[8],[9] | $ 21,252 | 24,225 | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | [9] | 1,129,453 | [9] | 1,129,453 | [9] | 1,019,169 | ||||||||
Investment owned, at cost | [9] | $ 1,159 | |||||||||||||
Investments at fair value | $ 0 | $ 1,005 | [9] | $ 1,243 | 1,223 | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | [1] | 78,045 | [1] | 78,045 | [1] | 78,045 | [9] | 78,045 | [9] | 78,045 | [9] | 70,425 | ||
Investment owned, at cost | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | $ 0 | 0 | |||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [5] | 5.25% | [5] | 5.25% | [5] | 5.25% | [8] | 5.25% | [8] | 5.25% | [8] | |||
Investment, interest rate | 10.86% | [4],[5] | 10.86% | [4],[5] | 10.86% | [4],[5] | 10.90% | [8],[10] | 10.90% | [8],[10] | 10.90% | [8],[10] | |||
Investment, principal | $ 15,688 | [5],[11] | $ 8,490 | [8],[12] | |||||||||||
Investment owned, at cost | 13,112 | [5] | 8,168 | [8] | |||||||||||
Investments at fair value | $ 10,230 | [5] | $ 6,414 | [8] | |||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | |||||||||
Investment, principal | $ 5,052 | $ 5,052 | |||||||||||||
Investment owned, at cost | 4,895 | 4,888 | |||||||||||||
Investments at fair value | $ 3,294 | $ 3,817 | |||||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | |||||||||
Investment, principal | $ 2,078 | $ 2,078 | |||||||||||||
Investment owned, at cost | 2,040 | 2,039 | |||||||||||||
Investments at fair value | $ 1,355 | $ 1,570 | |||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.42% | 9.42% | 9.42% | |||||||||
Investment, principal | $ 5,920 | $ 4,950 | |||||||||||||
Investment owned, at cost | 5,734 | 4,747 | |||||||||||||
Investments at fair value | $ 5,904 | $ 4,809 | |||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.71% | 9.71% | 9.71% | 9.42% | 9.42% | 9.42% | |||||||||
Investment, principal | $ 993 | $ 1,980 | |||||||||||||
Investment owned, at cost | 942 | 1,899 | |||||||||||||
Investments at fair value | $ 990 | $ 1,924 | |||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4.25% | 4.25% | 4.25% | |||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.67% | 9.67% | 9.67% | |||||||||
Investment, principal | $ 613 | $ 1,990 | |||||||||||||
Investment owned, at cost | 589 | 1,884 | |||||||||||||
Investments at fair value | $ 612 | $ 1,937 | |||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4.25% | 4.25% | 4.25% | |||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.67% | 9.67% | 9.67% | |||||||||
Investment, principal | $ 2,773 | $ 995 | |||||||||||||
Investment owned, at cost | 2,687 | 942 | |||||||||||||
Investments at fair value | $ 2,765 | $ 968 | |||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 3 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 9.71% | 9.71% | 9.71% | ||||||||||||
Investment, principal | $ 1,985 | ||||||||||||||
Investment owned, at cost | 1,884 | ||||||||||||||
Investments at fair value | $ 1,981 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.68% | 10.68% | 10.68% | ||||||||||||
Investment, principal | $ 4,346 | ||||||||||||||
Investment owned, at cost | 4,036 | ||||||||||||||
Investments at fair value | $ 3,871 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.68% | 10.68% | 10.68% | ||||||||||||
Investment, principal | $ 2,423 | ||||||||||||||
Investment owned, at cost | 2,244 | ||||||||||||||
Investments at fair value | $ 2,158 | ||||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5],[13] | 7% | [1],[5],[13] | 7% | [1],[5],[13] | 6% | [8],[9],[15] | 6% | [8],[9],[15] | 6% | [8],[9],[15] | |||
Investment, interest rate | 8.45% | [1],[4],[5],[13] | 8.45% | [1],[4],[5],[13] | 8.45% | [1],[4],[5],[13] | 11.49% | [8],[9],[10],[15] | 11.49% | [8],[9],[10],[15] | 11.49% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 4% | 4% | 4% | ||||||||||||
Investment, principal | $ 29,801 | [1],[5],[11],[13] | $ 29,509 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 29,483 | [1],[5],[13] | 29,164 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 28,311 | [1],[5],[13] | $ 28,284 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | 7% | 7% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 8.45% | 8.45% | 8.45% | 11.49% | 11.49% | 11.49% | |||||||||
Investment, interest rate, paid in kind | 4% | 4% | 4% | ||||||||||||
Investment, principal | $ 6,351 | $ 6,289 | |||||||||||||
Investment owned, at cost | 6,284 | 6,216 | |||||||||||||
Investments at fair value | $ 6,033 | $ 6,028 | |||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | 7% | 7% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 8.45% | 8.45% | 8.45% | 11.49% | 11.49% | 11.49% | |||||||||
Investment, interest rate, paid in kind | 4% | 4% | 4% | ||||||||||||
Investment, principal | $ 3,664 | $ 3,628 | |||||||||||||
Investment owned, at cost | 3,625 | 3,586 | |||||||||||||
Investments at fair value | $ 3,481 | $ 3,478 | |||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[2],[5] | 7.25% | [1],[2],[5] | 7.25% | [1],[2],[5] | 7.25% | [6],[8],[9] | 7.25% | [6],[8],[9] | 7.25% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (102) | [1],[2],[5] | (108) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (63) | [1],[2],[5] | $ (78) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [8],[9] | 7.25% | [8],[9] | 7.25% | [8],[9] | |||
Investment, interest rate | 12.60% | [4],[5] | 12.60% | [4],[5] | 12.60% | [4],[5] | 12.64% | [8],[9],[10] | 12.64% | [8],[9],[10] | 12.64% | [8],[9],[10] | |||
Investment, principal | $ 50,470 | [1],[5],[11] | $ 50,470 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 49,718 | [1],[5] | 49,679 | [8],[9] | |||||||||||
Investments at fair value | $ 49,839 | [1],[5] | $ 49,688 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | |||||||||
Investment, principal | $ 1,749 | $ 1,753 | |||||||||||||
Investment owned, at cost | 1,737 | 1,742 | |||||||||||||
Investments at fair value | $ 1,684 | $ 1,711 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | |||||||||
Investment, principal | $ 3,355 | $ 3,363 | |||||||||||||
Investment owned, at cost | 3,323 | 3,332 | |||||||||||||
Investments at fair value | $ 3,230 | $ 3,282 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | |||||||||
Investment, principal | $ 6,290 | $ 6,306 | |||||||||||||
Investment owned, at cost | 6,231 | 6,247 | |||||||||||||
Investments at fair value | $ 6,057 | $ 6,155 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | |||||||||
Investment, principal | $ 798 | $ 800 | |||||||||||||
Investment owned, at cost | 793 | 795 | |||||||||||||
Investments at fair value | $ 768 | $ 780 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[5] | 5% | [1],[5] | 5% | [1],[5] | 5% | [8],[9] | 5% | [8],[9] | 5% | [8],[9] | |||
Investment, interest rate | 10.61% | [1],[4],[5] | 10.61% | [1],[4],[5] | 10.61% | [1],[4],[5] | 10.65% | [8],[9],[10] | 10.65% | [8],[9],[10] | 10.65% | [8],[9],[10] | |||
Investment, principal | $ 3,239 | [1],[5],[11] | $ 3,247 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 3,208 | [1],[5] | 3,216 | [8],[9] | |||||||||||
Investments at fair value | $ 3,119 | [1],[5] | $ 3,169 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[5] | 5% | [1],[5] | 5% | [1],[5] | 5% | [8],[9] | 5% | [8],[9] | 5% | [8],[9] | |||
Investment, interest rate | 10.61% | [1],[4],[5] | 10.61% | [1],[4],[5] | 10.61% | [1],[4],[5] | 10.65% | [8],[9],[10] | 10.65% | [8],[9],[10] | 10.65% | [8],[9],[10] | |||
Investment, principal | $ 1,258 | [1],[5],[11] | $ 1,261 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 1,265 | [1],[5] | 1,269 | [8],[9] | |||||||||||
Investments at fair value | $ 1,211 | [1],[5] | $ 1,231 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [8],[9] | 8.50% | [8],[9] | 8.50% | [8],[9] | |||
Investment, interest rate | 14.15% | [1],[4],[5] | 14.15% | [1],[4],[5] | 14.15% | [1],[4],[5] | 14.15% | [8],[9],[10] | 14.15% | [8],[9],[10] | 14.15% | [8],[9],[10] | |||
Investment, principal | $ 2,091 | [1],[5],[11] | $ 8,920 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 2,070 | [1],[5] | 8,819 | [8],[9] | |||||||||||
Investments at fair value | $ 1,842 | [1],[5] | $ 8,492 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [8],[9] | 8.50% | [8],[9] | 8.50% | [8],[9] | |||
Investment, interest rate | 14.11% | [1],[4],[5] | 14.11% | [1],[4],[5] | 14.11% | [1],[4],[5] | 14.15% | [8],[9],[10] | 14.15% | [8],[9],[10] | 14.15% | [8],[9],[10] | |||
Investment, principal | $ 4,361 | [1],[5],[11] | $ 2,091 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 4,298 | [1],[5] | 2,068 | [8],[9] | |||||||||||
Investments at fair value | $ 3,842 | [1],[5] | $ 1,991 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [8],[9] | 8.50% | [8],[9] | 8.50% | [8],[9] | |||
Investment, interest rate | 14.11% | [1],[4],[5] | 14.11% | [1],[4],[5] | 14.11% | [1],[4],[5] | 14.15% | [8],[9],[10] | 14.15% | [8],[9],[10] | 14.15% | [8],[9],[10] | |||
Investment, principal | $ 8,920 | [1],[5],[11] | $ 4,361 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 8,818 | [1],[5] | 4,297 | [8],[9] | |||||||||||
Investments at fair value | $ 7,859 | [1],[5] | $ 4,152 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.25% | 3.25% | 3.25% | ||||||||||||
Investment, interest rate | 8.71% | 8.71% | 8.71% | ||||||||||||
Investment, principal | $ 3,990 | ||||||||||||||
Investment owned, at cost | 3,884 | ||||||||||||||
Investments at fair value | $ 3,957 | ||||||||||||||
Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.25% | 3.25% | 3.25% | ||||||||||||
Investment, interest rate | 8.71% | 8.71% | 8.71% | ||||||||||||
Investment, principal | $ 1,995 | ||||||||||||||
Investment owned, at cost | 1,942 | ||||||||||||||
Investments at fair value | $ 1,979 | ||||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [1],[2],[5] | 4.50% | [1],[2],[5] | 4.50% | [1],[2],[5] | 4.50% | [6],[8],[9] | 4.50% | [6],[8],[9] | 4.50% | [6],[8],[9] | |||
Investment, interest rate | 13% | [1],[2],[4],[5] | 13% | [1],[2],[4],[5] | 13% | [1],[2],[4],[5] | 13% | [6],[8],[9],[10] | 13% | [6],[8],[9],[10] | 13% | [6],[8],[9],[10] | |||
Investment, principal | $ 1,836 | [1],[2],[5],[11] | $ 2,221 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 1,806 | [1],[2],[5] | 2,188 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 1,798 | [1],[2],[5] | $ 2,178 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[5] | 5.50% | [1],[5] | 5.50% | [1],[5] | 5.50% | [8],[9] | 5.50% | [8],[9] | 5.50% | [8],[9] | |||
Investment, interest rate | 11.03% | [1],[4],[5] | 11.03% | [1],[4],[5] | 11.03% | [1],[4],[5] | 11.02% | [8],[9],[10] | 11.02% | [8],[9],[10] | 11.02% | [8],[9],[10] | |||
Investment, principal | $ 40,557 | [1],[5],[11] | $ 40,660 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 40,352 | [1],[5] | 40,440 | [8],[9] | |||||||||||
Investments at fair value | $ 40,070 | [1],[5] | $ 40,213 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5],[13] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[15] | 8% | 8% | 8% | |||||||||||
Investment, interest rate, paid in kind | [9],[15] | 2.25% | 2.25% | 2.25% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11],[13] | $ 6,757 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[5],[13] | 6,560 | [9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[5],[13] | 6,225 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5],[13] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [1],[4],[5],[13] | 12.89% | 12.89% | 12.89% | |||||||||||
Investment, principal | $ 2,815 | [1],[5],[11],[13] | 3,316 | [6],[9],[12],[15],[16] | |||||||||||
Investment owned, at cost | 2,815 | [1],[5],[13] | 3,335 | [6],[9],[15],[16] | |||||||||||
Investments at fair value | $ 2,625 | [1],[5],[13] | $ 3,169 | [6],[9],[15],[16] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8% | [1],[2],[4],[5],[13] | 8% | [1],[2],[4],[5],[13] | 8% | [1],[2],[4],[5],[13] | 8% | [6],[8],[9],[10],[15] | 8% | [6],[8],[9],[10],[15] | 8% | [6],[8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 2.25% | [1],[13] | 2.25% | [1],[13] | 2.25% | [1],[13] | 2.25% | [6],[9],[15] | 2.25% | [6],[9],[15] | 2.25% | [6],[9],[15] | |||
Investment, principal | $ 0 | [1],[2],[11],[13] | $ 0 | [6],[9],[12],[15] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[13] | 0 | [6],[9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[13] | $ 0 | [6],[9],[15] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8% | [1],[2],[4],[5],[13] | 8% | [1],[2],[4],[5],[13] | 8% | [1],[2],[4],[5],[13] | 8% | [6],[8],[9],[10],[15] | 8% | [6],[8],[9],[10],[15] | 8% | [6],[8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 2.25% | [1],[2],[13] | 2.25% | [1],[2],[13] | 2.25% | [1],[2],[13] | 2.25% | [6],[9],[15] | 2.25% | [6],[9],[15] | 2.25% | [6],[9],[15] | |||
Investment, principal | $ 0 | [1],[2],[11],[13] | $ 0 | [6],[9],[12],[15] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[13] | 0 | [6],[9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[13] | 0 | [6],[9],[15] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[4],[5],[13] | 8% | 8% | 8% | |||||||||||
Investment, interest rate, paid in kind | [1],[13] | 2.25% | 2.25% | 2.25% | |||||||||||
Investment, principal | $ 6,785 | [1],[11],[13] | 0 | [6],[9],[12],[15],[16] | |||||||||||
Investment owned, at cost | 6,602 | [1],[13] | 0 | [6],[9],[15],[16] | |||||||||||
Investments at fair value | $ 6,327 | [1],[13] | 0 | [6],[9],[15],[16] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | [6],[9],[12],[15],[16] | 0 | |||||||||||||
Investment owned, at cost | [6],[9],[15],[16] | 0 | |||||||||||||
Investments at fair value | [6],[9],[15],[16] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 32,664 | [1],[13] | 32,664 | [1],[13] | 32,664 | [1],[13] | 26,131 | [9],[15] | 26,131 | [9],[15] | 26,131 | [9],[15] | |||
Investment owned, at cost | $ 225 | [1],[13] | $ 225 | [9],[15] | |||||||||||
Investments at fair value | $ 46 | [1],[13] | $ 3 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [5] | 7% | [5] | 7% | [5] | 7% | [8] | 7% | [8] | 7% | [8] | |||
Investment, interest rate | 12.46% | [4],[5] | 12.46% | [4],[5] | 12.46% | [4],[5] | 12.43% | [8],[10] | 12.43% | [8],[10] | 12.43% | [8],[10] | |||
Investment, principal | $ 30,625 | [5],[11] | $ 30,625 | [8],[12] | |||||||||||
Investment owned, at cost | 30,394 | [5] | 30,370 | [8] | |||||||||||
Investments at fair value | $ 30,319 | [5] | $ 29,989 | [8] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [1] | 394,297 | [1] | 394,297 | [1] | 394,297 | [9] | 394,297 | [9] | 394,297 | [9] | |||
Investment owned, at cost | $ 424 | [1] | $ 424 | [9] | |||||||||||
Investments at fair value | $ 95 | [1] | $ 158 | [9] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 9% | [1],[4],[5] | 9% | [1],[4],[5] | 9% | [1],[4],[5] | 9% | [8],[9],[10] | 9% | [8],[9],[10] | 9% | [8],[9],[10] | |||
Investment, principal | $ 5,257 | [1],[11] | $ 5,257 | [9],[12] | |||||||||||
Investment owned, at cost | 5,263 | [1] | 5,258 | [9] | |||||||||||
Investments at fair value | $ 5,205 | [1] | $ 5,251 | [9] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,708,618 | [1] | 1,708,618 | [1] | 1,708,618 | [1] | 1,708,618 | [9] | 1,708,618 | [9] | 1,708,618 | [9] | |||
Investment owned, at cost | $ 1,711 | [1] | $ 1,711 | [9] | |||||||||||
Investments at fair value | $ 1,982 | [1] | $ 1,999 | [9] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [1] | 394,297 | [1] | 394,297 | [1] | 394,297 | [9] | 394,297 | [9] | 394,297 | [9] | |||
Investment owned, at cost | $ 395 | [1] | $ 395 | [9] | |||||||||||
Investments at fair value | $ 434 | [1] | $ 442 | [9] | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 171 | 171 | 171 | 171 | 171 | 171 | |||||||||
Investment owned, at cost | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 0 | $ 0 | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 829 | [1] | 829 | [1] | 829 | [1] | 829 | [9] | 829 | [9] | 829 | [9] | 829 | ||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | $ 0 | 0 | |||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | [1] | 34,984,460 | [1] | 34,984,460 | [1] | 34,984,460 | [9] | 34,984,460 | [9] | 34,984,460 | [9] | 34,984,460 | ||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | $ 34,984 | [1] | $ 34,984 | [9] | |||||||||||
Investments at fair value | $ 27,638 | [1] | $ 27,638 | [9] | $ 27,638 | 27,638 | |||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 7,193,540 | 7,193,540 | 7,193,540 | 7,193,540 | 7,193,540 | 7,193,540 | |||||||||
Investment owned, at cost | $ 7,194 | $ 7,194 | |||||||||||||
Investments at fair value | $ 5,683 | $ 5,683 | |||||||||||||
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [5],[13] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [4],[5],[13] | 11.29% | 11.29% | 11.29% | |||||||||||
Investment, principal | [5],[11],[13] | $ 16,185 | |||||||||||||
Investment owned, at cost | [5],[13] | 20,053 | |||||||||||||
Investments at fair value | [5],[13] | $ 20,281 | |||||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [1],[5],[17] | 7.75% | [1],[5],[17] | 7.75% | [1],[5],[17] | 7.75% | [8],[9],[18] | 7.75% | [8],[9],[18] | 7.75% | [8],[9],[18] | |||
Investment, principal | $ 727 | [1],[5],[11],[17] | $ 727 | [8],[9],[12],[18] | |||||||||||
Investment owned, at cost | 413 | [1],[5],[17] | 462 | [8],[9],[18] | |||||||||||
Investments at fair value | $ 365 | [1],[5],[17] | $ 396 | [8],[9],[18] | |||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [8],[9],[12] | $ 37 | |||||||||||||
Investment owned, at cost | [8],[9] | 37 | |||||||||||||
Investments at fair value | [8],[9] | $ 37 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [8],[9],[12] | $ 3,031 | |||||||||||||
Investment owned, at cost | [8],[9] | 2,899 | |||||||||||||
Investments at fair value | [8],[9] | $ 3,031 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [8],[9],[12] | $ 1,557 | |||||||||||||
Investment owned, at cost | [8],[9] | 1,489 | |||||||||||||
Investments at fair value | [8],[9] | $ 1,557 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.07% | 12.07% | 12.07% | |||||||||||
Investment, principal | [8],[9],[12] | $ 1,024 | |||||||||||||
Investment owned, at cost | [8],[9] | 994 | |||||||||||||
Investments at fair value | [8],[9] | $ 1,024 | |||||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,398 | [1] | 1,080,398 | [1] | 1,080,398 | [1] | 1,080,399 | [9] | 1,080,399 | [9] | 1,080,399 | [9] | 1,080,399 | ||
Investment owned, at cost | $ 1,079 | [1] | $ 1,080 | [9] | |||||||||||
Investments at fair value | $ 432 | [1] | $ 432 | [9] | $ 324 | 378 | |||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.54% | 11.54% | 11.54% | 11.57% | 11.57% | 11.57% | |||||||||
Investment, principal | $ 600 | $ 600 | |||||||||||||
Investment owned, at cost | 593 | 592 | |||||||||||||
Investments at fair value | $ 543 | $ 581 | |||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.53% | 11.53% | 11.53% | 11.55% | 11.55% | 11.55% | |||||||||
Investment, principal | $ 2,348 | $ 2,354 | |||||||||||||
Investment owned, at cost | 2,318 | 2,322 | |||||||||||||
Investments at fair value | $ 2,125 | $ 2,281 | |||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.53% | 11.53% | 11.53% | 11.55% | 11.55% | 11.55% | |||||||||
Investment, principal | $ 1,978 | $ 1,983 | |||||||||||||
Investment owned, at cost | 1,951 | 1,954 | |||||||||||||
Investments at fair value | $ 1,790 | $ 1,921 | |||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.53% | 11.53% | 11.53% | 11.55% | 11.55% | 11.55% | |||||||||
Investment, principal | $ 1,955 | $ 1,960 | |||||||||||||
Investment owned, at cost | 1,932 | 1,935 | |||||||||||||
Investments at fair value | $ 1,769 | $ 1,899 | |||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 7.50% | [4],[5],[13] | 7.50% | [4],[5],[13] | 7.50% | [4],[5],[13] | 7.50% | [8],[10],[15] | 7.50% | [8],[10],[15] | 7.50% | [8],[10],[15] | |||
Investment, principal | $ 2,632 | [11],[13] | $ 2,632 | [12],[15] | |||||||||||
Investment owned, at cost | 2,632 | [13] | 2,632 | [15] | |||||||||||
Investments at fair value | $ 2,191 | [13] | $ 2,017 | [15] | |||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 7.75% | [4],[5],[13] | 7.75% | [4],[5],[13] | 7.75% | [4],[5],[13] | 7.75% | [8],[10],[15] | 7.75% | [8],[10],[15] | 7.75% | [8],[10],[15] | |||
Investment, principal | $ 176 | [11],[13] | $ 176 | [12],[15] | |||||||||||
Investment owned, at cost | 170 | [13] | 170 | [15] | |||||||||||
Investments at fair value | $ 152 | [13] | $ 141 | [15] | |||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 7.38% | [4],[5] | 7.38% | [4],[5] | 7.38% | [4],[5] | 7.38% | [8],[10] | 7.38% | [8],[10] | 7.38% | [8],[10] | |||
Investment, principal | $ 10,720 | [11] | $ 8,420 | [12] | |||||||||||
Investment owned, at cost | 10,282 | 8,261 | |||||||||||||
Investments at fair value | $ 9,804 | 7,059 | |||||||||||||
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5],[13] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, principal | [11],[13] | $ 1,670 | |||||||||||||
Investment owned, at cost | [13] | 1,625 | |||||||||||||
Investments at fair value | [13] | $ 1,661 | |||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1] | 22,267,661 | 22,267,661 | 22,267,661 | |||||||||||
Investment owned, at cost | [1] | $ 16,172 | |||||||||||||
Investments at fair value | $ 16,173 | [1] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[18] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [8],[9],[12],[18] | $ 22,084 | |||||||||||||
Investment owned, at cost | [8],[9],[18] | 21,336 | |||||||||||||
Investments at fair value | [8],[9],[18] | 16,040 | |||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | [9] | 706 | |||||||||||||
Investments at fair value | [9] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,851 | [1] | 417,851 | [1] | 417,851 | [1] | 417,851 | [9] | 417,851 | [9] | 417,851 | [9] | |||
Investment owned, at cost | $ 605 | [1] | $ 605 | [9] | |||||||||||
Investments at fair value | $ 894 | [1] | $ 894 | [9] | |||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (19) | [1],[2],[5] | (20) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (19) | [1],[2],[5] | $ (20) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [8],[9] | 7.50% | [8],[9] | 7.50% | [8],[9] | |||
Investment, interest rate | [8],[9],[10] | 12.82% | 12.82% | 12.82% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 13,157 | [8],[9],[12] | |||||||||||
Investment owned, at cost | (15) | [1],[2],[5] | 12,855 | [8],[9] | |||||||||||
Investments at fair value | $ (11) | [1],[2],[5] | $ 12,858 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | |||
Investment, interest rate | [1],[4],[5] | 12.86% | 12.86% | 12.86% | |||||||||||
Investment, principal | $ 13,157 | [1],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 12,867 | [1],[5] | (15) | [6],[8],[9] | |||||||||||
Investments at fair value | $ 12,883 | [1],[5] | $ (13) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.35% | 10.35% | 10.35% | 10.39% | 10.39% | 10.39% | |||||||||
Investment, principal | $ 6,327 | $ 6,343 | |||||||||||||
Investment owned, at cost | 5,985 | 5,983 | |||||||||||||
Investments at fair value | $ 6,332 | $ 6,285 | |||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.35% | 10.35% | 10.35% | 10.39% | 10.39% | 10.39% | |||||||||
Investment, principal | $ 2,759 | $ 2,766 | |||||||||||||
Investment owned, at cost | 2,607 | 2,607 | |||||||||||||
Investments at fair value | $ 2,762 | $ 2,741 | |||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [5] | 5% | [5] | 5% | [5] | 5% | [8] | 5% | [8] | 5% | [8] | |||
Investment, interest rate | 10.35% | [4],[5] | 10.35% | [4],[5] | 10.35% | [4],[5] | 10.39% | [8],[10] | 10.39% | [8],[10] | 10.39% | [8],[10] | |||
Investment, principal | $ 14,713 | [5],[11] | $ 14,750 | [8],[12] | |||||||||||
Investment owned, at cost | 14,160 | [5] | 14,173 | [8] | |||||||||||
Investments at fair value | $ 14,724 | [5] | $ 14,616 | [8] | |||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | |||
Investment, interest rate | [6],[8],[9],[10] | 11.47% | 11.47% | 11.47% | |||||||||||
Investment, principal | $ 0 | [1],[5],[11] | $ 933 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (13) | [1],[5] | 920 | [6],[8],[9] | |||||||||||
Investments at fair value | $ (15) | [1],[5] | $ 918 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.53% | [4],[5] | 11.53% | [4],[5] | 11.53% | [4],[5] | 11.52% | [8],[9],[10] | 11.52% | [8],[9],[10] | 11.52% | [8],[9],[10] | |||
Investment, principal | $ 17,967 | [1],[5],[11] | $ 18,013 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 17,666 | [1],[5] | 17,690 | [8],[9] | |||||||||||
Investments at fair value | $ 17,765 | [1],[5] | $ 17,812 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, principal | [1],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[5] | (53) | |||||||||||||
Investments at fair value | [1],[5] | $ (52) | |||||||||||||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, interest rate | [4],[5] | 12.10% | 12.10% | 12.10% | |||||||||||
Investment, principal | [1],[11] | $ 20,924 | |||||||||||||
Investment owned, at cost | [1] | 20,412 | |||||||||||||
Investments at fair value | [1] | $ 20,422 | |||||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.85% | 9.85% | 9.85% | 9.89% | 9.89% | 9.89% | |||||||||
Investment, principal | $ 8,708 | $ 8,730 | |||||||||||||
Investment owned, at cost | 8,621 | 8,642 | |||||||||||||
Investments at fair value | $ 8,714 | $ 8,730 | |||||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.85% | 9.85% | 9.85% | 9.89% | 9.89% | 9.89% | |||||||||
Investment, principal | $ 2,834 | $ 2,841 | |||||||||||||
Investment owned, at cost | 2,813 | 2,820 | |||||||||||||
Investments at fair value | $ 2,836 | $ 2,841 | |||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | |||||||||
Investment, interest rate | 10.13% | 10.13% | 10.13% | 10.12% | 10.12% | 10.12% | |||||||||
Investment, principal | $ 8,698 | $ 7,920 | |||||||||||||
Investment owned, at cost | 8,563 | 7,792 | |||||||||||||
Investments at fair value | $ 8,619 | $ 7,729 | |||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | |||||||||
Investment, interest rate | 10.13% | 10.13% | 10.13% | 10.12% | 10.12% | 10.12% | |||||||||
Investment, principal | $ 3,361 | $ 2,970 | |||||||||||||
Investment owned, at cost | 3,309 | 2,922 | |||||||||||||
Investments at fair value | $ 3,331 | $ 2,899 | |||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | [5] | 4.75% | [5] | 4.75% | [5] | 4.75% | [8] | 4.75% | [8] | 4.75% | [8] | |||
Investment, interest rate | 10.13% | [4],[5] | 10.13% | [4],[5] | 10.13% | [4],[5] | 10.12% | [8],[10] | 10.12% | [8],[10] | 10.12% | [8],[10] | |||
Investment, principal | $ 4,938 | [5],[11] | $ 4,950 | [8],[12] | |||||||||||
Investment owned, at cost | 4,862 | [5] | 4,871 | [8] | |||||||||||
Investments at fair value | $ 4,893 | [5] | $ 4,831 | [8] | |||||||||||
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 8% | 8% | 8% | |||||||||||
Investment, principal | [11] | $ 440 | |||||||||||||
Investment owned, at cost | 423 | ||||||||||||||
Investments at fair value | $ 436 | ||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 2 | [1],[13] | 2 | [1],[13] | 2 | [1],[13] | 2 | [9],[15] | 2 | [9],[15] | 2 | [9],[15] | |||
Investment owned, at cost | $ 2 | [1],[13] | $ 2 | [9],[15] | |||||||||||
Investments at fair value | $ 2 | [1],[13] | $ 2 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 419 | [1],[13] | 419 | [1],[13] | 419 | [1],[13] | 419 | [9],[15] | 419 | [9],[15] | 419 | [9],[15] | |||
Investment owned, at cost | $ 419 | [1],[13] | $ 419 | [9],[15] | |||||||||||
Investments at fair value | $ 419 | [1],[13] | $ 419 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[4],[5],[13] | 3% | [1],[4],[5],[13] | 3% | [1],[4],[5],[13] | 3% | [6],[8],[9],[10],[15] | 3% | [6],[8],[9],[10],[15] | 3% | [6],[8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 7% | [1],[13] | 7% | [1],[13] | 7% | [1],[13] | 7% | [6],[9],[15] | 7% | [6],[9],[15] | 7% | [6],[9],[15] | |||
Investment, principal | $ 32,104 | [1],[11],[13] | $ 17,465 | [6],[9],[12],[15] | |||||||||||
Investment owned, at cost | 32,104 | [1],[13] | 17,465 | [6],[9],[15] | |||||||||||
Investments at fair value | $ 32,104 | [1],[13] | $ 17,465 | [6],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 31 | [1],[13] | 31 | [1],[13] | 31 | [1],[13] | 31 | [9],[15] | 31 | [9],[15] | 31 | [9],[15] | |||
Investment owned, at cost | $ 0 | [1],[13] | $ 0 | [9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[13] | $ 0 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9% | [1],[5] | 9% | [1],[5] | 9% | [1],[5] | 9% | [8],[9] | 9% | [8],[9] | 9% | [8],[9] | |||
Investment, interest rate | 14.50% | [1],[4],[5] | 14.50% | [1],[4],[5] | 14.50% | [1],[4],[5] | 14.54% | [8],[9],[10] | 14.54% | [8],[9],[10] | 14.54% | [8],[9],[10] | |||
Investment, principal | $ 20,757 | [1],[5],[11] | $ 20,757 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 20,201 | [1],[5] | 20,146 | [8],[9] | |||||||||||
Investments at fair value | $ 20,639 | [1],[5] | $ 20,653 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate, paid in kind | 8% | [1] | 8% | [1] | 8% | [1] | 8% | [9] | 8% | [9] | 8% | [9] | |||
Investment, principal | $ 667 | [1],[11] | $ 654 | [9],[12] | |||||||||||
Investment owned, at cost | 666 | [1] | 653 | [9] | |||||||||||
Investments at fair value | $ 643 | [1] | $ 631 | [9] | |||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 6,397,254 | [1] | 6,397,254 | [1] | 6,397,254 | [1] | 6,397,254 | [9] | 6,397,254 | [9] | 6,397,254 | [9] | |||
Investment owned, at cost | $ 1,642 | [1] | $ 1,642 | [9] | |||||||||||
Investments at fair value | $ 128 | [1] | $ 1,152 | [9] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | |||
Investment, interest rate | 12.45% | [1],[2],[4],[5] | 12.45% | [1],[2],[4],[5] | 12.45% | [1],[2],[4],[5] | 12.49% | [6],[8],[9],[10] | 12.49% | [6],[8],[9],[10] | 12.49% | [6],[8],[9],[10] | |||
Investment, principal | $ 578 | [1],[2],[5],[11] | $ 284 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 561 | [1],[2],[5] | 265 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 550 | [1],[2],[5] | $ 252 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate | 12.45% | [1],[4],[5] | 12.45% | [1],[4],[5] | 12.45% | [1],[4],[5] | 12.49% | [8],[9],[10] | 12.49% | [8],[9],[10] | 12.49% | [8],[9],[10] | |||
Investment, principal | $ 12,355 | [1],[5],[11] | $ 12,386 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 12,191 | [1],[5] | 12,208 | [8],[9] | |||||||||||
Investments at fair value | $ 12,083 | [1],[5] | $ 12,101 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | [8] | 5% | [8] | 5% | [8] | ||||||
Investment, interest rate | 10.65% | [4],[5] | 10.65% | [4],[5] | 10.65% | [4],[5] | 10.43% | [8],[10] | 10.43% | [8],[10] | 10.43% | [8],[10] | |||
Investment, principal | $ 4,514 | [5],[11] | $ 4,641 | [8],[12] | |||||||||||
Investment owned, at cost | 4,491 | [5] | 4,619 | [8] | |||||||||||
Investments at fair value | $ 4,522 | [5] | $ 4,546 | [8] | |||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 5.88% | 5.88% | 5.88% | |||||||||||
Investment, principal | [11] | $ 5,090 | |||||||||||||
Investment owned, at cost | 4,455 | ||||||||||||||
Investments at fair value | $ 4,787 | ||||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.65% | 10.65% | 10.65% | 10.43% | 10.43% | 10.43% | |||||||||
Investment, principal | $ 7,196 | $ 5,799 | |||||||||||||
Investment owned, at cost | 7,110 | 5,715 | |||||||||||||
Investments at fair value | $ 7,209 | $ 5,681 | |||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.65% | 10.65% | 10.65% | 10.43% | 10.43% | 10.43% | |||||||||
Investment, principal | $ 3,171 | $ 2,460 | |||||||||||||
Investment owned, at cost | 3,144 | 2,435 | |||||||||||||
Investments at fair value | $ 3,176 | $ 2,410 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | [1] | 30,031 | [1] | 30,031 | [1] | 30,031 | [9] | 30,031 | [9] | 30,031 | [9] | 30,031 | ||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | $ 15,222 | [1] | $ 15,222 | [9] | |||||||||||
Investments at fair value | $ 2,711 | [1] | $ 2,711 | [9] | $ 4,227 | 4,946 | |||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[5] | 5% | [1],[5] | 5% | [1],[5] | 5% | [8],[9] | 5% | [8],[9] | 5% | [8],[9] | 5% | ||
Investment, interest rate | 10.50% | [1],[4],[5] | 10.50% | [1],[4],[5] | 10.50% | [1],[4],[5] | 10.54% | [8],[9],[10] | 10.54% | [8],[9],[10] | 10.54% | [8],[9],[10] | |||
Investment, principal | $ 5,574 | [1],[5],[11] | $ 5,574 | [8],[9],[12] | $ 0 | ||||||||||
Investment owned, at cost | 5,574 | [1],[5] | 5,574 | [8],[9] | |||||||||||
Investments at fair value | $ 5,574 | [1],[5] | $ 5,574 | [8],[9] | $ 0 | 0 | |||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | ||||||||||||||
Investment, interest rate | 9.73% | ||||||||||||||
Investment, principal | $ 14,297 | ||||||||||||||
Investments at fair value | 14,297 | 14,333 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[5] | 5% | [1],[5] | 5% | [1],[5] | 5% | [8],[9] | 5% | [8],[9] | 5% | [8],[9] | |||
Investment, interest rate | 10.50% | [1],[4],[5] | 10.50% | [1],[4],[5] | 10.50% | [1],[4],[5] | 10.54% | [8],[9],[10] | 10.54% | [8],[9],[10] | 10.54% | [8],[9],[10] | |||
Investment, principal | $ 14,033 | [1],[5],[11] | $ 14,068 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 14,032 | [1],[5] | 14,068 | [8],[9] | |||||||||||
Investments at fair value | $ 14,033 | [1],[5] | $ 14,068 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[2],[5] | 5% | [1],[2],[5] | 5% | [1],[2],[5] | 5% | [6],[8],[9] | 5% | [6],[8],[9] | 5% | [6],[8],[9] | |||
Investment, interest rate | 10.46% | [1],[2],[4],[5] | 10.46% | [1],[2],[4],[5] | 10.46% | [1],[2],[4],[5] | 10.42% | [6],[8],[9],[10] | 10.42% | [6],[8],[9],[10] | 10.42% | [6],[8],[9],[10] | |||
Investment, principal | $ 1,393 | [1],[2],[5],[11] | $ 2,090 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 1,393 | [1],[2],[5] | 2,090 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 1,394 | [1],[2],[5] | $ 2,090 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 12,500 | [1] | 12,500 | [1] | 12,500 | [1] | 12,500 | [9] | 12,500 | [9] | 12,500 | [9] | |||
Investment owned, at cost | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 488 | [1] | 488 | [1] | 488 | [1] | 488 | [9] | 488 | [9] | 488 | [9] | |||
Investment owned, at cost | $ 488 | [1] | $ 488 | [9] | |||||||||||
Investments at fair value | $ 1,345 | [1] | $ 1,345 | [9] | |||||||||||
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 9.60% | 9.60% | 9.60% | ||||||||||||
Investment, principal | $ 2,992 | ||||||||||||||
Investment owned, at cost | 2,948 | ||||||||||||||
Investments at fair value | $ 2,971 | ||||||||||||||
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 9.60% | 9.60% | 9.60% | ||||||||||||
Investment, principal | $ 1,496 | ||||||||||||||
Investment owned, at cost | 1,474 | ||||||||||||||
Investments at fair value | $ 1,486 | ||||||||||||||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [8],[9] | 7.50% | [8],[9] | 7.50% | [8],[9] | |||
Investment, interest rate | 13% | [1],[4],[5] | 13% | [1],[4],[5] | 13% | [1],[4],[5] | 13.04% | [8],[9],[10] | 13.04% | [8],[9],[10] | 13.04% | [8],[9],[10] | |||
Investment, principal | $ 8,974 | [1],[5],[11] | $ 8,974 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 8,884 | [1],[5] | 8,884 | [8],[9] | |||||||||||
Investments at fair value | $ 8,032 | [1],[5] | $ 7,987 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (28) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (28) | |||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[4],[5] | 10.84% | 10.84% | 10.84% | |||||||||||
Investment, principal | [1],[5],[11] | $ 24,865 | |||||||||||||
Investment owned, at cost | [1],[5] | 24,492 | |||||||||||||
Investments at fair value | [1],[5] | $ 24,492 | |||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (19) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (19) | |||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[4],[5],[13] | 3% | [1],[4],[5],[13] | 3% | [1],[4],[5],[13] | 3% | [8],[9],[10],[15] | 3% | [8],[9],[10],[15] | 3% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 6% | [1],[13] | 6% | [1],[13] | 6% | [1],[13] | 6% | [9],[15] | 6% | [9],[15] | 6% | [9],[15] | |||
Investment, principal | $ 1,799 | [1],[11],[13] | $ 11,065 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 1,777 | [1],[13] | 10,953 | [9],[15] | |||||||||||
Investments at fair value | $ 1,718 | [1],[13] | $ 10,677 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[2],[4],[5],[13] | 3% | [1],[2],[4],[5],[13] | 3% | [1],[2],[4],[5],[13] | 3% | [8],[9],[10],[15] | 3% | [8],[9],[10],[15] | 3% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 6% | [1],[2],[13] | 6% | [1],[2],[13] | 6% | [1],[2],[13] | 6% | [9],[15] | 6% | [9],[15] | 6% | [9],[15] | |||
Investment, principal | $ 0 | [1],[2],[11],[13] | $ 1,772 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 1 | [1],[2],[13] | 1,748 | [9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[13] | $ 1,710 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[2],[4],[5],[13] | 3% | [1],[2],[4],[5],[13] | 3% | [1],[2],[4],[5],[13] | 3% | [6],[8],[9],[10],[15] | 3% | [6],[8],[9],[10],[15] | 3% | [6],[8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 6% | [1],[2],[13] | 6% | [1],[2],[13] | 6% | [1],[2],[13] | 6% | [6],[9],[15] | 6% | [6],[9],[15] | 6% | [6],[9],[15] | |||
Investment, principal | $ 0 | [1],[2],[11],[13] | $ 0 | [6],[9],[12],[15] | |||||||||||
Investment owned, at cost | 1 | [1],[2],[13] | 1 | [6],[9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[13] | $ 0 | [6],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[4],[5],[13] | 3% | [1],[4],[5],[13] | 3% | [1],[4],[5],[13] | 3% | [6],[8],[9],[10],[15] | 3% | [6],[8],[9],[10],[15] | 3% | [6],[8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 6% | [1],[13] | 6% | [1],[13] | 6% | [1],[13] | 6% | [6],[9],[15] | 6% | [6],[9],[15] | 6% | [6],[9],[15] | |||
Investment, principal | $ 11,232 | [1],[11],[13] | $ 0 | [6],[9],[12],[15] | |||||||||||
Investment owned, at cost | 11,129 | [1],[13] | 1 | [6],[9],[15] | |||||||||||
Investments at fair value | $ 10,727 | [1],[13] | $ 0 | [6],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (39) | [1],[2],[5] | (41) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (37) | [1],[2],[5] | $ (41) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.35% | [4],[5] | 11.35% | [4],[5] | 11.35% | [4],[5] | 11.32% | [8],[9],[10] | 11.32% | [8],[9],[10] | 11.32% | [8],[9],[10] | |||
Investment, principal | $ 14,736 | [1],[2],[5],[11] | $ 14,736 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 14,381 | [1],[2],[5] | 14,368 | [8],[9] | |||||||||||
Investments at fair value | $ 14,394 | [1],[2],[5] | $ 14,368 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [5] | 4% | 4% | 4% | |||||||||||
Investment, interest rate | [4],[5] | 9.47% | 9.47% | 9.47% | |||||||||||
Investment, principal | [5],[11] | $ 4,324 | |||||||||||||
Investment owned, at cost | [5] | 3,497 | |||||||||||||
Investments at fair value | [5] | $ 3,457 | |||||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [5] | 6.75% | [5] | 6.75% | [5] | 6.75% | [8],[15] | 6.75% | [8],[15] | 6.75% | [8],[15] | |||
Investment, interest rate | 12.22% | [4],[5] | 12.22% | [4],[5] | 12.22% | [4],[5] | 12.18% | [8],[10],[15] | 12.18% | [8],[10],[15] | 12.18% | [8],[10],[15] | |||
Investment, principal | $ 31,074 | [5],[11] | $ 31,074 | [8],[12],[15] | |||||||||||
Investment owned, at cost | 29,191 | [5] | 29,127 | [8],[15] | |||||||||||
Investments at fair value | $ 18,745 | [5] | $ 19,917 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 9% | [1],[2],[4],[5] | 9% | [1],[2],[4],[5] | 9% | [1],[2],[4],[5] | 9% | [6],[8],[9],[10] | 9% | [6],[8],[9],[10] | 9% | [6],[8],[9],[10] | |||
Investment, principal | $ 61,500 | [1],[2],[11] | $ 59,950 | [6],[9],[12] | |||||||||||
Investment owned, at cost | 61,500 | [1],[2] | 59,950 | [6],[9] | |||||||||||
Investments at fair value | $ 61,500 | [1],[2] | $ 59,950 | [6],[9] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 3,750 | [1],[13],[21] | 3,750 | [1],[13],[21] | 3,750 | [1],[13],[21] | 3,750 | [9],[15] | 3,750 | [9],[15] | 3,750 | [9],[15] | |||
Investment owned, at cost | $ 0 | [1],[13],[21] | $ 0 | [9],[15] | |||||||||||
Investments at fair value | $ 4 | [1],[13],[21] | $ 3 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[2],[5],[13] | 7.25% | [1],[2],[5],[13] | 7.25% | [1],[2],[5],[13] | 7.25% | [6],[8],[9],[15] | 7.25% | [6],[8],[9],[15] | 7.25% | [6],[8],[9],[15] | |||
Investment, interest rate | 12.61% | [1],[2],[4],[5],[13] | 12.61% | [1],[2],[4],[5],[13] | 12.61% | [1],[2],[4],[5],[13] | 12.55% | [6],[8],[9],[10],[15] | 12.55% | [6],[8],[9],[10],[15] | 12.55% | [6],[8],[9],[10],[15] | |||
Investment, principal | $ 322 | [1],[2],[5],[11],[13] | $ 258 | [6],[8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 299 | [1],[2],[5],[13] | 234 | [6],[8],[9],[15] | |||||||||||
Investments at fair value | $ 301 | [1],[2],[5],[13] | $ 234 | [6],[8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 7.25% | [1],[5],[13] | 7.25% | [8],[9],[15] | 7.25% | [8],[9],[15] | 7.25% | [8],[9],[15] | |||
Investment, interest rate | 12.71% | [1],[4],[5],[13] | 12.71% | [1],[4],[5],[13] | 12.71% | [1],[4],[5],[13] | 12.55% | [8],[9],[10],[15] | 12.55% | [8],[9],[10],[15] | 12.55% | [8],[9],[10],[15] | |||
Investment, principal | $ 11,742 | [1],[5],[11],[13] | $ 11,742 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 11,519 | [1],[5],[13] | 11,509 | [8],[9],[15] | |||||||||||
Investments at fair value | 11,538 | [1],[5],[13] | 11,511 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investments at fair value | 0 | 0 | |||||||||||||
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 51,354 | 54,051 | |||||||||||||
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | $ 27,867 | $ 28,396 | |||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11% | [1],[4],[5],[13] | 11% | [1],[4],[5],[13] | 11% | [1],[4],[5],[13] | 11% | [8],[9],[10],[15] | 11% | [8],[9],[10],[15] | 11% | [8],[9],[10],[15] | |||
Investment, principal | $ 11,918 | [1],[11],[13] | $ 11,918 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 11,653 | [1],[13] | 11,612 | [9],[15] | |||||||||||
Investments at fair value | $ 11,173 | [1],[13] | $ 11,144 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,011 | [1],[13] | 417,011 | [1],[13] | 417,011 | [1],[13] | 417,011 | [9],[15] | 417,011 | [9],[15] | 417,011 | [9],[15] | |||
Investment owned, at cost | $ 427 | [1],[13] | $ 427 | [9],[15] | |||||||||||
Investments at fair value | $ 354 | [1],[13] | $ 42 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | ||||||||||||
Investment, principal | $ 2,992 | ||||||||||||||
Investment owned, at cost | 2,955 | ||||||||||||||
Investments at fair value | $ 2,981 | ||||||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | ||||||||||||
Investment, principal | $ 1,496 | ||||||||||||||
Investment owned, at cost | 1,477 | ||||||||||||||
Investments at fair value | $ 1,491 | ||||||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 6% | [4],[5],[13] | 6% | [4],[5],[13] | 6% | [4],[5],[13] | 6% | [8],[10],[15] | 6% | [8],[10],[15] | 6% | [8],[10],[15] | |||
Investment, principal | $ 4,881 | [11],[13] | $ 4,881 | [12],[15] | |||||||||||
Investment owned, at cost | 4,482 | [13] | 4,469 | [15] | |||||||||||
Investments at fair value | $ 4,170 | [13] | $ 3,577 | [15] | |||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[2],[5] | 7.25% | [1],[2],[5] | 7.25% | [1],[2],[5] | 7.25% | [6],[8],[9] | 7.25% | [6],[8],[9] | 7.25% | [6],[8],[9] | |||
Investment, interest rate | 12.60% | [1],[2],[4],[5] | 12.60% | [1],[2],[4],[5] | 12.60% | [1],[2],[4],[5] | 12.64% | [6],[8],[9],[10] | 12.64% | [6],[8],[9],[10] | 12.64% | [6],[8],[9],[10] | |||
Investment, principal | $ 1,215 | [1],[2],[5],[11] | $ 1,638 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 1,117 | [1],[2],[5] | 1,535 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 1,152 | [1],[2],[5] | $ 1,535 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [8],[9] | 7.25% | [8],[9] | 7.25% | [8],[9] | |||
Investment, interest rate | 12.60% | [1],[4],[5] | 12.60% | [1],[4],[5] | 12.60% | [1],[4],[5] | 12.64% | [8],[9],[10] | 12.64% | [8],[9],[10] | 12.64% | [8],[9],[10] | |||
Investment, principal | $ 23,714 | [1],[5],[11] | $ 23,774 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 23,082 | [1],[5] | 23,110 | [8],[9] | |||||||||||
Investments at fair value | $ 23,306 | [1],[5] | $ 23,110 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.66% | 10.66% | 10.66% | 10.57% | 10.57% | 10.57% | |||||||||
Investment, principal | $ 7,350 | $ 7,369 | |||||||||||||
Investment owned, at cost | 7,277 | 7,295 | |||||||||||||
Investments at fair value | $ 6,590 | $ 6,190 | |||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.66% | 10.66% | 10.66% | 10.57% | 10.57% | 10.57% | |||||||||
Investment, principal | $ 3,920 | $ 3,930 | |||||||||||||
Investment owned, at cost | 3,881 | 3,891 | |||||||||||||
Investments at fair value | $ 3,515 | $ 3,301 | |||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[5] | 5% | [1],[5] | 5% | [1],[5] | 5% | [8] | 5% | [8] | 5% | [8] | |||
Investment, interest rate | 10.66% | [1],[4],[5] | 10.66% | [1],[4],[5] | 10.66% | [1],[4],[5] | 10.57% | [8],[10] | 10.57% | [8],[10] | 10.57% | [8],[10] | |||
Investment, principal | $ 2,450 | [1],[5],[11] | $ 2,456 | [8],[12] | |||||||||||
Investment owned, at cost | 2,070 | [1],[5] | 2,055 | [8] | |||||||||||
Investments at fair value | $ 2,197 | [1],[5] | $ 2,063 | [8] | |||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 2.85% | [5],[13] | 2.85% | [5],[13] | 2.85% | [5],[13] | 2.85% | [8],[15] | 2.85% | [8],[15] | 2.85% | [8],[15] | |||
Investment, interest rate | 6.84% | [4],[5],[13] | 6.84% | [4],[5],[13] | 6.84% | [4],[5],[13] | 6.56% | [8],[10],[15] | 6.56% | [8],[10],[15] | 6.56% | [8],[10],[15] | |||
Investment, principal | € | € 1,000 | [5],[11],[13] | € 1,000 | [8],[12],[15] | |||||||||||
Investment owned, at cost | $ 880 | [5],[13] | $ 876 | [8],[15] | |||||||||||
Investments at fair value | $ 1,033 | [5],[13] | $ 963 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[2],[5] | 8% | [1],[2],[5] | 8% | [1],[2],[5] | 8% | [6],[8],[9] | 8% | [6],[8],[9] | 8% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (25) | [1],[2],[5] | (27) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (29) | [1],[2],[5] | $ (35) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[2],[5] | 8% | [1],[2],[5] | 8% | [1],[2],[5] | 8% | [8],[9] | 8% | [8],[9] | 8% | [8],[9] | |||
Investment, interest rate | [8],[9],[10] | 13.42% | 13.42% | 13.42% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 17,444 | [8],[9],[12] | |||||||||||
Investment owned, at cost | (50) | [1],[2],[5] | 17,276 | [8],[9] | |||||||||||
Investments at fair value | $ (59) | [1],[2],[5] | $ 17,096 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[5] | 8% | [1],[5] | 8% | [1],[5] | 8% | [6],[8],[9] | 8% | [6],[8],[9] | 8% | [6],[8],[9] | |||
Investment, interest rate | [1],[4],[5] | 13.46% | 13.46% | 13.46% | |||||||||||
Investment, principal | $ 17,400 | [1],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 17,244 | [1],[5] | (54) | [6],[8],[9] | |||||||||||
Investments at fair value | $ 17,112 | [1],[5] | $ (70) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [5] | 5.25% | [5] | 5.25% | [5] | 5.25% | [8] | 5.25% | [8] | 5.25% | [8] | |||
Investment, interest rate | 10.71% | [4],[5] | 10.71% | [4],[5] | 10.71% | [4],[5] | 10.67% | [8],[10] | 10.67% | [8],[10] | 10.67% | [8],[10] | |||
Investment, principal | $ 8,538 | [5],[11] | $ 14,347 | [8],[12] | |||||||||||
Investment owned, at cost | 8,257 | [5] | 13,871 | [8] | |||||||||||
Investments at fair value | $ 8,396 | [5] | $ 13,618 | [8] | |||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | |||||||||
Investment, principal | $ 7,900 | $ 7,920 | |||||||||||||
Investment owned, at cost | 7,720 | 7,731 | |||||||||||||
Investments at fair value | $ 7,769 | $ 7,517 | |||||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | |||||||||
Investment, principal | $ 3,950 | $ 3,960 | |||||||||||||
Investment owned, at cost | 3,860 | 3,865 | |||||||||||||
Investments at fair value | $ 3,884 | $ 3,759 | |||||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5],[13] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[4],[5],[13] | 12% | 12% | 12% | |||||||||||
Investment, principal | [1],[5],[11],[13] | $ 7,448 | |||||||||||||
Investment owned, at cost | [1],[5],[13] | 7,313 | |||||||||||||
Investments at fair value | [1],[5],[13] | $ 7,355 | |||||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[2],[5],[13] | 6.50% | [1],[2],[5],[13] | 6.50% | [1],[2],[5],[13] | 6.50% | [8],[9],[15] | 6.50% | [8],[9],[15] | 6.50% | [8],[9],[15] | |||
Investment, interest rate | [8],[9],[10],[15] | 11.89% | 11.89% | 11.89% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11],[13] | $ 7,448 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | (73) | [1],[2],[5],[13] | 7,296 | [8],[9],[15] | |||||||||||
Investments at fair value | $ (50) | [1],[2],[5],[13] | $ 7,301 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5],[13] | 6.50% | [1],[5],[13] | 6.50% | [1],[5],[13] | 6.50% | [6],[8],[9],[15] | 6.50% | [6],[8],[9],[15] | 6.50% | [6],[8],[9],[15] | |||
Investment, interest rate | [4],[5] | 12% | 12% | 12% | |||||||||||
Investment, principal | $ 1,432 | [1],[5],[11],[13] | $ 0 | [6],[8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 1,403 | [1],[5],[13] | (82) | [6],[8],[9],[15] | |||||||||||
Investments at fair value | $ 1,414 | [1],[5],[13] | $ (79) | [6],[8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[15] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[15] | 12.04% | 12.04% | 12.04% | |||||||||||
Investment, principal | [8],[9],[12],[15] | $ 1,432 | |||||||||||||
Investment owned, at cost | [8],[9],[15] | 1,399 | |||||||||||||
Investments at fair value | [8],[9],[15] | $ 1,404 | |||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 4.46% | [4],[5],[13] | 4.46% | [4],[5],[13] | 4.46% | [4],[5],[13] | 4.46% | [8],[9],[10],[15] | 4.46% | [8],[9],[10],[15] | 4.46% | [8],[9],[10],[15] | |||
Investment, principal | $ 9,406 | [11],[13] | $ 6,808 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 7,727 | [13] | 5,490 | [9],[15] | |||||||||||
Investments at fair value | $ 8,155 | [13] | $ 5,873 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.25% | [8],[9],[15] | 8.25% | [8],[9],[15] | 8.25% | [8],[9],[15] | |||
Investment, interest rate | 13.63% | [1],[4],[5],[13] | 13.63% | [1],[4],[5],[13] | 13.63% | [1],[4],[5],[13] | 13.62% | [8],[9],[10],[15] | 13.62% | [8],[9],[10],[15] | 13.62% | [8],[9],[10],[15] | |||
Investment, principal | $ 23,975 | [1],[5],[11],[13] | $ 23,975 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 23,347 | [1],[5],[13] | 23,310 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 23,519 | [1],[5],[13] | $ 23,328 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||
Investment, interest rate | 11.36% | 11.36% | 11.36% | 11.40% | 11.40% | 11.40% | |||||||||
Investment, principal | $ 8,875 | $ 9,000 | |||||||||||||
Investment owned, at cost | 8,728 | 8,839 | |||||||||||||
Investments at fair value | $ 7,100 | $ 7,080 | |||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||
Investment, interest rate | 11.36% | 11.36% | 11.36% | 11.40% | 11.40% | 11.40% | |||||||||
Investment, principal | $ 2,219 | $ 2,250 | |||||||||||||
Investment owned, at cost | 2,182 | 2,210 | |||||||||||||
Investments at fair value | $ 1,775 | $ 1,770 | |||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | [1],[5] | 5.75% | [1],[5] | 5.75% | [1],[5] | 5.75% | [8],[9] | 5.75% | [8],[9] | 5.75% | [8],[9] | |||
Investment, interest rate | 11.36% | [1],[4],[5] | 11.36% | [1],[4],[5] | 11.36% | [1],[4],[5] | 11.40% | [8],[9],[10] | 11.40% | [8],[9],[10] | 11.40% | [8],[9],[10] | |||
Investment, principal | $ 43,931 | [1],[5],[11] | $ 44,550 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 42,440 | [1],[5] | 42,918 | [8],[9] | |||||||||||
Investments at fair value | $ 35,145 | [1],[5] | $ 35,046 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 12.06% | [1],[4],[5] | 12.06% | [1],[4],[5] | 12.06% | [1],[4],[5] | 11.92% | [8],[9],[10] | 11.92% | [8],[9],[10] | 11.92% | [8],[9],[10] | |||
Investment, principal | $ 40,587 | [1],[5],[11] | $ 40,587 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 39,991 | [1],[5] | 39,935 | [8],[9] | |||||||||||
Investments at fair value | $ 38,963 | [1],[5] | $ 38,963 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10.75% | [1],[17] | 10.75% | [1],[17] | 10.75% | [1],[17] | 10.75% | [8],[9] | 10.75% | [8],[9] | 10.75% | [8],[9] | |||
Investment, interest rate, paid in kind | [8],[9] | 16.06% | 16.06% | 16.06% | |||||||||||
Investment, principal | $ 1,001 | [1],[11],[17] | $ 26,613 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 983 | [1],[17] | 26,492 | [8],[9] | |||||||||||
Investments at fair value | $ 793 | [1],[17] | $ 24,484 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10.75% | [1],[5],[17] | 10.75% | [1],[5],[17] | 10.75% | [1],[5],[17] | 10.75% | [8],[9] | 10.75% | [8],[9] | 10.75% | [8],[9] | |||
Investment, interest rate, paid in kind | [8],[9] | 16.05% | 16.05% | 16.05% | |||||||||||
Investment, principal | $ 2,232 | [1],[5],[11],[17] | $ 787 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 2,163 | [1],[5],[17] | 771 | [8],[9] | |||||||||||
Investments at fair value | $ 1,768 | [1],[5],[17] | $ 787 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10.75% | [1],[5],[17] | 10.75% | [1],[5],[17] | 10.75% | [1],[5],[17] | 10.75% | [6],[8],[9] | 10.75% | [6],[8],[9] | 10.75% | [6],[8],[9] | |||
Investment, interest rate, paid in kind | [6],[8],[9] | 16.06% | 16.06% | 16.06% | |||||||||||
Investment, principal | $ 839 | [1],[5],[11],[17] | $ 688 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 785 | [1],[5],[17] | 688 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 664 | [1],[5],[17] | $ 688 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5],[17] | 10.75% | 10.75% | 10.75% | |||||||||||
Investment, principal | [1],[5],[11],[17] | $ 28,010 | |||||||||||||
Investment owned, at cost | [1],[5],[17] | 26,687 | |||||||||||||
Investments at fair value | [1],[5],[17] | $ 14,817 | |||||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 350,241 | 350,241 | 350,241 | 350,241 | 350,241 | 350,241 | |||||||||
Investment owned, at cost | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 0 | $ 147 | |||||||||||||
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | |||||||||
Investment, principal | $ 7,313 | $ 7,331 | |||||||||||||
Investment owned, at cost | 7,238 | 7,249 | |||||||||||||
Investments at fair value | $ 7,313 | $ 7,340 | |||||||||||||
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.86% | 10.86% | 10.86% | 10.90% | 10.90% | 10.90% | |||||||||
Investment, principal | $ 3,900 | $ 3,910 | |||||||||||||
Investment owned, at cost | 3,860 | 3,866 | |||||||||||||
Investments at fair value | $ 3,900 | $ 3,915 | |||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[15] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[9],[10],[15] | 11.14% | 11.14% | 11.14% | |||||||||||
Investment, interest rate, paid in kind | [8],[9],[15] | 2.75% | 2.75% | 2.75% | |||||||||||
Investment, principal | [8],[9],[12],[15] | $ 7,179 | |||||||||||||
Investment owned, at cost | [8],[9],[15] | 6,969 | |||||||||||||
Investments at fair value | [8],[9],[15] | $ 6,568 | |||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 112,990 | [1],[13] | 112,990 | [1],[13] | 112,990 | [1],[13] | 112,990 | [9],[15] | 112,990 | [9],[15] | 112,990 | [9],[15] | |||
Investment owned, at cost | $ 300 | [1],[13] | $ 300 | [9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[13] | $ 105 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,078,284 | [1] | 1,078,284 | [1] | 1,078,284 | [1] | 1,078,284 | [9] | 1,078,284 | [9] | 1,078,284 | [9] | |||
Investment owned, at cost | $ 113 | [1] | $ 113 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (85) | [1],[2],[5] | (99) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (86) | [1],[2],[5] | $ (86) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [8],[9] | 7.50% | [8],[9] | 7.50% | [8],[9] | |||
Investment, interest rate | 12.97% | [1],[4],[5] | 12.97% | [1],[4],[5] | 12.97% | [1],[4],[5] | 12.93% | [8],[9],[10] | 12.93% | [8],[9],[10] | 12.93% | [8],[9],[10] | |||
Investment, principal | $ 33,331 | [1],[5],[11] | $ 33,414 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 32,585 | [1],[5] | 32,539 | [8],[9] | |||||||||||
Investments at fair value | $ 32,577 | [1],[5] | $ 32,659 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [5] | 7.25% | [5] | 7.25% | [5] | 7.25% | [8] | 7.25% | [8] | 7.25% | [8] | |||
Investment, interest rate | 12.91% | [4],[5] | 12.91% | [4],[5] | 12.91% | [4],[5] | 12.78% | [8],[10] | 12.78% | [8],[10] | 12.78% | [8],[10] | |||
Investment, principal | $ 13,939 | [5],[11] | $ 13,939 | [8],[12] | |||||||||||
Investment owned, at cost | 12,721 | [5] | 12,661 | [8] | |||||||||||
Investments at fair value | 11,314 | [5] | 10,094 | [8] | |||||||||||
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | 8,722 | 83,262 | |||||||||||||
Investments at fair value | $ 8,722 | $ 83,262 | |||||||||||||
Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.36% | 10.36% | 10.36% | 10.32% | 10.32% | 10.32% | |||||||||
Investment, principal | $ 7,910 | $ 10,000 | |||||||||||||
Investment owned, at cost | 7,658 | 9,666 | |||||||||||||
Investments at fair value | $ 7,857 | $ 9,665 | |||||||||||||
Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.36% | 10.36% | 10.36% | 10.32% | 10.32% | 10.32% | |||||||||
Investment, principal | $ 3,560 | $ 4,500 | |||||||||||||
Investment owned, at cost | 3,447 | 4,350 | |||||||||||||
Investments at fair value | $ 3,536 | $ 4,349 | |||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | |||
Investment, interest rate | [6],[8],[9],[10] | 11.84% | 11.84% | 11.84% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 272 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (44) | [1],[2],[5] | 246 | [6],[8],[9] | |||||||||||
Investments at fair value | $ (47) | [1],[2],[5] | $ 238 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (26) | [1],[2],[5] | (47) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (35) | [1],[2],[5] | $ (47) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 11.99% | [4],[5] | 11.99% | [4],[5] | 11.99% | [4],[5] | 11.84% | [8],[9],[10] | 11.84% | [8],[9],[10] | 11.84% | [8],[9],[10] | |||
Investment, principal | $ 38,015 | [1],[5],[11] | $ 16,752 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 37,482 | [1],[5] | 16,623 | [8],[9] | |||||||||||
Investments at fair value | $ 37,445 | [1],[5] | $ 16,500 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 11.84% | [1],[4],[5] | 11.84% | [1],[4],[5] | 11.84% | [1],[4],[5] | 11.80% | [8],[9],[10] | 11.80% | [8],[9],[10] | 11.80% | [8],[9],[10] | |||
Investment, principal | $ 16,722 | [1],[5],[11] | $ 38,015 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 16,593 | [1],[5] | 37,447 | [8],[9] | |||||||||||
Investments at fair value | $ 16,471 | [1],[5] | $ 37,445 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.46% | 10.46% | 10.46% | 10.42% | 10.42% | 10.42% | |||||||||
Investment, principal | $ 3,952 | $ 3,962 | |||||||||||||
Investment owned, at cost | 3,813 | 3,815 | |||||||||||||
Investments at fair value | $ 3,801 | $ 3,955 | |||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (39) | [1],[2],[5] | (41) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (199) | [1],[2],[5] | $ (172) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.46% | [1],[4],[5] | 11.46% | [1],[4],[5] | 11.46% | [1],[4],[5] | 11.42% | [8],[9],[10] | 11.42% | [8],[9],[10] | 11.42% | [8],[9],[10] | |||
Investment, principal | $ 2,729 | [1],[5],[11] | $ 2,736 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 2,597 | [1],[5] | 2,595 | [8],[9] | |||||||||||
Investments at fair value | $ 2,524 | [1],[5] | $ 2,558 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.46% | [4],[5] | 11.46% | [4],[5] | 11.46% | [4],[5] | 11.42% | [8],[9],[10] | 11.42% | [8],[9],[10] | 11.42% | [8],[9],[10] | |||
Investment, principal | $ 23,435 | [1],[5],[11] | $ 23,494 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 23,091 | [1],[5] | 23,128 | [8],[9] | |||||||||||
Investments at fair value | 21,677 | [1],[5] | 21,967 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 11,220 | 11,286 | |||||||||||||
Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | $ 6,147 | $ 6,230 | |||||||||||||
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||
Investment, interest rate | 11.41% | 11.41% | 11.41% | 11.32% | 11.32% | 11.32% | |||||||||
Investment, principal | $ 7,350 | $ 7,369 | |||||||||||||
Investment owned, at cost | 7,257 | 7,269 | |||||||||||||
Investments at fair value | $ 7,267 | $ 7,267 | |||||||||||||
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||
Investment, interest rate | 11.41% | 11.41% | 11.41% | 11.32% | 11.32% | 11.32% | |||||||||
Investment, principal | $ 3,920 | $ 3,930 | |||||||||||||
Investment owned, at cost | 3,870 | 3,877 | |||||||||||||
Investments at fair value | $ 3,876 | $ 3,876 | |||||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [5],[13] | 9.50% | [5],[13] | 9.50% | [5],[13] | 9.50% | [8],[15] | 9.50% | [8],[15] | 9.50% | [8],[15] | |||
Investment, interest rate | 15.08% | [4],[5],[13] | 15.08% | [4],[5],[13] | 15.08% | [4],[5],[13] | 14.95% | [8],[10],[15] | 14.95% | [8],[10],[15] | 14.95% | [8],[10],[15] | |||
Investment, principal | $ 26,356 | [5],[11],[13] | $ 26,422 | [8],[12],[15] | |||||||||||
Investment owned, at cost | 24,952 | [5],[13] | 24,920 | [8],[15] | |||||||||||
Investments at fair value | $ 27,163 | [5],[13] | $ 27,512 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [9] | 2,000,000 | 2,000,000 | 2,000,000 | |||||||||||
Investment owned, at cost | [9] | $ 1,399 | |||||||||||||
Investments at fair value | [9] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.65% | 10.65% | 10.65% | |||||||||
Investment, principal | $ 11,220 | $ 11,249 | |||||||||||||
Investment owned, at cost | 11,091 | 11,106 | |||||||||||||
Investments at fair value | $ 10,883 | $ 10,912 | |||||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[5] | 5% | [1],[5] | 5% | [1],[5] | 5% | [8],[9] | 5% | [8],[9] | 5% | [8],[9] | |||
Investment, interest rate | 10.61% | [1],[4],[5] | 10.61% | [1],[4],[5] | 10.61% | [1],[4],[5] | 10.65% | [8],[9],[10] | 10.65% | [8],[9],[10] | 10.65% | [8],[9],[10] | |||
Investment, principal | $ 45,125 | [1],[5],[11] | $ 45,243 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 44,652 | [1],[5] | 44,717 | [8],[9] | |||||||||||
Investments at fair value | $ 43,771 | [1],[5] | $ 43,886 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 559 | [1] | 559 | [1] | 559 | [1] | 559 | [9] | 559 | [9] | 559 | [9] | |||
Investment, principal | [9],[12] | ||||||||||||||
Investment owned, at cost | $ 563 | [1] | 563 | [9] | |||||||||||
Investments at fair value | $ 268 | [1] | $ 372 | [9] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [1],[5] | 9.50% | [1],[5] | 9.50% | [1],[5] | 8.50% | [8],[9] | 8.50% | [8],[9] | 8.50% | [8],[9] | |||
Investment, interest rate | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 13.99% | [8],[9],[10] | 13.99% | [8],[9],[10] | 13.99% | [8],[9],[10] | |||
Investment, interest rate, paid in kind | 9.95% | 9.95% | 9.95% | ||||||||||||
Investment, principal | $ 3,012 | [1],[5],[11] | $ 5,403 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 2,968 | [1],[5] | 5,348 | [8],[9] | |||||||||||
Investments at fair value | $ 2,846 | [1],[5] | $ 5,160 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [1],[5] | 9.50% | [1],[5] | 9.50% | [1],[5] | 8.50% | [6],[8],[9] | 8.50% | [6],[8],[9] | 8.50% | [6],[8],[9] | |||
Investment, interest rate | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 13.99% | [6],[8],[9],[10] | 13.99% | [6],[8],[9],[10] | 13.99% | [6],[8],[9],[10] | |||
Investment, interest rate, paid in kind | 9.95% | 9.95% | 9.95% | ||||||||||||
Investment, principal | $ 5,536 | [1],[5],[11] | $ 2,939 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 5,486 | [1],[5] | 2,884 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 5,232 | [1],[5] | $ 2,745 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | 6% | [6],[8],[9] | |||
Investment, interest rate | [6],[8],[9],[10] | 11.42% | 11.42% | 11.42% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 964 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (26) | [1],[2],[5] | 936 | [6],[8],[9] | |||||||||||
Investments at fair value | $ (27) | [1],[2],[5] | $ 938 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.53% | [1],[4],[5] | 11.53% | [1],[4],[5] | 11.53% | [1],[4],[5] | 11.52% | [8],[9],[10] | 11.52% | [8],[9],[10] | 11.52% | [8],[9],[10] | |||
Investment, principal | $ 2,624 | [1],[5],[11] | $ 20,125 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 2,581 | [1],[5] | 19,912 | [8],[9] | |||||||||||
Investments at fair value | $ 2,585 | [1],[5] | $ 19,823 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [1],[2],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.53% | [4],[5] | 11.53% | [4],[5] | 11.53% | [4],[5] | 11.52% | [8],[9],[10] | 11.52% | [8],[9],[10] | 11.52% | [8],[9],[10] | |||
Investment, principal | $ 11,802 | [1],[2],[5],[11] | $ 2,631 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 11,685 | [1],[2],[5] | 2,587 | [8],[9] | |||||||||||
Investments at fair value | $ 11,625 | [1],[2],[5] | $ 2,591 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [1],[2],[5] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | 7.50% | [6],[8],[9] | |||
Investment, interest rate | 12.86% | [1],[2],[4],[5] | 12.86% | [1],[2],[4],[5] | 12.86% | [1],[2],[4],[5] | 12.83% | [6],[8],[9],[10] | 12.83% | [6],[8],[9],[10] | 12.83% | [6],[8],[9],[10] | |||
Investment, principal | $ 8,308 | [1],[2],[5],[11] | $ 1,466 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 8,070 | [1],[2],[5] | 1,215 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 8,308 | [1],[2],[5] | $ 1,282 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [1],[5] | 7.50% | [8],[9] | 7.50% | [8],[9] | 7.50% | [8],[9] | |||
Investment, interest rate | 12.89% | [1],[4],[5] | 12.89% | [1],[4],[5] | 12.89% | [1],[4],[5] | 12.89% | [8],[9],[10] | 12.89% | [8],[9],[10] | 12.89% | [8],[9],[10] | |||
Investment, principal | $ 40,538 | [1],[5],[11] | $ 40,538 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 39,910 | [1],[5] | 39,873 | [8],[9] | |||||||||||
Investments at fair value | $ 40,944 | [1],[5] | $ 39,833 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[2],[5] | 5.50% | [1],[2],[5] | 5.50% | [1],[2],[5] | 5.50% | [6],[8],[9] | 5.50% | [6],[8],[9] | 5.50% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (55) | [1],[2],[5] | (28) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (27) | [1],[2],[5] | $ (47) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[5] | 5.50% | [1],[5] | 5.50% | [1],[5] | 5.50% | [8],[9] | 5.50% | [8],[9] | 5.50% | [8],[9] | |||
Investment, interest rate | 10.95% | [4],[5] | 10.95% | [4],[5] | 10.95% | [4],[5] | 10.99% | [8],[9],[10] | 10.99% | [8],[9],[10] | 10.99% | [8],[9],[10] | |||
Investment, principal | $ 21,272 | [1],[5],[11] | $ 13,973 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 20,949 | [1],[5] | 13,936 | [8],[9] | |||||||||||
Investments at fair value | $ 21,060 | [1],[5] | $ 13,685 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[5] | 5.50% | [1],[5] | 5.50% | [1],[5] | 5.50% | [8],[9] | 5.50% | [8],[9] | 5.50% | [8],[9] | |||
Investment, interest rate | 10.95% | [1],[4],[5] | 10.95% | [1],[4],[5] | 10.95% | [1],[4],[5] | 10.99% | [8],[9],[10] | 10.99% | [8],[9],[10] | 10.99% | [8],[9],[10] | |||
Investment, principal | $ 13,937 | [1],[5],[11] | $ 21,328 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 13,897 | [1],[5] | 21,021 | [8],[9] | |||||||||||
Investments at fair value | $ 13,797 | [1],[5] | $ 20,888 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | 0 | |||||||||||||
Investments at fair value | [1],[2],[5] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investment owned, at cost | (3) | (3) | |||||||||||||
Investments at fair value | $ (2) | $ (7) | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investment owned, at cost | (1) | (1) | |||||||||||||
Investments at fair value | $ (1) | $ (3) | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||
Investment, interest rate | 10.95% | 10.95% | 10.95% | 10.99% | 10.99% | 10.99% | |||||||||
Investment, principal | $ 1,625 | $ 1,630 | |||||||||||||
Investment owned, at cost | 1,612 | 1,616 | |||||||||||||
Investments at fair value | $ 1,609 | $ 1,596 | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||
Investment, interest rate | 10.95% | 10.95% | 10.95% | 10.99% | 10.99% | 10.99% | |||||||||
Investment, principal | $ 8,297 | $ 8,319 | |||||||||||||
Investment owned, at cost | 8,143 | 8,164 | |||||||||||||
Investments at fair value | $ 8,215 | $ 8,147 | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||
Investment, interest rate | 10.95% | 10.95% | 10.95% | 10.99% | 10.99% | 10.99% | |||||||||
Investment, principal | $ 2,205 | $ 2,211 | |||||||||||||
Investment owned, at cost | 2,205 | 2,210 | |||||||||||||
Investments at fair value | $ 2,183 | $ 2,165 | |||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11.50% | [1],[4],[5],[13] | 11.50% | [1],[4],[5],[13] | 11.50% | [1],[4],[5],[13] | 11.50% | [8],[9],[10],[15] | 11.50% | [8],[9],[10],[15] | 11.50% | [8],[9],[10],[15] | |||
Investment, principal | $ 8,568 | [1],[11],[13] | $ 8,568 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 8,502 | [1],[13] | 8,495 | [9],[15] | |||||||||||
Investments at fair value | $ 8,139 | [1],[13] | $ 8,132 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11.50% | [1],[4],[5],[13] | 11.50% | [1],[4],[5],[13] | 11.50% | [1],[4],[5],[13] | 11.50% | [8],[9],[10],[15] | 11.50% | [8],[9],[10],[15] | 11.50% | [8],[9],[10],[15] | |||
Investment, principal | $ 8,568 | [1],[11],[13] | $ 4,284 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 8,502 | [1],[13] | 4,247 | [9],[15] | |||||||||||
Investments at fair value | $ 8,139 | [1],[13] | $ 4,066 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11.50% | [1],[4],[5],[13] | 11.50% | [1],[4],[5],[13] | 11.50% | [1],[4],[5],[13] | 11.50% | [8],[9],[10],[15] | 11.50% | [8],[9],[10],[15] | 11.50% | [8],[9],[10],[15] | |||
Investment, principal | $ 4,284 | [1],[11],[13] | $ 8,568 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 4,251 | [1],[13] | 8,495 | [9],[15] | |||||||||||
Investments at fair value | $ 4,070 | [1],[13] | $ 8,132 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||
Investment, interest rate | 9.19% | 9.19% | 9.19% | 9.18% | 9.18% | 9.18% | |||||||||
Investment, principal | $ 5,925 | $ 5,940 | |||||||||||||
Investment owned, at cost | 5,653 | 5,654 | |||||||||||||
Investments at fair value | $ 5,916 | $ 5,812 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8% | [1],[4],[5],[13] | 8% | [1],[4],[5],[13] | 8% | [1],[4],[5],[13] | 8% | [8],[9],[10],[15] | 8% | [8],[9],[10],[15] | 8% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 1.75% | [1],[13] | 1.75% | [1],[13] | 1.75% | [1],[13] | 1.75% | [9],[15] | 1.75% | [9],[15] | 1.75% | [9],[15] | |||
Investment, principal | $ 9,129 | [1],[11],[13] | $ 9,106 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 8,644 | [1],[13] | 8,580 | [9],[15] | |||||||||||
Investments at fair value | $ 8,147 | [1],[13] | $ 8,013 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,817 | [1],[13] | 66,817 | [1],[13] | 66,817 | [1],[13] | 259,877 | [9],[15] | 259,877 | [9],[15] | 259,877 | [9],[15] | |||
Investment, principal | [9],[12],[15] | ||||||||||||||
Investment owned, at cost | $ 23 | [1],[13] | 545 | [9],[15] | |||||||||||
Investments at fair value | $ 27 | [1],[13] | $ 78 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 259,877 | [1],[13] | 259,877 | [1],[13] | 259,877 | [1],[13] | 66,817 | [9],[15] | 66,817 | [9],[15] | 66,817 | [9],[15] | |||
Investment, principal | [9],[12],[15] | ||||||||||||||
Investment owned, at cost | $ 545 | [1],[13] | 23 | [9],[15] | |||||||||||
Investments at fair value | $ 65 | [1],[13] | $ 33 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | 7% | 7% | 7% | 7% | 7% | |||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investment owned, at cost | (2) | (2) | |||||||||||||
Investments at fair value | $ (7) | $ (8) | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | 7% | 7% | 7% | 7% | 7% | |||||||||
Investment, interest rate | 12.53% | 12.53% | 12.53% | 12.52% | 12.52% | 12.52% | |||||||||
Investment, principal | $ 4,669 | $ 4,669 | |||||||||||||
Investment owned, at cost | 4,652 | 4,648 | |||||||||||||
Investments at fair value | $ 4,603 | $ 4,594 | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (35) | [1],[2],[5] | (43) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (67) | [1],[2],[5] | $ (76) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate | 12.53% | [4],[5] | 12.53% | [4],[5] | 12.53% | [4],[5] | 12.52% | [8],[9],[10] | 12.52% | [8],[9],[10] | 12.52% | [8],[9],[10] | |||
Investment, principal | $ 46,687 | [1],[5],[11] | $ 5,248 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 46,322 | [1],[5] | 5,220 | [8],[9] | |||||||||||
Investments at fair value | $ 46,033 | [1],[5] | $ 5,164 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate | 12.53% | [1],[4],[5] | 12.53% | [1],[4],[5] | 12.53% | [1],[4],[5] | 12.52% | [8],[9],[10] | 12.52% | [8],[9],[10] | 12.52% | [8],[9],[10] | |||
Investment, principal | $ 5,248 | [1],[5],[11] | $ 46,687 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 5,225 | [1],[5] | 46,239 | [8],[9] | |||||||||||
Investments at fair value | $ 5,175 | [1],[5] | $ 45,940 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||
Investment, interest rate | 9.40% | 9.40% | 9.40% | 9.18% | 9.18% | 9.18% | |||||||||
Investment, principal | $ 2,977 | $ 2,985 | |||||||||||||
Investment owned, at cost | 2,845 | 2,845 | |||||||||||||
Investments at fair value | $ 2,980 | $ 2,941 | |||||||||||||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[5] | 6.75% | [1],[5] | 6.75% | [1],[5] | 6.75% | [8],[9] | 6.75% | [8],[9] | 6.75% | [8],[9] | |||
Investment, interest rate | 13.60% | [1],[4],[5] | 13.60% | [1],[4],[5] | 13.60% | [1],[4],[5] | 12.51% | [8],[9],[10] | 12.51% | [8],[9],[10] | 12.51% | [8],[9],[10] | |||
Investment, principal | $ 49,266 | [1],[5],[11] | $ 54,559 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 49,001 | [1],[5] | 54,236 | [8],[9] | |||||||||||
Investments at fair value | $ 48,034 | [1],[5] | $ 53,168 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 6.88% | [4],[5] | 6.88% | [4],[5] | 6.88% | [4],[5] | 6.88% | [8],[10] | 6.88% | [8],[10] | 6.88% | [8],[10] | |||
Investment, principal | $ 10,191 | [11] | $ 10,191 | [12] | |||||||||||
Investment owned, at cost | 9,846 | 9,831 | |||||||||||||
Investments at fair value | $ 10,368 | $ 8,743 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.88% | [1],[5],[13] | 6.88% | [1],[5],[13] | 6.88% | [1],[5],[13] | 6.88% | [8],[9],[15] | 6.88% | [8],[9],[15] | 6.88% | [8],[9],[15] | |||
Investment, interest rate | 12.33% | [1],[4],[5],[13] | 12.33% | [1],[4],[5],[13] | 12.33% | [1],[4],[5],[13] | 12.29% | [8],[9],[10],[15] | 12.29% | [8],[9],[10],[15] | 12.29% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 2% | [1],[5],[13] | 2% | [1],[5],[13] | 2% | [1],[5],[13] | 2% | [8],[9],[15] | 2% | [8],[9],[15] | 2% | [8],[9],[15] | |||
Investment, principal | $ 73,547 | [1],[5],[11],[13] | $ 73,362 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 72,724 | [1],[5],[13] | 72,459 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 70,201 | [1],[5],[13] | $ 69,694 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | [13] | 487,870 | [13] | 487,870 | [13] | 487,870 | [15] | 487,870 | [15] | 487,870 | [15] | |||
Investment owned, at cost | $ 0 | [13] | $ 0 | [15] | |||||||||||
Investments at fair value | $ 1,947 | [13] | $ 903 | [15] | |||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | [13] | 487,870 | [13] | 487,870 | [13] | 487,870 | [15] | 487,870 | [15] | 487,870 | [15] | |||
Investment owned, at cost | $ 0 | [13] | $ 0 | [15] | |||||||||||
Investments at fair value | $ 1,947 | [13] | $ 903 | [15] | |||||||||||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [1],[5] | 8.50% | [8],[9] | 8.50% | [8],[9] | 8.50% | [8],[9] | |||
Investment, interest rate | 13.93% | [1],[4],[5] | 13.93% | [1],[4],[5] | 13.93% | [1],[4],[5] | 13.99% | [8],[9],[10] | 13.99% | [8],[9],[10] | 13.99% | [8],[9],[10] | |||
Investment, principal | $ 30,339 | [1],[5],[11] | $ 30,339 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 30,040 | [1],[5] | 30,021 | [8],[9] | |||||||||||
Investments at fair value | $ 30,166 | [1],[5] | $ 29,007 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.50% | [1],[5] | 9.50% | [1],[5] | 9.50% | [1],[5] | 9.50% | [8],[9] | 9.50% | [8],[9] | 9.50% | [8],[9] | |||
Investment, interest rate | 14.83% | [1],[4],[5] | 14.83% | [1],[4],[5] | 14.83% | [1],[4],[5] | 14.89% | [8],[9],[10] | 14.89% | [8],[9],[10] | 14.89% | [8],[9],[10] | |||
Investment, principal | $ 64,606 | [1],[5],[11] | $ 64,606 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 64,689 | [1],[5] | 64,720 | [8],[9] | |||||||||||
Investments at fair value | $ 63,185 | [1],[5] | $ 63,185 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 6% | 6% | 6% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (28) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (23) | |||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[4],[5] | 11.37% | 11.37% | 11.37% | |||||||||||
Investment, principal | [1],[5],[11] | $ 19,995 | |||||||||||||
Investment owned, at cost | [1],[5] | 19,695 | |||||||||||||
Investments at fair value | [1],[5] | $ 19,751 | |||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 6% | 6% | 6% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (38) | |||||||||||||
Investments at fair value | [1],[2],[5] | (38) | |||||||||||||
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.76% | 4.76% | 4.76% | ||||||||||||
Investment, interest rate | 10.15% | 10.15% | 10.15% | ||||||||||||
Investment, principal | $ 6,615 | ||||||||||||||
Investment owned, at cost | 6,608 | ||||||||||||||
Investments at fair value | $ 6,565 | ||||||||||||||
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.76% | 4.76% | 4.76% | ||||||||||||
Investment, interest rate | 10.15% | 10.15% | 10.15% | ||||||||||||
Investment, principal | $ 5,198 | ||||||||||||||
Investment owned, at cost | 5,192 | ||||||||||||||
Investments at fair value | 5,159 | ||||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 0 | ||||||||||||||
Investment owned, at cost | 0 | [2],[13],[22],[23] | 0 | [6],[15],[24],[25] | |||||||||||
Investments at fair value | $ 0 | [2],[13],[22],[23] | $ 0 | [6],[15],[24],[25] | $ 0 | 0 | |||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [1],[2],[5],[13],[22] | 4.50% | [1],[2],[5],[13],[22] | 4.50% | [1],[2],[5],[13],[22] | 4.50% | [6],[9],[15],[24] | 4.50% | [6],[9],[15],[24] | 4.50% | [6],[9],[15],[24] | 4.50% | ||
Investment, interest rate | 9.94% | [1],[2],[4],[5],[13],[22] | 9.94% | [1],[2],[4],[5],[13],[22] | 9.94% | [1],[2],[4],[5],[13],[22] | 9.76% | [6],[8],[9],[10],[15],[24] | 9.76% | [6],[8],[9],[10],[15],[24] | 9.76% | [6],[8],[9],[10],[15],[24] | 7.67% | ||
Investment, principal | $ 58,349 | [1],[2],[5],[11],[13],[22] | $ 58,349 | [6],[9],[12],[15],[24] | $ 59,049 | ||||||||||
Investment owned, at cost | 50,621 | [1],[2],[5],[13],[22] | 50,330 | [6],[9],[15],[24] | |||||||||||
Investments at fair value | $ 50,957 | [1],[2],[5],[13],[22] | $ 50,017 | [6],[9],[15],[24] | 49,536 | 50,283 | |||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate | 12.46% | [1],[4],[5] | 12.46% | [1],[4],[5] | 12.46% | [1],[4],[5] | 12.49% | [8],[9],[10] | 12.49% | [8],[9],[10] | 12.49% | [8],[9],[10] | |||
Investment, principal | $ 9,323 | [1],[5],[11] | $ 9,323 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 9,216 | [1],[5] | 9,210 | [8],[9] | |||||||||||
Investments at fair value | $ 9,183 | [1],[5] | $ 9,183 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.43% | 9.43% | 9.43% | |||||||||
Investment, principal | $ 10,958 | $ 10,987 | |||||||||||||
Investment owned, at cost | 10,810 | 10,827 | |||||||||||||
Investments at fair value | $ 10,954 | $ 10,971 | |||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.46% | 9.46% | 9.46% | 9.43% | 9.43% | 9.43% | |||||||||
Investment, principal | $ 3,839 | $ 3,849 | |||||||||||||
Investment owned, at cost | 3,821 | 3,830 | |||||||||||||
Investments at fair value | $ 3,837 | $ 3,843 | |||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10% | [1],[5],[17] | 10% | [1],[5],[17] | 10% | [1],[5],[17] | 10% | [8],[9] | 10% | [8],[9] | 10% | [8],[9] | |||
Investment, interest rate, paid in kind | [8],[9] | 15.67% | 15.67% | 15.67% | |||||||||||
Investment, principal | $ 1,303 | [1],[5],[11],[17] | $ 25,712 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 1,202 | [1],[5],[17] | 25,615 | [8],[9] | |||||||||||
Investments at fair value | $ 1,074 | [1],[5],[17] | $ 25,069 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10% | [1],[5],[17] | 10% | [1],[5],[17] | 10% | [1],[5],[17] | 10% | [6],[8],[9] | 10% | [6],[8],[9] | 10% | [6],[8],[9] | |||
Investment, principal | $ 31,515 | [1],[5],[11],[17] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 26,979 | [1],[5],[17] | (11) | [6],[8],[9] | |||||||||||
Investments at fair value | $ 25,959 | [1],[5],[17] | $ (69) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 12% | [1],[2],[5],[17] | 12% | [1],[2],[5],[17] | 12% | [1],[2],[5],[17] | 10% | [6],[8],[9] | 10% | [6],[8],[9] | 10% | [6],[8],[9] | |||
Investment, interest rate, paid in kind | [6],[8],[9] | 15.64% | 15.64% | 15.64% | |||||||||||
Investment, principal | $ 233 | [1],[2],[5],[11],[17] | $ 1,210 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 233 | [1],[2],[5],[17] | 1,193 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 233 | [1],[2],[5],[17] | $ 1,169 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [1],[2],[5] | 7.75% | [1],[2],[5] | 7.75% | [1],[2],[5] | 7.75% | [6],[8],[9] | 7.75% | [6],[8],[9] | 7.75% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (40) | [1],[2],[5] | (42) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (29) | [1],[2],[5] | $ (36) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [1],[5] | 7.75% | [1],[5] | 7.75% | [1],[5] | 7.75% | [8],[9] | 7.75% | [8],[9] | 7.75% | [8],[9] | |||
Investment, interest rate | 13.13% | [1],[4],[5] | 13.13% | [1],[4],[5] | 13.13% | [1],[4],[5] | 13.12% | [8],[9],[10] | 13.12% | [8],[9],[10] | 13.12% | [8],[9],[10] | |||
Investment, principal | $ 15,231 | [1],[5],[11] | $ 15,231 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 14,908 | [1],[5] | 14,892 | [8],[9] | |||||||||||
Investments at fair value | 15,003 | [1],[5] | 14,945 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Other cash accounts | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | 122,975 | 62,277 | |||||||||||||
Investments at fair value | $ 122,975 | $ 62,277 | |||||||||||||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [8],[10] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [12] | $ 4,519 | |||||||||||||
Investment owned, at cost | 4,550 | ||||||||||||||
Investments at fair value | $ 3,305 | ||||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [1],[2],[5] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | 7% | [6],[8],[9] | |||
Investment, interest rate | [1],[2],[4],[5] | 12.35% | 12.35% | 12.35% | |||||||||||
Investment, principal | $ 98 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 48 | [1],[2],[5] | (53) | [6],[8],[9] | |||||||||||
Investments at fair value | $ 44 | [1],[2],[5] | $ (54) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate | 12.36% | [1],[4],[5] | 12.36% | [1],[4],[5] | 12.36% | [1],[4],[5] | 12.32% | [8],[9],[10] | 12.32% | [8],[9],[10] | 12.32% | [8],[9],[10] | |||
Investment, principal | $ 10,868 | [1],[5],[11] | $ 10,895 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 10,497 | [1],[5] | 10,505 | [8],[9] | |||||||||||
Investments at fair value | $ 10,469 | [1],[5] | $ 10,495 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 100,000 | [1] | 100,000 | [1] | 100,000 | [1] | 100,000 | [9] | 100,000 | [9] | 100,000 | [9] | |||
Investment owned, at cost | $ 109 | [1] | $ 109 | [9] | |||||||||||
Investments at fair value | $ 300 | [1] | $ 248 | [9] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (30) | [1],[2],[5] | (34) | [6],[8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[5] | $ (3) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 12.04% | [1],[4],[5] | 12.04% | [1],[4],[5] | 12.04% | [1],[4],[5] | 12.01% | [8],[9],[10] | 12.01% | [8],[9],[10] | 12.01% | [8],[9],[10] | |||
Investment, principal | $ 38,308 | [1],[5],[11] | $ 38,414 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 37,902 | [1],[5] | 37,960 | [8],[9] | |||||||||||
Investments at fair value | $ 38,308 | [1],[5] | $ 38,380 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.46% | 10.46% | 10.46% | 10.42% | 10.42% | 10.42% | |||||||||
Investment, principal | $ 9,799 | $ 9,825 | |||||||||||||
Investment owned, at cost | 9,488 | 9,492 | |||||||||||||
Investments at fair value | $ 9,778 | $ 9,698 | |||||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [5] | 5% | [5] | 5% | [5] | 5% | [8] | 5% | [8] | 5% | [8] | |||
Investment, interest rate | 10.46% | [4],[5] | 10.46% | [4],[5] | 10.46% | [4],[5] | 10.42% | [8],[10] | 10.42% | [8],[10] | 10.42% | [8],[10] | |||
Investment, principal | $ 9,651 | [5],[11] | $ 9,676 | [8],[12] | |||||||||||
Investment owned, at cost | 9,500 | [5] | 9,518 | [8] | |||||||||||
Investments at fair value | $ 9,630 | [5] | $ 9,551 | [8] | |||||||||||
Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | ||||||||||||
Investment, principal | $ 1,995 | ||||||||||||||
Investment owned, at cost | 1,994 | ||||||||||||||
Investments at fair value | $ 2,002 | ||||||||||||||
Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | ||||||||||||
Investment, principal | $ 997 | ||||||||||||||
Investment owned, at cost | 997 | ||||||||||||||
Investments at fair value | $ 1,001 | ||||||||||||||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | [1],[5] | 5.75% | [1],[5] | 5.75% | [1],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.32% | [1],[4],[5] | 11.32% | [1],[4],[5] | 11.32% | [1],[4],[5] | 11.57% | [8],[9],[10] | 11.57% | [8],[9],[10] | 11.57% | [8],[9],[10] | |||
Investment, principal | $ 22,375 | [1],[5],[11] | $ 22,375 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 22,201 | [1],[5] | 22,189 | [8],[9] | |||||||||||
Investments at fair value | $ 21,928 | [1],[5] | $ 21,896 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | ||||||||||||
Investment, principal | $ 4,000 | ||||||||||||||
Investment owned, at cost | 3,930 | ||||||||||||||
Investments at fair value | $ 3,962 | ||||||||||||||
Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.21% | 9.21% | 9.21% | ||||||||||||
Investment, principal | $ 2,000 | ||||||||||||||
Investment owned, at cost | 1,965 | ||||||||||||||
Investments at fair value | $ 1,981 | ||||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 6% | 6% | 6% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (134) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (133) | |||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[4],[5] | 11.36% | 11.36% | 11.36% | |||||||||||
Investment, principal | [1],[5],[11] | $ 52,639 | |||||||||||||
Investment owned, at cost | [1],[5] | 51,606 | |||||||||||||
Investments at fair value | [1],[5] | $ 51,618 | |||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 6% | 6% | 6% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (69) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (69) | |||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1] | 4,531,000 | 4,531,000 | 4,531,000 | |||||||||||
Investment owned, at cost | [1] | $ 4,440 | |||||||||||||
Investments at fair value | [1] | $ 4,444 | |||||||||||||
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [11] | $ 2,300 | |||||||||||||
Investment owned, at cost | 2,122 | ||||||||||||||
Investments at fair value | $ 2,192 | ||||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [8],[9] | 7.25% | [8],[9] | 7.25% | [8],[9] | |||
Investment, interest rate | 12.70% | [1],[4],[5] | 12.70% | [1],[4],[5] | 12.70% | [1],[4],[5] | 12.74% | [8],[9],[10] | 12.74% | [8],[9],[10] | 12.74% | [8],[9],[10] | |||
Investment, principal | $ 36,499 | [1],[5],[11] | $ 36,499 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 35,490 | [1],[5] | 35,458 | [8],[9] | |||||||||||
Investments at fair value | $ 33,397 | [1],[5] | $ 33,214 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | 9.65% | 9.65% | 9.65% | |||||||||
Investment, principal | $ 2,410 | $ 2,416 | |||||||||||||
Investment owned, at cost | 2,299 | 2,298 | |||||||||||||
Investments at fair value | $ 2,395 | $ 2,390 | |||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | 9.65% | 9.65% | 9.65% | |||||||||
Investment, principal | $ 681 | $ 683 | |||||||||||||
Investment owned, at cost | 650 | 650 | |||||||||||||
Investments at fair value | $ 677 | $ 676 | |||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | 7.25% | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||
Investment, interest rate | 12.70% | 12.70% | 12.70% | 12.74% | 12.74% | 12.74% | |||||||||
Investment, principal | $ 4,503 | $ 4,503 | |||||||||||||
Investment owned, at cost | 4,435 | 4,435 | |||||||||||||
Investments at fair value | $ 4,120 | $ 4,098 | |||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | 7.25% | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||
Investment, interest rate | 12.70% | 12.70% | 12.70% | 12.74% | 12.74% | 12.74% | |||||||||
Investment, principal | $ 2,842 | $ 2,842 | |||||||||||||
Investment owned, at cost | 2,799 | 2,799 | |||||||||||||
Investments at fair value | $ 2,600 | $ 2,586 | |||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[2],[5] | 8% | [1],[2],[5] | 8% | [1],[2],[5] | 8% | [6],[8],[9] | 8% | [6],[8],[9] | 8% | [6],[8],[9] | |||
Investment, interest rate | 13.56% | [1],[2],[4],[5] | 13.56% | [1],[2],[4],[5] | 13.56% | [1],[2],[4],[5] | 13.45% | [6],[8],[9],[10] | 13.45% | [6],[8],[9],[10] | 13.45% | [6],[8],[9],[10] | |||
Investment, principal | $ 3,722 | [1],[2],[5],[11] | $ 3,003 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 3,649 | [1],[2],[5] | 2,926 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 3,540 | [1],[2],[5] | $ 2,801 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[5] | 8% | [1],[5] | 8% | [1],[5] | 8% | [8],[9] | 8% | [8],[9] | 8% | [8],[9] | |||
Investment, interest rate | 13.56% | [1],[4],[5] | 13.56% | [1],[4],[5] | 13.56% | [1],[4],[5] | 13.45% | [8],[9],[10] | 13.45% | [8],[9],[10] | 13.45% | [8],[9],[10] | |||
Investment, principal | $ 67,244 | [1],[5],[11] | $ 67,244 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 66,418 | [1],[5] | 66,353 | [8],[9] | |||||||||||
Investments at fair value | $ 64,689 | [1],[5] | $ 64,406 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | 8% | 8% | 8% | |||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | |||||||||
Investment, principal | $ 394 | $ 318 | |||||||||||||
Investment owned, at cost | 379 | 301 | |||||||||||||
Investments at fair value | $ 375 | $ 297 | |||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | 8% | 8% | 8% | |||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | |||||||||
Investment, principal | $ 281 | $ 226 | |||||||||||||
Investment owned, at cost | 271 | 216 | |||||||||||||
Investments at fair value | $ 266 | $ 211 | |||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | 8% | 8% | 8% | |||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | |||||||||
Investment, principal | $ 8,116 | $ 8,116 | |||||||||||||
Investment owned, at cost | 7,869 | 7,850 | |||||||||||||
Investments at fair value | $ 7,807 | $ 7,773 | |||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | 8% | 8% | 8% | |||||||||
Investment, interest rate | 13.56% | 13.56% | 13.56% | 13.45% | 13.45% | 13.45% | |||||||||
Investment, principal | $ 5,182 | $ 5,182 | |||||||||||||
Investment owned, at cost | 5,040 | 5,029 | |||||||||||||
Investments at fair value | $ 4,985 | $ 4,964 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5],[13] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [1],[4],[5],[13] | 12.60% | 12.60% | 12.60% | |||||||||||
Investment, principal | [1],[5],[11],[13] | $ 28,818 | |||||||||||||
Investment owned, at cost | [1],[5],[13] | 28,530 | |||||||||||||
Investments at fair value | [1],[5],[13] | $ 28,530 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.78% | 12.78% | 12.78% | |||||||||||
Investment, principal | [8],[9],[12] | $ 24,503 | |||||||||||||
Investment owned, at cost | [8],[9] | 24,255 | |||||||||||||
Investments at fair value | [8],[9] | $ 24,081 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.78% | 12.78% | 12.78% | |||||||||||
Investment, principal | [8],[9],[12] | $ 2,819 | |||||||||||||
Investment owned, at cost | [8],[9] | 2,797 | |||||||||||||
Investments at fair value | [8],[9] | $ 2,771 | |||||||||||||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[5],[13] | 5.50% | [1],[5],[13] | 5.50% | [1],[5],[13] | 5.75% | [8],[9],[15] | 5.75% | [8],[9],[15] | 5.75% | [8],[9],[15] | |||
Investment, interest rate | 10.96% | [1],[4],[5],[13] | 10.96% | [1],[4],[5],[13] | 10.96% | [1],[4],[5],[13] | 11.21% | [8],[9],[10],[15] | 11.21% | [8],[9],[10],[15] | 11.21% | [8],[9],[10],[15] | |||
Investment, principal | £ | £ 6,136 | [1],[5],[11],[13] | £ 4,626 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | $ 7,677 | [1],[5],[13] | $ 5,897 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 7,353 | [1],[5],[13] | $ 5,166 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 64,887,669 | [1] | 64,887,669 | [1] | 64,887,669 | [1] | 64,887,669 | [9] | 64,887,669 | [9] | 64,887,669 | [9] | |||
Investment owned, at cost | $ 375 | [1] | $ 375 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [1],[2],[5] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | 6.50% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (40) | [1],[2],[5] | (43) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (35) | [1],[2],[5] | $ (47) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [1],[5] | 6.50% | [8],[9] | 6.50% | [8],[9] | 6.50% | [8],[9] | |||
Investment, interest rate | 11.96% | [1],[4],[5] | 11.96% | [1],[4],[5] | 11.96% | [1],[4],[5] | 11.92% | [8],[9],[10] | 11.92% | [8],[9],[10] | 11.92% | [8],[9],[10] | |||
Investment, principal | $ 32,329 | [1],[5],[11] | $ 32,329 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 32,089 | [1],[5] | 32,070 | [8],[9] | |||||||||||
Investments at fair value | $ 31,915 | [1],[5] | $ 31,779 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | |||||||||
Investment, interest rate | 10.11% | 10.11% | 10.11% | 9.99% | 9.99% | 9.99% | |||||||||
Investment, principal | $ 4,988 | $ 5,000 | |||||||||||||
Investment owned, at cost | 4,853 | 4,860 | |||||||||||||
Investments at fair value | $ 5,012 | $ 4,969 | |||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.25% | [8],[9],[15] | 8.25% | [8],[9],[15] | 8.25% | [8],[9],[15] | |||
Investment, interest rate | 13.86% | [1],[4],[5],[13] | 13.86% | [1],[4],[5],[13] | 13.86% | [1],[4],[5],[13] | 13.90% | [8],[9],[10],[15] | 13.90% | [8],[9],[10],[15] | 13.90% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 0.50% | [1],[5],[13] | 0.50% | [1],[5],[13] | 0.50% | [1],[5],[13] | 0.50% | [8],[9],[15] | 0.50% | [8],[9],[15] | 0.50% | [8],[9],[15] | |||
Investment, principal | $ 9,697 | [1],[5],[11],[13] | $ 36,707 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 9,405 | [1],[5],[13] | 35,548 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 9,115 | [1],[5],[13] | $ 34,505 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.25% | [8],[9],[15] | 8.25% | [8],[9],[15] | 8.25% | [8],[9],[15] | |||
Investment, interest rate | 13.86% | [1],[4],[5],[13] | 13.86% | [1],[4],[5],[13] | 13.86% | [1],[4],[5],[13] | 13.90% | [8],[9],[10],[15] | 13.90% | [8],[9],[10],[15] | 13.90% | [8],[9],[10],[15] | |||
Investment, interest rate, paid in kind | 0.50% | [1],[5],[13] | 0.50% | [1],[5],[13] | 0.50% | [1],[5],[13] | 0.50% | [8],[9],[15] | 0.50% | [8],[9],[15] | 0.50% | [8],[9],[15] | |||
Investment, principal | $ 32,133 | [1],[5],[11],[13] | $ 13,504 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 31,203 | [1],[5],[13] | 13,058 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 30,205 | [1],[5],[13] | $ 12,694 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 204,454 | [1],[13] | 204,454 | [1],[13] | 204,454 | [1],[13] | 204,454 | [9],[15] | 204,454 | [9],[15] | 204,454 | [9],[15] | |||
Investment owned, at cost | $ 1,202 | [1],[13] | $ 1,202 | [9],[15] | |||||||||||
Investments at fair value | $ 1,073 | [1],[13] | $ 756 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 4.88% | 4.88% | 4.88% | |||||||||||
Investment, principal | [11] | $ 1,680 | |||||||||||||
Investment owned, at cost | 1,539 | ||||||||||||||
Investments at fair value | $ 1,573 | ||||||||||||||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | ||||||||||||
Investment, principal | $ 2,991 | ||||||||||||||
Investment owned, at cost | 2,991 | ||||||||||||||
Investments at fair value | $ 2,999 | ||||||||||||||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | ||||||||||||
Investment, principal | $ 1,495 | ||||||||||||||
Investment owned, at cost | 1,495 | ||||||||||||||
Investments at fair value | $ 1,500 | ||||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,037 | [1] | 1,037 | [1] | 1,037 | [1] | 1,037 | [9] | 1,037 | [9] | 1,037 | [9] | |||
Investment owned, at cost | $ 1,037 | [1] | $ 1,037 | [9] | |||||||||||
Investments at fair value | $ 1,024 | [1] | $ 951 | [9] | |||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [1],[2],[5] | 8.75% | [1],[2],[5] | 8.75% | [1],[2],[5] | 8.75% | [8],[9] | 8.75% | [8],[9] | 8.75% | [8],[9] | |||
Investment, interest rate | 14.20% | [1],[2],[4],[5] | 14.20% | [1],[2],[4],[5] | 14.20% | [1],[2],[4],[5] | 14.18% | [8],[9],[10] | 14.18% | [8],[9],[10] | 14.18% | [8],[9],[10] | |||
Investment, principal | $ 990 | [1],[2],[5],[11] | $ 8,010 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 954 | [1],[2],[5] | 7,799 | [8],[9] | |||||||||||
Investments at fair value | $ 921 | [1],[2],[5] | $ 7,778 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [1],[5] | 8.75% | [1],[5] | 8.75% | [1],[5] | 8.75% | [6],[8],[9] | 8.75% | [6],[8],[9] | 8.75% | [6],[8],[9] | |||
Investment, interest rate | [1],[4],[5] | 14.21% | 14.21% | 14.21% | |||||||||||
Investment, principal | $ 8,010 | [1],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 7,807 | [1],[5] | (35) | [6],[8],[9] | |||||||||||
Investments at fair value | $ 7,778 | [1],[5] | $ (68) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.23% | 5.23% | 5.23% | 5.23% | 5.23% | 5.23% | |||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.86% | 10.86% | 10.86% | |||||||||
Investment, principal | $ 158 | $ 138 | |||||||||||||
Investment owned, at cost | 158 | 138 | |||||||||||||
Investments at fair value | $ 107 | $ 94 | |||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.63% | 10.63% | 10.63% | 10.88% | 10.88% | 10.88% | |||||||||
Investment, principal | $ 6,012 | $ 6,029 | |||||||||||||
Investment owned, at cost | 6,010 | 6,025 | |||||||||||||
Investments at fair value | $ 4,073 | $ 4,110 | |||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.63% | 10.63% | 10.63% | 10.88% | 10.88% | 10.88% | |||||||||
Investment, principal | $ 8,091 | $ 8,113 | |||||||||||||
Investment owned, at cost | 8,090 | 8,111 | |||||||||||||
Investments at fair value | $ 5,482 | $ 5,531 | |||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.23% | 5.23% | 5.23% | 5.23% | 5.23% | 5.23% | |||||||||
Investment, interest rate | 10.61% | 10.61% | 10.61% | 10.86% | 10.86% | 10.86% | |||||||||
Investment, principal | $ 117 | $ 103 | |||||||||||||
Investment owned, at cost | 117 | 102 | |||||||||||||
Investments at fair value | $ 79 | $ 70 | |||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,184,630 | [1] | 1,184,630 | [1] | 1,184,630 | [1] | 1,184,630 | [9] | 1,184,630 | [9] | 1,184,630 | [9] | |||
Investment owned, at cost | $ 40,094 | [1] | $ 40,093 | [9] | |||||||||||
Investments at fair value | $ 36,226 | [1] | $ 36,226 | [9] | |||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate, paid in kind | 12% | [1] | 12% | [1] | 12% | [1] | 12% | [9] | 12% | [9] | 12% | [9] | |||
Investment, principal | $ 16,355 | [1],[11] | $ 15,874 | [9],[12] | |||||||||||
Investment owned, at cost | 14,634 | [1] | 14,100 | [9] | |||||||||||
Investments at fair value | $ 16,355 | [1] | $ 15,874 | [9] | |||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate, paid in kind | 12% | [1],[2] | 12% | [1],[2] | 12% | [1],[2] | 12% | [6],[9] | 12% | [6],[9] | 12% | [6],[9] | |||
Investment, principal | $ 3,005 | [1],[2],[11] | $ 1,359 | [6],[9],[12] | |||||||||||
Investment owned, at cost | 2,951 | [1],[2] | 1,337 | [6],[9] | |||||||||||
Investments at fair value | $ 3,005 | [1],[2] | $ 1,359 | [6],[9] | |||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,686 | [1] | 66,686 | [1] | 66,686 | [1] | 66,686 | [9] | 66,686 | [9] | 66,686 | [9] | |||
Investment owned, at cost | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | |||||||||
Investment, interest rate | 10.39% | 10.39% | 10.39% | 10.38% | 10.38% | 10.38% | |||||||||
Investment, principal | $ 2,970 | $ 2,977 | |||||||||||||
Investment owned, at cost | 2,595 | 2,580 | |||||||||||||
Investments at fair value | $ 2,881 | $ 2,799 | |||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | [1],[5] | 4.75% | [1],[5] | 4.75% | [1],[5] | 4.75% | [8],[9] | 4.75% | [8],[9] | 4.75% | [8],[9] | |||
Investment, interest rate | 10.39% | [1],[4],[5] | 10.39% | [1],[4],[5] | 10.39% | [1],[4],[5] | 10.38% | [8],[9],[10] | 10.38% | [8],[9],[10] | 10.38% | [8],[9],[10] | |||
Investment, principal | $ 4,440 | [1],[5],[11] | $ 4,452 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 3,833 | [1],[5] | 3,806 | [8],[9] | |||||||||||
Investments at fair value | $ 4,307 | [1],[5] | $ 4,184 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[5] | 8% | [1],[5] | 8% | [1],[5] | 8% | [8],[9] | 8% | [8],[9] | 8% | [8],[9] | |||
Investment, interest rate | 13.64% | [1],[4],[5] | 13.64% | [1],[4],[5] | 13.64% | [1],[4],[5] | 13.63% | [8],[9],[10] | 13.63% | [8],[9],[10] | 13.63% | [8],[9],[10] | |||
Investment, principal | $ 12,034 | [1],[5],[11] | $ 12,034 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 11,280 | [1],[5] | 11,250 | [8],[9] | |||||||||||
Investments at fair value | $ 10,169 | [1],[5] | $ 9,928 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.96% | 9.96% | 9.96% | 9.92% | 9.92% | 9.92% | |||||||||
Investment, principal | $ 8,801 | $ 8,801 | |||||||||||||
Investment owned, at cost | 8,459 | 8,442 | |||||||||||||
Investments at fair value | $ 8,842 | $ 8,794 | |||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.96% | 9.96% | 9.96% | 9.92% | 9.92% | 9.92% | |||||||||
Investment, principal | $ 5,228 | $ 5,227 | |||||||||||||
Investment owned, at cost | 5,041 | 5,032 | |||||||||||||
Investments at fair value | $ 5,252 | $ 5,224 | |||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [11] | $ 1,590 | |||||||||||||
Investment owned, at cost | 1,531 | ||||||||||||||
Investments at fair value | $ 1,592 | ||||||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[5],[17] | 6.75% | [1],[5],[17] | 6.75% | [1],[5],[17] | 6.75% | [8],[9] | 6.75% | [8],[9] | 6.75% | [8],[9] | |||
Investment, interest rate | [8],[9],[10] | 12.40% | 12.40% | 12.40% | |||||||||||
Investment, principal | $ 25,462 | [1],[5],[11],[17] | $ 25,527 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 23,085 | [1],[5],[17] | 23,859 | [8],[9] | |||||||||||
Investments at fair value | $ 14,131 | [1],[5],[17] | $ 19,954 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10% | [1],[2],[5] | 10% | [1],[2],[5] | 10% | [1],[2],[5] | 10% | [6],[8],[9] | 10% | [6],[8],[9] | 10% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (87) | [1],[2],[5] | (95) | [6],[8],[9] | |||||||||||
Investments at fair value | $ (85) | [1],[2],[5] | $ (93) | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10% | [1],[5] | 10% | [1],[5] | 10% | [1],[5] | 10% | [8],[9] | 10% | [8],[9] | 10% | [8],[9] | |||
Investment, interest rate | 15.36% | [1],[4],[5] | 15.36% | [1],[4],[5] | 15.36% | [1],[4],[5] | 15.24% | [8],[9],[10] | 15.24% | [8],[9],[10] | 15.24% | [8],[9],[10] | |||
Investment, principal | $ 25,418 | [1],[5],[11] | $ 25,558 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 24,707 | [1],[5] | 24,777 | [8],[9] | |||||||||||
Investments at fair value | $ 24,719 | [1],[5] | $ 24,791 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 991,019 | [1] | 991,019 | [1] | 991,019 | [1] | 991,019 | [9] | 991,019 | [9] | 991,019 | [9] | |||
Investment owned, at cost | $ 327 | [1] | $ 327 | [9] | |||||||||||
Investments at fair value | $ 1,536 | [1] | $ 1,625 | [9] | |||||||||||
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 9,307 | [13] | 9,307 | [13] | 9,307 | [13] | 9,307 | [15] | 9,307 | [15] | 9,307 | [15] | |||
Investment owned, at cost | $ 78 | [13] | $ 78 | [15] | |||||||||||
Investments at fair value | 19 | [13] | 13 | [15] | |||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 0 | ||||||||||||||
Investment owned, at cost | 54,791 | [2],[13],[21],[22],[23] | 54,791 | [6],[15],[24],[25],[26] | |||||||||||
Investments at fair value | $ 29,587 | [2],[13],[21],[22],[23] | $ 28,878 | [6],[15],[24],[25],[26] | $ 24,108 | 20,715 | |||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[2],[5],[13],[22] | 7% | [1],[2],[5],[13],[22] | 7% | [1],[2],[5],[13],[22] | 7% | [6],[9],[15],[24] | 7% | [6],[9],[15],[24] | 7% | [6],[9],[15],[24] | 7% | ||
Investment, interest rate | 12.44% | [1],[2],[4],[5],[13],[22] | 12.44% | [1],[2],[4],[5],[13],[22] | 12.44% | [1],[2],[4],[5],[13],[22] | 12.26% | [6],[8],[9],[10],[15],[24] | 12.26% | [6],[8],[9],[10],[15],[24] | 12.26% | [6],[8],[9],[10],[15],[24] | 10.17% | ||
Investment, principal | $ 112,656 | [1],[2],[5],[11],[13],[22] | $ 112,656 | [6],[9],[12],[15],[24] | $ 112,656 | ||||||||||
Investment owned, at cost | 112,656 | [1],[2],[5],[13],[22] | 112,656 | [6],[9],[15],[24] | |||||||||||
Investments at fair value | $ 112,656 | [1],[2],[5],[13],[22] | $ 112,656 | [6],[9],[15],[24] | $ 112,656 | $ 96,250 | |||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [1],[2],[5],[13] | 7.88% | [1],[2],[5],[13] | 7.88% | [1],[2],[5],[13] | 7.88% | [8],[9],[15] | 7.88% | [8],[9],[15] | 7.88% | [8],[9],[15] | |||
Investment, interest rate | [8],[9],[10],[15] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11],[13] | $ 7,191 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[5],[13] | 6,934 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[5],[13] | $ 6,937 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [1],[2],[5],[13] | 7.88% | [1],[2],[5],[13] | 7.88% | [1],[2],[5],[13] | 7.88% | [8],[9],[15] | 7.88% | [8],[9],[15] | 7.88% | [8],[9],[15] | |||
Investment, interest rate | [8],[9],[10],[15] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11],[13] | $ 2,697 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[5],[13] | 2,601 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[5],[13] | $ 2,602 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [1],[5],[13] | 7.88% | [1],[5],[13] | 7.88% | [1],[5],[13] | 7.88% | [6],[8],[9],[15] | 7.88% | [6],[8],[9],[15] | 7.88% | [6],[8],[9],[15] | |||
Investment, interest rate | [1],[4],[5],[13] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 7,191 | [1],[5],[11],[13] | $ 0 | [6],[8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 6,946 | [1],[5],[13] | 0 | [6],[8],[9],[15] | |||||||||||
Investments at fair value | $ 6,880 | [1],[5],[13] | $ 0 | [6],[8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.88% | [1],[5],[13] | 7.88% | [1],[5],[13] | 7.88% | [1],[5],[13] | 7.88% | [6],[8],[9],[15] | 7.88% | [6],[8],[9],[15] | 7.88% | [6],[8],[9],[15] | |||
Investment, interest rate | [1],[4],[5],[13] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | $ 2,697 | [1],[5],[11],[13] | $ 0 | [6],[8],[9],[12],[15] | |||||||||||
Investment owned, at cost | 2,605 | [1],[5],[13] | 0 | [6],[8],[9],[15] | |||||||||||
Investments at fair value | $ 2,580 | [1],[5],[13] | $ 0 | [6],[8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 58,210 | [1],[13] | 58,210 | [1],[13] | 58,210 | [1],[13] | 58,210 | [9],[15] | 58,210 | [9],[15] | 58,210 | [9],[15] | |||
Investment owned, at cost | $ 182 | [1],[13] | $ 182 | [9],[15] | |||||||||||
Investments at fair value | $ 44 | [1],[13] | $ 87 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 345,452 | [1] | 345,452 | [1] | 345,452 | [1] | 345,452 | [9] | 345,452 | [9] | 345,452 | [9] | |||
Investment owned, at cost | $ 367 | [1] | $ 367 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [8],[9],[10] | 13.04% | 13.04% | 13.04% | |||||||||||
Investment, principal | [8],[9],[12] | $ 821 | |||||||||||||
Investment owned, at cost | [8],[9] | 813 | |||||||||||||
Investments at fair value | [8],[9] | $ 776 | |||||||||||||
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,000 | [13] | 66,000 | [13] | 66,000 | [13] | 66,000 | [15] | 66,000 | [15] | 66,000 | [15] | |||
Investment owned, at cost | $ 139 | [13] | $ 139 | [15] | |||||||||||
Investments at fair value | $ 8 | [13] | $ 6 | [15] | |||||||||||
Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | 9.43% | 9.43% | 9.43% | |||||||||
Investment, principal | $ 7,661 | $ 7,680 | |||||||||||||
Investment owned, at cost | 7,622 | 7,642 | |||||||||||||
Investments at fair value | $ 7,646 | $ 7,643 | |||||||||||||
Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | 9.43% | 9.43% | 9.43% | |||||||||
Investment, principal | $ 3,283 | $ 3,292 | |||||||||||||
Investment owned, at cost | 3,267 | 3,275 | |||||||||||||
Investments at fair value | $ 3,277 | $ 3,276 | |||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[2],[5] | 5% | [1],[2],[5] | 5% | [1],[2],[5] | 5% | [6],[8],[9] | 5% | [6],[8],[9] | 5% | [6],[8],[9] | |||
Investment, interest rate | [6],[8],[9],[10] | 10.42% | 10.42% | 10.42% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 618 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | (40) | [1],[2],[5] | 576 | [6],[8],[9] | |||||||||||
Investments at fair value | $ (19) | [1],[2],[5] | $ 577 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [1],[5] | 5.25% | [1],[5] | 5.25% | [1],[5] | 5.25% | [8],[9] | 5.25% | [8],[9] | 5.25% | [8],[9] | |||
Investment, interest rate | 10.71% | [4],[5] | 10.71% | [4],[5] | 10.71% | [4],[5] | 10.67% | [8],[9],[10] | 10.67% | [8],[9],[10] | 10.67% | [8],[9],[10] | |||
Investment, principal | $ 4,477 | [1],[5],[11] | $ 4,488 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 4,415 | [1],[5] | 4,423 | [8],[9] | |||||||||||
Investments at fair value | $ 4,438 | [1],[5] | $ 4,425 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | |||||||||
Investment, principal | $ 8,820 | $ 8,843 | |||||||||||||
Investment owned, at cost | 8,697 | 8,713 | |||||||||||||
Investments at fair value | $ 8,743 | $ 8,717 | |||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.71% | 10.71% | 10.71% | 10.67% | 10.67% | 10.67% | |||||||||
Investment, principal | $ 4,900 | $ 4,913 | |||||||||||||
Investment owned, at cost | 4,832 | 4,840 | |||||||||||||
Investments at fair value | $ 4,857 | $ 4,843 | |||||||||||||
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [11] | $ 4,700 | |||||||||||||
Investment owned, at cost | 4,162 | ||||||||||||||
Investments at fair value | $ 4,377 | ||||||||||||||
Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.35% | 9.35% | 9.35% | 9.33% | 9.33% | 9.33% | |||||||||
Investment, principal | $ 8,000 | $ 8,000 | |||||||||||||
Investment owned, at cost | 7,880 | 7,880 | |||||||||||||
Investments at fair value | $ 7,926 | $ 7,834 | |||||||||||||
Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.35% | 9.35% | 9.35% | 9.33% | 9.33% | 9.33% | |||||||||
Investment, principal | $ 4,000 | $ 4,000 | |||||||||||||
Investment owned, at cost | 3,940 | 3,939 | |||||||||||||
Investments at fair value | $ 3,963 | $ 3,916 | |||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.25% | [1],[5],[13] | 8.50% | [8],[9],[15] | 8.50% | [8],[9],[15] | 8.50% | [8],[9],[15] | |||
Investment, interest rate | 12.21% | [1],[4],[5],[13] | 12.21% | [1],[4],[5],[13] | 12.21% | [1],[4],[5],[13] | 12.32% | [8],[9],[10],[15] | 12.32% | [8],[9],[10],[15] | 12.32% | [8],[9],[10],[15] | |||
Investment, principal | € | € 23,731 | [1],[5],[11],[13] | € 23,731 | [8],[9],[12],[15] | |||||||||||
Investment owned, at cost | $ 26,702 | [1],[5],[13] | $ 26,772 | [8],[9],[15] | |||||||||||
Investments at fair value | $ 26,149 | [1],[5],[13] | $ 24,937 | [8],[9],[15] | |||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[5] | 8% | [1],[5] | 8% | [1],[5] | 8% | [8],[9] | 8% | [8],[9] | 8% | [8],[9] | |||
Investment, interest rate | 13.36% | [1],[4],[5] | 13.36% | [1],[4],[5] | 13.36% | [1],[4],[5] | 13.32% | [8],[9],[10] | 13.32% | [8],[9],[10] | 13.32% | [8],[9],[10] | |||
Investment, principal | $ 49,395 | [1],[5],[11] | $ 49,520 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 48,462 | [1],[5] | 48,536 | [8],[9] | |||||||||||
Investments at fair value | $ 48,901 | [1],[5] | $ 49,148 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9],[27] | 7% | [8],[9],[27] | 7% | [8],[9],[27] | |||
Investment, interest rate | 12.66% | [1],[4],[5] | 12.66% | [1],[4],[5] | 12.66% | [1],[4],[5] | 12.44% | [8],[9],[10],[27] | 12.44% | [8],[9],[10],[27] | 12.44% | [8],[9],[10],[27] | |||
Investment, principal | $ 1,552 | [1],[5],[11] | $ 1,552 | [8],[9],[12],[27] | |||||||||||
Investment owned, at cost | 1,541 | [1],[5] | 1,540 | [8],[9],[27] | |||||||||||
Investments at fair value | $ 1,476 | [1],[5] | $ 1,478 | [8],[9],[27] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [6],[8],[9],[27] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [6],[8],[9],[10],[27] | 12.51% | 12.51% | 12.51% | |||||||||||
Investment, principal | [6],[8],[9],[12],[27] | $ 1,099 | |||||||||||||
Investment owned, at cost | [6],[8],[9],[27] | 1,062 | |||||||||||||
Investments at fair value | [6],[8],[9],[27] | $ 943 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[5] | 7% | [1],[5] | 7% | [1],[5] | 7% | [8],[9],[27] | 7% | [8],[9],[27] | 7% | [8],[9],[27] | |||
Investment, interest rate | 12.66% | [1],[4],[5] | 12.66% | [1],[4],[5] | 12.66% | [1],[4],[5] | 12.51% | [8],[9],[10],[27] | 12.51% | [8],[9],[10],[27] | 12.51% | [8],[9],[10],[27] | |||
Investment, principal | $ 2,742 | [1],[5],[11] | $ 32,104 | [8],[9],[12],[27] | |||||||||||
Investment owned, at cost | 2,721 | [1],[5] | 31,861 | [8],[9],[27] | |||||||||||
Investments at fair value | $ 2,608 | [1],[5] | $ 30,579 | [8],[9],[27] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 7% | [8],[9],[27] | 7% | [8],[9],[27] | 7% | [8],[9],[27] | |||
Investment, interest rate | 14.50% | [1],[4],[5] | 14.50% | [1],[4],[5] | 14.50% | [1],[4],[5] | 12.51% | [8],[9],[10],[27] | 12.51% | [8],[9],[10],[27] | 12.51% | [8],[9],[10],[27] | |||
Investment, principal | $ 3,298 | [1],[5],[11] | $ 2,749 | [8],[9],[12],[27] | |||||||||||
Investment owned, at cost | 3,175 | [1],[5] | 2,726 | [8],[9],[27] | |||||||||||
Investments at fair value | $ 3,137 | [1],[5] | $ 2,618 | [8],[9],[27] | |||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[4],[5] | 12.66% | 12.66% | 12.66% | |||||||||||
Investment, principal | [1],[5],[11] | $ 32,022 | |||||||||||||
Investment owned, at cost | [1],[5] | 31,799 | |||||||||||||
Investments at fair value | [1],[5] | $ 30,456 | |||||||||||||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[15] | 11.50% | 11.50% | 11.50% | |||||||||||
Investment, principal | [7],[9],[12],[15] | $ 4,984 | |||||||||||||
Investment owned, at cost | [7],[9],[15] | 4,894 | |||||||||||||
Investments at fair value | [7],[9],[15] | $ 4,785 | |||||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 13% | [1],[4],[5],[13] | 13% | [1],[4],[5],[13] | 13% | [1],[4],[5],[13] | 13% | [8],[9],[10],[15] | 13% | [8],[9],[10],[15] | 13% | [8],[9],[10],[15] | |||
Investment, principal | $ 50,419 | [1],[11],[13] | $ 50,419 | [9],[12],[15] | |||||||||||
Investment owned, at cost | 49,898 | [1],[13] | 49,842 | [9],[15] | |||||||||||
Investments at fair value | $ 49,869 | [1],[13] | $ 49,869 | [9],[15] | |||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.95% | 9.95% | 9.95% | 9.99% | 9.99% | 9.99% | |||||||||
Investment, principal | $ 8,194 | $ 8,215 | |||||||||||||
Investment owned, at cost | 7,570 | 7,559 | |||||||||||||
Investments at fair value | $ 8,025 | $ 7,913 | |||||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.95% | 9.95% | 9.95% | 9.99% | 9.99% | 9.99% | |||||||||
Investment, principal | $ 2,634 | $ 2,641 | |||||||||||||
Investment owned, at cost | 2,442 | 2,439 | |||||||||||||
Investments at fair value | $ 2,580 | $ 2,544 | |||||||||||||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[5] | 8% | [1],[5] | 8% | [1],[5] | 8% | [8] | 8% | [8] | 8% | [8] | |||
Investment, interest rate | 13.47% | [1],[4],[5] | 13.47% | [1],[4],[5] | 13.47% | [1],[4],[5] | 13.43% | [8],[10] | 13.43% | [8],[10] | 13.43% | [8],[10] | |||
Investment, principal | $ 12,843 | [1],[5],[11] | $ 12,843 | [8],[12] | |||||||||||
Investment owned, at cost | 12,617 | [1],[5] | 12,603 | [8] | |||||||||||
Investments at fair value | $ 12,847 | [1],[5] | $ 12,464 | [8] | |||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [6],[8],[9],[15] | 6% | 6% | 6% | |||||||||||
Investment, principal | [6],[8],[9],[12],[15] | $ 0 | |||||||||||||
Investment owned, at cost | [6],[8],[9],[15] | (29) | |||||||||||||
Investments at fair value | [6],[8],[9],[15] | $ (22) | |||||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[15] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[9],[10],[15] | 11.42% | 11.42% | 11.42% | |||||||||||
Investment, principal | [8],[9],[12],[15] | $ 28,826 | |||||||||||||
Investment owned, at cost | [8],[9],[15] | 28,595 | |||||||||||||
Investments at fair value | [8],[9],[15] | $ 28,537 | |||||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [1],[2],[5] | 9.75% | [1],[2],[5] | 9.75% | [1],[2],[5] | 9.75% | [6],[8],[9] | 9.75% | [6],[8],[9] | 9.75% | [6],[8],[9] | |||
Investment, interest rate | 15.21% | [1],[2],[4],[5] | 15.21% | [1],[2],[4],[5] | 15.21% | [1],[2],[4],[5] | 15.17% | [6],[8],[9],[10] | 15.17% | [6],[8],[9],[10] | 15.17% | [6],[8],[9],[10] | |||
Investment, principal | $ 2,119 | [1],[2],[5],[11] | $ 1,861 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 2,105 | [1],[2],[5] | 1,845 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 2,040 | [1],[2],[5] | $ 1,802 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [1],[5] | 9.75% | [1],[5] | 9.75% | [1],[5] | 9.75% | [8],[9] | 9.75% | [8],[9] | 9.75% | [8],[9] | |||
Investment, interest rate | 15.28% | [1],[4],[5] | 15.28% | [1],[4],[5] | 15.28% | [1],[4],[5] | 15.26% | [8],[9],[10] | 15.26% | [8],[9],[10] | 15.26% | [8],[9],[10] | |||
Investment, principal | $ 23,363 | [1],[5],[11] | $ 23,423 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 23,174 | [1],[5] | 23,207 | [8],[9] | |||||||||||
Investments at fair value | $ 22,545 | [1],[5] | $ 22,814 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.36% | [1],[4],[5] | 11.36% | [1],[4],[5] | 11.36% | [1],[4],[5] | 11.32% | [8],[9],[10] | 11.32% | [8],[9],[10] | 11.32% | [8],[9],[10] | |||
Investment, principal | $ 19,894 | [1],[5],[11] | $ 19,947 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 19,014 | [1],[5] | 19,013 | [8],[9] | |||||||||||
Investments at fair value | $ 19,211 | [1],[5] | $ 19,199 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[18] | 7.30% | 7.30% | 7.30% | |||||||||||
Investment, principal | [8],[9],[12],[18] | $ 19,163 | |||||||||||||
Investment owned, at cost | [8],[9],[18] | 19,163 | |||||||||||||
Investments at fair value | [8],[9],[18] | 18,340 | |||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate, paid in kind | [1],[17] | 10% | 10% | 10% | |||||||||||
Investment, principal | [1],[11],[17] | $ 5,065 | |||||||||||||
Investment owned, at cost | [1],[17] | 4,657 | |||||||||||||
Investments at fair value | $ 4,290 | [1],[17] | 0 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate, paid in kind | [1],[17] | 10% | 10% | 10% | |||||||||||
Investment, principal | [1],[11],[17] | $ 20,871 | |||||||||||||
Investment owned, at cost | [1],[17] | 19,217 | |||||||||||||
Investments at fair value | 18,723 | [1],[17] | 0 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 0 | ||||||||||||||
Investment owned, at cost | [1] | 0 | |||||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[18] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [8],[9],[12],[18] | $ 4,641 | |||||||||||||
Investment owned, at cost | [8],[9],[18] | 4,641 | |||||||||||||
Investments at fair value | [8],[9],[18] | $ 4,170 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9% | [1],[5],[17] | 9% | [1],[5],[17] | 9% | [1],[5],[17] | 7% | [8],[9] | 7% | [8],[9] | 7% | [8],[9] | |||
Investment, interest rate, paid in kind | [8],[9] | 12.65% | 12.65% | 12.65% | |||||||||||
Investment, principal | $ 46,832 | [1],[5],[11],[17] | $ 46,832 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 45,698 | [1],[5],[17] | 45,698 | [8],[9] | |||||||||||
Investments at fair value | $ 28,099 | [1],[5],[17] | $ 37,231 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 358,299 | [1] | 358,299 | [1] | 358,299 | [1] | 10,616 | [9] | 10,616 | [9] | 10,616 | [9] | |||
Investment owned, at cost | $ 2,912 | [1] | $ 120 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 10,616 | [1] | 10,616 | [1] | 10,616 | [1] | 358,299 | [9] | 358,299 | [9] | 358,299 | [9] | |||
Investment owned, at cost | $ 120 | [1] | $ 2,912 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 0 | [9] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 60,862 | [1] | 60,862 | [1] | 60,862 | [1] | 60,862 | [9] | 60,862 | [9] | 60,862 | [9] | |||
Investment owned, at cost | $ 1,207 | [1] | $ 1,207 | [9] | |||||||||||
Investments at fair value | $ 0 | [1] | $ 108 | [9] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 32,447 | [1] | 32,447 | [1] | 32,447 | [1] | 32,447 | [9] | 32,447 | [9] | 32,447 | [9] | |||
Investment owned, at cost | $ 33,353 | [1],[5] | $ 33,353 | [9] | |||||||||||
Investments at fair value | $ 11,131 | [1],[5] | 31,701 | [9] | |||||||||||
Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 332,637 | ||||||||||||||
Investment owned, at cost | 331,808 | ||||||||||||||
Investments at fair value | $ 322,179 | ||||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.48% | 11.48% | 11.48% | 11.42% | 11.42% | 11.42% | |||||||||
Investment, principal | $ 7,194 | $ 7,212 | |||||||||||||
Investment owned, at cost | 7,091 | 7,103 | |||||||||||||
Investments at fair value | $ 6,996 | $ 7,022 | |||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.48% | 11.48% | 11.48% | 11.42% | 11.42% | 11.42% | |||||||||
Investment, principal | $ 2,986 | $ 2,993 | |||||||||||||
Investment owned, at cost | 2,943 | 2,948 | |||||||||||||
Investments at fair value | $ 2,904 | $ 2,914 | |||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[5] | 6% | [1],[5] | 6% | [1],[5] | 6% | [8],[9] | 6% | [8],[9] | 6% | [8],[9] | |||
Investment, interest rate | 11.48% | [1],[4],[5] | 11.48% | [1],[4],[5] | 11.48% | [1],[4],[5] | 11.42% | [8],[9],[10] | 11.42% | [8],[9],[10] | 11.42% | [8],[9],[10] | |||
Investment, principal | $ 11,642 | [1],[5],[11] | $ 11,671 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 11,618 | [1],[5] | 11,646 | [8],[9] | |||||||||||
Investments at fair value | $ 11,321 | [1],[5] | $ 11,363 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | ||||||||||||
Investment, principal | $ 2,992 | ||||||||||||||
Investment owned, at cost | 2,944 | ||||||||||||||
Investments at fair value | $ 2,987 | ||||||||||||||
Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.61% | 9.61% | 9.61% | ||||||||||||
Investment, principal | $ 1,496 | ||||||||||||||
Investment owned, at cost | 1,472 | ||||||||||||||
Investments at fair value | $ 1,494 | ||||||||||||||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.71% | [5],[13] | 7.71% | [5],[13] | 7.71% | [5],[13] | 7.71% | [8],[15] | 7.71% | [8],[15] | 7.71% | [8],[15] | |||
Investment, interest rate | 13.12% | [4],[5],[13] | 13.12% | [4],[5],[13] | 13.12% | [4],[5],[13] | 13.06% | [8],[10],[15] | 13.06% | [8],[10],[15] | 13.06% | [8],[10],[15] | |||
Investment, principal | $ 1,000 | [5],[11],[13] | $ 1,000 | [8],[12],[15] | |||||||||||
Investment owned, at cost | 818 | [5],[13] | 816 | [8],[15] | |||||||||||
Investments at fair value | $ 930 | [5],[13] | $ 917 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 4.75% | [4],[5],[13] | 4.75% | [4],[5],[13] | 4.75% | [4],[5],[13] | 6.50% | [8],[10],[15] | 6.50% | [8],[10],[15] | 6.50% | [8],[10],[15] | |||
Investment, principal | $ 300 | [11],[13] | $ 4,500 | [12],[15] | |||||||||||
Investment owned, at cost | 266 | [13] | 4,115 | [15] | |||||||||||
Investments at fair value | $ 259 | [13] | $ 2,953 | [15] | |||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 6.50% | [4],[5],[13] | 6.50% | [4],[5],[13] | 6.50% | [4],[5],[13] | 4.75% | [8],[10],[15] | 4.75% | [8],[10],[15] | 4.75% | [8],[10],[15] | |||
Investment, principal | $ 4,500 | [11],[13] | $ 300 | [12],[15] | |||||||||||
Investment owned, at cost | 4,129 | [13] | 264 | [15] | |||||||||||
Investments at fair value | $ 3,252 | [13] | $ 245 | [15] | |||||||||||
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, principal | [5],[11] | $ 6,620 | |||||||||||||
Investment owned, at cost | [5] | 6,620 | |||||||||||||
Investments at fair value | [5] | $ 7,009 | |||||||||||||
Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.47% | 10.47% | 10.47% | 10.43% | 10.43% | 10.43% | |||||||||
Investment, principal | $ 6,289 | $ 6,305 | |||||||||||||
Investment owned, at cost | 6,247 | 6,257 | |||||||||||||
Investments at fair value | $ 5,248 | $ 5,500 | |||||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.68% | 12.68% | 12.68% | |||||||||||
Investment, principal | [8],[9],[12] | $ 1,140 | |||||||||||||
Investment owned, at cost | [8],[9] | 927 | |||||||||||||
Investments at fair value | [8],[9] | $ 1,139 | |||||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [1],[4],[5] | 21.66% | 21.66% | 21.66% | |||||||||||
Investment, principal | [1],[5],[11] | $ 1,290 | |||||||||||||
Investment owned, at cost | [1],[5] | 1,278 | |||||||||||||
Investments at fair value | [1],[5] | $ 1,203 | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[5] | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, principal | [1],[2],[5],[11] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[2],[5] | (81) | |||||||||||||
Investments at fair value | [1],[2],[5] | $ (82) | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[5] | 6.75% | [1],[5] | 6.75% | [1],[5] | 3.75% | [8] | 3.75% | [8] | 3.75% | [8] | |||
Investment, interest rate | 12.06% | [1],[4],[5] | 12.06% | [1],[4],[5] | 12.06% | [1],[4],[5] | 9.27% | [8],[10] | 9.27% | [8],[10] | 9.27% | [8],[10] | |||
Investment, principal | $ 29,838 | [1],[5],[11] | $ 11,792 | [8],[12] | |||||||||||
Investment owned, at cost | 29,105 | [1],[5] | 11,281 | [8] | |||||||||||
Investments at fair value | $ 29,092 | [1],[5] | $ 11,127 | [8] | |||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.27% | 9.27% | 9.27% | ||||||||||||
Investment, principal | $ 1,965 | ||||||||||||||
Investment owned, at cost | 1,920 | ||||||||||||||
Investments at fair value | $ 1,855 | ||||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.27% | 9.27% | 9.27% | ||||||||||||
Investment, principal | $ 983 | ||||||||||||||
Investment owned, at cost | 960 | ||||||||||||||
Investments at fair value | $ 927 | ||||||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10] | 12.65% | 12.65% | 12.65% | |||||||||||
Investment, principal | [8],[9],[12] | $ 5,000 | |||||||||||||
Investment owned, at cost | [8],[9] | 4,925 | |||||||||||||
Investments at fair value | [8],[9] | $ 4,263 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [1],[4],[5] | 21.66% | 21.66% | 21.66% | |||||||||||
Investment, principal | [1],[5],[11] | $ 1,543 | |||||||||||||
Investment owned, at cost | [1],[5] | 1,530 | |||||||||||||
Investments at fair value | [1],[5] | $ 1,439 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [8],[9],[10] | 21.68% | 21.68% | 21.68% | |||||||||||
Investment, principal | [8],[9],[12] | $ 1,565 | |||||||||||||
Investment owned, at cost | [8],[9] | 1,551 | |||||||||||||
Investments at fair value | [8],[9] | $ 1,464 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [8],[9],[10] | 21.68% | 21.68% | 21.68% | |||||||||||
Investment, principal | [8],[9],[12] | $ 1,323 | |||||||||||||
Investment owned, at cost | [8],[9] | 1,311 | |||||||||||||
Investments at fair value | [8],[9] | $ 1,237 | |||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 4,871 | [1] | 4,871 | [1] | 4,871 | [1] | 4,871 | [9] | 4,871 | [9] | 4,871 | [9] | |||
Investment owned, at cost | $ 46 | [1] | $ 46 | [9] | |||||||||||
Investments at fair value | $ 42 | [1] | $ 107 | [9] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||
Investment, interest rate | 11.71% | 11.71% | 11.71% | 11.67% | 11.67% | 11.67% | |||||||||
Investment, principal | $ 3,249 | $ 6,148 | |||||||||||||
Investment owned, at cost | 3,180 | 6,008 | |||||||||||||
Investments at fair value | $ 3,083 | $ 5,939 | |||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||
Investment, interest rate | 11.71% | 11.71% | 11.71% | 11.67% | 11.67% | 11.67% | |||||||||
Investment, principal | $ 2,035 | $ 3,843 | |||||||||||||
Investment owned, at cost | 1,992 | 3,756 | |||||||||||||
Investments at fair value | $ 1,931 | $ 3,712 | |||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 127,452 | [1] | 127,452 | [1] | 127,452 | [1] | 127,452 | [9] | 127,452 | [9] | 127,452 | [9] | |||
Investment owned, at cost | $ 2,057 | [1] | $ 2,057 | [9] | |||||||||||
Investments at fair value | $ 1,485 | [1] | $ 1,319 | [9] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [5] | 6.25% | [5] | 6.25% | [5] | 6.25% | [8] | 6.25% | [8] | 6.25% | [8] | |||
Investment, interest rate | 11.71% | [4],[5] | 11.71% | [4],[5] | 11.71% | [4],[5] | 11.67% | [8],[10] | 11.67% | [8],[10] | 11.67% | [8],[10] | |||
Investment, principal | $ 4,664 | [5],[11] | $ 8,983 | [8],[12] | |||||||||||
Investment owned, at cost | 4,526 | [5] | 8,698 | [8] | |||||||||||
Investments at fair value | $ 4,425 | [5] | $ 8,678 | [8] | |||||||||||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | [1],[5] | 4% | [1],[5] | 4% | [1],[5] | 4% | [8],[9] | 4% | [8],[9] | 4% | [8],[9] | |||
Investment, interest rate | 9.35% | [1],[4],[5] | 9.35% | [1],[4],[5] | 9.35% | [1],[4],[5] | 9.32% | [8],[9],[10] | 9.32% | [8],[9],[10] | 9.32% | [8],[9],[10] | |||
Investment, principal | $ 19,578 | [1],[5],[11] | $ 19,578 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 19,556 | [1],[5] | 19,568 | [8],[9] | |||||||||||
Investments at fair value | $ 19,577 | [1],[5] | $ 19,489 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[15] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[15] | 12.72% | 12.72% | 12.72% | |||||||||||
Investment, principal | £ | [8],[9],[12],[15] | £ 20,000 | |||||||||||||
Investment owned, at cost | [8],[9],[15] | $ 25,841 | |||||||||||||
Investments at fair value | [8],[9],[15] | $ 22,914 | |||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.25% | 3.25% | 3.25% | ||||||||||||
Investment, interest rate | 8.57% | 8.57% | 8.57% | ||||||||||||
Investment, principal | $ 4,320 | ||||||||||||||
Investment owned, at cost | 4,080 | ||||||||||||||
Investments at fair value | $ 4,251 | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.25% | 3.25% | 3.25% | 3.25% | 3.25% | 3.25% | |||||||||
Investment, interest rate | 8.61% | 8.61% | 8.61% | 8.57% | 8.57% | 8.57% | |||||||||
Investment, principal | $ 2,965 | $ 1,772 | |||||||||||||
Investment owned, at cost | 2,856 | 1,674 | |||||||||||||
Investments at fair value | $ 2,956 | $ 1,744 | |||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.25% | 3.25% | 3.25% | ||||||||||||
Investment, interest rate | 8.61% | 8.61% | 8.61% | ||||||||||||
Investment, principal | $ 2,394 | ||||||||||||||
Investment owned, at cost | 2,364 | ||||||||||||||
Investments at fair value | $ 2,387 | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.25% | 3.25% | 3.25% | ||||||||||||
Investment, interest rate | 8.61% | 8.61% | 8.61% | ||||||||||||
Investment, principal | $ 4,309 | ||||||||||||||
Investment owned, at cost | 4,081 | ||||||||||||||
Investments at fair value | $ 4,296 | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [11] | $ 4,960 | |||||||||||||
Investment owned, at cost | 4,379 | ||||||||||||||
Investments at fair value | $ 4,506 | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 21,523 | [1] | 21,523 | [1] | 21,523 | [1] | 21,523 | [9] | 21,523 | [9] | 21,523 | [9] | |||
Investment owned, at cost | $ 20,789 | [1] | $ 20,789 | [9] | |||||||||||
Investments at fair value | $ 20,542 | [1] | $ 20,074 | [9] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[2],[5] | 6.75% | [1],[2],[5] | 6.75% | [1],[2],[5] | 6.75% | [6],[8],[9] | 6.75% | [6],[8],[9] | 6.75% | [6],[8],[9] | |||
Investment, interest rate | 12.10% | [4],[5] | 12.10% | [4],[5] | 12.10% | [4],[5] | 12.14% | [6],[8],[9],[10] | 12.14% | [6],[8],[9],[10] | 12.14% | [6],[8],[9],[10] | |||
Investment, principal | $ 377 | [1],[2],[5],[11] | $ 377 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 336 | [1],[2],[5] | 334 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 276 | [1],[2],[5] | $ 296 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [8],[9] | 7.25% | [8],[9] | 7.25% | [8],[9] | |||
Investment, interest rate | 12.62% | [1],[4],[5] | 12.62% | [1],[4],[5] | 12.62% | [1],[4],[5] | 12.63% | [8],[9],[10] | 12.63% | [8],[9],[10] | 12.63% | [8],[9],[10] | |||
Investment, interest rate, paid in kind | [8],[9] | ||||||||||||||
Investment, principal | $ 24,427 | [1],[5],[11] | $ 24,427 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 24,151 | [1],[5] | 24,135 | [8],[9] | |||||||||||
Investments at fair value | $ 23,531 | [1],[5] | $ 23,548 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [1],[5] | 7.25% | [8],[9] | 7.25% | [8],[9] | 7.25% | [8],[9] | |||
Investment, interest rate | 12.62% | [1],[4],[5] | 12.62% | [1],[4],[5] | 12.62% | [1],[4],[5] | 12.63% | [8],[9],[10] | 12.63% | [8],[9],[10] | 12.63% | [8],[9],[10] | |||
Investment, principal | $ 3,636 | [1],[5],[11] | $ 3,636 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 3,604 | [1],[5] | 3,602 | [8],[9] | |||||||||||
Investments at fair value | $ 3,537 | [1],[5] | $ 3,574 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[2],[5] | 7.25% | [1],[2],[5] | 7.25% | [1],[2],[5] | 7.25% | [6],[8],[9] | 7.25% | [6],[8],[9] | 7.25% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[5] | 0 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[5] | $ 0 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [1],[2],[5] | 8.75% | [1],[2],[5] | 8.75% | [1],[2],[5] | 8.75% | [8],[9] | 8.75% | [8],[9] | 8.75% | [8],[9] | |||
Investment, interest rate | [8],[9],[10] | 11.75% | 11.75% | 11.75% | |||||||||||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 5,212 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[5] | 4,987 | [8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[5] | $ 4,990 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [1],[2],[5] | 8.75% | [1],[2],[5] | 8.75% | [1],[2],[5] | 8.75% | [6],[8],[9] | 8.75% | [6],[8],[9] | 8.75% | [6],[8],[9] | |||
Investment, principal | $ 0 | [1],[2],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 0 | [1],[2],[5] | 0 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[5] | $ 0 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [1],[5] | 8.75% | [1],[5] | 8.75% | [1],[5] | 8.75% | [6],[8],[9] | 8.75% | [6],[8],[9] | 8.75% | [6],[8],[9] | |||
Investment, interest rate | [1],[4],[5] | 11.75% | 11.75% | 11.75% | |||||||||||
Investment, principal | $ 5,212 | [1],[5],[11] | $ 0 | [6],[8],[9],[12] | |||||||||||
Investment owned, at cost | 5,001 | [1],[5] | 0 | [6],[8],[9] | |||||||||||
Investments at fair value | $ 5,043 | [1],[5] | $ 0 | [6],[8],[9] | |||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 53,700 | [1] | 53,700 | [1] | 53,700 | [1] | 53,700 | [9] | 53,700 | [9] | 53,700 | [9] | |||
Investment, principal | [11] | $ 0 | |||||||||||||
Investment owned, at cost | 175 | [1] | $ 175 | [9] | |||||||||||
Investments at fair value | $ 212 | [1] | $ 258 | [9] | |||||||||||
[1] As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. ten twenty ten twenty ten twenty ten twenty Income producing through payment of dividends or distributions. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. Income producing through payment of dividends or distributions. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC. |
Portfolio Investments - Summari
Portfolio Investments - Summarized Balance Sheet Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Dec. 31, 2023 | Sep. 30, 2023 | |
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Investments at fair value | $ 3,018,552 | $ 2,892,420 |
Cash and cash equivalents | 112,369 | 136,450 |
Restricted cash | 19,328 | 9,089 |
Other assets | 2,587 | 1,681 |
Total assets | 3,266,195 | 3,217,839 |
Credit facilities payable | 710,000 | 710,000 |
Secured borrowings | 12,965 | 18,106 |
Due to affiliate | 3,815 | 4,310 |
Total liabilities | 1,754,544 | 1,702,075 |
Total liabilities and net assets | 3,266,195 | 3,217,839 |
Investment owned, at cost | 3,187,750 | 3,044,119 |
SLF JV I | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Investments at fair value | 325,769 | 322,179 |
Cash and cash equivalents | 35,218 | 31,950 |
Restricted cash | 363 | 2,987 |
Other assets | 11,408 | 18,988 |
Total assets | 372,758 | 376,104 |
Credit facilities payable | 149,000 | 149,000 |
Secured borrowings | 30,760 | 38,845 |
Notes payable at fair value | 128,750 | 128,750 |
Due to affiliate | 30,648 | 26,630 |
Total liabilities | 339,158 | 343,225 |
Members' equity | 33,600 | 32,879 |
Total liabilities and net assets | 372,758 | 376,104 |
Investment owned, at cost | 334,451 | 331,808 |
Net proceeds | 128,750 | 128,750 |
OCSI Glick JV LLC | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Investments at fair value | 124,492 | 123,343 |
Cash and cash equivalents | 8,953 | 12,119 |
Restricted cash | 194 | 184 |
Other assets | 5,537 | 5,521 |
Total assets | 139,176 | 141,167 |
Credit facilities payable | 53,000 | 53,000 |
Notes payable at fair value | 58,259 | 57,201 |
Due to affiliate | 14,952 | 12,860 |
Total liabilities | 139,176 | 141,167 |
Members' equity | 0 | 0 |
Total liabilities and net assets | 139,176 | 141,167 |
Investment owned, at cost | 128,333 | 127,788 |
Net proceeds | $ 66,685 | $ 66,685 |
Portfolio Investments - Summa_2
Portfolio Investments - Summarized Statement of Operations Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Total investment income | $ 97,985 | $ 79,179 |
Interest expense | 32,170 | 20,719 |
Total expenses | 55,296 | 41,043 |
Net investment income before taxes | 44,189 | 38,886 |
Net increase (decrease) in net assets resulting from operations | 10,535 | 13,172 |
SLF JV I | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Interest income | 9,708 | 8,781 |
Fee income | 57 | 0 |
Total investment income | 9,765 | 8,781 |
Other expenses | 71 | 69 |
Total expenses | 8,070 | 6,760 |
Net investment income before taxes | 1,695 | 2,021 |
Net unrealized appreciation (depreciation) | 947 | (2,207) |
Realized gain (loss) | (322) | (992) |
Net increase (decrease) in net assets resulting from operations | 2,320 | (1,178) |
SLF JV I | Senior Credit Facility | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Interest expense | 3,906 | 3,709 |
SLF JV I | SLF JV I Notes | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Interest expense | 4,093 | 2,982 |
OCSI Glick JV LLC | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Interest income | 3,798 | 3,403 |
Fee income | 25 | 0 |
Total investment income | 3,823 | 3,403 |
Other expenses | 37 | 53 |
Total expenses | 3,183 | 2,662 |
Net investment income before taxes | 640 | 741 |
Net unrealized appreciation (depreciation) | (453) | (651) |
Realized gain (loss) | (187) | (90) |
Net increase (decrease) in net assets resulting from operations | 0 | 0 |
OCSI Glick JV LLC | Senior Credit Facility | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Interest expense | 1,452 | 1,285 |
OCSI Glick JV LLC | Glick JV Notes | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Interest expense | $ 1,694 | $ 1,324 |
Fee Income (Details)
Fee Income (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | ||
Fee income | $ 1,307 | $ 2,021 |
Recurring fee income | $ 200 | $ 200 |
Share Data and Net Assets - Sch
Share Data and Net Assets - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | ||
Earnings (loss) per common share — basic and diluted: | |||
Net increase (decrease) in net assets resulting from operations | $ 10,535 | $ 13,172 | |
Weighted average common shares outstanding - basic (shares) | [1] | 77,840 | 61,142 |
Weighted average common shares outstanding - diluted (shares) | [1] | 77,840 | 61,142 |
Earnings (loss) per common share - basic (dollars per share) | [1] | $ 0.14 | $ 0.22 |
Earnings (loss) per common share - diluted (dollars per share) | [1] | $ 0.14 | $ 0.22 |
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Share Data and Net Assets - S_2
Share Data and Net Assets - Schedule of Changes in Net Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Investment Company, Net Assets [Roll Forward] | ||
Beginning of period (shares) | 77,225,000 | |
Net assets at beginning of period | $ 1,515,764 | $ 1,245,563 |
Net investment income | 44,189 | 38,808 |
Net unrealized appreciation (depreciation) | (25,025) | (22,982) |
Net realized gains (losses) | (8,453) | (3,203) |
(Provision) benefit for taxes on realized and unrealized gains (losses) | (176) | 549 |
Distributions to stockholders | (48,897) | (58,679) |
Issuance of common stock in connection with the "at the market" offering | $ 32,313 | $ 0 |
Issuance of common stock under dividend reinvestment plan (shares) | 98,605,000 | 94,879,000 |
Issuance of common stock under dividend reinvestment plan | $ 1,936 | $ 1,933 |
End of period (shares) | 78,965,000 | |
Net assets at end of period | $ 1,511,651 | $ 1,201,989 |
Common Stock | ||
Investment Company, Net Assets [Roll Forward] | ||
Beginning of period (shares) | 77,225,000 | 61,125,000 |
Net assets at beginning of period | $ 772 | $ 611 |
Issuance of common stock in connection with the "at the market" offering (shares) | 1,641,000 | |
Issuance of common stock in connection with the "at the market" offering | $ 17 | |
Issuance of common stock under dividend reinvestment plan (shares) | 99,000 | 95,000 |
Issuance of common stock under dividend reinvestment plan | $ 1 | $ 1 |
End of period (shares) | 78,965,000 | 61,220,000 |
Net assets at end of period | $ 790 | $ 612 |
Additional paid-in-capital | ||
Investment Company, Net Assets [Roll Forward] | ||
Net assets at beginning of period | 2,166,330 | 1,827,721 |
Issuance of common stock in connection with the "at the market" offering | 32,296 | |
Issuance of common stock under dividend reinvestment plan | 1,935 | 1,932 |
Net assets at end of period | 2,200,561 | 1,829,653 |
Accumulated Overdistributed Earnings | ||
Investment Company, Net Assets [Roll Forward] | ||
Net assets at beginning of period | (651,338) | (582,769) |
Net investment income | 44,189 | 38,808 |
Net unrealized appreciation (depreciation) | (25,025) | (22,982) |
Net realized gains (losses) | (8,453) | (3,203) |
(Provision) benefit for taxes on realized and unrealized gains (losses) | (176) | 549 |
Distributions to stockholders | (48,897) | (58,679) |
Net assets at end of period | $ (689,700) | $ (628,276) |
Share Data and Net Assets - S_3
Share Data and Net Assets - Schedule of Distributions (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |||
Dec. 29, 2023 | Dec. 30, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Investment Company, Changes in Net Assets [Line Items] | ||||
Amount per share (in dollars per share) | $ 0.62 | $ 0.96 | ||
Distributions to stockholders | $ 47,000 | $ 56,800 | ||
Issuance of common stock under dividend reinvestment plan (shares) | 98,605,000 | 94,879,000 | ||
Issuance of common stock under dividend reinvestment plan | $ 1,936 | $ 1,933 | ||
Quarterly | ||||
Investment Company, Changes in Net Assets [Line Items] | ||||
Amount per share (in dollars per share) | $ 0.55 | $ 0.54 | ||
Distributions to stockholders | $ 41,700 | $ 32,000 | ||
Issuance of common stock under dividend reinvestment plan (shares) | 87,472,000 | 53,369,000 | ||
Issuance of common stock under dividend reinvestment plan | $ 1,700 | $ 1,100 | ||
Special | ||||
Investment Company, Changes in Net Assets [Line Items] | ||||
Amount per share (in dollars per share) | $ 0.07 | $ 0.42 | ||
Distributions to stockholders | $ 5,300 | $ 24,800 | ||
Issuance of common stock under dividend reinvestment plan (shares) | 11,133,000 | 41,510,000 | ||
Issuance of common stock under dividend reinvestment plan | $ 200 | $ 800 |
Share Data and Net Assets - Nar
Share Data and Net Assets - Narrative (Details) $ in Millions | 3 Months Ended | |||
Feb. 08, 2023 USD ($) | Feb. 07, 2022 USD ($) | Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 shares | |
Investment Company, Changes in Net Assets [Line Items] | ||||
Stock split, conversion ratio | 0.3333 | |||
Issuance of common stock under dividend reinvestment plan (shares) | 98,605,000 | 94,879,000 | ||
Aggregate offering price | $ | $ 125 | $ 125 | ||
At the Market | ||||
Investment Company, Changes in Net Assets [Line Items] | ||||
Dividend reinvestment plan, percent of current market price | 95% | |||
Number of shares issued (in shares) | 1,641,416 | |||
Net proceeds | $ | $ 32.3 | |||
Common Stock | ||||
Investment Company, Changes in Net Assets [Line Items] | ||||
Issuance of common stock under dividend reinvestment plan (shares) | 98,605 | 94,879 |
Share Data and Net Assets - S_4
Share Data and Net Assets - Schedule of Common Stock Issued and Sold (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Investment Company, Changes in Net Assets [Line Items] | ||
Gross Proceeds | $ 32,398 | $ 0 |
Placement Agent Fees | $ 85 | $ 0 |
At the Market | ||
Investment Company, Changes in Net Assets [Line Items] | ||
Number of Shares Issued (in shares) | 1,641,416 | |
Gross Proceeds | $ 32,725 | |
Placement Agent Fees | 327 | |
Net Proceeds | $ 32,398 | |
Average Sales Price per Share (in dollars per share) | $ 19.94 | |
Net proceeds excluding offering costs | $ 100 |
Borrowings - Narrative (Details
Borrowings - Narrative (Details) - USD ($) | 3 Months Ended | |||||
Aug. 15, 2023 | May 18, 2021 | Feb. 25, 2020 | Dec. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2023 | |
Line of Credit Facility [Line Items] | ||||||
Borrowings outstanding | $ 710,000,000 | $ 710,000,000 | ||||
Interest expense | 32,170,000 | $ 20,719,000 | ||||
Fair Value | $ 1,626,776,000 | 1,588,201,000 | ||||
Interest rate swap | Designated as Hedging Instrument | ||||||
Line of Credit Facility [Line Items] | ||||||
Interest rate | 2.70% | |||||
Notional amount | $ 350,000,000 | |||||
Secured Overnight Financing Rate | ||||||
Line of Credit Facility [Line Items] | ||||||
Interest rate | 2% | |||||
Secured Overnight Financing Rate | Minimum | ||||||
Line of Credit Facility [Line Items] | ||||||
Debt instrument, basis spread, variable rate | 0.11448% | |||||
Secured Overnight Financing Rate | Maximum | ||||||
Line of Credit Facility [Line Items] | ||||||
Debt instrument, basis spread, variable rate | 0.26161% | |||||
London Interbank Offered Rate (LIBOR) | Interest rate swap | Designated as Hedging Instrument | ||||||
Line of Credit Facility [Line Items] | ||||||
Floating interest rate | 1.658% | |||||
Base Rate | ||||||
Line of Credit Facility [Line Items] | ||||||
Interest rate | 1% | |||||
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest rate swap | Designated as Hedging Instrument | ||||||
Line of Credit Facility [Line Items] | ||||||
Floating interest rate | 0.26161% | |||||
2025 Notes | ||||||
Line of Credit Facility [Line Items] | ||||||
Principal amount | $ 300,000,000 | $ 300,000,000 | 300,000,000 | |||
Net proceeds | 293,800,000 | |||||
Unaccreted discount | 2,500,000 | $ 600,000 | 700,000 | |||
Underwriting commissions | 3,000,000 | |||||
Offering costs | $ 700,000 | |||||
Interest rate, percentage | 3.50% | 3.50% | ||||
Redemption price | 100% | |||||
2027 Notes | ||||||
Line of Credit Facility [Line Items] | ||||||
Principal amount | $ 350,000,000 | $ 350,000,000 | 350,000,000 | |||
Net proceeds | 344,800,000 | |||||
Unaccreted discount | 1,000,000 | $ 500,000 | 600,000 | |||
Underwriting commissions | 3,500,000 | |||||
Offering costs | $ 700,000 | |||||
Interest rate, percentage | 2.70% | 2.70% | ||||
Redemption price | 100% | |||||
2029 Notes | ||||||
Line of Credit Facility [Line Items] | ||||||
Principal amount | $ 300,000,000 | $ 300,000,000 | 300,000,000 | |||
Net proceeds | 292,900,000 | |||||
Unaccreted discount | 3,500,000 | $ 3,200,000 | 3,400,000 | |||
Underwriting commissions | 3,000,000 | |||||
Offering costs | $ 600,000 | |||||
Interest rate, percentage | 7.10% | 7.10% | ||||
Redemption price | 100% | |||||
2029 Notes | Interest rate swap | Designated as Hedging Instrument | ||||||
Line of Credit Facility [Line Items] | ||||||
Interest rate | 7.10% | |||||
Notional amount | $ 300,000,000 | |||||
2029 Notes | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest rate swap | Designated as Hedging Instrument | ||||||
Line of Credit Facility [Line Items] | ||||||
Floating interest rate | 3.1255% | |||||
Line of Credit | Revolving Credit Facility | Syndicated Facility | ||||||
Line of Credit Facility [Line Items] | ||||||
Borrowing capacity | $ 1,218,000,000 | |||||
Accordion feature, increase limit | 1,250,000,000 | |||||
Borrowing capacity subject to expiration | $ 1,035,000,000 | |||||
Debt instrument, covenant, total assets to total indebtedness, ratio, minimum threshold | 1.50 | |||||
Debt instrument, covenant, consolidated EBITDA to consolidated interest expense, ratio, minimum threshold | 2.25 | |||||
Borrowings outstanding | $ 430,000,000 | 430,000,000 | ||||
Fair value | $ 430,000,000 | 430,000,000 | ||||
Weighted average interest rate | 7.621% | 5.849% | ||||
Interest expense inclusive of fees | $ 9,600,000 | $ 10,000,000 | ||||
Line of Credit | Revolving Credit Facility | Citibank Facility | ||||||
Line of Credit Facility [Line Items] | ||||||
Weighted average interest rate | 6.508% | |||||
Interest expense inclusive of fees | $ 2,700,000 | |||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility payable | ||||||
Line of Credit Facility [Line Items] | ||||||
Borrowing capacity | 400,000,000 | |||||
Borrowings outstanding | $ 280,000,000 | 280,000,000 | ||||
Weighted average interest rate | 8.204% | |||||
Interest expense inclusive of fees | $ 6,100,000 | |||||
Unused capacity, commitment fee | 0.50% | |||||
Commitment fee, unused capacity threshold percentage | 30% | |||||
Fair Value | $ 280,000,000 | $ 280,000,000 | ||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility payable | Secured Overnight Financing Rate | After Reinvestment Period | ||||||
Line of Credit Facility [Line Items] | ||||||
Debt instrument, basis spread, variable rate | 4% | |||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility payable | Secured Overnight Financing Rate | Minimum | ||||||
Line of Credit Facility [Line Items] | ||||||
Debt instrument, basis spread, variable rate | 2.50% | |||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, Syndicated Loans | Secured Overnight Financing Rate | ||||||
Line of Credit Facility [Line Items] | ||||||
Debt instrument, basis spread, variable rate | 2% | |||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, All Other Loans | Secured Overnight Financing Rate | ||||||
Line of Credit Facility [Line Items] | ||||||
Debt instrument, basis spread, variable rate | 2.75% |
Borrowings - Components of the
Borrowings - Components of the Carrying Value of Notes (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 | Aug. 15, 2023 | May 18, 2021 | Feb. 25, 2020 |
Debt Instrument [Line Items] | |||||
Unamortized financing costs | $ (6,534) | $ (7,076) | |||
Net carrying value | 1,622,717 | 1,600,731 | |||
2025 Notes | |||||
Debt Instrument [Line Items] | |||||
Principal | 300,000 | 300,000 | $ 300,000 | ||
Unamortized financing costs | (900) | (1,100) | |||
Unaccreted discount | (600) | (700) | $ (2,500) | ||
Interest rate swap fair value adjustment | 0 | 0 | |||
Net carrying value | 298,500 | 298,200 | |||
Fair Value | 291,200 | 286,400 | |||
2027 Notes | |||||
Debt Instrument [Line Items] | |||||
Principal | 350,000 | 350,000 | $ 350,000 | ||
Unamortized financing costs | (2,300) | (2,500) | |||
Unaccreted discount | (500) | (600) | $ (1,000) | ||
Interest rate swap fair value adjustment | (30,400) | (40,500) | |||
Net carrying value | 316,800 | 306,400 | |||
Fair Value | 315,100 | 301,800 | |||
2029 Notes | |||||
Debt Instrument [Line Items] | |||||
Principal | 300,000 | 300,000 | $ 300,000 | ||
Unamortized financing costs | (3,400) | (3,500) | |||
Unaccreted discount | (3,200) | (3,400) | $ (3,500) | ||
Interest rate swap fair value adjustment | 4,000 | (7,000) | |||
Net carrying value | 297,400 | 286,100 | |||
Fair Value | $ 310,400 | $ 290,000 |
Borrowings - Components of Inte
Borrowings - Components of Interest and Other Debt Expenses (Details) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
2025 Notes | ||
Debt Instrument [Line Items] | ||
Coupon interest | $ 2.6 | $ 2.6 |
Amortization of financing costs and discount | 0.3 | 0.3 |
Effect of interest rate swap | 0 | 0 |
Total interest expense | $ 2.9 | $ 2.9 |
Coupon interest rate | 3.50% | 3.50% |
2027 Notes | ||
Debt Instrument [Line Items] | ||
Coupon interest | $ 2.4 | $ 2.4 |
Amortization of financing costs and discount | 0.2 | 0.2 |
Effect of interest rate swap | 4.2 | 2.5 |
Total interest expense | $ 6.8 | $ 5.1 |
Coupon interest rate | 7.455% | 5.586% |
2029 Notes | ||
Debt Instrument [Line Items] | ||
Coupon interest | $ 5.3 | |
Amortization of financing costs and discount | 0.3 | |
Effect of interest rate swap | 1.2 | |
Total interest expense | $ 6.8 | |
Coupon interest rate | 8.679% |
Taxable_Distributable Income _3
Taxable/Distributable Income and Dividend Distributions - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2023 | |
Investments, Owned, Federal Income Tax Note [Line Items] | |||
Undistributed ordinary income, net | $ 558,300 | ||
Valuation allowance | $ 8,200 | ||
Deferred tax assets | 8,200 | ||
(Provision) benefit for taxes on realized and unrealized gains (losses) | $ 176 | $ (549) | |
Cost of investments | 3,070,000 | ||
Unrealized appreciation | 529,500 | ||
Unrealized depreciation | 704,500 | ||
Unrealized appreciation (depreciation) | 175,000 | ||
Short-Term Capital Loss Carryforward | |||
Investments, Owned, Federal Income Tax Note [Line Items] | |||
Undistributed ordinary income, net | 70,300 | ||
Long-Term Capital Loss Carryforward | |||
Investments, Owned, Federal Income Tax Note [Line Items] | |||
Undistributed ordinary income, net | $ 488,000 |
Taxable_Distributable Income _4
Taxable/Distributable Income and Dividend Distributions - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | ||
Net increase (decrease) in net assets resulting from operations | $ 10,535 | $ 13,172 |
Net unrealized (appreciation) depreciation | 25,025 | 22,982 |
Book/tax difference due to capital losses suspended (utilized) | 6,540 | 8,013 |
Other book/tax differences | (7,178) | (12,910) |
Taxable/Distributable Income | $ 34,922 | $ 31,257 |
Taxable_Distributable Income _5
Taxable/Distributable Income and Dividend Distributions - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 |
Income Tax Disclosure [Abstract] | ||
Undistributed ordinary income, net | $ 33,525 | |
Net realized capital losses | (509,832) | |
Unrealized losses, net | (175,031) | |
Accumulated overdistributed earnings | $ (689,700) | $ (651,338) |
Realized Gains or Losses and _3
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Aggregate Net Realized Gains (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | $ (8,453) | $ (3,203) |
Continental Intermodal Group LP | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | (6,800) | |
P&L Development LLC | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | (1,900) | |
Zephyr Bidco Limited | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | (1,700) | |
Lift Brands Holdings, Inc. | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | (1,400) | |
Foreign currency forward contracts | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | 4,100 | 4,400 |
Other, net | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | $ (800) | (1,700) |
Carvana Co. | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | (2,800) | |
ASP Unifrax Holdings Inc. | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | (2,100) | |
Global Medical Response Inc. | ||
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | $ (1,000) |
Realized Gains or Losses and _4
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule of Investments [Line Items] | ||
Net realized gains (losses) | $ (8,453) | $ (3,203) |
Net unrealized appreciation (depreciation) | (25,025) | (22,982) |
Investments in equity securities | ||
Schedule of Investments [Line Items] | ||
Net unrealized appreciation (depreciation) | (18,800) | 2,800 |
Investments in debt securities | ||
Schedule of Investments [Line Items] | ||
Net unrealized appreciation (depreciation) | (13,700) | 18,700 |
Foreign currency forward contract | ||
Schedule of Investments [Line Items] | ||
Net unrealized appreciation (depreciation) | (7,800) | 11,000 |
Exited Investments | ||
Schedule of Investments [Line Items] | ||
Net unrealized appreciation (depreciation) | $ 15,300 | $ 3,900 |
Related Party Transactions (Det
Related Party Transactions (Details) | 3 Months Ended | ||||
May 03, 2019 | May 02, 2019 | Dec. 31, 2023 USD ($) component | Dec. 31, 2022 USD ($) | Sep. 30, 2023 USD ($) | |
Related Party Transaction [Line Items] | |||||
Base management fee and incentive fee payable | $ 19,004,000 | $ 19,547,000 | |||
Base management fee rate (as a percent) | 1% | 1.50% | |||
Base management fee, threshold (as a percent) | 200% | ||||
Base management fee | 11,477,000 | $ 9,917,000 | |||
Part I incentive fee | 9,028,000 | 7,703,000 | |||
Due to affiliate | $ 3,815,000 | 4,310,000 | |||
Affiliated Entity | |||||
Related Party Transaction [Line Items] | |||||
Related party transaction, termination, notice period | 60 days | ||||
Administrator expense | $ 400,000 | 400,000 | |||
General and administrative expenses | 100,000 | 100,000 | |||
Due to affiliate | 3,800,000 | $ 4,300,000 | |||
Oaktree Strategic Income Corporation Merger | |||||
Related Party Transaction [Line Items] | |||||
Investment company, contractual fee waived | $ 6,000,000 | ||||
Contractual fee waived, period otherwise receivable (in years) | 2 years | ||||
Contractual fee waived, per quarter | $ 750,000 | ||||
Oaktree Strategic Income II, Inc. Merger | |||||
Related Party Transaction [Line Items] | |||||
Investment company, contractual fee waived | 9,000,000 | ||||
Oaktree Strategic Income II, Inc Merger, Year One | |||||
Related Party Transaction [Line Items] | |||||
Investment company, contractual fee waived | 6,000,000 | ||||
Contractual fee waived, per quarter | 1,500,000 | ||||
Oaktree Strategic Income II, Inc Merger, Year Two | |||||
Related Party Transaction [Line Items] | |||||
Investment company, contractual fee waived | 3,000,000 | ||||
Contractual fee waived, per quarter | $ 750,000 | ||||
Investment Advisory Agreement | |||||
Related Party Transaction [Line Items] | |||||
Number of components | component | 2 | ||||
Related party transaction, termination, notice period | 60 days | ||||
Base management fee | $ 10,000,000 | 9,200,000 | |||
Management incentive rate | 1.50% | ||||
Investment Advisory Agreement | Affiliated Entity | |||||
Related Party Transaction [Line Items] | |||||
Part I incentive fee | $ 9,000,000 | 7,700,000 | |||
Incentive fee expense | 9,600,000 | ||||
Accrued capital gains incentive fees expensed (reversed) | $ 0 | $ 0 | |||
Investment Advisory Agreement Incentive Rate Pre Incentive Fee Net Investment Income Below Catch Up | |||||
Related Party Transaction [Line Items] | |||||
Management incentive rate | 100% | ||||
Investment Advisory Agreement Incentive Rate Quarterly Catch Up Threshold | |||||
Related Party Transaction [Line Items] | |||||
Management incentive rate | 1.8182% | ||||
Investment Advisory Agreement Cumulative Pre Incentive Fee Net Investment Income | |||||
Related Party Transaction [Line Items] | |||||
Management incentive rate | 17.50% | ||||
Investment Advisory Agreement - Incentive Rate, Realized Capital Gains | Affiliated Entity | |||||
Related Party Transaction [Line Items] | |||||
Management incentive rate | 17.50% |
Financial Highlights - Portfoli
Financial Highlights - Portfolio Composition (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | ||
Dec. 31, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | ||
Investment Company, Financial Highlights [Roll Forward] | |||
Net asset value per share at beginning of period (in dollars per share) | $ 19.63 | $ 20.38 | |
Net investment income (in dollars per share) | [1] | 0.57 | 0.63 |
Net unrealized appreciation (depreciation) (in dollars per share) | (0.33) | (0.38) | |
Net realized gains (losses) (in dollars per share) | (0.11) | (0.05) | |
(Provision) benefit for taxes on realized and unrealized gains (losses) (in dollars per share) | 0 | 0.01 | |
Distributions of net investment income to stockholders (dollars per share) | (0.62) | (0.96) | |
Net asset value per share at end of period (in dollars per share) | [2] | 19.14 | 19.63 |
Per share market value at beginning of period (in dollars per share) | 20.12 | 18 | |
Per share market value at end of period (in dollars per share) | $ 20.42 | $ 20.61 | |
Total return | 4.70% | 19.90% | |
Common shares outstanding at beginning of period (in shares) | shares | 77,225 | 61,125 | |
Common shares outstanding at end of period (in shares) | shares | [2] | 78,965 | 61,220 |
Net assets at beginning of period | $ | $ 1,515,764 | $ 1,245,563 | |
Net assets at end of period | $ | 1,511,651 | 1,201,989 | |
Average net assets | $ | $ 1,524,243 | $ 1,241,806 | |
Ratio of net investment income to average net assets | 11.50% | 12.40% | |
Ratio of total expenses to average net assets | 14.39% | 13.11% | |
Ratio of net expenses to average net assets | 14% | 12.87% | |
Ratio of portfolio turnover to average investments at fair value | 7.36% | 4.24% | |
Weighted average outstanding debt | $ | $ 1,660,435 | $ 1,441,326 | |
Average debt per share (dollars per share) | $ 21.33 | $ 23.57 | |
Asset coverage ratio | 188.66% | 176.31% | |
Stock split, conversion ratio | 0.3333 | ||
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.[2]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Derivative Instruments - Schedu
Derivative Instruments - Schedule of Foreign Currency Forward Contracts and Interest Rate Swap (Details) € in Thousands, £ in Thousands, $ in Thousands | Dec. 31, 2023 USD ($) | Dec. 31, 2023 EUR (€) | Dec. 31, 2023 GBP (£) | Sep. 30, 2023 USD ($) | Sep. 30, 2023 EUR (€) | Sep. 30, 2023 GBP (£) |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Derivative assets at fair value | $ 0 | $ 4,910 | ||||
Derivative liability at fair value | 29,316 | 47,519 | ||||
Foreign currency forward contract | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Derivative assets at fair value | 0 | 4,910 | ||||
Derivative liability at fair value | 2,914 | 0 | ||||
Interest rate swap | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Derivative assets at fair value | 4,013 | 0 | ||||
Derivative liability at fair value | 30,415 | 47,519 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 8, 2024 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 36,775 | |||||
Notional Amount to be Sold | € | € 34,350 | |||||
Derivative assets at fair value | 0 | |||||
Derivative liability at fair value | 1,227 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 42,182 | |||||
Notional Amount to be Sold | € | € 34,350 | € 38,026 | ||||
Derivative assets at fair value | 1,857 | |||||
Derivative liability at fair value | 1,227 | 0 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 8, 2024 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 47,403 | |||||
Notional Amount to be Sold | £ | £ 38,500 | |||||
Derivative assets at fair value | 0 | |||||
Derivative liability at fair value | 1,687 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 72,098 | |||||
Notional Amount to be Sold | £ | £ 56,556 | |||||
Derivative assets at fair value | 3,053 | |||||
Derivative liability at fair value | 1,687 | 0 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount | 300,000 | 300,000 | ||||
Derivative assets at fair value | 4,013 | 0 | ||||
Derivative liability at fair value | 0 | 7,000 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount | 350,000 | 350,000 | ||||
Derivative assets at fair value | 0 | 0 | ||||
Derivative liability at fair value | $ 30,415 | $ 40,519 |
Derivative Instruments - Narrat
Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Due from broker | $ 26,520 | $ 54,260 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 |
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 226,613 | $ 232,740 |
Debt and Equity Financing | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 199,500 | 205,600 |
Amount which can be drawn immediately | $ 165,900 | 154,200 |
JV Financing | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 27,100 |
Commitments and Contingencies_2
Commitments and Contingencies - Schedule of Unfunded Commitments by Investment (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Sep. 30, 2023 |
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 226,613 | $ 232,740 |
Investment, Identifier [Axis]: 107 Fair Street LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,227 | 4,227 |
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 26,969 | 26,969 |
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,139 | 2,343 |
Investment, Identifier [Axis]: ADC Therapeutics SA | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,020 | 3,020 |
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 396 | 396 |
Investment, Identifier [Axis]: Accupac, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,500 | 4,500 |
Investment, Identifier [Axis]: Acquia Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,376 | 1,376 |
Investment, Identifier [Axis]: Amspec Parent LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 9,372 | 0 |
Investment, Identifier [Axis]: Assembled Brands Capital LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 7,514 |
Investment, Identifier [Axis]: Avalara, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 5,047 | 5,047 |
Investment, Identifier [Axis]: Berner Food & Beverage, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,005 | 1,622 |
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 9,383 | 14,547 |
Investment, Identifier [Axis]: Coupa Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,075 | 2,075 |
Investment, Identifier [Axis]: Coyote Buyer, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,333 | 400 |
Investment, Identifier [Axis]: Crewline Buyer, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,180 | 0 |
Investment, Identifier [Axis]: Delta Leasing SPV II LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 14,639 |
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 782 | 1,078 |
Investment, Identifier [Axis]: Dominion Diagnostics, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,484 | 3,484 |
Investment, Identifier [Axis]: Enverus Holdings, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,135 | 0 |
Investment, Identifier [Axis]: Establishment Labs Holdings Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,384 | 3,384 |
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,626 | 1,626 |
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 9,465 | 13,090 |
Investment, Identifier [Axis]: Finastra USA, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 896 | 960 |
Investment, Identifier [Axis]: Galileo Parent, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,484 | 2,061 |
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 5,286 | 5,286 |
Investment, Identifier [Axis]: Harrow, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,011 | 4,011 |
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 2,458 |
Investment, Identifier [Axis]: Inventus Power, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,792 | 3,792 |
Investment, Identifier [Axis]: Kings Buyer, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 5,462 | 5,189 |
Investment, Identifier [Axis]: LSL Holdco, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,650 | 2,650 |
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 1,383 |
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,786 | 821 |
Investment, Identifier [Axis]: MND Holdings III Corp | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,280 | 9,122 |
Investment, Identifier [Axis]: MRI Software LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 7,260 | 2,261 |
Investment, Identifier [Axis]: Mindbody, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,762 | 4,762 |
Investment, Identifier [Axis]: Next Holdco, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 7,051 | 0 |
Investment, Identifier [Axis]: OCSI Glick JV LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 13,998 | 13,998 |
Investment, Identifier [Axis]: OTG Management, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 467 | 3,190 |
Investment, Identifier [Axis]: Oranje Holdco, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,904 | 1,904 |
Investment, Identifier [Axis]: PPW Aero Buyer, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,368 | 1,466 |
Investment, Identifier [Axis]: PRGX Global, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,127 | 3,127 |
Investment, Identifier [Axis]: PetVet Care Centers, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 13,732 | 0 |
Investment, Identifier [Axis]: Pluralsight, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,068 | 1,787 |
Investment, Identifier [Axis]: Relativity ODA LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,762 | 2,762 |
Investment, Identifier [Axis]: SCP Eye Care Services, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,366 | 2,356 |
Investment, Identifier [Axis]: SIO2 Medical Products, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 238 | 1,821 |
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,102 | 3,102 |
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 13,125 | 13,125 |
Investment, Identifier [Axis]: Seres Therapeutics, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 8,090 | 8,090 |
Investment, Identifier [Axis]: Spanx, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,092 | 2,473 |
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 2,199 |
Investment, Identifier [Axis]: Tahoe Bidco B.V. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 2,162 |
Investment, Identifier [Axis]: Telestream Holdings Corporation | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 148 | 407 |
Investment, Identifier [Axis]: WP CPP Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,272 | 0 |
Investment, Identifier [Axis]: iCIMs, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 6,924 | 7,466 |
Investment, Identifier [Axis]: scPharmaceuticals Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 5,212 | $ 5,212 |
Subsequent Events (Details)
Subsequent Events (Details) | Jan. 26, 2024 $ / shares |
Subsequent Event | Quarterly | |
Subsequent Event [Line Items] | |
Common stock, dividends, per share, declared (in dollars per share) | $ 0.55 |
Schedule_12-14 - Schedule of In
Schedule 12-14 - Schedule of Investments in and Advances to Affiliates (Details) € in Thousands, £ in Thousands, $ in Thousands | 3 Months Ended | |||||||||||||
Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2023 EUR (€) shares | Dec. 31, 2023 GBP (£) shares | Sep. 30, 2023 USD ($) shares | Sep. 30, 2023 EUR (€) shares | Sep. 30, 2023 GBP (£) shares | ||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | $ 2,892,420 | |||||||||||||
Fair Value, Ending Balance | $ 3,018,552 | |||||||||||||
Investment owned, percent of net assets | 199.69% | 199.69% | 199.69% | 190.82% | 190.82% | 190.82% | ||||||||
Affiliate investments | ||||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | $ 23,349 | |||||||||||||
Fair Value, Ending Balance | 24,442 | |||||||||||||
Control investments | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | 211,365 | $ 186,002 | ||||||||||||
Net Realized Gain (Loss) | 786 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 7,962 | 5,630 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 297,091 | [1],[2] | 214,165 | |||||||||||
Gross Additions | 20,002 | 22,255 | ||||||||||||
Gross Reductions | (784) | (3,958) | ||||||||||||
Fair Value, Ending Balance | $ 316,309 | [3],[4] | $ 232,462 | |||||||||||
Investment owned, percent of net assets | 20.90% | 19.30% | 20.90% | 20.90% | 20.90% | [3],[4] | 20.90% | [3],[4] | 20.90% | [3],[4] | ||||
Affiliate Investments | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | $ 25,936 | $ 21,464 | ||||||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 329 | 646 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 23,349 | [5] | 26,196 | |||||||||||
Gross Additions | 25,220 | 75 | ||||||||||||
Gross Reductions | (24,127) | (3,098) | ||||||||||||
Fair Value, Ending Balance | $ 24,442 | [6] | $ 23,173 | |||||||||||
Investment owned, percent of net assets | 1.60% | 1.90% | 1.60% | 1.60% | 1.60% | [6] | 1.60% | [6] | 1.60% | [6] | ||||
Investment, Affiliated Issuer, Control and Affiliate | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | $ 237,301 | $ 207,466 | ||||||||||||
Net Realized Gain (Loss) | 786 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 8,291 | 6,276 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 320,440 | 240,361 | ||||||||||||
Gross Additions | 45,222 | 22,330 | ||||||||||||
Gross Reductions | (24,911) | (7,056) | ||||||||||||
Fair Value, Ending Balance | $ 340,751 | $ 255,635 | ||||||||||||
Investment owned, percent of net assets | 22.50% | 21.20% | 22.50% | 22.50% | ||||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 12.50% | [7],[8],[9],[10],[11] | 12.50% | [7],[8],[9],[10],[11] | 12.50% | [7],[8],[9],[10],[11] | 12.50% | [12],[13],[14],[15],[16] | 12.50% | [12],[13],[14],[15],[16] | 12.50% | [12],[13],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 1,269 | [7],[8],[9],[17] | $ 1,269 | [12],[13],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[13],[15] | 1,214 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[9] | $ 1,228 | ||||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11% | [7],[8],[10],[11] | 11% | [7],[8],[10],[11] | 11% | [7],[8],[10],[11] | 11% | [12],[14],[15],[16] | 11% | [12],[14],[15],[16] | 11% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 18,869 | [7],[8],[17] | $ 18,869 | [12],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15] | 18,443 | ||||||||||||
Fair Value, Ending Balance | [7],[8] | $ 18,443 | ||||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 12% | [7],[8],[9],[10],[11] | 12% | [7],[8],[9],[10],[11] | 12% | [7],[8],[9],[10],[11] | 12% | [12],[13],[14],[15],[16] | 12% | [12],[13],[14],[15],[16] | 12% | [12],[13],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 4,274 | [7],[8],[9],[17] | $ 4,070 | [12],[13],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[13],[15] | 4,022 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[9] | $ 4,210 | ||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 14.25% | [7],[10],[11],[19],[20] | 14.25% | [7],[10],[11],[19],[20] | 14.25% | [7],[10],[11],[19],[20] | 14.25% | [14],[15],[16],[21],[22] | 14.25% | [14],[15],[16],[21],[22] | 14.25% | [14],[15],[16],[21],[22] | ||
Investment owned, balance, principal amount | $ 21,434 | [7],[17],[19],[20] | $ 21,434 | [15],[18],[21],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21],[22] | 21,220 | ||||||||||||
Fair Value, Ending Balance | [7],[19],[20] | $ 21,273 | ||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate, paid in kind | 22.50% | [7],[19] | 22.50% | [7],[19] | 22.50% | [7],[19] | 20% | [15],[21] | 20% | [15],[21] | 20% | [15],[21] | ||
Investment owned, balance, principal amount | $ 6,329 | [7],[17],[19] | $ 6,021 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 5,900 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 6,219 | ||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 12.11% | [7],[10],[11] | 12.11% | [7],[10],[11] | 12.11% | [7],[10],[11] | 11.90% | [14],[15],[16] | 11.90% | [14],[15],[16] | 11.90% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 3,373 | [7],[11],[17] | $ 3,446 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 3,383 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 3,295 | ||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 12.14% | [7],[10],[11] | 12.14% | [7],[10],[11] | 12.14% | [7],[10],[11] | 12.15% | [14],[15],[16] | 12.15% | [14],[15],[16] | 12.15% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 944 | [7],[11],[17] | $ 17,901 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 17,575 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 922 | ||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 12.11% | [7],[10],[11] | 12.11% | [7],[10],[11] | 12.11% | [7],[10],[11] | 12.13% | [14],[15],[16] | 12.13% | [14],[15],[16] | 12.13% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 17,532 | [7],[11],[17] | $ 963 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 945 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 17,130 | ||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[11],[19] | 7.50% | [7],[11],[19] | 7.50% | [7],[11],[19] | 7.50% | [14],[15],[21] | 7.50% | [14],[15],[21] | 7.50% | [14],[15],[21] | ||
Investment, interest rate | [14],[15],[16],[21] | 13.04% | 13.04% | 13.04% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17],[19] | $ 6,589 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 6,276 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[19] | $ (38) | ||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[11],[19] | 7.50% | [7],[11],[19] | 7.50% | [7],[11],[19] | 7.50% | [12],[14],[15],[21] | 7.50% | [12],[14],[15],[21] | 7.50% | [12],[14],[15],[21] | ||
Investment, interest rate | [10],[11] | 13% | 13% | 13% | ||||||||||
Investment owned, balance, principal amount | $ 6,589 | [7],[11],[17],[19] | $ 0 | [12],[14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[21] | (38) | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 6,276 | ||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 28,948 | [7],[19] | 28,948 | [7],[19] | 28,948 | [7],[19] | 28,948 | [15],[21] | 28,948 | [15],[21] | 28,948 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 6 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | 13 | ||||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[21] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [14],[16],[21] | 8.86% | 8.86% | 8.86% | ||||||||||
Investment owned, balance, principal amount | € | [14],[18],[21] | € 5,500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[21] | $ 5,825 | ||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 17,870 | [7] | 17,870 | [7] | 17,870 | [7] | 17,870 | [15] | 17,870 | [15] | 17,870 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 2,826 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 2,494 | ||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[11] | 7.75% | [7],[11] | 7.75% | [7],[11] | 7.75% | [14],[15] | 7.75% | [14],[15] | 7.75% | [14],[15] | ||
Investment, interest rate | 13.21% | [7],[10],[11] | 13.21% | [7],[10],[11] | 13.21% | [7],[10],[11] | 13.17% | [14],[15],[16] | 13.17% | [14],[15],[16] | 13.17% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 16,032 | [7],[11],[17] | $ 17,873 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 17,687 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 15,743 | ||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11],[19] | 6% | [7],[8],[11],[19] | 6% | [7],[8],[11],[19] | 6% | [12],[14],[15],[21] | 6% | [12],[14],[15],[21] | 6% | [12],[14],[15],[21] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17],[19] | $ 0 | [12],[14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[21] | (23) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[19] | $ (24) | ||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11],[19] | 6% | [7],[11],[19] | 6% | [7],[11],[19] | 6% | [14],[15],[21] | 6% | [14],[15],[21] | 6% | [14],[15],[21] | ||
Investment, interest rate | 11.64% | [10],[11] | 11.64% | [10],[11] | 11.64% | [10],[11] | 11.63% | [14],[15],[16],[21] | 11.63% | [14],[15],[16],[21] | 11.63% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 3,268 | [7],[11],[17],[19] | $ 3,276 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 3,084 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | 3,072 | ||||||||||||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | 12,583 | [7],[17],[19],[20] | $ 12,222 | [15],[18],[21],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21],[22] | 11,795 | ||||||||||||
Fair Value, Ending Balance | [7],[19],[20] | $ 12,268 | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | ||
Investment, interest rate | 11.52% | [7],[8],[10],[11] | 11.52% | [7],[8],[10],[11] | 11.52% | [7],[8],[10],[11] | 11.55% | [12],[14],[15],[16] | 11.55% | [12],[14],[15],[16] | 11.55% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 2,033 | [7],[8],[11],[17] | $ 2,033 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 2,027 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 2,027 | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | [14],[15],[16] | 11.55% | 11.55% | 11.55% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 20,234 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 20,194 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (8) | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | ||
Investment, interest rate | 11.52% | [7],[10],[11] | 11.52% | [7],[10],[11] | 11.52% | [7],[10],[11] | [12],[14],[15],[16] | [12],[14],[15],[16] | [12],[14],[15],[16] | |||||
Investment owned, balance, principal amount | $ 20,182 | [7],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (8) | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 20,141 | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | ||
Investment, interest rate | 12.72% | [7],[8],[10],[11] | 12.72% | [7],[8],[10],[11] | 12.72% | [7],[8],[10],[11] | 12.72% | [12],[14],[15],[16] | 12.72% | [12],[14],[15],[16] | 12.72% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 1,333 | [7],[8],[11],[17] | $ 1,333 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 1,324 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 1,333 | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate | 12.74% | [7],[10],[11] | 12.74% | [7],[10],[11] | 12.74% | [7],[10],[11] | 12.34% | [14],[15],[16] | 12.34% | [14],[15],[16] | 12.34% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 6,400 | [7],[11],[17] | $ 6,400 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 6,380 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 6,406 | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate | 12.74% | [7],[8],[10],[11] | 12.74% | [7],[8],[10],[11] | 12.74% | [7],[8],[10],[11] | 12.34% | [14],[15],[16] | 12.34% | [14],[15],[16] | 12.34% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 25,332 | [7],[8],[11],[17] | $ 25,332 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 25,253 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 25,357 | ||||||||||||
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 5,715 | [7] | 5,715 | [7] | 5,715 | [7] | 5,715 | [15] | 5,715 | [15] | 5,715 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[11],[23] | 8.50% | [7],[11],[23] | 8.50% | [7],[11],[23] | 8.50% | [14],[15],[24] | 8.50% | [14],[15],[24] | 8.50% | [14],[15],[24] | ||
Investment owned, balance, principal amount | $ 23,562 | [7],[11],[17],[23] | $ 23,562 | [14],[15],[18],[24] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[24] | 9,797 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 9,797 | ||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 5.50% | [10],[11],[19] | 5.50% | [10],[11],[19] | 5.50% | [10],[11],[19] | 5.50% | [14],[16],[21] | 5.50% | [14],[16],[21] | 5.50% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 4,050 | [17],[19] | $ 4,050 | [18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | 2,918 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 3,181 | ||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 11.50% | [7],[11] | 11.50% | [7],[11] | 11.50% | [7],[11] | 11.50% | [14],[15] | 11.50% | [14],[15] | 11.50% | [14],[15] | ||
Investment, interest rate | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 5% | [14],[15],[16] | 5% | [14],[15],[16] | 5% | [14],[15],[16] | ||
Investment, interest rate, paid in kind | 11.95% | [7],[11] | 11.95% | [7],[11] | 11.95% | [7],[11] | 11.99% | [14],[15] | 11.99% | [14],[15] | 11.99% | [14],[15] | ||
Investment owned, balance, principal amount | $ 9,331 | [7],[11],[17] | $ 9,057 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 8,332 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 8,585 | ||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 598,283 | 598,283 | 598,283 | 598,283 | [15] | 598,283 | [15] | 598,283 | [15] | |||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 1,915 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 1,562 | ||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [14],[15] | 7.50% | [14],[15] | 7.50% | [14],[15] | ||
Investment, interest rate | 13% | [7],[10],[11] | 13% | [7],[10],[11] | 13% | [7],[10],[11] | 13.04% | [14],[15],[16] | 13.04% | [14],[15],[16] | 13.04% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 16,825 | [7],[11],[17] | $ 17,053 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 15,929 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 15,732 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 382,275 | [19] | 382,275 | [19] | 382,275 | [19] | 471,253 | [21] | 471,253 | [21] | 471,253 | [21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | $ 4,298 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 4,389 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 141,640 | [7],[19],[25] | 141,640 | [7],[19],[25] | 141,640 | [7],[19],[25] | 141,640 | [15],[21],[26] | 141,640 | [15],[21],[26] | 141,640 | [15],[21],[26] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21],[26] | $ 368 | ||||||||||||
Fair Value, Ending Balance | [7],[19],[25] | $ 446 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [15],[21] | 3.50% | [15],[21] | 3.50% | [15],[21] | ||
Investment owned, balance, principal amount | $ 28,964 | [7],[17],[19] | $ 28,464 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 27,687 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 28,167 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [15],[21] | 3.50% | [15],[21] | 3.50% | [15],[21] | ||
Investment owned, balance, principal amount | $ 28,178 | [7],[17],[19] | $ 2,121 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 2,063 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 27,403 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [15],[21] | 3.50% | [15],[21] | 3.50% | [15],[21] | ||
Investment owned, balance, principal amount | $ 2,159 | [7],[17],[19] | $ 27,692 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 26,936 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 2,099 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [7],[10],[11],[19] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | 8.50% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [7],[19] | 3.50% | [15],[21] | 3.50% | [15],[21] | 3.50% | [15],[21] | ||
Investment owned, balance, principal amount | $ 2,100 | [7],[17],[19] | $ 2,064 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 2,007 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | 2,042 | ||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment, interest rate | [14],[15],[16] | 14.14% | 14.14% | 14.14% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 17,048 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 15,087 | ||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment, interest rate | [7],[10],[11] | 14.25% | 14.25% | 14.25% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 17,048 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 15,940 | ||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.25% | [11] | 6.25% | [11] | 6.25% | [11] | 6.25% | [14] | 6.25% | [14] | 6.25% | [14] | ||
Investment, interest rate | 11.91% | [10],[11] | 11.91% | [10],[11] | 11.91% | [10],[11] | 11.81% | [14],[16] | 11.81% | [14],[16] | 11.81% | [14],[16] | ||
Investment owned, balance, principal amount | $ 14,907 | [11],[17] | $ 19,115 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 16,798 | ||||||||||||
Fair Value, Ending Balance | [11] | 12,548 | ||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[21] | 8% | 8% | 8% | ||||||||||
Investment, interest rate | [14],[16],[21] | 13.54% | 13.54% | 13.54% | ||||||||||
Investment owned, balance, principal amount | [14],[18],[21] | $ 12,500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[21] | $ 11,865 | ||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (113) | ||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [7],[10],[11] | 11.10% | 11.10% | 11.10% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 33,558 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 32,719 | ||||||||||||
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (60) | ||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 3.75% | [11] | 3.75% | [11] | 3.75% | [11] | 3.75% | [14] | 3.75% | [14] | 3.75% | [14] | ||
Investment, interest rate | 9.36% | [10],[11] | 9.36% | [10],[11] | 9.36% | [10],[11] | 9.40% | [14],[16] | 9.40% | [14],[16] | 9.40% | [14],[16] | ||
Investment owned, balance, principal amount | $ 3,691 | [11],[17] | $ 3,700 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 2,669 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 2,257 | ||||||||||||
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[10],[11] | 10.86% | 10.86% | 10.86% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 47,810 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 47,093 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 7% | [14],[15],[21] | 7% | [14],[15],[21] | 7% | [14],[15],[21] | ||
Investment, interest rate | 12.71% | [7],[10],[11],[19] | 12.71% | [7],[10],[11],[19] | 12.71% | [7],[10],[11],[19] | 10.95% | [14],[15],[16],[21] | 10.95% | [14],[15],[16],[21] | 10.95% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | € | € 4,949 | [7],[11],[17],[19] | € 3,017 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 3,226 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 6,372 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11],[19] | 6% | [7],[11],[19] | 6% | [7],[11],[19] | 5.75% | [14],[15],[21] | 5.75% | [14],[15],[21] | 5.75% | [14],[15],[21] | ||
Investment, interest rate | 11.82% | [7],[10],[11],[19] | 11.82% | [7],[10],[11],[19] | 11.82% | [7],[10],[11],[19] | 11.57% | [14],[15],[16],[21] | 11.57% | [14],[15],[16],[21] | 11.57% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 10,519 | [7],[11],[17],[19] | $ 10,519 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 10,624 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 10,624 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11],[19] | 6% | [7],[11],[19] | 6% | [7],[11],[19] | 7% | [14],[15],[21] | 7% | [14],[15],[21] | 7% | [14],[15],[21] | ||
Investment, interest rate | 9.95% | [7],[10],[11],[19] | 9.95% | [7],[10],[11],[19] | 9.95% | [7],[10],[11],[19] | 12.46% | [14],[15],[16],[21] | 12.46% | [14],[15],[16],[21] | 12.46% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | £ | £ 3,649 | [7],[11],[17],[19] | £ 4,949 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 6,101 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 4,083 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 7% | [14],[15],[21] | 7% | [14],[15],[21] | 7% | [14],[15],[21] | ||
Investment, interest rate | 11.20% | [7],[10],[11],[19] | 11.20% | [7],[10],[11],[19] | 11.20% | [7],[10],[11],[19] | 12.46% | [14],[15],[16],[21] | 12.46% | [14],[15],[16],[21] | 12.46% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | £ | £ 3,017 | [7],[11],[17],[19] | £ 23,675 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 29,185 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 3,366 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 5.75% | [14],[15],[21] | 5.75% | [14],[15],[21] | 5.75% | [14],[15],[21] | ||
Investment, interest rate | 12.71% | [7],[10],[11],[19] | 12.71% | [7],[10],[11],[19] | 12.71% | [7],[10],[11],[19] | 9.70% | [14],[15],[16],[21] | 9.70% | [14],[15],[16],[21] | 9.70% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | £ | £ 23,675 | [7],[11],[17],[19] | £ 3,649 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 3,914 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 30,482 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 12,463,242 | [7] | 1,609,201 | 12,463,242 | [7] | 12,463,242 | [7] | 1,783,332 | [15] | 1,783,332 | [15] | 1,783,332 | [15] | |
Net Realized Gain (Loss) | $ 0 | $ 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 89 | [15] | 370 | |||||||||||
Gross Additions | 1,159 | 0 | ||||||||||||
Gross Reductions | (251) | (16) | ||||||||||||
Fair Value, Ending Balance | $ 997 | [7] | $ 354 | |||||||||||
Investment owned, percent of net assets | 0.10% | 0% | 0.10% | 0.10% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | 6.75% | [12],[14],[15] | 6.75% | [12],[14],[15] | 6.75% | [12],[14],[15] | |||||||
Investment, interest rate | 11.48% | 12.14% | [12],[14],[15],[16] | 12.14% | [12],[14],[15],[16] | 12.14% | [12],[14],[15],[16] | |||||||
Investment owned, balance, principal amount | $ 21,464 | $ 21,852 | [12],[14],[15],[18] | |||||||||||
Net Realized Gain (Loss) | $ 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 329 | 646 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 21,823 | [12],[14],[15] | 24,225 | |||||||||||
Gross Additions | 33 | 55 | ||||||||||||
Gross Reductions | (21,856) | (3,028) | ||||||||||||
Fair Value, Ending Balance | $ 0 | $ 21,252 | ||||||||||||
Investment owned, percent of net assets | 0% | 1.80% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,019,169 | 1,129,453 | [15] | 1,129,453 | [15] | 1,129,453 | [15] | |||||||
Net Realized Gain (Loss) | $ 0 | $ 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 1,005 | [15] | 1,223 | |||||||||||
Gross Additions | 154 | 20 | ||||||||||||
Gross Reductions | (1,159) | 0 | ||||||||||||
Fair Value, Ending Balance | $ 0 | $ 1,243 | ||||||||||||
Investment owned, percent of net assets | 0% | 0.10% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | [7] | 70,425 | 78,045 | [7] | 78,045 | [7] | 78,045 | [15] | 78,045 | [15] | 78,045 | [15] | |
Net Realized Gain (Loss) | $ 0 | $ 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | [15] | 0 | |||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 0 | [7] | $ 0 | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.25% | [11] | 5.25% | [11] | 5.25% | [11] | 5.25% | [14] | 5.25% | [14] | 5.25% | [14] | ||
Investment, interest rate | 10.86% | [10],[11] | 10.86% | [10],[11] | 10.86% | [10],[11] | 10.90% | [14],[16] | 10.90% | [14],[16] | 10.90% | [14],[16] | ||
Investment owned, balance, principal amount | $ 15,688 | [11],[17] | $ 8,490 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 6,414 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 10,230 | ||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11],[19] | 7% | [7],[11],[19] | 7% | [7],[11],[19] | 6% | [14],[15],[21] | 6% | [14],[15],[21] | 6% | [14],[15],[21] | ||
Investment, interest rate | 8.45% | [7],[10],[11],[19] | 8.45% | [7],[10],[11],[19] | 8.45% | [7],[10],[11],[19] | 11.49% | [14],[15],[16],[21] | 11.49% | [14],[15],[16],[21] | 11.49% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 4% | 4% | 4% | |||||||||||
Investment owned, balance, principal amount | $ 29,801 | [7],[11],[17],[19] | $ 29,509 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 28,284 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 28,311 | ||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[8],[11] | 7.25% | [7],[8],[11] | 7.25% | [7],[8],[11] | 7.25% | [12],[14],[15] | 7.25% | [12],[14],[15] | 7.25% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (78) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (63) | ||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [14],[15] | 7.25% | [14],[15] | 7.25% | [14],[15] | ||
Investment, interest rate | 12.60% | [10],[11] | 12.60% | [10],[11] | 12.60% | [10],[11] | 12.64% | [14],[15],[16] | 12.64% | [14],[15],[16] | 12.64% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 50,470 | [7],[11],[17] | $ 50,470 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 49,688 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 49,839 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[11] | 5% | [7],[11] | 5% | [7],[11] | 5% | [14],[15] | 5% | [14],[15] | 5% | [14],[15] | ||
Investment, interest rate | 10.61% | [7],[10],[11] | 10.61% | [7],[10],[11] | 10.61% | [7],[10],[11] | 10.65% | [14],[15],[16] | 10.65% | [14],[15],[16] | 10.65% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 3,239 | [7],[11],[17] | $ 3,247 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 3,169 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 3,119 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[11] | 5% | [7],[11] | 5% | [7],[11] | 5% | [14],[15] | 5% | [14],[15] | 5% | [14],[15] | ||
Investment, interest rate | 10.61% | [7],[10],[11] | 10.61% | [7],[10],[11] | 10.61% | [7],[10],[11] | 10.65% | [14],[15],[16] | 10.65% | [14],[15],[16] | 10.65% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 1,258 | [7],[11],[17] | $ 1,261 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 1,231 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 1,211 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [14],[15] | 8.50% | [14],[15] | 8.50% | [14],[15] | ||
Investment, interest rate | 14.15% | [7],[10],[11] | 14.15% | [7],[10],[11] | 14.15% | [7],[10],[11] | 14.15% | [14],[15],[16] | 14.15% | [14],[15],[16] | 14.15% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 2,091 | [7],[11],[17] | $ 8,920 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 8,492 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 1,842 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [14],[15] | 8.50% | [14],[15] | 8.50% | [14],[15] | ||
Investment, interest rate | 14.11% | [7],[10],[11] | 14.11% | [7],[10],[11] | 14.11% | [7],[10],[11] | 14.15% | [14],[15],[16] | 14.15% | [14],[15],[16] | 14.15% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 4,361 | [7],[11],[17] | $ 2,091 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 1,991 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 3,842 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [14],[15] | 8.50% | [14],[15] | 8.50% | [14],[15] | ||
Investment, interest rate | 14.11% | [7],[10],[11] | 14.11% | [7],[10],[11] | 14.11% | [7],[10],[11] | 14.15% | [14],[15],[16] | 14.15% | [14],[15],[16] | 14.15% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 8,920 | [7],[11],[17] | $ 4,361 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 4,152 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 7,859 | ||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.50% | [7],[8],[11] | 4.50% | [7],[8],[11] | 4.50% | [7],[8],[11] | 4.50% | [12],[14],[15] | 4.50% | [12],[14],[15] | 4.50% | [12],[14],[15] | ||
Investment, interest rate | 13% | [7],[8],[10],[11] | 13% | [7],[8],[10],[11] | 13% | [7],[8],[10],[11] | 13% | [12],[14],[15],[16] | 13% | [12],[14],[15],[16] | 13% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 1,836 | [7],[8],[11],[17] | $ 2,221 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 2,178 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 1,798 | ||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[11] | 5.50% | [7],[11] | 5.50% | [7],[11] | 5.50% | [14],[15] | 5.50% | [14],[15] | 5.50% | [14],[15] | ||
Investment, interest rate | 11.03% | [7],[10],[11] | 11.03% | [7],[10],[11] | 11.03% | [7],[10],[11] | 11.02% | [14],[15],[16] | 11.02% | [14],[15],[16] | 11.02% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 40,557 | [7],[11],[17] | $ 40,660 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 40,213 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 40,070 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11],[19] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[21] | 8% | 8% | 8% | ||||||||||
Investment, interest rate, paid in kind | [15],[21] | 2.25% | 2.25% | 2.25% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17],[19] | $ 6,757 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 6,225 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11],[19] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [7],[10],[11],[19] | 12.89% | 12.89% | 12.89% | ||||||||||
Investment owned, balance, principal amount | $ 2,815 | [7],[11],[17],[19] | $ 3,316 | [12],[15],[18],[21],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21],[22] | 3,169 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 2,625 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8% | [7],[8],[10],[11],[19] | 8% | [7],[8],[10],[11],[19] | 8% | [7],[8],[10],[11],[19] | 8% | [12],[14],[15],[16],[21] | 8% | [12],[14],[15],[16],[21] | 8% | [12],[14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 2.25% | [7],[19] | 2.25% | [7],[19] | 2.25% | [7],[19] | 2.25% | [12],[15],[21] | 2.25% | [12],[15],[21] | 2.25% | [12],[15],[21] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[17],[19] | $ 0 | [12],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8% | [7],[8],[10],[11],[19] | 8% | [7],[8],[10],[11],[19] | 8% | [7],[8],[10],[11],[19] | 8% | [12],[14],[15],[16],[21] | 8% | [12],[14],[15],[16],[21] | 8% | [12],[14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 2.25% | [7],[8],[19] | 2.25% | [7],[8],[19] | 2.25% | [7],[8],[19] | 2.25% | [12],[15],[21] | 2.25% | [12],[15],[21] | 2.25% | [12],[15],[21] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[17],[19] | $ 0 | [12],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[10],[11],[19] | 8% | 8% | 8% | ||||||||||
Investment, interest rate, paid in kind | [7],[19] | 2.25% | 2.25% | 2.25% | ||||||||||
Investment owned, balance, principal amount | $ 6,785 | [7],[17],[19] | 0 | [12],[15],[18],[21],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21],[22] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | 6,327 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | [12],[15],[18],[21],[22] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21],[22] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 32,664 | [7],[19] | 32,664 | [7],[19] | 32,664 | [7],[19] | 26,131 | [15],[21] | 26,131 | [15],[21] | 26,131 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 3 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 46 | ||||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [11] | 7% | [11] | 7% | [11] | 7% | [14] | 7% | [14] | 7% | [14] | ||
Investment, interest rate | 12.46% | [10],[11] | 12.46% | [10],[11] | 12.46% | [10],[11] | 12.43% | [14],[16] | 12.43% | [14],[16] | 12.43% | [14],[16] | ||
Investment owned, balance, principal amount | $ 30,625 | [11],[17] | $ 30,625 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 29,989 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 30,319 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [7] | 394,297 | [7] | 394,297 | [7] | 394,297 | [15] | 394,297 | [15] | 394,297 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 158 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 95 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 9% | [7],[10],[11] | 9% | [7],[10],[11] | 9% | [7],[10],[11] | 9% | [14],[15],[16] | 9% | [14],[15],[16] | 9% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 5,257 | [7],[17] | $ 5,257 | [15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 5,251 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 5,205 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,708,618 | [7] | 1,708,618 | [7] | 1,708,618 | [7] | 1,708,618 | [15] | 1,708,618 | [15] | 1,708,618 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 1,999 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 1,982 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [7] | 394,297 | [7] | 394,297 | [7] | 394,297 | [15] | 394,297 | [15] | 394,297 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 442 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 434 | ||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 829 | [7] | 829 | 829 | [7] | 829 | [7] | 829 | [15] | 829 | [15] | 829 | [15] | |
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | $ 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | [15] | 0 | |||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 0 | [7] | $ 0 | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | [7] | 34,984,460 | 34,984,460 | [7] | 34,984,460 | [7] | 34,984,460 | [15] | 34,984,460 | [15] | 34,984,460 | [15] | |
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | $ 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 27,638 | [15] | 27,638 | |||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 27,638 | [7] | $ 27,638 | |||||||||||
Investment owned, percent of net assets | 1.80% | 2.30% | 1.80% | 1.80% | ||||||||||
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [11],[19] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [10],[11],[19] | 11.29% | 11.29% | 11.29% | ||||||||||
Investment owned, balance, principal amount | [11],[17],[19] | $ 16,185 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [11],[19] | $ 20,281 | ||||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[11],[23] | 7.75% | [7],[11],[23] | 7.75% | [7],[11],[23] | 7.75% | [14],[15],[24] | 7.75% | [14],[15],[24] | 7.75% | [14],[15],[24] | ||
Investment owned, balance, principal amount | $ 727 | [7],[11],[17],[23] | $ 727 | [14],[15],[18],[24] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[24] | 396 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | 365 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 37 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 37 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 3,031 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 3,031 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 1,557 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 1,557 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.07% | 12.07% | 12.07% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 1,024 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 1,024 | ||||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,398 | [7] | 1,080,399 | 1,080,398 | [7] | 1,080,398 | [7] | 1,080,399 | [15] | 1,080,399 | [15] | 1,080,399 | [15] | |
Net Realized Gain (Loss) | $ 0 | $ 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 432 | [15] | 378 | |||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | (54) | ||||||||||||
Fair Value, Ending Balance | $ 432 | [7] | $ 324 | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 7.50% | [10],[11],[19] | 7.50% | [10],[11],[19] | 7.50% | [10],[11],[19] | 7.50% | [14],[16],[21] | 7.50% | [14],[16],[21] | 7.50% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 2,632 | [17],[19] | $ 2,632 | [18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | 2,017 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 2,191 | ||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 7.75% | [10],[11],[19] | 7.75% | [10],[11],[19] | 7.75% | [10],[11],[19] | 7.75% | [14],[16],[21] | 7.75% | [14],[16],[21] | 7.75% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 176 | [17],[19] | $ 176 | [18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | 141 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 152 | ||||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 7.38% | [10],[11] | 7.38% | [10],[11] | 7.38% | [10],[11] | 7.38% | [14],[16] | 7.38% | [14],[16] | 7.38% | [14],[16] | ||
Investment owned, balance, principal amount | $ 10,720 | [17] | $ 8,420 | [18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 7,059 | |||||||||||||
Fair Value, Ending Balance | $ 9,804 | |||||||||||||
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11],[19] | 6.75% | 6.75% | 6.75% | ||||||||||
Investment owned, balance, principal amount | [17],[19] | $ 1,670 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [19] | $ 1,661 | ||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7] | 22,267,661 | 22,267,661 | 22,267,661 | ||||||||||
Net Realized Gain (Loss) | $ 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 16,173 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [7] | $ 16,173 | ||||||||||||
Investment owned, percent of net assets | 1.10% | 1.10% | 1.10% | |||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[24] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[24] | $ 22,084 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[24] | $ 16,040 | ||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants | ||||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 417,851 | [7] | 417,851 | [7] | 417,851 | [7] | 417,851 | [15] | 417,851 | [15] | 417,851 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 894 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 894 | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (20) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (19) | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [14],[15] | 7.50% | [14],[15] | 7.50% | [14],[15] | ||
Investment, interest rate | [14],[15],[16] | 12.82% | 12.82% | 12.82% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 13,157 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 12,858 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (11) | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | ||
Investment, interest rate | [7],[10],[11] | 12.86% | 12.86% | 12.86% | ||||||||||
Investment owned, balance, principal amount | $ 13,157 | [7],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (13) | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 12,883 | ||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [11] | 5% | [11] | 5% | [11] | 5% | [14] | 5% | [14] | 5% | [14] | ||
Investment, interest rate | 10.35% | [10],[11] | 10.35% | [10],[11] | 10.35% | [10],[11] | 10.39% | [14],[16] | 10.39% | [14],[16] | 10.39% | [14],[16] | ||
Investment owned, balance, principal amount | $ 14,713 | [11],[17] | $ 14,750 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 14,616 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 14,724 | ||||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | ||
Investment, interest rate | [12],[14],[15],[16] | 11.47% | 11.47% | 11.47% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[11],[17] | $ 933 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 918 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ (15) | ||||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.53% | [10],[11] | 11.53% | [10],[11] | 11.53% | [10],[11] | 11.52% | [14],[15],[16] | 11.52% | [14],[15],[16] | 11.52% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 17,967 | [7],[11],[17] | $ 18,013 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 17,812 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 17,765 | ||||||||||||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 6.75% | 6.75% | 6.75% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ (52) | ||||||||||||
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7] | 6.75% | 6.75% | 6.75% | ||||||||||
Investment, interest rate | [10],[11] | 12.10% | 12.10% | 12.10% | ||||||||||
Investment owned, balance, principal amount | [7],[17] | $ 20,924 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7] | $ 20,422 | ||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.75% | [11] | 4.75% | [11] | 4.75% | [11] | 4.75% | [14] | 4.75% | [14] | 4.75% | [14] | ||
Investment, interest rate | 10.13% | [10],[11] | 10.13% | [10],[11] | 10.13% | [10],[11] | 10.12% | [14],[16] | 10.12% | [14],[16] | 10.12% | [14],[16] | ||
Investment owned, balance, principal amount | $ 4,938 | [11],[17] | $ 4,950 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 4,831 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 4,893 | ||||||||||||
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 8% | 8% | 8% | ||||||||||
Investment owned, balance, principal amount | [17] | $ 440 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 436 | |||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 2 | [7],[19] | 2 | [7],[19] | 2 | [7],[19] | 2 | [15],[21] | 2 | [15],[21] | 2 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 2 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 2 | ||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 419 | [7],[19] | 419 | [7],[19] | 419 | [7],[19] | 419 | [15],[21] | 419 | [15],[21] | 419 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 419 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 419 | ||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[10],[11],[19] | 3% | [7],[10],[11],[19] | 3% | [7],[10],[11],[19] | 3% | [12],[14],[15],[16],[21] | 3% | [12],[14],[15],[16],[21] | 3% | [12],[14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 7% | [7],[19] | 7% | [7],[19] | 7% | [7],[19] | 7% | [12],[15],[21] | 7% | [12],[15],[21] | 7% | [12],[15],[21] | ||
Investment owned, balance, principal amount | $ 32,104 | [7],[17],[19] | $ 17,465 | [12],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21] | 17,465 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 32,104 | ||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 31 | [7],[19] | 31 | [7],[19] | 31 | [7],[19] | 31 | [15],[21] | 31 | [15],[21] | 31 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9% | [7],[11] | 9% | [7],[11] | 9% | [7],[11] | 9% | [14],[15] | 9% | [14],[15] | 9% | [14],[15] | ||
Investment, interest rate | 14.50% | [7],[10],[11] | 14.50% | [7],[10],[11] | 14.50% | [7],[10],[11] | 14.54% | [14],[15],[16] | 14.54% | [14],[15],[16] | 14.54% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 20,757 | [7],[11],[17] | $ 20,757 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 20,653 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 20,639 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate, paid in kind | 8% | [7] | 8% | [7] | 8% | [7] | 8% | [15] | 8% | [15] | 8% | [15] | ||
Investment owned, balance, principal amount | $ 667 | [7],[17] | $ 654 | [15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 631 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 643 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 6,397,254 | [7] | 6,397,254 | [7] | 6,397,254 | [7] | 6,397,254 | [15] | 6,397,254 | [15] | 6,397,254 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 1,152 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 128 | ||||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | ||
Investment, interest rate | 12.45% | [7],[8],[10],[11] | 12.45% | [7],[8],[10],[11] | 12.45% | [7],[8],[10],[11] | 12.49% | [12],[14],[15],[16] | 12.49% | [12],[14],[15],[16] | 12.49% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 578 | [7],[8],[11],[17] | $ 284 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 252 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 550 | ||||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate | 12.45% | [7],[10],[11] | 12.45% | [7],[10],[11] | 12.45% | [7],[10],[11] | 12.49% | [14],[15],[16] | 12.49% | [14],[15],[16] | 12.49% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 12,355 | [7],[11],[17] | $ 12,386 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 12,101 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 12,083 | ||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | [14] | 5% | [14] | 5% | [14] | |||||
Investment, interest rate | 10.65% | [10],[11] | 10.65% | [10],[11] | 10.65% | [10],[11] | 10.43% | [14],[16] | 10.43% | [14],[16] | 10.43% | [14],[16] | ||
Investment owned, balance, principal amount | $ 4,514 | [11],[17] | $ 4,641 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 4,546 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 4,522 | ||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 5.88% | 5.88% | 5.88% | ||||||||||
Investment owned, balance, principal amount | [17] | $ 5,090 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 4,787 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | [7] | 30,031 | 30,031 | [7] | 30,031 | [7] | 30,031 | [15] | 30,031 | [15] | 30,031 | [15] | |
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | $ 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 2,711 | [15] | 4,946 | |||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | (719) | ||||||||||||
Fair Value, Ending Balance | $ 2,711 | [7] | $ 4,227 | |||||||||||
Investment owned, percent of net assets | 0.20% | 0.40% | 0.20% | 0.20% | ||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[11] | 5% | 5% | [7],[11] | 5% | [7],[11] | 5% | [14],[15] | 5% | [14],[15] | 5% | [14],[15] | |
Investment, interest rate | 10.50% | [7],[10],[11] | 10.50% | [7],[10],[11] | 10.50% | [7],[10],[11] | 10.54% | [14],[15],[16] | 10.54% | [14],[15],[16] | 10.54% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 5,574 | [7],[11],[17] | $ 0 | $ 5,574 | [14],[15],[18] | |||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 150 | 14 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 5,574 | [14],[15] | 0 | |||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 5,574 | [7],[11] | $ 0 | |||||||||||
Investment owned, percent of net assets | 0.40% | 0% | 0.40% | 0.40% | ||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | |||||||||||||
Investment, interest rate | 9.73% | |||||||||||||
Investment owned, balance, principal amount | $ 14,297 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 331 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 14,333 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (36) | |||||||||||||
Fair Value, Ending Balance | $ 14,297 | |||||||||||||
Investment owned, percent of net assets | 1.20% | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[11] | 5% | [7],[11] | 5% | [7],[11] | 5% | [14],[15] | 5% | [14],[15] | 5% | [14],[15] | ||
Investment, interest rate | 10.50% | [7],[10],[11] | 10.50% | [7],[10],[11] | 10.50% | [7],[10],[11] | 10.54% | [14],[15],[16] | 10.54% | [14],[15],[16] | 10.54% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 14,033 | [7],[11],[17] | $ 14,068 | [14],[15],[18] | ||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 391 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 14,068 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (35) | |||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 14,033 | ||||||||||||
Investment owned, percent of net assets | 0.90% | 0.90% | 0.90% | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[8],[11] | 5% | [7],[8],[11] | 5% | [7],[8],[11] | 5% | [12],[14],[15] | 5% | [12],[14],[15] | 5% | [12],[14],[15] | ||
Investment, interest rate | 10.46% | [7],[8],[10],[11] | 10.46% | [7],[8],[10],[11] | 10.46% | [7],[8],[10],[11] | 10.42% | [12],[14],[15],[16] | 10.42% | [12],[14],[15],[16] | 10.42% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 1,393 | [7],[8],[11],[17] | $ 2,090 | [12],[14],[15],[18] | ||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 58 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 2,090 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (696) | |||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 1,394 | ||||||||||||
Investment owned, percent of net assets | 0.10% | 0.10% | 0.10% | |||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 12,500 | [7] | 12,500 | [7] | 12,500 | [7] | 12,500 | [15] | 12,500 | [15] | 12,500 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 488 | [7] | 488 | [7] | 488 | [7] | 488 | [15] | 488 | [15] | 488 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 1,345 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 1,345 | ||||||||||||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [14],[15] | 7.50% | [14],[15] | 7.50% | [14],[15] | ||
Investment, interest rate | 13% | [7],[10],[11] | 13% | [7],[10],[11] | 13% | [7],[10],[11] | 13.04% | [14],[15],[16] | 13.04% | [14],[15],[16] | 13.04% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 8,974 | [7],[11],[17] | $ 8,974 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 7,987 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 8,032 | ||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (28) | ||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[10],[11] | 10.84% | 10.84% | 10.84% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 24,865 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 24,492 | ||||||||||||
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (19) | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[10],[11],[19] | 3% | [7],[10],[11],[19] | 3% | [7],[10],[11],[19] | 3% | [14],[15],[16],[21] | 3% | [14],[15],[16],[21] | 3% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 6% | [7],[19] | 6% | [7],[19] | 6% | [7],[19] | 6% | [15],[21] | 6% | [15],[21] | 6% | [15],[21] | ||
Investment owned, balance, principal amount | $ 1,799 | [7],[17],[19] | $ 11,065 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 10,677 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 1,718 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[8],[10],[11],[19] | 3% | [7],[8],[10],[11],[19] | 3% | [7],[8],[10],[11],[19] | 3% | [14],[15],[16],[21] | 3% | [14],[15],[16],[21] | 3% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 6% | [7],[8],[19] | 6% | [7],[8],[19] | 6% | [7],[8],[19] | 6% | [15],[21] | 6% | [15],[21] | 6% | [15],[21] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[17],[19] | $ 1,772 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 1,710 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[8],[10],[11],[19] | 3% | [7],[8],[10],[11],[19] | 3% | [7],[8],[10],[11],[19] | 3% | [12],[14],[15],[16],[21] | 3% | [12],[14],[15],[16],[21] | 3% | [12],[14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 6% | [7],[8],[19] | 6% | [7],[8],[19] | 6% | [7],[8],[19] | 6% | [12],[15],[21] | 6% | [12],[15],[21] | 6% | [12],[15],[21] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[17],[19] | $ 0 | [12],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[10],[11],[19] | 3% | [7],[10],[11],[19] | 3% | [7],[10],[11],[19] | 3% | [12],[14],[15],[16],[21] | 3% | [12],[14],[15],[16],[21] | 3% | [12],[14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 6% | [7],[19] | 6% | [7],[19] | 6% | [7],[19] | 6% | [12],[15],[21] | 6% | [12],[15],[21] | 6% | [12],[15],[21] | ||
Investment owned, balance, principal amount | $ 11,232 | [7],[17],[19] | $ 0 | [12],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15],[21] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 10,727 | ||||||||||||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (41) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (37) | ||||||||||||
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.35% | [10],[11] | 11.35% | [10],[11] | 11.35% | [10],[11] | 11.32% | [14],[15],[16] | 11.32% | [14],[15],[16] | 11.32% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 14,736 | [7],[8],[11],[17] | $ 14,736 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 14,368 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 14,394 | ||||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [11] | 4% | 4% | 4% | ||||||||||
Investment, interest rate | [10],[11] | 9.47% | 9.47% | 9.47% | ||||||||||
Investment owned, balance, principal amount | [11],[17] | $ 4,324 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [11] | $ 3,457 | ||||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [11] | 6.75% | [11] | 6.75% | [11] | 6.75% | [14],[21] | 6.75% | [14],[21] | 6.75% | [14],[21] | ||
Investment, interest rate | 12.22% | [10],[11] | 12.22% | [10],[11] | 12.22% | [10],[11] | 12.18% | [14],[16],[21] | 12.18% | [14],[16],[21] | 12.18% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 31,074 | [11],[17] | $ 31,074 | [14],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[21] | 19,917 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 18,745 | ||||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 9% | [7],[8],[10],[11] | 9% | [7],[8],[10],[11] | 9% | [7],[8],[10],[11] | 9% | [12],[14],[15],[16] | 9% | [12],[14],[15],[16] | 9% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 61,500 | [7],[8],[17] | $ 59,950 | [12],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15] | 59,950 | ||||||||||||
Fair Value, Ending Balance | [7],[8] | $ 61,500 | ||||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 3,750 | [7],[19],[27] | 3,750 | [7],[19],[27] | 3,750 | [7],[19],[27] | 3,750 | [15],[21] | 3,750 | [15],[21] | 3,750 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 3 | ||||||||||||
Fair Value, Ending Balance | [7],[19],[27] | $ 4 | ||||||||||||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[8],[11],[19] | 7.25% | [7],[8],[11],[19] | 7.25% | [7],[8],[11],[19] | 7.25% | [12],[14],[15],[21] | 7.25% | [12],[14],[15],[21] | 7.25% | [12],[14],[15],[21] | ||
Investment, interest rate | 12.61% | [7],[8],[10],[11],[19] | 12.61% | [7],[8],[10],[11],[19] | 12.61% | [7],[8],[10],[11],[19] | 12.55% | [12],[14],[15],[16],[21] | 12.55% | [12],[14],[15],[16],[21] | 12.55% | [12],[14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 322 | [7],[8],[11],[17],[19] | $ 258 | [12],[14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[21] | 234 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[19] | $ 301 | ||||||||||||
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 7.25% | [7],[11],[19] | 7.25% | [14],[15],[21] | 7.25% | [14],[15],[21] | 7.25% | [14],[15],[21] | ||
Investment, interest rate | 12.71% | [7],[10],[11],[19] | 12.71% | [7],[10],[11],[19] | 12.71% | [7],[10],[11],[19] | 12.55% | [14],[15],[16],[21] | 12.55% | [14],[15],[16],[21] | 12.55% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 11,742 | [7],[11],[17],[19] | $ 11,742 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 11,511 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | 11,538 | ||||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Net Realized Gain (Loss) | 786 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | $ 0 | |||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11% | [7],[10],[11],[19] | 11% | [7],[10],[11],[19] | 11% | [7],[10],[11],[19] | 11% | [14],[15],[16],[21] | 11% | [14],[15],[16],[21] | 11% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 11,918 | [7],[17],[19] | $ 11,918 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 11,144 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 11,173 | ||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 417,011 | [7],[19] | 417,011 | [7],[19] | 417,011 | [7],[19] | 417,011 | [15],[21] | 417,011 | [15],[21] | 417,011 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 42 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 354 | ||||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 6% | [10],[11],[19] | 6% | [10],[11],[19] | 6% | [10],[11],[19] | 6% | [14],[16],[21] | 6% | [14],[16],[21] | 6% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 4,881 | [17],[19] | $ 4,881 | [18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | 3,577 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 4,170 | ||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[8],[11] | 7.25% | [7],[8],[11] | 7.25% | [7],[8],[11] | 7.25% | [12],[14],[15] | 7.25% | [12],[14],[15] | 7.25% | [12],[14],[15] | ||
Investment, interest rate | 12.60% | [7],[8],[10],[11] | 12.60% | [7],[8],[10],[11] | 12.60% | [7],[8],[10],[11] | 12.64% | [12],[14],[15],[16] | 12.64% | [12],[14],[15],[16] | 12.64% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 1,215 | [7],[8],[11],[17] | $ 1,638 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 1,535 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 1,152 | ||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [14],[15] | 7.25% | [14],[15] | 7.25% | [14],[15] | ||
Investment, interest rate | 12.60% | [7],[10],[11] | 12.60% | [7],[10],[11] | 12.60% | [7],[10],[11] | 12.64% | [14],[15],[16] | 12.64% | [14],[15],[16] | 12.64% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 23,714 | [7],[11],[17] | $ 23,774 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 23,110 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 23,306 | ||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[11] | 5% | [7],[11] | 5% | [7],[11] | 5% | [14] | 5% | [14] | 5% | [14] | ||
Investment, interest rate | 10.66% | [7],[10],[11] | 10.66% | [7],[10],[11] | 10.66% | [7],[10],[11] | 10.57% | [14],[16] | 10.57% | [14],[16] | 10.57% | [14],[16] | ||
Investment owned, balance, principal amount | $ 2,450 | [7],[11],[17] | $ 2,456 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 2,063 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 2,197 | ||||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 2.85% | [11],[19] | 2.85% | [11],[19] | 2.85% | [11],[19] | 2.85% | [14],[21] | 2.85% | [14],[21] | 2.85% | [14],[21] | ||
Investment, interest rate | 6.84% | [10],[11],[19] | 6.84% | [10],[11],[19] | 6.84% | [10],[11],[19] | 6.56% | [14],[16],[21] | 6.56% | [14],[16],[21] | 6.56% | [14],[16],[21] | ||
Investment owned, balance, principal amount | € | € 1,000 | [11],[17],[19] | € 1,000 | [14],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[21] | $ 963 | ||||||||||||
Fair Value, Ending Balance | [11],[19] | $ 1,033 | ||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[8],[11] | 8% | [7],[8],[11] | 8% | [7],[8],[11] | 8% | [12],[14],[15] | 8% | [12],[14],[15] | 8% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (35) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (29) | ||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[8],[11] | 8% | [7],[8],[11] | 8% | [7],[8],[11] | 8% | [14],[15] | 8% | [14],[15] | 8% | [14],[15] | ||
Investment, interest rate | [14],[15],[16] | 13.42% | 13.42% | 13.42% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 17,444 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 17,096 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (59) | ||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[11] | 8% | [7],[11] | 8% | [7],[11] | 8% | [12],[14],[15] | 8% | [12],[14],[15] | 8% | [12],[14],[15] | ||
Investment, interest rate | [7],[10],[11] | 13.46% | 13.46% | 13.46% | ||||||||||
Investment owned, balance, principal amount | $ 17,400 | [7],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (70) | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 17,112 | ||||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.25% | [11] | 5.25% | [11] | 5.25% | [11] | 5.25% | [14] | 5.25% | [14] | 5.25% | [14] | ||
Investment, interest rate | 10.71% | [10],[11] | 10.71% | [10],[11] | 10.71% | [10],[11] | 10.67% | [14],[16] | 10.67% | [14],[16] | 10.67% | [14],[16] | ||
Investment owned, balance, principal amount | $ 8,538 | [11],[17] | $ 14,347 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 13,618 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 8,396 | ||||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11],[19] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[10],[11],[19] | 12% | 12% | 12% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17],[19] | $ 7,448 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 7,355 | ||||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[8],[11],[19] | 6.50% | [7],[8],[11],[19] | 6.50% | [7],[8],[11],[19] | 6.50% | [14],[15],[21] | 6.50% | [14],[15],[21] | 6.50% | [14],[15],[21] | ||
Investment, interest rate | [14],[15],[16],[21] | 11.89% | 11.89% | 11.89% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17],[19] | $ 7,448 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 7,301 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[19] | $ (50) | ||||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11],[19] | 6.50% | [7],[11],[19] | 6.50% | [7],[11],[19] | 6.50% | [12],[14],[15],[21] | 6.50% | [12],[14],[15],[21] | 6.50% | [12],[14],[15],[21] | ||
Investment, interest rate | [10],[11] | 12% | 12% | 12% | ||||||||||
Investment owned, balance, principal amount | $ 1,432 | [7],[11],[17],[19] | $ 0 | [12],[14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[21] | (79) | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | 1,414 | ||||||||||||
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[21] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[21] | 12.04% | 12.04% | 12.04% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[21] | $ 1,432 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 1,404 | ||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 4.46% | [10],[11],[19] | 4.46% | [10],[11],[19] | 4.46% | [10],[11],[19] | 4.46% | [14],[15],[16],[21] | 4.46% | [14],[15],[16],[21] | 4.46% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 9,406 | [17],[19] | $ 6,808 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 5,873 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 8,155 | ||||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.25% | [14],[15],[21] | 8.25% | [14],[15],[21] | 8.25% | [14],[15],[21] | ||
Investment, interest rate | 13.63% | [7],[10],[11],[19] | 13.63% | [7],[10],[11],[19] | 13.63% | [7],[10],[11],[19] | 13.62% | [14],[15],[16],[21] | 13.62% | [14],[15],[16],[21] | 13.62% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 23,975 | [7],[11],[17],[19] | $ 23,975 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 23,328 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 23,519 | ||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.75% | [7],[11] | 5.75% | [7],[11] | 5.75% | [7],[11] | 5.75% | [14],[15] | 5.75% | [14],[15] | 5.75% | [14],[15] | ||
Investment, interest rate | 11.36% | [7],[10],[11] | 11.36% | [7],[10],[11] | 11.36% | [7],[10],[11] | 11.40% | [14],[15],[16] | 11.40% | [14],[15],[16] | 11.40% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 43,931 | [7],[11],[17] | $ 44,550 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 35,046 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 35,145 | ||||||||||||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 12.06% | [7],[10],[11] | 12.06% | [7],[10],[11] | 12.06% | [7],[10],[11] | 11.92% | [14],[15],[16] | 11.92% | [14],[15],[16] | 11.92% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 40,587 | [7],[11],[17] | $ 40,587 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 38,963 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 38,963 | ||||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10.75% | [7],[23] | 10.75% | [7],[23] | 10.75% | [7],[23] | 10.75% | [14],[15] | 10.75% | [14],[15] | 10.75% | [14],[15] | ||
Investment, interest rate, paid in kind | [14],[15] | 16.06% | 16.06% | 16.06% | ||||||||||
Investment owned, balance, principal amount | $ 1,001 | [7],[17],[23] | $ 26,613 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 24,484 | ||||||||||||
Fair Value, Ending Balance | [7],[23] | $ 793 | ||||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10.75% | [7],[11],[23] | 10.75% | [7],[11],[23] | 10.75% | [7],[11],[23] | 10.75% | [14],[15] | 10.75% | [14],[15] | 10.75% | [14],[15] | ||
Investment, interest rate, paid in kind | [14],[15] | 16.05% | 16.05% | 16.05% | ||||||||||
Investment owned, balance, principal amount | $ 2,232 | [7],[11],[17],[23] | $ 787 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 787 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 1,768 | ||||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10.75% | [7],[11],[23] | 10.75% | [7],[11],[23] | 10.75% | [7],[11],[23] | 10.75% | [12],[14],[15] | 10.75% | [12],[14],[15] | 10.75% | [12],[14],[15] | ||
Investment, interest rate, paid in kind | [12],[14],[15] | 16.06% | 16.06% | 16.06% | ||||||||||
Investment owned, balance, principal amount | $ 839 | [7],[11],[17],[23] | $ 688 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 688 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 664 | ||||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11],[23] | 10.75% | 10.75% | 10.75% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17],[23] | $ 28,010 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 14,817 | ||||||||||||
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 350,241 | 350,241 | 350,241 | 350,241 | 350,241 | 350,241 | ||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | $ 147 | |||||||||||||
Fair Value, Ending Balance | 0 | |||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[21] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [14],[15],[16],[21] | 11.14% | 11.14% | 11.14% | ||||||||||
Investment, interest rate, paid in kind | [14],[15],[21] | 2.75% | 2.75% | 2.75% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[21] | $ 7,179 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 6,568 | ||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 112,990 | [7],[19] | 112,990 | [7],[19] | 112,990 | [7],[19] | 112,990 | [15],[21] | 112,990 | [15],[21] | 112,990 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 105 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,078,284 | [7] | 1,078,284 | [7] | 1,078,284 | [7] | 1,078,284 | [15] | 1,078,284 | [15] | 1,078,284 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (86) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (86) | ||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [14],[15] | 7.50% | [14],[15] | 7.50% | [14],[15] | ||
Investment, interest rate | 12.97% | [7],[10],[11] | 12.97% | [7],[10],[11] | 12.97% | [7],[10],[11] | 12.93% | [14],[15],[16] | 12.93% | [14],[15],[16] | 12.93% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 33,331 | [7],[11],[17] | $ 33,414 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 32,659 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 32,577 | ||||||||||||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [11] | 7.25% | [11] | 7.25% | [11] | 7.25% | [14] | 7.25% | [14] | 7.25% | [14] | ||
Investment, interest rate | 12.91% | [10],[11] | 12.91% | [10],[11] | 12.91% | [10],[11] | 12.78% | [14],[16] | 12.78% | [14],[16] | 12.78% | [14],[16] | ||
Investment owned, balance, principal amount | $ 13,939 | [11],[17] | $ 13,939 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 10,094 | ||||||||||||
Fair Value, Ending Balance | [11] | 11,314 | ||||||||||||
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares | ||||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 83,262 | |||||||||||||
Fair Value, Ending Balance | $ 8,722 | |||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | ||
Investment, interest rate | [12],[14],[15],[16] | 11.84% | 11.84% | 11.84% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 272 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 238 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (47) | ||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (47) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (35) | ||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 11.99% | [10],[11] | 11.99% | [10],[11] | 11.99% | [10],[11] | 11.84% | [14],[15],[16] | 11.84% | [14],[15],[16] | 11.84% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 38,015 | [7],[11],[17] | $ 16,752 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 16,500 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 37,445 | ||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 11.84% | [7],[10],[11] | 11.84% | [7],[10],[11] | 11.84% | [7],[10],[11] | 11.80% | [14],[15],[16] | 11.80% | [14],[15],[16] | 11.80% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 16,722 | [7],[11],[17] | $ 38,015 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 37,445 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 16,471 | ||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (172) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (199) | ||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.46% | [7],[10],[11] | 11.46% | [7],[10],[11] | 11.46% | [7],[10],[11] | 11.42% | [14],[15],[16] | 11.42% | [14],[15],[16] | 11.42% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 2,729 | [7],[11],[17] | $ 2,736 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 2,558 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 2,524 | ||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.46% | [10],[11] | 11.46% | [10],[11] | 11.46% | [10],[11] | 11.42% | [14],[15],[16] | 11.42% | [14],[15],[16] | 11.42% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 23,435 | [7],[11],[17] | $ 23,494 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 21,967 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 21,677 | ||||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.50% | [11],[19] | 9.50% | [11],[19] | 9.50% | [11],[19] | 9.50% | [14],[21] | 9.50% | [14],[21] | 9.50% | [14],[21] | ||
Investment, interest rate | 15.08% | [10],[11],[19] | 15.08% | [10],[11],[19] | 15.08% | [10],[11],[19] | 14.95% | [14],[16],[21] | 14.95% | [14],[16],[21] | 14.95% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 26,356 | [11],[17],[19] | $ 26,422 | [14],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[21] | 27,512 | ||||||||||||
Fair Value, Ending Balance | [11],[19] | 27,163 | ||||||||||||
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [15] | 2,000,000 | 2,000,000 | 2,000,000 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[11] | 5% | [7],[11] | 5% | [7],[11] | 5% | [14],[15] | 5% | [14],[15] | 5% | [14],[15] | ||
Investment, interest rate | 10.61% | [7],[10],[11] | 10.61% | [7],[10],[11] | 10.61% | [7],[10],[11] | 10.65% | [14],[15],[16] | 10.65% | [14],[15],[16] | 10.65% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 45,125 | [7],[11],[17] | $ 45,243 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 43,886 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 43,771 | ||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 559 | [7] | 559 | [7] | 559 | [7] | 559 | [15] | 559 | [15] | 559 | [15] | ||
Investment owned, balance, principal amount | [15],[18] | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 372 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 268 | ||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.50% | [7],[11] | 9.50% | [7],[11] | 9.50% | [7],[11] | 8.50% | [14],[15] | 8.50% | [14],[15] | 8.50% | [14],[15] | ||
Investment, interest rate | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 13.99% | [14],[15],[16] | 13.99% | [14],[15],[16] | 13.99% | [14],[15],[16] | ||
Investment, interest rate, paid in kind | 9.95% | 9.95% | 9.95% | |||||||||||
Investment owned, balance, principal amount | $ 3,012 | [7],[11],[17] | $ 5,403 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 5,160 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 2,846 | ||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.50% | [7],[11] | 9.50% | [7],[11] | 9.50% | [7],[11] | 8.50% | [12],[14],[15] | 8.50% | [12],[14],[15] | 8.50% | [12],[14],[15] | ||
Investment, interest rate | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 13.99% | [12],[14],[15],[16] | 13.99% | [12],[14],[15],[16] | 13.99% | [12],[14],[15],[16] | ||
Investment, interest rate, paid in kind | 9.95% | 9.95% | 9.95% | |||||||||||
Investment owned, balance, principal amount | $ 5,536 | [7],[11],[17] | $ 2,939 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 2,745 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 5,232 | ||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | 6% | [12],[14],[15] | ||
Investment, interest rate | [12],[14],[15],[16] | 11.42% | 11.42% | 11.42% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 964 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 938 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (27) | ||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.53% | [7],[10],[11] | 11.53% | [7],[10],[11] | 11.53% | [7],[10],[11] | 11.52% | [14],[15],[16] | 11.52% | [14],[15],[16] | 11.52% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 2,624 | [7],[11],[17] | $ 20,125 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 19,823 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 2,585 | ||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [7],[8],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.53% | [10],[11] | 11.53% | [10],[11] | 11.53% | [10],[11] | 11.52% | [14],[15],[16] | 11.52% | [14],[15],[16] | 11.52% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 11,802 | [7],[8],[11],[17] | $ 2,631 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 2,591 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 11,625 | ||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [7],[8],[11] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | 7.50% | [12],[14],[15] | ||
Investment, interest rate | 12.86% | [7],[8],[10],[11] | 12.86% | [7],[8],[10],[11] | 12.86% | [7],[8],[10],[11] | 12.83% | [12],[14],[15],[16] | 12.83% | [12],[14],[15],[16] | 12.83% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 8,308 | [7],[8],[11],[17] | $ 1,466 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 1,282 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 8,308 | ||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [7],[11] | 7.50% | [14],[15] | 7.50% | [14],[15] | 7.50% | [14],[15] | ||
Investment, interest rate | 12.89% | [7],[10],[11] | 12.89% | [7],[10],[11] | 12.89% | [7],[10],[11] | 12.89% | [14],[15],[16] | 12.89% | [14],[15],[16] | 12.89% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 40,538 | [7],[11],[17] | $ 40,538 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 39,833 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 40,944 | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[8],[11] | 5.50% | [7],[8],[11] | 5.50% | [7],[8],[11] | 5.50% | [12],[14],[15] | 5.50% | [12],[14],[15] | 5.50% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (47) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (27) | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[11] | 5.50% | [7],[11] | 5.50% | [7],[11] | 5.50% | [14],[15] | 5.50% | [14],[15] | 5.50% | [14],[15] | ||
Investment, interest rate | 10.95% | [10],[11] | 10.95% | [10],[11] | 10.95% | [10],[11] | 10.99% | [14],[15],[16] | 10.99% | [14],[15],[16] | 10.99% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 21,272 | [7],[11],[17] | $ 13,973 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 13,685 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 21,060 | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[11] | 5.50% | [7],[11] | 5.50% | [7],[11] | 5.50% | [14],[15] | 5.50% | [14],[15] | 5.50% | [14],[15] | ||
Investment, interest rate | 10.95% | [7],[10],[11] | 10.95% | [7],[10],[11] | 10.95% | [7],[10],[11] | 10.99% | [14],[15],[16] | 10.99% | [14],[15],[16] | 10.99% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 13,937 | [7],[11],[17] | $ 21,328 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 20,888 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 13,797 | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11.50% | [7],[10],[11],[19] | 11.50% | [7],[10],[11],[19] | 11.50% | [7],[10],[11],[19] | 11.50% | [14],[15],[16],[21] | 11.50% | [14],[15],[16],[21] | 11.50% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 8,568 | [7],[17],[19] | $ 8,568 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 8,132 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 8,139 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11.50% | [7],[10],[11],[19] | 11.50% | [7],[10],[11],[19] | 11.50% | [7],[10],[11],[19] | 11.50% | [14],[15],[16],[21] | 11.50% | [14],[15],[16],[21] | 11.50% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 8,568 | [7],[17],[19] | $ 4,284 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 4,066 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 8,139 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11.50% | [7],[10],[11],[19] | 11.50% | [7],[10],[11],[19] | 11.50% | [7],[10],[11],[19] | 11.50% | [14],[15],[16],[21] | 11.50% | [14],[15],[16],[21] | 11.50% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 4,284 | [7],[17],[19] | $ 8,568 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 8,132 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 4,070 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8% | [7],[10],[11],[19] | 8% | [7],[10],[11],[19] | 8% | [7],[10],[11],[19] | 8% | [14],[15],[16],[21] | 8% | [14],[15],[16],[21] | 8% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 1.75% | [7],[19] | 1.75% | [7],[19] | 1.75% | [7],[19] | 1.75% | [15],[21] | 1.75% | [15],[21] | 1.75% | [15],[21] | ||
Investment owned, balance, principal amount | $ 9,129 | [7],[17],[19] | $ 9,106 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 8,013 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 8,147 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 66,817 | [7],[19] | 66,817 | [7],[19] | 66,817 | [7],[19] | 259,877 | [15],[21] | 259,877 | [15],[21] | 259,877 | [15],[21] | ||
Investment owned, balance, principal amount | [15],[18],[21] | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 78 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 27 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 259,877 | [7],[19] | 259,877 | [7],[19] | 259,877 | [7],[19] | 66,817 | [15],[21] | 66,817 | [15],[21] | 66,817 | [15],[21] | ||
Investment owned, balance, principal amount | [15],[18],[21] | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 33 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 65 | ||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (76) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (67) | ||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate | 12.53% | [10],[11] | 12.53% | [10],[11] | 12.53% | [10],[11] | 12.52% | [14],[15],[16] | 12.52% | [14],[15],[16] | 12.52% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 46,687 | [7],[11],[17] | $ 5,248 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 5,164 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 46,033 | ||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate | 12.53% | [7],[10],[11] | 12.53% | [7],[10],[11] | 12.53% | [7],[10],[11] | 12.52% | [14],[15],[16] | 12.52% | [14],[15],[16] | 12.52% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 5,248 | [7],[11],[17] | $ 46,687 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 45,940 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 5,175 | ||||||||||||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[11] | 6.75% | [7],[11] | 6.75% | [7],[11] | 6.75% | [14],[15] | 6.75% | [14],[15] | 6.75% | [14],[15] | ||
Investment, interest rate | 13.60% | [7],[10],[11] | 13.60% | [7],[10],[11] | 13.60% | [7],[10],[11] | 12.51% | [14],[15],[16] | 12.51% | [14],[15],[16] | 12.51% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 49,266 | [7],[11],[17] | $ 54,559 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 53,168 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 48,034 | ||||||||||||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 6.88% | [10],[11] | 6.88% | [10],[11] | 6.88% | [10],[11] | 6.88% | [14],[16] | 6.88% | [14],[16] | 6.88% | [14],[16] | ||
Investment owned, balance, principal amount | $ 10,191 | [17] | $ 10,191 | [18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 8,743 | |||||||||||||
Fair Value, Ending Balance | $ 10,368 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.88% | [7],[11],[19] | 6.88% | [7],[11],[19] | 6.88% | [7],[11],[19] | 6.88% | [14],[15],[21] | 6.88% | [14],[15],[21] | 6.88% | [14],[15],[21] | ||
Investment, interest rate | 12.33% | [7],[10],[11],[19] | 12.33% | [7],[10],[11],[19] | 12.33% | [7],[10],[11],[19] | 12.29% | [14],[15],[16],[21] | 12.29% | [14],[15],[16],[21] | 12.29% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 2% | [7],[11],[19] | 2% | [7],[11],[19] | 2% | [7],[11],[19] | 2% | [14],[15],[21] | 2% | [14],[15],[21] | 2% | [14],[15],[21] | ||
Investment owned, balance, principal amount | $ 73,547 | [7],[11],[17],[19] | $ 73,362 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 69,694 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 70,201 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | [19] | 487,870 | [19] | 487,870 | [19] | 487,870 | [21] | 487,870 | [21] | 487,870 | [21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | $ 903 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 1,947 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | [19] | 487,870 | [19] | 487,870 | [19] | 487,870 | [21] | 487,870 | [21] | 487,870 | [21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | $ 903 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 1,947 | ||||||||||||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [7],[11] | 8.50% | [14],[15] | 8.50% | [14],[15] | 8.50% | [14],[15] | ||
Investment, interest rate | 13.93% | [7],[10],[11] | 13.93% | [7],[10],[11] | 13.93% | [7],[10],[11] | 13.99% | [14],[15],[16] | 13.99% | [14],[15],[16] | 13.99% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 30,339 | [7],[11],[17] | $ 30,339 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 29,007 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 30,166 | ||||||||||||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.50% | [7],[11] | 9.50% | [7],[11] | 9.50% | [7],[11] | 9.50% | [14],[15] | 9.50% | [14],[15] | 9.50% | [14],[15] | ||
Investment, interest rate | 14.83% | [7],[10],[11] | 14.83% | [7],[10],[11] | 14.83% | [7],[10],[11] | 14.89% | [14],[15],[16] | 14.89% | [14],[15],[16] | 14.89% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 64,606 | [7],[11],[17] | $ 64,606 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 63,185 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 63,185 | ||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 6% | 6% | 6% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (23) | ||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[10],[11] | 11.37% | 11.37% | 11.37% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 19,995 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 19,751 | ||||||||||||
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 6% | 6% | 6% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (38) | ||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, ownership percentage | 87.50% | [8],[19],[28],[29] | 87.50% | [8],[19],[28],[29] | 87.50% | [8],[19],[28],[29] | 87.50% | [12],[21],[30],[31] | 87.50% | [12],[21],[30],[31] | 87.50% | [12],[21],[30],[31] | ||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | $ 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | [12],[21],[30],[31] | 0 | |||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 0 | [8],[19],[28],[29] | $ 0 | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.50% | [7],[8],[11],[19],[28] | 4.50% | 4.50% | [7],[8],[11],[19],[28] | 4.50% | [7],[8],[11],[19],[28] | 4.50% | [12],[15],[21],[30] | 4.50% | [12],[15],[21],[30] | 4.50% | [12],[15],[21],[30] | |
Investment, interest rate | 9.94% | [7],[8],[10],[11],[19],[28] | 7.67% | 9.94% | [7],[8],[10],[11],[19],[28] | 9.94% | [7],[8],[10],[11],[19],[28] | 9.76% | [12],[14],[15],[16],[21],[30] | 9.76% | [12],[14],[15],[16],[21],[30] | 9.76% | [12],[14],[15],[16],[21],[30] | |
Investment owned, balance, principal amount | $ 58,349 | [7],[8],[11],[17],[19],[28] | $ 59,049 | $ 58,349 | [12],[15],[18],[21],[30] | |||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 1,773 | 1,624 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 50,017 | [12],[15],[21],[30] | 50,283 | |||||||||||
Gross Additions | 940 | 380 | ||||||||||||
Gross Reductions | 0 | (1,127) | ||||||||||||
Fair Value, Ending Balance | $ 50,957 | [7],[8],[11],[19],[28] | $ 49,536 | |||||||||||
Investment owned, percent of net assets | 3.40% | 4.10% | 3.40% | 3.40% | ||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate | 12.46% | [7],[10],[11] | 12.46% | [7],[10],[11] | 12.46% | [7],[10],[11] | 12.49% | [14],[15],[16] | 12.49% | [14],[15],[16] | 12.49% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 9,323 | [7],[11],[17] | $ 9,323 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 9,183 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 9,183 | ||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[11],[23] | 10% | [7],[11],[23] | 10% | [7],[11],[23] | 10% | [14],[15] | 10% | [14],[15] | 10% | [14],[15] | ||
Investment, interest rate, paid in kind | [14],[15] | 15.67% | 15.67% | 15.67% | ||||||||||
Investment owned, balance, principal amount | $ 1,303 | [7],[11],[17],[23] | $ 25,712 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 25,069 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 1,074 | ||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[11],[23] | 10% | [7],[11],[23] | 10% | [7],[11],[23] | 10% | [12],[14],[15] | 10% | [12],[14],[15] | 10% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 31,515 | [7],[11],[17],[23] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (69) | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 25,959 | ||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 12% | [7],[8],[11],[23] | 12% | [7],[8],[11],[23] | 12% | [7],[8],[11],[23] | 10% | [12],[14],[15] | 10% | [12],[14],[15] | 10% | [12],[14],[15] | ||
Investment, interest rate, paid in kind | [12],[14],[15] | 15.64% | 15.64% | 15.64% | ||||||||||
Investment owned, balance, principal amount | $ 233 | [7],[8],[11],[17],[23] | $ 1,210 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 1,169 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[23] | $ 233 | ||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[8],[11] | 7.75% | [7],[8],[11] | 7.75% | [7],[8],[11] | 7.75% | [12],[14],[15] | 7.75% | [12],[14],[15] | 7.75% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (36) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (29) | ||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[11] | 7.75% | [7],[11] | 7.75% | [7],[11] | 7.75% | [14],[15] | 7.75% | [14],[15] | 7.75% | [14],[15] | ||
Investment, interest rate | 13.13% | [7],[10],[11] | 13.13% | [7],[10],[11] | 13.13% | [7],[10],[11] | 13.12% | [14],[15],[16] | 13.12% | [14],[15],[16] | 13.12% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 15,231 | [7],[11],[17] | $ 15,231 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 14,945 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | 15,003 | ||||||||||||
Investment, Identifier [Axis]: Other cash accounts | ||||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 62,277 | |||||||||||||
Fair Value, Ending Balance | 122,975 | |||||||||||||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [14],[16] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment owned, balance, principal amount | [18] | $ 4,519 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | $ 3,305 | |||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [7],[8],[11] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | 7% | [12],[14],[15] | ||
Investment, interest rate | [7],[8],[10],[11] | 12.35% | 12.35% | 12.35% | ||||||||||
Investment owned, balance, principal amount | $ 98 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (54) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 44 | ||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate | 12.36% | [7],[10],[11] | 12.36% | [7],[10],[11] | 12.36% | [7],[10],[11] | 12.32% | [14],[15],[16] | 12.32% | [14],[15],[16] | 12.32% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 10,868 | [7],[11],[17] | $ 10,895 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 10,495 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 10,469 | ||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 100,000 | [7] | 100,000 | [7] | 100,000 | [7] | 100,000 | [15] | 100,000 | [15] | 100,000 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 248 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 300 | ||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (3) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 12.04% | [7],[10],[11] | 12.04% | [7],[10],[11] | 12.04% | [7],[10],[11] | 12.01% | [14],[15],[16] | 12.01% | [14],[15],[16] | 12.01% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 38,308 | [7],[11],[17] | $ 38,414 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 38,380 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 38,308 | ||||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [11] | 5% | [11] | 5% | [11] | 5% | [14] | 5% | [14] | 5% | [14] | ||
Investment, interest rate | 10.46% | [10],[11] | 10.46% | [10],[11] | 10.46% | [10],[11] | 10.42% | [14],[16] | 10.42% | [14],[16] | 10.42% | [14],[16] | ||
Investment owned, balance, principal amount | $ 9,651 | [11],[17] | $ 9,676 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 9,551 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 9,630 | ||||||||||||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.75% | [7],[11] | 5.75% | [7],[11] | 5.75% | [7],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.32% | [7],[10],[11] | 11.32% | [7],[10],[11] | 11.32% | [7],[10],[11] | 11.57% | [14],[15],[16] | 11.57% | [14],[15],[16] | 11.57% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 22,375 | [7],[11],[17] | $ 22,375 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 21,896 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 21,928 | ||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 6% | 6% | 6% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (133) | ||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[10],[11] | 11.36% | 11.36% | 11.36% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 52,639 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 51,618 | ||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 6% | 6% | 6% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (69) | ||||||||||||
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7] | 4,531,000 | 4,531,000 | 4,531,000 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7] | $ 4,444 | ||||||||||||
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment owned, balance, principal amount | [17] | $ 2,300 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 2,192 | |||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [14],[15] | 7.25% | [14],[15] | 7.25% | [14],[15] | ||
Investment, interest rate | 12.70% | [7],[10],[11] | 12.70% | [7],[10],[11] | 12.70% | [7],[10],[11] | 12.74% | [14],[15],[16] | 12.74% | [14],[15],[16] | 12.74% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 36,499 | [7],[11],[17] | $ 36,499 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 33,214 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 33,397 | ||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[8],[11] | 8% | [7],[8],[11] | 8% | [7],[8],[11] | 8% | [12],[14],[15] | 8% | [12],[14],[15] | 8% | [12],[14],[15] | ||
Investment, interest rate | 13.56% | [7],[8],[10],[11] | 13.56% | [7],[8],[10],[11] | 13.56% | [7],[8],[10],[11] | 13.45% | [12],[14],[15],[16] | 13.45% | [12],[14],[15],[16] | 13.45% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 3,722 | [7],[8],[11],[17] | $ 3,003 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 2,801 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 3,540 | ||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[11] | 8% | [7],[11] | 8% | [7],[11] | 8% | [14],[15] | 8% | [14],[15] | 8% | [14],[15] | ||
Investment, interest rate | 13.56% | [7],[10],[11] | 13.56% | [7],[10],[11] | 13.56% | [7],[10],[11] | 13.45% | [14],[15],[16] | 13.45% | [14],[15],[16] | 13.45% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 67,244 | [7],[11],[17] | $ 67,244 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 64,406 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 64,689 | ||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11],[19] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [7],[10],[11],[19] | 12.60% | 12.60% | 12.60% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17],[19] | $ 28,818 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | 28,530 | ||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.78% | 12.78% | 12.78% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 24,503 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 24,081 | ||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.78% | 12.78% | 12.78% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 2,819 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 2,771 | ||||||||||||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[11],[19] | 5.50% | [7],[11],[19] | 5.50% | [7],[11],[19] | 5.75% | [14],[15],[21] | 5.75% | [14],[15],[21] | 5.75% | [14],[15],[21] | ||
Investment, interest rate | 10.96% | [7],[10],[11],[19] | 10.96% | [7],[10],[11],[19] | 10.96% | [7],[10],[11],[19] | 11.21% | [14],[15],[16],[21] | 11.21% | [14],[15],[16],[21] | 11.21% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | £ | £ 6,136 | [7],[11],[17],[19] | £ 4,626 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 5,166 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 7,353 | ||||||||||||
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 64,887,669 | [7] | 64,887,669 | [7] | 64,887,669 | [7] | 64,887,669 | [15] | 64,887,669 | [15] | 64,887,669 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [7],[8],[11] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | 6.50% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (47) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (35) | ||||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [7],[11] | 6.50% | [14],[15] | 6.50% | [14],[15] | 6.50% | [14],[15] | ||
Investment, interest rate | 11.96% | [7],[10],[11] | 11.96% | [7],[10],[11] | 11.96% | [7],[10],[11] | 11.92% | [14],[15],[16] | 11.92% | [14],[15],[16] | 11.92% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 32,329 | [7],[11],[17] | $ 32,329 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 31,779 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 31,915 | ||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.25% | [14],[15],[21] | 8.25% | [14],[15],[21] | 8.25% | [14],[15],[21] | ||
Investment, interest rate | 13.86% | [7],[10],[11],[19] | 13.86% | [7],[10],[11],[19] | 13.86% | [7],[10],[11],[19] | 13.90% | [14],[15],[16],[21] | 13.90% | [14],[15],[16],[21] | 13.90% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 0.50% | [7],[11],[19] | 0.50% | [7],[11],[19] | 0.50% | [7],[11],[19] | 0.50% | [14],[15],[21] | 0.50% | [14],[15],[21] | 0.50% | [14],[15],[21] | ||
Investment owned, balance, principal amount | $ 9,697 | [7],[11],[17],[19] | $ 36,707 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 34,505 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 9,115 | ||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.25% | [14],[15],[21] | 8.25% | [14],[15],[21] | 8.25% | [14],[15],[21] | ||
Investment, interest rate | 13.86% | [7],[10],[11],[19] | 13.86% | [7],[10],[11],[19] | 13.86% | [7],[10],[11],[19] | 13.90% | [14],[15],[16],[21] | 13.90% | [14],[15],[16],[21] | 13.90% | [14],[15],[16],[21] | ||
Investment, interest rate, paid in kind | 0.50% | [7],[11],[19] | 0.50% | [7],[11],[19] | 0.50% | [7],[11],[19] | 0.50% | [14],[15],[21] | 0.50% | [14],[15],[21] | 0.50% | [14],[15],[21] | ||
Investment owned, balance, principal amount | $ 32,133 | [7],[11],[17],[19] | $ 13,504 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 12,694 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 30,205 | ||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 204,454 | [7],[19] | 204,454 | [7],[19] | 204,454 | [7],[19] | 204,454 | [15],[21] | 204,454 | [15],[21] | 204,454 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 756 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 1,073 | ||||||||||||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 4.88% | 4.88% | 4.88% | ||||||||||
Investment owned, balance, principal amount | [17] | $ 1,680 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 1,573 | |||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,037 | [7] | 1,037 | [7] | 1,037 | [7] | 1,037 | [15] | 1,037 | [15] | 1,037 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 951 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 1,024 | ||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[8],[11] | 8.75% | [7],[8],[11] | 8.75% | [7],[8],[11] | 8.75% | [14],[15] | 8.75% | [14],[15] | 8.75% | [14],[15] | ||
Investment, interest rate | 14.20% | [7],[8],[10],[11] | 14.20% | [7],[8],[10],[11] | 14.20% | [7],[8],[10],[11] | 14.18% | [14],[15],[16] | 14.18% | [14],[15],[16] | 14.18% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 990 | [7],[8],[11],[17] | $ 8,010 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 7,778 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 921 | ||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[11] | 8.75% | [7],[11] | 8.75% | [7],[11] | 8.75% | [12],[14],[15] | 8.75% | [12],[14],[15] | 8.75% | [12],[14],[15] | ||
Investment, interest rate | [7],[10],[11] | 14.21% | 14.21% | 14.21% | ||||||||||
Investment owned, balance, principal amount | $ 8,010 | [7],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (68) | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 7,778 | ||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,184,630 | [7] | 1,184,630 | [7] | 1,184,630 | [7] | 1,184,630 | [15] | 1,184,630 | [15] | 1,184,630 | [15] | ||
Net Realized Gain (Loss) | $ 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 36,226 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [7] | $ 36,226 | ||||||||||||
Investment owned, percent of net assets | 2.40% | 2.40% | 2.40% | |||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate, paid in kind | 12% | [7] | 12% | [7] | 12% | [7] | 12% | [15] | 12% | [15] | 12% | [15] | ||
Investment owned, balance, principal amount | $ 16,355 | [7],[17] | $ 15,874 | [15],[18] | ||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 540 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 15,874 | ||||||||||||
Gross Additions | 534 | |||||||||||||
Gross Reductions | (53) | |||||||||||||
Fair Value, Ending Balance | [7] | $ 16,355 | ||||||||||||
Investment owned, percent of net assets | 1.10% | 1.10% | 1.10% | |||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate, paid in kind | 12% | [7],[8] | 12% | [7],[8] | 12% | [7],[8] | 12% | [12],[15] | 12% | [12],[15] | 12% | [12],[15] | ||
Investment owned, balance, principal amount | $ 3,005 | [7],[8],[17] | $ 1,359 | [12],[15],[18] | ||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 69 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[15] | 1,359 | ||||||||||||
Gross Additions | 1,646 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [7],[8] | $ 3,005 | ||||||||||||
Investment owned, percent of net assets | 0.20% | 0.20% | 0.20% | |||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 66,686 | [7] | 66,686 | [7] | 66,686 | [7] | 66,686 | [15] | 66,686 | [15] | 66,686 | [15] | ||
Net Realized Gain (Loss) | $ 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 0 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.75% | [7],[11] | 4.75% | [7],[11] | 4.75% | [7],[11] | 4.75% | [14],[15] | 4.75% | [14],[15] | 4.75% | [14],[15] | ||
Investment, interest rate | 10.39% | [7],[10],[11] | 10.39% | [7],[10],[11] | 10.39% | [7],[10],[11] | 10.38% | [14],[15],[16] | 10.38% | [14],[15],[16] | 10.38% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 4,440 | [7],[11],[17] | $ 4,452 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 4,184 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 4,307 | ||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[11] | 8% | [7],[11] | 8% | [7],[11] | 8% | [14],[15] | 8% | [14],[15] | 8% | [14],[15] | ||
Investment, interest rate | 13.64% | [7],[10],[11] | 13.64% | [7],[10],[11] | 13.64% | [7],[10],[11] | 13.63% | [14],[15],[16] | 13.63% | [14],[15],[16] | 13.63% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 12,034 | [7],[11],[17] | $ 12,034 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 9,928 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 10,169 | ||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment owned, balance, principal amount | [17] | $ 1,590 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 1,592 | |||||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[11],[23] | 6.75% | [7],[11],[23] | 6.75% | [7],[11],[23] | 6.75% | [14],[15] | 6.75% | [14],[15] | 6.75% | [14],[15] | ||
Investment, interest rate | [14],[15],[16] | 12.40% | 12.40% | 12.40% | ||||||||||
Investment owned, balance, principal amount | $ 25,462 | [7],[11],[17],[23] | $ 25,527 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 19,954 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 14,131 | ||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[8],[11] | 10% | [7],[8],[11] | 10% | [7],[8],[11] | 10% | [12],[14],[15] | 10% | [12],[14],[15] | 10% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | (93) | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (85) | ||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[11] | 10% | [7],[11] | 10% | [7],[11] | 10% | [14],[15] | 10% | [14],[15] | 10% | [14],[15] | ||
Investment, interest rate | 15.36% | [7],[10],[11] | 15.36% | [7],[10],[11] | 15.36% | [7],[10],[11] | 15.24% | [14],[15],[16] | 15.24% | [14],[15],[16] | 15.24% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 25,418 | [7],[11],[17] | $ 25,558 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 24,791 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 24,719 | ||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 991,019 | [7] | 991,019 | [7] | 991,019 | [7] | 991,019 | [15] | 991,019 | [15] | 991,019 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 1,625 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 1,536 | ||||||||||||
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 9,307 | [19] | 9,307 | [19] | 9,307 | [19] | 9,307 | [21] | 9,307 | [21] | 9,307 | [21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | $ 13 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 19 | ||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, ownership percentage | 87.50% | [8],[19],[27],[28],[29] | 87.50% | [8],[19],[27],[28],[29] | 87.50% | [8],[19],[27],[28],[29] | 87.50% | [12],[21],[30],[31],[32] | 87.50% | [12],[21],[30],[31],[32] | 87.50% | [12],[21],[30],[31],[32] | ||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | $ 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 1,400 | 1,050 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 28,878 | [12],[21],[30],[31],[32] | 20,715 | |||||||||||
Gross Additions | 709 | 5,469 | ||||||||||||
Gross Reductions | 0 | (2,076) | ||||||||||||
Fair Value, Ending Balance | $ 29,587 | [8],[19],[27],[28],[29] | $ 24,108 | |||||||||||
Investment owned, percent of net assets | 2% | 2% | 2% | 2% | ||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[8],[11],[19],[28] | 7% | 7% | [7],[8],[11],[19],[28] | 7% | [7],[8],[11],[19],[28] | 7% | [12],[15],[21],[30] | 7% | [12],[15],[21],[30] | 7% | [12],[15],[21],[30] | |
Investment, interest rate | 12.44% | [7],[8],[10],[11],[19],[28] | 10.17% | 12.44% | [7],[8],[10],[11],[19],[28] | 12.44% | [7],[8],[10],[11],[19],[28] | 12.26% | [12],[14],[15],[16],[21],[30] | 12.26% | [12],[14],[15],[16],[21],[30] | 12.26% | [12],[14],[15],[16],[21],[30] | |
Investment owned, balance, principal amount | $ 112,656 | [7],[8],[11],[17],[19],[28] | $ 112,656 | $ 112,656 | [12],[15],[18],[21],[30] | |||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 3,581 | 2,611 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 112,656 | [12],[15],[21],[30] | 96,250 | |||||||||||
Gross Additions | 0 | 16,406 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 112,656 | [7],[8],[11],[19],[28] | $ 112,656 | |||||||||||
Investment owned, percent of net assets | 7.50% | 9.40% | 7.50% | 7.50% | ||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.88% | [7],[8],[11],[19] | 7.88% | [7],[8],[11],[19] | 7.88% | [7],[8],[11],[19] | 7.88% | [14],[15],[21] | 7.88% | [14],[15],[21] | 7.88% | [14],[15],[21] | ||
Investment, interest rate | [14],[15],[16],[21] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17],[19] | $ 7,191 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 6,937 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.88% | [7],[8],[11],[19] | 7.88% | [7],[8],[11],[19] | 7.88% | [7],[8],[11],[19] | 7.88% | [14],[15],[21] | 7.88% | [14],[15],[21] | 7.88% | [14],[15],[21] | ||
Investment, interest rate | [14],[15],[16],[21] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17],[19] | $ 2,697 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | 2,602 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.88% | [7],[11],[19] | 7.88% | [7],[11],[19] | 7.88% | [7],[11],[19] | 7.88% | [12],[14],[15],[21] | 7.88% | [12],[14],[15],[21] | 7.88% | [12],[14],[15],[21] | ||
Investment, interest rate | [7],[10],[11],[19] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment owned, balance, principal amount | $ 7,191 | [7],[11],[17],[19] | $ 0 | [12],[14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[21] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 6,880 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.88% | [7],[11],[19] | 7.88% | [7],[11],[19] | 7.88% | [7],[11],[19] | 7.88% | [12],[14],[15],[21] | 7.88% | [12],[14],[15],[21] | 7.88% | [12],[14],[15],[21] | ||
Investment, interest rate | [7],[10],[11],[19] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment owned, balance, principal amount | $ 2,697 | [7],[11],[17],[19] | $ 0 | [12],[14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[21] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 2,580 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 58,210 | [7],[19] | 58,210 | [7],[19] | 58,210 | [7],[19] | 58,210 | [15],[21] | 58,210 | [15],[21] | 58,210 | [15],[21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | $ 87 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 44 | ||||||||||||
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 345,452 | [7] | 345,452 | [7] | 345,452 | [7] | 345,452 | [15] | 345,452 | [15] | 345,452 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7] | 0 | ||||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [14],[15],[16] | 13.04% | 13.04% | 13.04% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 821 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 776 | ||||||||||||
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 66,000 | [19] | 66,000 | [19] | 66,000 | [19] | 66,000 | [21] | 66,000 | [21] | 66,000 | [21] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | $ 6 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 8 | ||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[8],[11] | 5% | [7],[8],[11] | 5% | [7],[8],[11] | 5% | [12],[14],[15] | 5% | [12],[14],[15] | 5% | [12],[14],[15] | ||
Investment, interest rate | [12],[14],[15],[16] | 10.42% | 10.42% | 10.42% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 618 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 577 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (19) | ||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.25% | [7],[11] | 5.25% | [7],[11] | 5.25% | [7],[11] | 5.25% | [14],[15] | 5.25% | [14],[15] | 5.25% | [14],[15] | ||
Investment, interest rate | 10.71% | [10],[11] | 10.71% | [10],[11] | 10.71% | [10],[11] | 10.67% | [14],[15],[16] | 10.67% | [14],[15],[16] | 10.67% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 4,477 | [7],[11],[17] | $ 4,488 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 4,425 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 4,438 | ||||||||||||
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment owned, balance, principal amount | [17] | $ 4,700 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 4,377 | |||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.25% | [7],[11],[19] | 8.50% | [14],[15],[21] | 8.50% | [14],[15],[21] | 8.50% | [14],[15],[21] | ||
Investment, interest rate | 12.21% | [7],[10],[11],[19] | 12.21% | [7],[10],[11],[19] | 12.21% | [7],[10],[11],[19] | 12.32% | [14],[15],[16],[21] | 12.32% | [14],[15],[16],[21] | 12.32% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | € | € 23,731 | [7],[11],[17],[19] | € 23,731 | [14],[15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 24,937 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[19] | $ 26,149 | ||||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[11] | 8% | [7],[11] | 8% | [7],[11] | 8% | [14],[15] | 8% | [14],[15] | 8% | [14],[15] | ||
Investment, interest rate | 13.36% | [7],[10],[11] | 13.36% | [7],[10],[11] | 13.36% | [7],[10],[11] | 13.32% | [14],[15],[16] | 13.32% | [14],[15],[16] | 13.32% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 49,395 | [7],[11],[17] | $ 49,520 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 49,148 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 48,901 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15],[33] | 7% | [14],[15],[33] | 7% | [14],[15],[33] | ||
Investment, interest rate | 12.66% | [7],[10],[11] | 12.66% | [7],[10],[11] | 12.66% | [7],[10],[11] | 12.44% | [14],[15],[16],[33] | 12.44% | [14],[15],[16],[33] | 12.44% | [14],[15],[16],[33] | ||
Investment owned, balance, principal amount | $ 1,552 | [7],[11],[17] | $ 1,552 | [14],[15],[18],[33] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[33] | 1,478 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | 1,476 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [12],[14],[15],[33] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [12],[14],[15],[16],[33] | 12.51% | 12.51% | 12.51% | ||||||||||
Investment owned, balance, principal amount | [12],[14],[15],[18],[33] | $ 1,099 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[33] | $ 943 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[11] | 7% | [7],[11] | 7% | [7],[11] | 7% | [14],[15],[33] | 7% | [14],[15],[33] | 7% | [14],[15],[33] | ||
Investment, interest rate | 12.66% | [7],[10],[11] | 12.66% | [7],[10],[11] | 12.66% | [7],[10],[11] | 12.51% | [14],[15],[16],[33] | 12.51% | [14],[15],[16],[33] | 12.51% | [14],[15],[16],[33] | ||
Investment owned, balance, principal amount | $ 2,742 | [7],[11],[17] | $ 32,104 | [14],[15],[18],[33] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[33] | 30,579 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 2,608 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 7% | [14],[15],[33] | 7% | [14],[15],[33] | 7% | [14],[15],[33] | ||
Investment, interest rate | 14.50% | [7],[10],[11] | 14.50% | [7],[10],[11] | 14.50% | [7],[10],[11] | 12.51% | [14],[15],[16],[33] | 12.51% | [14],[15],[16],[33] | 12.51% | [14],[15],[16],[33] | ||
Investment owned, balance, principal amount | $ 3,298 | [7],[11],[17] | $ 2,749 | [14],[15],[18],[33] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[33] | 2,618 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 3,137 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[10],[11] | 12.66% | 12.66% | 12.66% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 32,022 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | 30,456 | ||||||||||||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [13],[14],[15],[16],[21] | 11.50% | 11.50% | 11.50% | ||||||||||
Investment owned, balance, principal amount | [13],[15],[18],[21] | $ 4,984 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [13],[15],[21] | $ 4,785 | ||||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 13% | [7],[10],[11],[19] | 13% | [7],[10],[11],[19] | 13% | [7],[10],[11],[19] | 13% | [14],[15],[16],[21] | 13% | [14],[15],[16],[21] | 13% | [14],[15],[16],[21] | ||
Investment owned, balance, principal amount | $ 50,419 | [7],[17],[19] | $ 50,419 | [15],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[21] | 49,869 | ||||||||||||
Fair Value, Ending Balance | [7],[19] | $ 49,869 | ||||||||||||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[11] | 8% | [7],[11] | 8% | [7],[11] | 8% | [14] | 8% | [14] | 8% | [14] | ||
Investment, interest rate | 13.47% | [7],[10],[11] | 13.47% | [7],[10],[11] | 13.47% | [7],[10],[11] | 13.43% | [14],[16] | 13.43% | [14],[16] | 13.43% | [14],[16] | ||
Investment owned, balance, principal amount | $ 12,843 | [7],[11],[17] | $ 12,843 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 12,464 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | 12,847 | ||||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [12],[14],[15],[21] | 6% | 6% | 6% | ||||||||||
Investment owned, balance, principal amount | [12],[14],[15],[18],[21] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15],[21] | (22) | ||||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[21] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [14],[15],[16],[21] | 11.42% | 11.42% | 11.42% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[21] | $ 28,826 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 28,537 | ||||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.75% | [7],[8],[11] | 9.75% | [7],[8],[11] | 9.75% | [7],[8],[11] | 9.75% | [12],[14],[15] | 9.75% | [12],[14],[15] | 9.75% | [12],[14],[15] | ||
Investment, interest rate | 15.21% | [7],[8],[10],[11] | 15.21% | [7],[8],[10],[11] | 15.21% | [7],[8],[10],[11] | 15.17% | [12],[14],[15],[16] | 15.17% | [12],[14],[15],[16] | 15.17% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 2,119 | [7],[8],[11],[17] | $ 1,861 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 1,802 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 2,040 | ||||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.75% | [7],[11] | 9.75% | [7],[11] | 9.75% | [7],[11] | 9.75% | [14],[15] | 9.75% | [14],[15] | 9.75% | [14],[15] | ||
Investment, interest rate | 15.28% | [7],[10],[11] | 15.28% | [7],[10],[11] | 15.28% | [7],[10],[11] | 15.26% | [14],[15],[16] | 15.26% | [14],[15],[16] | 15.26% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 23,363 | [7],[11],[17] | $ 23,423 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 22,814 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 22,545 | ||||||||||||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.36% | [7],[10],[11] | 11.36% | [7],[10],[11] | 11.36% | [7],[10],[11] | 11.32% | [14],[15],[16] | 11.32% | [14],[15],[16] | 11.32% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 19,894 | [7],[11],[17] | $ 19,947 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 19,199 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | 19,211 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[24] | 7.30% | 7.30% | 7.30% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[24] | $ 19,163 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[24] | $ 18,340 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate, paid in kind | [7],[23] | 10% | 10% | 10% | ||||||||||
Investment owned, balance, principal amount | [7],[17],[23] | $ 5,065 | ||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 4,657 | |||||||||||||
Gross Reductions | (367) | |||||||||||||
Fair Value, Ending Balance | [7],[23] | $ 4,290 | ||||||||||||
Investment owned, percent of net assets | 0.30% | 0.30% | 0.30% | |||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate, paid in kind | [7],[23] | 10% | 10% | 10% | ||||||||||
Investment owned, balance, principal amount | [7],[17],[23] | $ 20,871 | ||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 19,217 | |||||||||||||
Gross Reductions | (494) | |||||||||||||
Fair Value, Ending Balance | [7],[23] | $ 18,723 | ||||||||||||
Investment owned, percent of net assets | 1.20% | 1.20% | 1.20% | |||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, ownership percentage | [7] | 6.40% | 6.40% | 6.40% | ||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[24] | 12.50% | 12.50% | 12.50% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[24] | $ 4,641 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[24] | $ 4,170 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9% | [7],[11],[23] | 9% | [7],[11],[23] | 9% | [7],[11],[23] | 7% | [14],[15] | 7% | [14],[15] | 7% | [14],[15] | ||
Investment, interest rate, paid in kind | [14],[15] | 12.65% | 12.65% | 12.65% | ||||||||||
Investment owned, balance, principal amount | $ 46,832 | [7],[11],[17],[23] | $ 46,832 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 37,231 | ||||||||||||
Fair Value, Ending Balance | [7],[11],[23] | $ 28,099 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 358,299 | [7] | 358,299 | [7] | 358,299 | [7] | 10,616 | [15] | 10,616 | [15] | 10,616 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 10,616 | [7] | 10,616 | [7] | 10,616 | [7] | 358,299 | [15] | 358,299 | [15] | 358,299 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 60,862 | [7] | 60,862 | [7] | 60,862 | [7] | 60,862 | [15] | 60,862 | [15] | 60,862 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 108 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 32,447 | [7] | 32,447 | [7] | 32,447 | [7] | 32,447 | [15] | 32,447 | [15] | 32,447 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 31,701 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 11,131 | ||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[11] | 6% | [7],[11] | 6% | [7],[11] | 6% | [14],[15] | 6% | [14],[15] | 6% | [14],[15] | ||
Investment, interest rate | 11.48% | [7],[10],[11] | 11.48% | [7],[10],[11] | 11.48% | [7],[10],[11] | 11.42% | [14],[15],[16] | 11.42% | [14],[15],[16] | 11.42% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 11,642 | [7],[11],[17] | $ 11,671 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 11,363 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 11,321 | ||||||||||||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.71% | [11],[19] | 7.71% | [11],[19] | 7.71% | [11],[19] | 7.71% | [14],[21] | 7.71% | [14],[21] | 7.71% | [14],[21] | ||
Investment, interest rate | 13.12% | [10],[11],[19] | 13.12% | [10],[11],[19] | 13.12% | [10],[11],[19] | 13.06% | [14],[16],[21] | 13.06% | [14],[16],[21] | 13.06% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 1,000 | [11],[17],[19] | $ 1,000 | [14],[18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[21] | 917 | ||||||||||||
Fair Value, Ending Balance | [11],[19] | $ 930 | ||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 4.75% | [10],[11],[19] | 4.75% | [10],[11],[19] | 4.75% | [10],[11],[19] | 6.50% | [14],[16],[21] | 6.50% | [14],[16],[21] | 6.50% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 300 | [17],[19] | $ 4,500 | [18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | 2,953 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 259 | ||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 6.50% | [10],[11],[19] | 6.50% | [10],[11],[19] | 6.50% | [10],[11],[19] | 4.75% | [14],[16],[21] | 4.75% | [14],[16],[21] | 4.75% | [14],[16],[21] | ||
Investment owned, balance, principal amount | $ 4,500 | [17],[19] | $ 300 | [18],[21] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [21] | 245 | ||||||||||||
Fair Value, Ending Balance | [19] | $ 3,252 | ||||||||||||
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 9.50% | 9.50% | 9.50% | ||||||||||
Investment owned, balance, principal amount | [11],[17] | $ 6,620 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [11] | 7,009 | ||||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.68% | 12.68% | 12.68% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 1,140 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 1,139 | ||||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 15% | 15% | 15% | ||||||||||
Investment, interest rate | [7],[10],[11] | 21.66% | 21.66% | 21.66% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 1,290 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 1,203 | ||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[8],[11] | 6.75% | 6.75% | 6.75% | ||||||||||
Investment owned, balance, principal amount | [7],[8],[11],[17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ (82) | ||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[11] | 6.75% | [7],[11] | 6.75% | [7],[11] | 3.75% | [14] | 3.75% | [14] | 3.75% | [14] | ||
Investment, interest rate | 12.06% | [7],[10],[11] | 12.06% | [7],[10],[11] | 12.06% | [7],[10],[11] | 9.27% | [14],[16] | 9.27% | [14],[16] | 9.27% | [14],[16] | ||
Investment owned, balance, principal amount | $ 29,838 | [7],[11],[17] | $ 11,792 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 11,127 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | 29,092 | ||||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16] | 12.65% | 12.65% | 12.65% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 5,000 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 4,263 | ||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[11] | 15% | 15% | 15% | ||||||||||
Investment, interest rate | [7],[10],[11] | 21.66% | 21.66% | 21.66% | ||||||||||
Investment owned, balance, principal amount | [7],[11],[17] | $ 1,543 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[11] | 1,439 | ||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 15% | 15% | 15% | ||||||||||
Investment, interest rate | [14],[15],[16] | 21.68% | 21.68% | 21.68% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 1,565 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 1,464 | ||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15] | 15% | 15% | 15% | ||||||||||
Investment, interest rate | [14],[15],[16] | 21.68% | 21.68% | 21.68% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 1,323 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 1,237 | ||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 4,871 | [7] | 4,871 | [7] | 4,871 | [7] | 4,871 | [15] | 4,871 | [15] | 4,871 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 107 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 42 | ||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 127,452 | [7] | 127,452 | [7] | 127,452 | [7] | 127,452 | [15] | 127,452 | [15] | 127,452 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 1,319 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 1,485 | ||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.25% | [11] | 6.25% | [11] | 6.25% | [11] | 6.25% | [14] | 6.25% | [14] | 6.25% | [14] | ||
Investment, interest rate | 11.71% | [10],[11] | 11.71% | [10],[11] | 11.71% | [10],[11] | 11.67% | [14],[16] | 11.67% | [14],[16] | 11.67% | [14],[16] | ||
Investment owned, balance, principal amount | $ 4,664 | [11],[17] | $ 8,983 | [14],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14] | 8,678 | ||||||||||||
Fair Value, Ending Balance | [11] | $ 4,425 | ||||||||||||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4% | [7],[11] | 4% | [7],[11] | 4% | [7],[11] | 4% | [14],[15] | 4% | [14],[15] | 4% | [14],[15] | ||
Investment, interest rate | 9.35% | [7],[10],[11] | 9.35% | [7],[10],[11] | 9.35% | [7],[10],[11] | 9.32% | [14],[15],[16] | 9.32% | [14],[15],[16] | 9.32% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 19,578 | [7],[11],[17] | $ 19,578 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 19,489 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | 19,577 | ||||||||||||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[21] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[21] | 12.72% | 12.72% | 12.72% | ||||||||||
Investment owned, balance, principal amount | £ | [14],[15],[18],[21] | £ 20,000 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[21] | $ 22,914 | ||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment owned, balance, principal amount | [17] | $ 4,960 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 4,506 | |||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 21,523 | [7] | 21,523 | [7] | 21,523 | [7] | 21,523 | [15] | 21,523 | [15] | 21,523 | [15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 20,074 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 20,542 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[8],[11] | 6.75% | [7],[8],[11] | 6.75% | [7],[8],[11] | 6.75% | [12],[14],[15] | 6.75% | [12],[14],[15] | 6.75% | [12],[14],[15] | ||
Investment, interest rate | 12.10% | [10],[11] | 12.10% | [10],[11] | 12.10% | [10],[11] | 12.14% | [12],[14],[15],[16] | 12.14% | [12],[14],[15],[16] | 12.14% | [12],[14],[15],[16] | ||
Investment owned, balance, principal amount | $ 377 | [7],[8],[11],[17] | $ 377 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 296 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 276 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [14],[15] | 7.25% | [14],[15] | 7.25% | [14],[15] | ||
Investment, interest rate | 12.62% | [7],[10],[11] | 12.62% | [7],[10],[11] | 12.62% | [7],[10],[11] | 12.63% | [14],[15],[16] | 12.63% | [14],[15],[16] | 12.63% | [14],[15],[16] | ||
Investment, interest rate, paid in kind | [14],[15] | |||||||||||||
Investment owned, balance, principal amount | $ 24,427 | [7],[11],[17] | $ 24,427 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 23,548 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 23,531 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [7],[11] | 7.25% | [14],[15] | 7.25% | [14],[15] | 7.25% | [14],[15] | ||
Investment, interest rate | 12.62% | [7],[10],[11] | 12.62% | [7],[10],[11] | 12.62% | [7],[10],[11] | 12.63% | [14],[15],[16] | 12.63% | [14],[15],[16] | 12.63% | [14],[15],[16] | ||
Investment owned, balance, principal amount | $ 3,636 | [7],[11],[17] | $ 3,636 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 3,574 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 3,537 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[8],[11] | 7.25% | [7],[8],[11] | 7.25% | [7],[8],[11] | 7.25% | [12],[14],[15] | 7.25% | [12],[14],[15] | 7.25% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[8],[11] | 8.75% | [7],[8],[11] | 8.75% | [7],[8],[11] | 8.75% | [14],[15] | 8.75% | [14],[15] | 8.75% | [14],[15] | ||
Investment, interest rate | [14],[15],[16] | 11.75% | 11.75% | 11.75% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 5,212 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 4,990 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[8],[11] | 8.75% | [7],[8],[11] | 8.75% | [7],[8],[11] | 8.75% | [12],[14],[15] | 8.75% | [12],[14],[15] | 8.75% | [12],[14],[15] | ||
Investment owned, balance, principal amount | $ 0 | [7],[8],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[8],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[11] | 8.75% | [7],[11] | 8.75% | [7],[11] | 8.75% | [12],[14],[15] | 8.75% | [12],[14],[15] | 8.75% | [12],[14],[15] | ||
Investment, interest rate | [7],[10],[11] | 11.75% | 11.75% | 11.75% | ||||||||||
Investment owned, balance, principal amount | $ 5,212 | [7],[11],[17] | $ 0 | [12],[14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [12],[14],[15] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[11] | $ 5,043 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 53,700 | [7] | 53,700 | [7] | 53,700 | [7] | 53,700 | [15] | 53,700 | [15] | 53,700 | [15] | ||
Investment owned, balance, principal amount | [17] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 258 | ||||||||||||
Fair Value, Ending Balance | [7] | $ 212 | ||||||||||||
[1] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. ten twenty ten twenty ten twenty ten twenty Income producing through payment of dividends or distributions. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. Income producing through payment of dividends or distributions. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC. |
Uncategorized Items - ocsl-2023
Label | Element | Value |
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | $ 145,539,000 |